OUTDOOR HOLDING CO, 10-K/A filed on 5/20/2025
Amended Annual Report
v3.25.1
Cover - USD ($)
12 Months Ended
Mar. 31, 2024
May 15, 2025
Sep. 30, 2023
Document Type 10-K/A    
Amendment Flag true    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Mar. 31, 2024    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2024    
Current Fiscal Year End Date --03-31    
Entity File Number 001-13101    
Entity Registrant Name Outdoor Holding Company    
Entity Central Index Key 0001015383    
Entity Tax Identification Number 83-1950534    
Entity Incorporation, State or Country Code DE    
Entity Address, Address Line One 7681 E Gray Road    
Entity Address, City or Town Scottsdale    
Entity Address, State or Province AZ    
Entity Address, Postal Zip Code 85260    
City Area Code (480)    
Local Phone Number 947-0001    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status No    
Entity Interactive Data Current No    
Entity Filer Category Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 179,118,089
Entity Common Stock, Shares Outstanding   118,744,062  
Documents Incorporated By Reference

DOCUMENTS INCORPORATED BY REFERENCE

None.

   
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction [Flag] true    
Document Financial Statement Restatement Recovery Analysis [Flag] true    
Amendment Description Outdoor Holding Company (formerly AMMO, Inc.) (“Ammo”, “we”, “us”, “our”, or the “Company”) is filing this Amendment No. 2 to Form 10-K (this “Amendment” or “Form 10-K/A”) to amend and restate certain items in its Annual Report on Form 10-K for the fiscal year ended March 31, 2024, originally filed with the Securities and Exchange Commission (the “SEC”) on June 13, 2024, as amended by Amendment No. 1 to Form 10-K filed with the SEC on July 29, 2024 (as amended, the “Original Filing”). In filing this Amendment, we are restating our previously issued (i) audited consolidated financial statements as of and for the fiscal years ended March 31, 2024, 2023 and 2022 and (ii) unaudited condensed consolidated interim financial information for each of the quarters within the fiscal year ended March 31, 2024 to account for the issues described in “Background of the Restatement” below. In addition, we intend to file an amendment to our Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2024 (such period, collectively with the fiscal years ended March 31, 2024, 2023 and 2022 and the quarters within the fiscal year ended March 31, 2024, the “Affected Periods”), originally filed with the SEC on August 8, 2024, which amendment will include restated unaudited condensed consolidated interim financial information as of and for the three months ended June 30, 2024 and 2023 (such report, together with this Amendment, the “Amended Reports”). The previously issued financial statements for the Affected Periods should no longer be relied upon. All material restatement information will be included in the Amended Reports, and we do not intend to separately amend other filings that we have previously filed with the SEC.Accordingly, investors and other readers should rely only on the financial information and other disclosures regarding the Affected Periods in the Amended Reports and in any other future filings with the SEC (as applicable) and should not rely on any previously issued or filed reports, press releases, corporate presentations or similar communications relating to the Affected Periods described above. Sale of Ammo Manufacturing Business and Name Change On April 18, 2025, the Company, together with its subsidiaries AMMO Technologies, Inc., an Arizona corporation (“AMMO Tech”), Enlight Group II, LLC d/b/a Jagemann Munition Components d/b/a Buythebullets, a Delaware limited liability company (“Enlight”), Firelight Group I, LLC, a Delaware limited liability company (“Firelight”, and together with AMMO Tech, and Enlight, collectively, the “Sellers”, and the Sellers together with the Company, the “Seller Group”) completed the previously announced (i) sale of all assets of the Sellers related to the Sellers’ business of designing, manufacturing, marketing, distributing and selling ammunition and ammunition components (collectively, the “Ammunition Manufacturing Business”) along with certain assets of the Company related to the Ammunition Manufacturing Business, and (ii) assumption of certain liabilities of the Seller Group related to the Ammunition Manufacturing Business, for a gross purchase price of $75,000,000, subject to certain adjustments, in accordance with the terms of that certain Asset Purchase Agreement, dated January 20, 2025, by and among the Seller Group and Olin Winchester, LLC, a Delaware limited liability company (the “Buyer”), as amended on April 18, 2025 by the First Amendment to the Asset Purchase Agreement (the “Purchase Agreement” and the transaction contemplated thereby, the “Transaction"). The assets acquired, and the liabilities assumed, by the Buyer were those primarily related to the Ammunition Manufacturing Business, including the Ammunition Manufacturing Business’ dedicated manufacturing facility located in Manitowoc, Wisconsin. The Company will continue to operate its online marketplace business associated with selling ammunition and firearms as a brokering agent or through direct sales through the Company’s subsidiary Speedlight Group I, LLC d/b/a GunBroker and its subsidiaries.In connection with the closing of the Transaction, effective April 21, 2025, the Company changed its name from “AMMO, Inc.” to “Outdoor Holding Company.” Except as otherwise provided in this Amendment, all references to the Company in this Amendment refer to the Company and its subsidiaries on a consolidated basis prior to the closing of the Transaction. Background of the Restatement In September 2024, a Special Committee (the "Special Committee") of the Board of Directors of the Company (the “Board of Directors”) initiated an independent investigation (the "Special Committee Investigation") through independent legal counsel and independent forensic accountants. During the course of the Special Committee Investigation, the Special Committee discovered accounting and financial reporting errors that required restatement resulting primarily from (i) inaccurate valuation of, and accounting for, share-based compensation awards to employees, non-employee directors, and other service providers, and shares issued in exchange for goods and services, (ii) inappropriate capitalization of certain share issuance costs, and (iii) inappropriate accounting for certain convertible notes and warrants issued by the Company. During the course of the Special Committee Investigation, the Special Committee also found that the Company had not properly disclosed certain executive officers, executive compensation and related party transactions. In conjunction with the restatement of the items above, we also made corresponding income tax adjustments to our consolidated financial statements, as these balances were impacted by the aforementioned adjustments.On September 27, 2024, the Company received a communication from its independent registered public accounting firm, Pannell Kerr Forster of Texas, P.C. (“PKF”), in which PKF requested that the Company take action to disclose that the historical financial statements and auditors’ reports previously reported by the Company relating to the financial statements as of and for the years ended March 31, 2024, 2023, 2022 and 2021 should no longer be relied upon. On October 3, 2024, the Company filed a Current Report on Form 8-K disclosing that the foregoing financial statements and auditors’ reports, as well as the financial statements for all interim periods within the fiscal years ended March 31, 2024, 2023, and 2022, should no longer be relied upon. The Company’s management concluded that in light of the Special Committee Investigation issues noted above, a material weakness existed in the Company’s internal control over financial reporting during such periods and that the Company’s disclosure controls and procedures were not effective.On February 4, 2025, the Audit Committee of the Board of Directors (the “Audit Committee”), in consultation with the Company’s management, determined that the Company’s financial statements for the Affected Periods would be restated. On February 24, 2025, the Audit Committee, after consultation with the Company’s management and its accounting advisors and consultants, concluded that the previously reported financial statements as of and for (i) the fiscal years ended March 31, 2020, 2019 and 2018 and December 31, 2017, (ii) all interim periods within such years and (iii) the transition period (the “Transition Period”) from January 1, 2018 to March 31, 2018 (collectively, the “Prior Periods”), including the auditors’ reports on the financial statements for all fiscal years within the Prior Periods and the Transition Period, should no longer be relied upon due to errors in such financial statements as addressed in FASB ASC Topic 250, Accounting Changes and Error Corrections. Furthermore, the Company’s management concluded that a material weakness existed in the Company’s internal control over financial reporting during the Prior Periods and that the Company’s disclosure controls and procedures were not effective.Effects of the RestatementAs discussed in Note 3 to the accompanying consolidated financial statements in this Amendment, we have restated our consolidated financial statements and the related disclosures for fiscal years ended March 31, 2024, 2023 and 2022. Specifically, we have restated our consolidated balance sheet as of March 31, 2024, 2023, and 2022 and the related consolidated statements of operations, stockholders’ equity and cash flows, including related disclosures, for the fiscal years ended March 31, 2024, 2023, and 2022. The accompanying Management’s Discussion and Analysis of Financial Condition and Results of Operations in Part II, Item 7, has been updated to reflect the effects of the restatement.In addition, this Amendment includes unaudited restated condensed consolidated financial information for the fiscal quarters ended June 30, 2023, September 30, 2023 and December 31, 2023.    
Auditor Firm ID 342    
Auditor Name Pannell Kerr Forster of Texas, P.C.    
Auditor Location Texas    
Auditor Opinion [Text Block]

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of Outdoor Holding Company and Subsidiaries (the “Company”) as of March 31, 2024, 2023 and 2022, the related consolidated statements of operations, stockholders’ equity and cash flows for each of the years in the three year period ended March 31, 2024, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of March 31, 2024, 2023 and 2022, and the results of its operations and its cash flows for each of the years in the three-year period ended March 31, 2024 in conformity with U. S. Generally Accepted Accounting Principles.

 

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of March 31, 2024 and 2023, based on criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), and our report dated May 20 ,2025, expressed an adverse opinion.

   
Common Stock 0.001 Par Value [Member]      
Title of 12(b) Security Common Stock, $0.001 par value    
Trading Symbol POWW    
Security Exchange Name NASDAQ    
8.75 Series A Cumulative Redeemable Perpetual Preferred Stock 0.001 Par Value [Member]      
Title of 12(b) Security 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.001 par value    
Trading Symbol POWWP    
Security Exchange Name NASDAQ    
v3.25.1
Consolidated Balance Sheets
Mar. 31, 2022
USD ($)
Current Assets:  
Cash and cash equivalents $ 23,281,475
Accounts receivable, net 43,955,084
Due from related parties 15,000
Inventories 59,016,152
Prepaid expenses 3,423,925
Current portion of restricted cash 0
Total Current Assets 129,691,636
Equipment, net 37,637,806
Other Assets:  
Deposits 11,360,322
Goodwill 90,870,094
Right of use assets - operating leases 2,791,850
Deferred income tax asset 1,350,868
TOTAL ASSETS 415,840,465
Current Liabilities:  
Accounts payable 26,817,083
Factoring liability 485,671
Accrued liabilities 6,213,592
Inventory credit facility 825,675
Current portion of operating lease liability 831,429
Note payable related party 684,639
Total Current Liabilities 35,858,089
Long-term Liabilities:  
Contingent consideration payable 204,142
Notes payable related party, net of current portion 181,132
Income tax payable 1,609,520
Construction note payable, net of unamortized issuance costs 38,330
Operating lease liability, net of current portion 2,091,351
Total Liabilities 39,982,564
Shareholders’ Equity:  
Series A cumulative perpetual preferred Stock 8.75%, ($25.00 per share, $0.001 par value) 1,400,000 shares issued and outstanding as of March 31, 2024 and March 31, 2023, respectively 1,400
Common stock, $0.001 par value, 200,000,000 shares authorized 120,531,507 and 118,562,806 shares issued and 119,181,067 and 118,294,478 outstanding at March 31, 2024 and March 31, 2023, respectively 116,487
Additional paid-in capital 414,084,541
Accumulated deficit (38,344,527)
Total Shareholders’ Equity 375,857,901
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY 415,840,465
Related Party  
Current Assets:  
Accounts receivable, net 139,164
Long-term Liabilities:  
Notes payable related party, net of current portion 181,132
Patents [Member]  
Other Assets:  
Intangible assets, net 5,837,502
Other Intangible Assets [Member]  
Other Assets:  
Intangible assets, net $ 136,300,387
v3.25.1
Consolidated Balance Sheets (Parenthetical) - $ / shares
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Statement of Financial Position [Abstract]      
Preferred stock, dividend rate percentage 8.75% 8.75% 8.75%
Preferred stock, stated value per share $ 25 $ 25 $ 25
Preferred stock, par value $ 0.001 $ 0.001 $ 0.001
Preferred stock, shares issued 1,400,000 1,400,000 1,400,000
Preferred stock, shares outstanding 1,400,000 1,400,000 1,400,000
Common stock, par value $ 0.001 $ 0.001 $ 0.001
Common stock, shares authorized 200,000,000 200,000,000 200,000,000
Common stock, shares issued 120,531,507 118,562,806 116,485,747
Common stock, shares outstanding 119,181,067 118,294,478 116,485,747
v3.25.1
Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Sep. 30, 2023
Dec. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Net Revenues                  
Total Revenues $ 40,421,147 $ 36,006,464 $ 34,372,386 $ 34,254,575 $ 68,626,961 $ 104,633,425 $ 145,054,572 $ 191,439,801 $ 240,269,166
Cost of Revenues 31,033,381 25,107,909 26,095,941 20,241,856 46,337,797 71,445,706 102,479,087 136,078,488 151,552,941
Gross Profit 9,387,766 10,898,555 8,276,445 14,012,719 22,289,164 33,187,719 42,575,485 55,361,313 88,716,225
Operating Expenses                  
Selling and marketing 547,981 236,565 289,952 295,581 585,533 822,098 1,370,079 4,729,540 7,310,216
Corporate general and administrative 7,976,832 5,803,255 7,855,624 7,947,563 15,803,187 21,606,442 29,583,274 24,980,079 24,120,483
Employee salaries and related expenses 3,470,974 4,034,076 5,771,020 4,423,932 10,194,952 14,229,028 17,700,002 19,820,498 15,034,408
Depreciation and amortization expense 3,425,790 3,401,156 3,371,802 3,344,043 6,715,845 10,117,001 13,542,791 13,278,762 13,725,065
Total operating expenses 15,421,577 13,475,052 17,288,398 16,011,119 33,299,517 46,774,569 62,196,146 62,808,879 60,190,172
Income/(Loss) from Operations (6,033,811) (2,576,497) (9,011,953) (1,998,400) (11,010,353) (13,586,850) (19,620,661) (7,447,566) 28,526,053
Other Expenses                  
Other (expense) income (708,779) 4,576 (321,341) 692,951 371,610 376,186 (332,593) 25,181 21,840
Interest expense 163,088 (193,046) (212,314) (204,201) (416,515) (609,561) (446,473) (632,062) (637,797)
Total other expense (545,691) (188,470) (533,655) 488,750 (44,905) (233,375) (779,066) (606,881) (615,957)
Income/(Loss) before Income Taxes (6,579,502) (2,764,967) (9,545,608) (1,509,650) (11,055,258) (13,820,225) (20,399,727) (8,054,447) 27,910,096
Provision for income taxes (1,361,700) (359,189) (1,879,641) (205,588) (2,085,229) (2,444,418) (3,806,118) 712,239 2,042,918
Net Income/(Loss) (5,217,802) (2,405,778) (7,665,967) (1,304,062) (8,970,029) (11,375,807) (16,593,609) (8,766,686) 25,867,178
Preferred Stock Dividend (782,639) (782,639) (782,639) (774,132) (1,556,771) (2,339,410) (3,122,049) (3,105,034) (2,668,649)
Net Income/(Loss) Attributable to Common Stock Shareholders $ (6,000,441) $ (3,188,417) $ (8,448,606) $ (2,078,194) $ (10,526,800) $ (13,715,217) $ (19,715,658) $ (11,871,720) $ 23,198,529
Net Income/(Loss) per share                  
Basic $ (0.05) $ (0.03) $ (0.07) $ (0.02) $ (0.09) $ (0.12) $ (0.17) $ (0.1) $ 0.21
Diluted $ (0.05) $ (0.03) $ (0.07) $ (0.02) $ (0.09) $ (0.12) $ (0.17) $ (0.1) $ 0.2
Weighted average number of shares outstanding                  
Basic             118,249,486 117,177,885 112,328,680
Diluted             118,249,486 117,177,885 114,825,835
Ammunition Sales [Member]                  
Net Revenues                  
Total Revenues $ 22,445,216 $ 17,322,967 $ 15,516,589 $ 14,106,029 $ 29,622,618 $ 46,945,585 $ 69,390,801 [1],[2] $ 114,116,044 [1],[2] $ 161,459,025 [1],[2]
Marketplace Fee Revenue [Member]                  
Net Revenues                  
Total Revenues 13,570,124 13,985,034 12,474,716 13,912,202 26,386,918 40,371,952 53,942,076 63,149,673 64,608,516
Ammunition Casings Sales [Member]                  
Net Revenues                  
Total Revenues $ 4,405,807 $ 4,698,463 $ 6,381,081 $ 6,236,344 $ 12,617,425 $ 17,315,888 $ 21,721,695 $ 14,174,084 $ 14,201,625
[1]
(1)
Included in revenue for the years ended March 31, 2024, 2023, and 2022 are excise taxes of $6,155,524, $9,789,897, and $14,646,983, respectively.
[2] Included in revenue for the years ended March 31, 2024, 2023, and 2022 are excises taxes of $6,155,524, $9,789,897, and $14,646,983, respectively.
v3.25.1
Consolidated Statements of Operations (Parenthetical) - USD ($)
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]      
Excises taxes $ 6,155,524 $ 9,789,897 $ 14,646,983
v3.25.1
Consolidated Statements of Shareholders' Equity - USD ($)
Total
Previously Reported [Member]
Series A Preferred Stock [Member]
Preferred Stock [Member]
Preferred Stock [Member]
Previously Reported [Member]
Preferred Stock [Member]
Series A Preferred Stock [Member]
Common Stock [Member]
Common Stock [Member]
Previously Reported [Member]
Common Stock [Member]
Series A Preferred Stock [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Previously Reported [Member]
Additional Paid-in Capital [Member]
Series A Preferred Stock [Member]
Retained Earnings [Member]
Retained Earnings [Member]
Previously Reported [Member]
Retained Earnings [Member]
Series A Preferred Stock [Member]
Treasury Stock, Common [Member]
Treasury Stock, Common [Member]
Previously Reported [Member]
Treasury Stock, Common [Member]
Series A Preferred Stock [Member]
Balance at Mar. 31, 2021 $ 160,729,013 $ 160,347,529       $ 93,100 $ 93,100   $ 222,178,969 $ 202,073,968   $ (61,543,056) $ (41,819,539)    
Balance, shares at Mar. 31, 2021           93,099,967 93,099,967                    
Prior period restatement 381,484                 20,105,001     (19,723,517)          
Acquisition stock issuances 143,377,654         $ 20,000     143,357,654 142,691,282          
Acquisition stock issuances, shares             20,000,000                      
Common stock issued for exercised warrants 943,907         $ 431     943,476            
Common stock issued for exercised warrants, shares             431,080                      
Common stock issued for cashless warrant exercise           $ 375     (375)            
Common stock issued for cashless warrant exercise, shares             374,584                      
Common stock issued for services and equipment (restated) 5,487,369         $ 773     5,486,596 1,631,701              
Common stock issued for services and equipment (restated), shares             772,450                      
Employee stock awards (restated) 7,430,458         $ 1,808     7,428,650                
Employee stock awards (restated), shares             1,807,666                      
Value of stock issued     $ 32,908,796     $ 1,400     32,907,396 31,008,796 $ 32,907,396        
Issuance of Series A Preferred Stock, net of issuance costs, shares           1,400,000                        
Warrants issued for services 1,782,175                 1,782,175 $ 1,090,076              
Preferred stock dividends declared (2,524,087)                 (2,524,087)        
Dividends accumulated on preferred stock (144,562)                 (144,562)        
Net Income (Loss) 25,867,178 33,247,436               25,867,178          
Balance at Mar. 31, 2022 375,857,901 374,303,566   $ 1,400     $ 116,487     414,084,541     (38,344,527)        
Balance, shares at Mar. 31, 2022       1,400,000     116,485,747                      
Common stock issued for exercised warrants 101,506           $ 200     101,306            
Common stock issued for exercised warrants, shares             200,003                      
Common stock issued for cashless warrant exercise           $ 99     (99)            
Common stock issued for cashless warrant exercise, shares             99,762                      
Employee stock awards (restated) 10,128,236           $ 1,776     10,126,460                
Employee stock awards (restated), shares             1,777,294                      
Warrants issued for services 427,639               427,639                
Preferred stock dividends declared (638,071)                   (638,071)        
Dividends accumulated on preferred stock (144,618)                   (144,618)        
Net Income (Loss) (8,766,686) (4,596,038)                 (8,766,686)        
Preferred stock dividend (2,322,346)                   (2,322,346)        
Treasury shares purchased (522,426)           $ (268)             (522,158)    
Treasury shares purchased, shares             (268,328)                      
Balance at Mar. 31, 2023 374,121,135 372,596,085   $ 1,400     $ 118,294     424,739,847     (50,216,248)     (522,158)    
Balance, shares at Mar. 31, 2023       1,400,000     118,294,478                      
Dividends accumulated on preferred stock (136,094)                       (136,094)          
Net Income (Loss) (1,304,062) (1,093,033)                     (1,304,062)          
Preferred stock dividend (638,038)                       (638,038)          
Treasury shares purchased             $ (739)                      
Balance at Jun. 30, 2023 371,767,397 370,145,723   $ 1,400     $ 117,946     425,920,655     (52,294,441)     (1,978,163)    
Balance, shares at Jun. 30, 2023       1,400,000     117,945,758                      
Balance at Mar. 31, 2023 374,121,135 372,596,085   $ 1,400     $ 118,294     424,739,847     (50,216,248)     (522,158)    
Balance, shares at Mar. 31, 2023       1,400,000     118,294,478                      
Net Income (Loss) (8,970,029) (8,588,330)                                
Balance at Sep. 30, 2023 364,619,650 362,987,661   $ 1,400     $ 118,461     427,619,626     (60,743,047)     (2,376,790)    
Balance, shares at Sep. 30, 2023       1,400,000     118,460,743                      
Balance at Mar. 31, 2023 374,121,135 372,596,085   $ 1,400     $ 118,294     424,739,847     (50,216,248)     (522,158)    
Balance, shares at Mar. 31, 2023       1,400,000     118,294,478                      
Net Income (Loss) (11,375,807) (10,232,319)                                
Balance at Dec. 31, 2023 362,896,539 361,382,416   $ 1,400     $ 118,644     429,381,115     (63,931,464)     (2,673,156)    
Balance, shares at Dec. 31, 2023       1,400,000     118,643,593                      
Balance at Mar. 31, 2023 374,121,135 372,596,085   $ 1,400     $ 118,294     424,739,847     (50,216,248)     (522,158)    
Balance, shares at Mar. 31, 2023       1,400,000     118,294,478                      
Common stock issued for exercised warrants 76,200           $ 32     76,168            
Common stock issued for exercised warrants, shares             31,750                      
Employee stock awards (restated) 5,281,288         $ 1,937     5,279,351                
Employee stock awards (restated), shares             1,936,951                      
Common stock purchase options 430,458               430,458                
Preferred stock dividends declared (638,071)                 (638,071)        
Dividends accumulated on preferred stock (144,618)                 (144,618)        
Net Income (Loss) (16,593,609) (15,565,200)               (16,593,609)          
Preferred stock dividend (2,330,852)                 (2,330,852)        
Treasury shares purchased (2,152,080)         $ (1,082)             (2,150,998)    
Treasury shares purchased, shares             (1,082,112)                      
Balance at Mar. 31, 2024 358,049,851 356,557,029   $ 1,400     $ 119,181     430,525,824     (69,923,398)     (2,673,156)    
Balance, shares at Mar. 31, 2024       1,400,000     119,181,067                      
Balance at Jun. 30, 2023 371,767,397 370,145,723   $ 1,400     $ 117,946     425,920,655     (52,294,441)     (1,978,163)    
Balance, shares at Jun. 30, 2023       1,400,000     117,945,758                      
Dividends accumulated on preferred stock (136,093)                       (136,093)          
Net Income (Loss) (7,665,967) (7,495,297)                     (7,665,967)          
Preferred stock dividend (646,545)                       (646,545)          
Treasury shares purchased             $ (198)                      
Balance at Sep. 30, 2023 364,619,650 362,987,661   $ 1,400     $ 118,461     427,619,626     (60,743,047)     (2,376,790)    
Balance, shares at Sep. 30, 2023       1,400,000     118,460,743                      
Common stock purchase options 380,045                 380,045                
Dividends accumulated on preferred stock (144,618)                       (144,618)          
Net Income (Loss) (2,405,778) (1,643,989)                     (2,405,778)          
Preferred stock dividend (638,021)                       (638,021)          
Treasury shares purchased             $ (145)                      
Balance at Dec. 31, 2023 362,896,539 361,382,416   $ 1,400     $ 118,644     429,381,115     (63,931,464)     (2,673,156)    
Balance, shares at Dec. 31, 2023       1,400,000     118,643,593                      
Net Income (Loss) (5,217,802) (5,332,881)                                
Balance at Mar. 31, 2024 $ 358,049,851 $ 356,557,029   $ 1,400     $ 119,181     $ 430,525,824     $ (69,923,398)     $ (2,673,156)    
Balance, shares at Mar. 31, 2024       1,400,000     119,181,067                      
v3.25.1
Consolidated Statements of Cash Flow - USD ($)
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:      
Net Income (Loss) $ (16,593,609) $ (8,766,686) $ 25,867,178
Adjustments to reconcile net loss to cash provided by operations:      
Depreciation and amortization 18,861,181 17,567,233 17,409,294
Debt discount amortization 83,253 83,253 38,330
Employee stock awards 5,281,288 10,128,236 7,430,457
Common stock purchase options 430,457
Stock for services     5,359,868
Contingent consideration payable fair value (80,540) (63,764) (385,750)
Allowance for doubtful accounts 419,527 191,299 2,748,250
(Gain)/loss on disposal of assets 259,540 (12,044)
Reduction in right of use asset 476,252 629,140 720,491
Warrants issued for services   213,819 1,410,144
Deferred income taxes (3,811,735) 712,239 293,430
Accounts receivable 705,532 14,417,405 (20,707,052)
Due to related parties 15,000 657
Inventories 8,781,485 4,671,333 (43,149,234)
Prepaid expenses 4,028,696 2,763,855 1,996,287
Deposits 6,679,669 4,306,375 (8,826,504)
Accounts payable 5,077,098 (8,694,813) 9,930,191
Accrued liabilities 2,532,695 (1,970,078) 2,374,686
Operating lease liability (499,448) (647,480) (732,468)
Net cash provided by operating activities 32,631,341 35,556,366 1,766,211
Cash flows from investing activities:      
Gemini acquisition (50,517,840)
Purchase of property, plant, and equipment (8,024,765) (12,541,325) (19,218,982)
Proceeds from disposal of assets 3,750   59,800
Net cash used in investing activities (8,021,015) (12,541,325) (69,677,022)
Cash flows from financing activities:      
Payments on inventory facility, net (825,675) (265,422)
Proceeds from factoring liability 37,252,869 71,348,761 121,488,045
Payments on factoring liability (37,252,869) (71,834,432) (122,844,562)
Payments on assumed debt from Gemini (50,000,000)
Payments on note payable - related party (180,850) (684,921) (625,147)
Payments on insurance premium note payment (3,174,834) (2,134,143) (2,208,369)
Proceeds from construction note payable 1,000,000
Payments on construction note payable (257,425) (150,743)
Payments on note payable (4,000,000)
Sale of preferred stock 35,000,000
Common stock issued for exercised warrants 76,200 101,506 943,907
Preferred stock issuance costs (2,113,550)
Preferred stock dividends paid (2,968,923) (2,960,416) (2,524,087)
Common stock repurchase plan (2,152,080) (522,426)
Net cash used in financing activities (8,657,912) (6,662,489) (27,149,185)
Net increase/(decrease) in cash 15,952,414 16,352,552 (95,059,996)
Cash, beginning of period 39,134,027 23,281,475 118,341,471
Restricted cash, beginning of period 500,000  
Cash and restricted cash, end of period 55,586,441 39,634,027 23,281,475
Restricted cash, end of period 0 500,000
Cash, end of period 55,586,441 39,134,027 23,281,475
Cash paid during the period for:      
Interest 667,063 665,043 626,571
Income taxes 0
Non-cash investing and financing activities:      
Operating lease liability 1,214,711 901,076 809,451
Note issued for insurance premium payment 1,056,199 4,252,778 2,166,852
Dividends accumulated on preferred stock 144,618 144,618 144,562
Construction note issued 0 387,968
Acquisition stock issuances 143,400,000
Warrant issued for services 801,176
Common stock issued for equipment $ 0 $ 0 $ 32,938
v3.25.1
Pay vs Performance Disclosure - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Sep. 30, 2023
Dec. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Pay vs Performance Disclosure                  
Net Income (Loss) $ (5,217,802) $ (2,405,778) $ (7,665,967) $ (1,304,062) $ (8,970,029) $ (11,375,807) $ (16,593,609) $ (8,766,686) $ 25,867,178
v3.25.1
Insider Trading Arrangements
12 Months Ended
Mar. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.25.1
Insider Trading Policies and Procedures
12 Months Ended
Mar. 31, 2024
Insider Trading Policies and Procedures [Line Items]  
Insider Trading Policies and Procedures Adopted true
v3.25.1
Cybersecurity Risk Management, Strategy, and Governance
12 Months Ended
Mar. 31, 2024
Cybersecurity Risk Management, Strategy, and Governance [Line Items]  
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]

Risk Management and Strategy

As a publicly traded ammo manufacturer and e-commerce outdoor company, we are acutely aware of the importance of robust cybersecurity measures in safeguarding our information assets, operational integrity, and reputation. Our approach to cybersecurity risk management is integrated into our broader risk management framework and overseen by our Board of Directors.

We have established comprehensive processes to assess, identify, and manage material risks from cybersecurity threats. These processes include continuous evaluation of potential threats, regular security assessments of third-party service providers, and stringent monitoring procedures to mitigate risks related to data breaches and other security incidents. We periodically engage third-party consultants, legal advisors, and audit firms to evaluate and assess our risk management systems and to assist in the remediation of potential cybersecurity incidents, as necessary.

Our Information Security Program (the “Program”) is designed to protect personal and proprietary information in compliance with federal and state requirements. The Program aims to:

ensure the security and confidentiality of employee and customer personal information, as well as Company proprietary information;
protect against anticipated threats or hazards to the security or integrity of such information; and
prevent unauthorized access to, use of, or transfer of such information, thereby protecting the Company, its employees, and customers from potential harm or inconvenience.

We use a variety of tools and services, including network monitoring, vulnerability assessments, and tabletop exercises, to enhance our cybersecurity posture. Our incident response plan is comprehensive, detailing procedures for preparing for, detecting, responding to, and recovering from cybersecurity incidents. This plan includes processes for triaging, assessing the severity of, escalating, containing, investigating, and remediating cybersecurity incidents, while ensuring compliance with relevant legal obligations.

In addition to internal measures, we manage cybersecurity risks associated with third-party suppliers, particularly those with access to our systems or confidential data. We perform due diligence on critical third-party suppliers and monitor identified cybersecurity threats. We require these suppliers to contractually agree to manage their cybersecurity risks according to our standards or to submit to cybersecurity audits conducted by our agents.

We regularly engage third-party experts to conduct information security testing, including penetration testing, on our systems and infrastructure. Our information security program undergoes periodic external assessments aligned with the National Institute of Standards and Technology Cybersecurity Framework and the Payment Card Industry Data Security Standard. This alignment helps us identify, assess, and manage cybersecurity risks relevant to our business.

Governance

Our Board of Directors oversees our cybersecurity risk management. Directors receive reports as requested from management, including senior information technology (“IT”) leadership and third parties, on cybersecurity matters. Additionally, the Board of Directors is kept informed about cybersecurity risks as part of our overall enterprise risk management program and through regular business updates.

Senior IT leaders and our compliance officer are responsible for developing and implementing appropriate cybersecurity programs and ensuring our compliance with applicable laws and regulations. These leaders, equipped with relevant degrees, certifications, and extensive work experience, are informed by their cybersecurity teams about ongoing efforts to prevent, detect, mitigate, and remediate cybersecurity incidents.

Information regarding cybersecurity risks is communicated through various channels, including direct discussions between key leaders and Company management, and reports to the Board of Directors and its committees. The Board of Directors regularly receives updates from our compliance officer and senior IT leadership on the status of our cybersecurity measures and any significant developments.

Our commitment to cybersecurity is a fundamental aspect of our operational strategy, ensuring the protection of our information assets, the continuity of our operations, and the trust of our stakeholders.

We have experienced cybersecurity incidents in the ordinary course of business and will continue to experience risks from cybersecurity threats that could have a material adverse effect on our business strategy, results of operations, or financial condition. Although prior cybersecurity incidents have not had a material adverse effect on our business strategy, results of operations, or financial condition to date, any actual or perceived breach of our security could damage our reputation, adversely affect our operations, or subject us to third-party lawsuits, regulatory investigations and fines or other actions or liabilities, any of which could materially adversely affect our business strategy, results of operations, or financial condition. For more information on our cybersecurity related risks, see “Breaches of our information systems could adversely affect our reputation, disrupt our operations, and result in increased costs and loss of sales.” and “A failure of our information technology systems, or an interruption in their operation due to internal or external factors including cyber-attacks, could have a material adverse effect on our business, financial condition or results of operations.” in Item 1A “Risk Factors” of this Amendment.

Cybersecurity Risk Management Processes Integrated [Flag] true
Cybersecurity Risk Management Processes Integrated [Text Block] Our approach to cybersecurity risk management is integrated into our broader risk management framework and overseen by our Board of Directors.
Cybersecurity Risk Management Third Party Engaged [Flag] true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block] We have experienced cybersecurity incidents in the ordinary course of business and will continue to experience risks from cybersecurity threats that could have a material adverse effect on our business strategy, results of operations, or financial condition.
Cybersecurity Risk Board of Directors Oversight [Text Block]

Our Board of Directors oversees our cybersecurity risk management. Directors receive reports as requested from management, including senior information technology (“IT”) leadership and third parties, on cybersecurity matters. Additionally, the Board of Directors is kept informed about cybersecurity risks as part of our overall enterprise risk management program and through regular business updates.

Senior IT leaders and our compliance officer are responsible for developing and implementing appropriate cybersecurity programs and ensuring our compliance with applicable laws and regulations. These leaders, equipped with relevant degrees, certifications, and extensive work experience, are informed by their cybersecurity teams about ongoing efforts to prevent, detect, mitigate, and remediate cybersecurity incidents.

Information regarding cybersecurity risks is communicated through various channels, including direct discussions between key leaders and Company management, and reports to the Board of Directors and its committees. The Board of Directors regularly receives updates from our compliance officer and senior IT leadership on the status of our cybersecurity measures and any significant developments.

Our commitment to cybersecurity is a fundamental aspect of our operational strategy, ensuring the protection of our information assets, the continuity of our operations, and the trust of our stakeholders.

Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] Directors receive reports as requested from management, including senior information technology (“IT”) leadership and third parties, on cybersecurity matters. Additionally, the Board of Directors is kept informed about cybersecurity risks as part of our overall enterprise risk management program and through regular business updates.
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]

Senior IT leaders and our compliance officer are responsible for developing and implementing appropriate cybersecurity programs and ensuring our compliance with applicable laws and regulations. These leaders, equipped with relevant degrees, certifications, and extensive work experience, are informed by their cybersecurity teams about ongoing efforts to prevent, detect, mitigate, and remediate cybersecurity incidents.

Cybersecurity Risk Management Expertise of Management Responsible [Text Block] These leaders, equipped with relevant degrees, certifications, and extensive work experience, are informed by their cybersecurity teams about ongoing efforts to prevent, detect, mitigate, and remediate cybersecurity incidents.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] Information regarding cybersecurity risks is communicated through various channels, including direct discussions between key leaders and Company management, and reports to the Board of Directors and its committees.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] true
v3.25.1
ORGANIZATION AND BUSINESS ACTIVITY
12 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
ORGANIZATION AND BUSINESS ACTIVITY

NOTE 1 – ORGANIZATION AND BUSINESS ACTIVITY

We were formed under the name Retrospettiva, Inc. in November 1990 to manufacture and import textile products, including both finished garments and fabrics. We were inactive until the following series of events in December 2016 and March 2017.

On December 15, 2016, the Company’s majority shareholders sold 475,681 (11,891,976 pre-split) of their outstanding shares to Mr. Fred W. Wagenhals (“Mr. Wagenhals”) resulting in a change in control of the Company. Mr. Wagenhals was appointed as sole officer and the sole member of the Company’s Board of Directors.

The Company also approved (i) doing business in the name AMMO, Inc., (ii) a change to the Company’s OTC trading symbol to POWW, (iii) an agreement and plan of merger to re-domicile and change the Company’s state of incorporation from California to Delaware, and (iv) a 1-for-25 reverse stock split of the issued and outstanding shares of the common stock of the Company ("Common Stock"). As a result of the reverse split, the previous issued and outstanding shares of Common Stock became 580,052 shares; no shareholder was reversed below 100 shares, and all fractional shares resulting from the reverse split were rounded up to the next whole share. All references to the outstanding stock have been retrospectively adjusted to reflect this split. These transactions were effective as of December 30, 2016.

On March 17, 2017, the Company entered into a definitive agreement with AMMO, Inc. a Delaware Corporation (PRIVCO) under which the Company acquired all of the outstanding shares of Common Stock of (PRIVCO). Under the terms of the Agreement, the Company issued 17,285,800 newly issued shares of Common Stock of the Company. In connection with this transaction the Company retired 475,681 shares of Common Stock and issued 500,000 shares of Common Stock to satisfy an issuance commitment. The acquisition was considered to be a capital transaction. The transaction was the equivalent to the issuance by PRIVCO of 604,371 shares to the Company’s shareholders accompanied by a recapitalization. The weighted average number of outstanding shares has been adjusted for this transaction. (PRIVCO) subsequently changes its name to AMMO Munitions, Inc.

The Company changed its name from AMMO, Inc. to Outdoor Holding Company on April 21, 2025.

v3.25.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
12 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidation

The consolidated financial statements include the accounts of AMMO, Inc. and its wholly owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires us to make estimates and assumptions that affect the amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates made in preparing the condensed consolidated financial statements include the valuation of allowances for credit losses, valuation of deferred tax assets, inventories, useful lives of assets, goodwill, intangible assets, stock-based compensation, and warrant-based compensation.

Goodwill

We evaluate goodwill for impairment annually or more frequently when an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. In testing for goodwill impairment, we may elect to utilize a qualitative assessment to evaluate whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If our qualitative assessment indicates that goodwill impairment is more likely than not, we perform a two-step impairment test. We test goodwill for impairment under the two-step impairment test by first comparing the book value of net assets to the fair value of the reporting unit. If the fair value is determined to be less than the book value or qualitative factors indicate that it is more likely than not that goodwill is impaired, a second step is performed to compute the amount of impairment as the difference between the estimated fair value of goodwill and the carrying value. We estimate the fair value of the reporting units using discounted cash flows. Forecasts of future cash flows are based on our best estimate of future net sales and operating expenses, based primarily on expected category expansion, pricing, market segment share, and general economic conditions. Due to the declines in the value of our stock price and market capitalization during the years ended March 31, 2024, 2023 and 2022, we assessed qualitative factors to determine if it is more likely than not that the fair value of the Marketplace segment is less than its carrying amount. Through our analysis we determined our stock price and market capitalization decline was not indicative of a decrease in the fair value of our Marketplace segment and a fair value calculation using the discounted cash flows was more appropriate due to the operational performance of the reporting segment. Accordingly, the impairment of Goodwill was not warranted for the year ended March 31, 2024. As of March 31, 2024, 2023 and 2022, the Company had a goodwill carrying value of $90,870,094, all of which was assigned to the Marketplace segment. However,

due to declines in the value of the Company’s Common Stock and market capitalization, it is possible that the book values of our Marketplace segment could exceed its fair value, which may result in the recognition of a material, noncash impairment of goodwill for the year ending March 31, 2025.

Accounts Receivable and Allowance for Credit Losses

Our accounts receivable represents amounts due from customers for products sold and include an allowance for estimated credit losses which is estimated based on the collectability and age of the accounts receivable balances and categorization of customers with similar financial condition. At March 31, 2024, March 31, 2023, and March 31, 2022 we reserved $3,666,078, $3,246,551, and $3,055,252 respectively, of allowance for credit losses.

Cash and Cash Equivalents

For purposes of the consolidated statements of cash flows, we consider highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents.

Restricted Cash

We consider cash to be restricted when withdrawal or general use is legally restricted. In the year ended March 31, 2023, our restricted cash balance was comprised of cash on deposit with banks to secure the Construction Loan Agreement as discussed in Note 13. During the year ended March 31, 2024, the remaining balance of our restricted cash was released. In the case that there is a balance, we report restricted cash in the consolidated balance sheets as current or non-current classification based on the expected duration of the restriction.

License Agreements

During the years ended March 31, 2024, 2023, and 2022 we were a party to a license agreement with Jesse James, a well-known motorcycle designer, and Jesse James Firearms, LLC, a Texas limited liability company. The license agreement grants us the exclusive worldwide rights through April 12, 2026 to Mr. James’ image rights and trademarks associated with him in connection with the marketing, promotion, advertising, sale, and commercial exploitation of Jesse James Branded Products. We agreed to pay Mr. James royalty fees on the sale of ammunition and non-ammunition Branded Products and to reimburse him for any out-of-pocket expenses and reasonable travel expenses.

We were a party to a license agreement with Jeff Rann, a well-known wild game hunter and spokesman for the firearm and ammunition industries. The license agreement, which expired February 2022, granted us the exclusive worldwide rights to Mr. Rann’s image rights and trademarks associated with him in connection with the marketing, promotion, advertising, sale, and commercial exploitation of all Jeff Rann Branded Products. We agreed to pay Mr. Rann royalty fees on the sale of ammunition and non-ammunition Branded Products and to reimburse him for any out-of-pocket expenses and reasonable travel expenses.

Patents

On September 28, 2017, AMMO Technologies Inc. (“ATI”), an Arizona corporation, which is 100% owned by us, merged with Hallam, Inc, a Texas corporation, with ATI being the survivor. The primary asset of Hallam, Inc. was an exclusive license to produce projectiles and ammunition using the Hybrid Luminescence Ammunition Technology under patent U.S. 8,402,896 B1 with a publication date of March 26, 2013 owned by University of Louisiana at Lafayette. The license was formally amended and assigned to ATI pursuant to an Assignment and First Amendment to Exclusive License Assumption Agreement dated to be effective as of August 22, 2017, the merger closing date. This asset will be amortized from September 2017, the first full month of the acquired rights, through October 29, 2028.

Under the terms of the Exclusive License Agreement, the Company is obligated to pay a royalty to the patent holder, based on a $0.01 per unit basis for each round of ammunition sold that incorporates this patented technology through October 29, 2028. For the years ended March 31, 2024, 2023, and 2022, the Company recognized royalty expenses of $22,754, $99,268, and $44,764 respectively under this agreement.

In August 2018, we applied for additional patent coverage for the manufacturing methods or application of the Hybrid Luminescence Ammunition Technology on a variety of projectile and ammunition types. The costs of filing this patent were expensed.

On October 5, 2018, we completed the acquisition of SW Kenetics, Inc. ATI succeeded all of the assets of SW Kenetics, Inc. and assumed all of the liabilities.

The primary asset of SW Kenetics, Inc. was a pending patent for modular projectiles. All rights to patent pending application were assigned and transferred to ATI pursuant to Intellectual Property Rights Agreement on September 27, 2018.

We intend to continue building our patent portfolio to protect our proprietary technologies and processes, and will file new applications where appropriate to preserve our rights to manufacture and sell our branded lines of ammunition.

Other Intangible Assets

On March 15, 2019, Enlight Group II, LLC d/b/a Jagemann Munition Components, a wholly owned subsidiary of AMMO, Inc., completed its acquisition of assets of Jagemann Stamping Company’s ammunition casing manufacturing and sales operations pursuant to the terms of the Amended and Restated Asset Purchase Agreement (See Note 20). The intangible assets acquired include a tradename, customer relationships, and intellectual property.

On April 30, 2021, we entered into an agreement and plan of merger (the “Merger Agreement”), by and among the Company, SpeedLight Group I, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company and Gemini Direct Investments, LLC, a Nevada limited liability company ("Gemini"), whereby SpeedLight Group I, LLC merged with and into Gemini, with SpeedLight Group I, LLC surviving the merger as a wholly owned subsidiary of the Company (the "Merger"). At the time of the Merger, Gemini had nine (9) subsidiaries, all of which are related to Gemini’s ownership of GunBroker, an online auction marketplace dedicated to firearms, hunting, shooting, and related products. The intangible assets acquired include a tradename, customer relationships, intellectual property, software, and domain names.

Impairment of Long-Lived Assets

We continually monitor events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable. When such events or changes in circumstances are present, we assess the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, we recognize an impairment loss based on the excess of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or the fair value less costs to sell. No impairment expense was recognized for the years ended March 31, 2024, 2023, and 2022.

Revenue Recognition

We generate revenue from the production and sale of ammunition, ammunition casings, and marketplace fee revenue, which includes auction revenue, payment processing revenue, and shipping income. We recognize revenue according to Accounting Standard Codification – Revenue from Contract with Customers (“ASC 606”). When the customer obtains control over the promised goods or services, we record revenue in the amount of consideration that we can expect to receive in exchange for those goods and services. We apply the following five-step model to determine revenue recognition:

Identification of a contract with a customer
Identification of the performance obligations in the contract
Determination of the transaction price
Allocation of the transaction price to the separate performance obligation
Recognition of revenue when performance obligations are satisfied

We only apply the five-step model when it is probable that we will collect the consideration we are entitled to in exchange for the goods or services we transfer to the customer. At contract inception and once the contract is determined to be within the scope of ASC 606, we assess the goods or services promised within each contract and determine those that are performance obligations, and assess whether each promised good or service is distinct.

For Ammunition Sales and Casing Sales, our contracts contain a single performance obligation and the entire transaction price is allocated to the single performance obligation. We recognize as revenues the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied. Accordingly, we recognize revenues (net) when the customer obtains control of our product, which typically occurs upon shipment of the product or the performance of the service. In the year ended March 31, 2021, we began accepting contract liabilities or deferred revenue. We included Deferred Revenue in our Accrued Liabilities. We will recognize revenue when the performance obligation is met.

For Marketplace revenue, the performance obligation is satisfied, and revenue is recognized, as follows:

Auction revenue consists of optional listing fees with variable pricing components based on customer options selected from the GunBroker website and final value fees based on a percentage of the final selling price of the listed item. The performance obligation is to process the transactions as initiated by the customer. Revenue is recognized at a point in time when the transaction is processed.

Compliance fee revenue consists of fees charged to customers based on a percentage of the final price of an item at the time of purchase. The performance obligation is to process the transactions as initiated by the customer. Revenue is recognized at a point in time when the transaction is processed.

Payment processing revenue consists of fees charged to customers on a transactional basis. The performance obligation is to process the transactions as initiated by the customer. The price is set by the GunBroker user agreement on the website based on stand-alone selling prices. Revenue is recognized at a point in time when the transaction is processed.

Shipping income consists of fees charged to customers for shipping of sold items listed on the GunBroker website. The performance obligation is to ship the item sold as initiated by the customer. The price is set based on the third-party service provider selected to be used by the customer as well as the speed and location of shipment. Revenue is recognized at a point in time when the shipping label is printed.

Banner Advertising Campaign Revenue consists of fees charged to customers for advertisement placement and impressions generated through the GunBroker website. The performance obligation is to generate the number of impressions specified by the customer on banner advertisements on the GunBroker website using the placement selected by the customer. The price is set by the GunBroker user agreement on the website based on standalone selling prices, or by advertising insertion order as negotiated by a media broker. If the number of impressions promised is not generated, the customer receives a refund and the refund is applied to the transaction price. Banner advertising campaigns generally run for one month, and revenue is recognized at a point in time at the end of the selected month.

Product Sales consists of fees charged for the liquidation of excess inventory for partner distributors. The performance obligation is to sell and ship the inventory item as initiated by the customer. The price depends on whether the inventory is a fixed price item or an auction item. For a fixed price item, the Company performs research to determine the current market rate for such an item, and the item is listed at that price. For an auction item, the price is set by what the buyer is willing to pay. The Company acts as a principal in these transactions due to the extent of control they have over the product prior to the sale. Due to the principal determination, gross revenue is recognized at a point in time when the item has been shipped.

Identity Verification consists of fees charged to customers for identity verification in order to gain access to the GunBroker website. The performance obligation is to process the identity verification as initiated by the customer. The price is set by the GunBroker user agreement on the website based on a stand-alone selling price. Revenue is recognized at a point in time when the identity verification is completed.

For the years ended March 31, 2024, 2023, and 2022, the Company’s customers that comprised more than ten percent (10%) of total revenues and accounts receivable were as follows:

 

For the Year Ended

 

 

For the Year Ended

 

 

For the Year Ended

 

 

 

March 31, 2024

 

 

March 31, 2023

 

 

March 31, 2022

 

PERCENTAGES

 

Revenues

 

 

Accounts
Receivable

 

 

Revenues

 

 

Accounts
Receivable

 

 

Revenues

 

 

Accounts
Receivable

 

Customers:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

A

 

 

-

 

 

 

11.8

%

 

 

12.2

%

 

 

-

 

 

 

-

 

 

 

-

 

B

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

11.8

%

 

 

-

 

 

 

11.8

%

 

 

12.2

%

 

 

-

 

 

 

-

 

 

 

11.8

%

 

Disaggregated Revenue Information

The following table presents a disaggregation of revenue from customers by category. We attribute net sales to categories by product or services types: ammunition, ammunition casings, and marketplace fees. The Company notes that revenue recognition processes are consistent between product and service type, however, the amount, timing and uncertainty of revenue and cash flows may vary by each product type due to the customers of each product and service type.

 

For the Year Ended

 

 

March 31,
2024

 

 

March 31,
2023

 

 

March 31,
2022

 

Ammunition Sales(1)

 

$

69,390,801

 

 

$

114,116,044

 

 

$

161,459,025

 

Marketplace Revenue

 

 

53,942,076

 

 

 

63,149,673

 

 

 

64,608,516

 

Casings Sales

 

 

21,721,695

 

 

 

14,174,084

 

 

 

14,201,625

 

Total Revenue

 

$

145,054,572

 

 

$

191,439,801

 

 

$

240,269,166

 

 

(1)
Included in revenue for the years ended March 31, 2024, 2023, and 2022 are excise taxes of $6,155,524, $9,789,897, and $14,646,983, respectively.

Ammunition products are sold through “Big Box” retailers, manufacturers, local ammunition stores, and shooting range operators. We also sell direct to customers online. In contrast, our ammunition casings products are sold to manufacturers. Marketplace fees are generated through our GunBroker online auction marketplace.

All ammunition product sales are recorded upon shipment and, depending on credit worthiness of customer, the payment terms will vary from thirty (30) to sixty (60) days. No refunds are allowed on any product shipped.

Each product manufactured by the Company has standard specifications and performance objectives. The Company has an extensive product testing program and, if the Company were given notice of a product defect by a customer, the Company would request the return of the product so that the manufacturing defect could be identified.

Contract Liabilities

Our contract liabilities consist of unearned revenue, which represents up front payments received from customers for product to be delivered at a future date. Contract liabilities are classified as current or long-term based on the timing of contract obligation. As of March 31, 2024, we had unearned revenue of $1.8 million, which is included in accrued liabilities on the consolidated balance sheet. Unearned revenue was $0.1 million and $0.2 million as of March 31, 2023 and 2022, respectively. Unearned revenue was $0.4 million as of April 1, 2021.

Advertising Costs

We expense advertising costs as they are incurred in selling and marketing expenses of operating expenses. Marketplace advertising costs are expensed as they are incurred and recorded in cost of revenues. For the years ended March 31, 2024, 2023, and 2022, we incurred advertising expenses of $1,149,596, $1,355,179, and $1,823,060, respectively, of which $384,002, $1,068,700, and $1,406,043 related to our ammunition segment. For the years ended March 31, 2024, 2023 and 2022 we incurred marketplace advertising expenses of $765,594, $286,479, and $417,017, respectively, in cost of revenues.

Fair Value of Financial Instruments

We measure options and warrants at fair value in accordance with Accounting Standards Codification 820 – Fair Value Measurement (“ASC 820”). The objective of ASC 820 is to increase consistency and comparability in fair value measurements and to expand disclosures about fair value measurements. ASC 820 defines fair value, establishes a framework for measuring fair value in accordance with GAAP, and expands disclosures about fair value measurements. ASC 820 specifies a valuation hierarchy based on whether the inputs to those valuation techniques are observable or unobservable.

Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s own assumptions. These two types of inputs have created the following fair value hierarchy:

Level 1 – Quoted prices for identical instruments in active markets;

Level 2 – Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and

Level 3 – Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

This hierarchy requires us to minimize the use of unobservable inputs and to use observable market data, if available, when estimating fair value.

The carrying values of cash and cash equivalents, accounts receivable and accounts payable approximated fair values due to the short-term maturities of these instruments.

In connection with our acquisition of Gemini, we used the Level 2 inputs in estimating the fair value of the transaction. Please refer to Note 16.

Inventories

We state inventories at the lower of cost or net realizable value. We determine cost using the average cost method. Our inventory consists of raw materials, work in progress, and finished goods. Cost of inventory includes cost of parts, labor, quality control, and all other costs incurred to bring our inventories to condition ready to be sold. We periodically evaluate and adjust inventories for obsolescence.

Property and Equipment

We state property and equipment at historical cost less accumulated depreciation. We compute depreciation using the straight-line method at rates intended to depreciate the cost of assets over their estimated useful lives, which are generally five to ten years. Upon retirement or sale of property and equipment, we remove the cost of the disposed assets and related accumulated depreciation from the accounts and any resulting gain or loss is credited or charged to other income or expenses. We charge expenditures for normal repairs and maintenance to expense as incurred.

We capitalize additions and expenditures for improving or rebuilding existing assets that extend the useful life. Leasehold improvements made either at the inception of the lease or during the lease term are amortized over the shorter of their economic lives or the lease term including any renewals that are reasonably assured.

Leases

We determine if an arrangement is a lease at inception of the contract. Operating lease assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease assets and liabilities are recognized at commencement date based on the present value of fixed lease payments over the lease term. Leases with an initial term of 12 months or less are not recorded on the balance sheet; instead, we recognize lease expense for these leases on a straight-line basis over the lease term. We do not account for lease components (e.g., fixed payments to use the underlying lease asset) separately from the non-lease components (e.g., fixed payments for common-area maintenance costs and other items that transfer a good or service). Some of our leases include variable lease payments, which primarily result from changes in consumer price and other market-based indices, which are generally updated annually, and maintenance and usage charges. These variable payments are excluded from the calculation of our lease assets and lease liabilities.

We utilize the interest rate implicit in the lease to determine the lease liability when the interest rate can be determined. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments.

Research and Development

To date, we have expensed all costs associated with developing our product specifications, manufacturing procedures, and products through our cost of revenues, as this work was done by the same employees who produced the finished product. We anticipate that it may become necessary to reclassify research and development costs into our operating expenses for reporting purposes as we begin to develop new technologies and lines of ammunition.

Excise Tax

As a result of regulations imposed by the Federal Government for sales of ammunition to non-government U.S. entities, we charge and collect an 11% excise tax for all products sold into these channels. During the years ended March 31, 2024, 2023, and 2022, we recognized approximately $6.2 million, $9.8 million, and $14.6 million respectively, in excise taxes. For ease in selling to commercial markets, excise tax is included in our unit price for the products sold. We record this through net sales and expense the offsetting tax expense to cost of revenues on our consolidated statement of operations.

Stock-Based Compensation

We account for stock-based compensation at fair value in accordance with Accounting Standards Codification 718 – Compensation – Stock Compensation (“ASC 718”), which requires the recognition of the cost of employee, director and non-employee services received in exchange for an award of equity over the period the employee, director or non-employee is required to perform the services in exchange for the award. Stock-based compensation is measured based on the grant-date fair value of the award. Stock-based compensation is recognized on a straight-line basis over the vesting periods and forfeitures are recognized in the periods they occur.

Concentrations of Credit Risk

Accounts at banks are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. As of March 31, 2024, 2023 and 2022, our bank account balances exceeded federally insured limits, however, we have not incurred losses related to these deposits.

Income Taxes

We file federal and state income tax returns in accordance with the applicable rules of each jurisdiction. We account for income taxes under the asset and liability method in accordance with Accounting Standards Codification 740 - Income Taxes (“ASC 740”). The provision for income taxes includes federal, state, and local income taxes currently payable, and deferred taxes. We recognize deferred tax assets and liabilities for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. We measure deferred tax assets and liabilities using enacted tax rates expected

to apply to taxable amounts in years in which those temporary differences are expected to be recovered or settled. If it is more likely than not that some portion or all of a deferred tax asset will not be realized, a valuation allowance is recognized. In accordance with ASC 740, we recognize the effect of income tax positions only if those positions are more likely than not of being sustained. We measure recognized income tax positions at the largest amount that is greater than 50% likely of being realized. We reflect changes in recognition or measurement in the period in which the change in judgment occurs.

Contingencies

Certain conditions may exist as of the date the consolidated financial statements are issued that may result in a loss to us but will only be resolved when one or more future events occur or fail to occur. We assess such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against us or unasserted claims that may result in such proceedings, we evaluate the perceived merits of any legal proceedings or unasserted claims and the perceived merits of the amount of relief sought or expected to be sought therein.

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability is reasonably estimated, the estimated liability would be accrued in our condensed consolidated financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of range of possible loss if determinable and material, would be disclosed.

On February 10, 2022, AMMO filed a Texas state court complaint against Expansion Industries pursing eight claims in pursuit of recovery of AMMO’s in primer acquisition deposit monies (i.e., Breach of Contract, Common Law Fraud, Violations of Texas Theft Liability Act, Conversion, Negligent Misrepresentation, Unjust Enrichment, Money Had and Received and Constructive Trust). AMMO moved aggressively to further the process, including successfully garnishing a portion of the deposit monies in Expansion bank accounts, filing a Motion for Summary Judgment, continuing to pursue written discovery, and amending the Complaint to add Expansion principal as an individual party. The putative primer manufacturer settled the two related lawsuits in September 2022 by repaying all deposit monies due AMMO, in addition to payment of principally all fees and costs incurred by us in pursuit of the resolution. The principal lawsuit and AMMO’s garnishment action against the defendant were dismissed with prejudice.

Along with countless other suppliers of Remington Outdoors, AMMO was served with an avoidance claim lawsuit by the bankruptcy trustee. AMMO presented substantial “ordinary course” defense evidence to the Trustee and the case was settled for a nominal sum in September 2022, with the lawsuit dismissed with prejudice.

AMMO was involved in three contract arbitration cases with adverse former employees. The first one involved an employee terminated for cause who was seeking contract wages and stock that was earned but clawed back upon his termination. In that case, the Company received a favorable ruling on a partial motion for summary judgment wherein the arbitrator ruled the employee had refused to return funds he received as reimbursement for invoices he never paid. The arbitrator granted the Company’s partially dispositive motion. The remaining claims went to an arbitration hearing in late September 2023. The arbitrator has entered an interim award as well as a supplemental briefing award fees. The parties have submitted their respective briefs on those issues. The arbitrator will enter the final award in June, 2024, which is not appealable.

 

The second case involved an employee who was terminated without cause wherein the former employee was seeking contract wages, commissions and allegedly earned common stock. The Company also received notice in October 2022 that an OSHA whistleblower complaint had been filed with the US Department of Labor by that same employee that had been terminated for cause. The regulatory filing was received after AMMO refused to capitulate to the former employee’s demands. AMMO has produced documents and submitted its position statement to OSHA and the matter is currently pending at the agency level. AMMO uncovered additional information through work with counsel and investigators and a supplemental response was provided to OHSA on or about July 10, 2023. The Company and the employee agreed to arbitrate the case. The parties reached a resolution of all outstanding claims in November 2023 and all claims have been dismissed.

The third case involved an employee who was terminated without cause wherein the former employee was seeking contract wages and commissions. The Company and the employee agreed to arbitrate the case in August 2023. The parties reached a resolution of all outstanding claims in January 2024 and all claims have been dismissed.

On April 30, 2023, director and stockholder Steve Urvan filed suit in the Delaware Court of Chancery (the"Delaware Court") against the Company, and certain AMMO directors, former directors, employees, former employees and consultants. Urvan’s claims include fraudulent inducement, unjust enrichment and violations of the Arizona Securities Act. The suit seeks a court order for partial rescission of the Merger and compensatory damages of not less than $140 million. The Company and named defendants are in alignment in all material respects and intend to vigorously defend Urvan’s claims. The Company has engaged Delaware Court litigation specialists to defend its interests in all respects in this case. The Company timely responded to the Urvan Complaint by filing a motion to dismiss.

On August 1, 2023, AMMO filed a separate lawsuit against Urvan in the Delaware Court alleging, among other things, that Urvan committed fraud in connection with the GunBroker.com sale, and that Urvan breached his indemnification obligations to AMMO after the sale. On September 11, 2023, the Delaware Court consolidated AMMO’s lawsuit against Urvan with Urvan’s lawsuit against AMMO and the individual defendants. On September 18, 2023, AMMO filed an amended complaint that added a claim against Urvan for breach of the Arizona Securities Act. Urvan moved to dismiss AMMO’s complaint in full. On December 18, 2023, the Delaware Court of heard argument on the parties’ motions to dismiss in the consolidated action. On February 27, 2024, the Delaware Court issued an opinion resolving all pending motions to dismiss. The Court dismissed Urvan’s aiding and abetting claims against the individual defendants, but it declined to dismiss Urvan’s other claims against the individuals and declined to dismiss Urvan’s claims against AMMO. The Delaware Court rejected Urvan’s motion to dismiss AMMO’s claims against him in its entirety. On May 8, 2024, the Delaware Court ordered a case schedule culminating in a five-day trial on July 28, 2025. For information about subsequent developments in this proceeding, see Note 23 "Subsequent Events."

On December 6, 2023, Steve Urvan initiated a separate action against the Company in his capacity as director under 8 Del. C. § 220(d) to inspect certain of the Company’s books and records (the “Books and Records Action”). In the Books and Records Action, Mr. Urvan alleges that the Company wrongfully refused to provide him with access to certain categories of documents following demands that he made on the Company on March 3, 2023 and November 9, 2023. The Company asserted as an affirmative defense that Mr. Urvan’s primary purpose for his demands is, among other things, to obtain documents to support his claims in the Delaware Plenary Litigation, in which discovery was then stayed. The court held a one-day trial on February 26, 2024 in Georgetown, Delaware. On February 27, 2024, the court in the Delaware Plenary Litigation issued an opinion that had the effect of lifting the discovery stay. On February 28, 2024, AMMO informed the judge presiding over the Books and Records Action that “[i]n AMMO’s view, the [Plenary Action] Opinion has effectively mooted this [Books and Records] action.” On April 9, 2024, AMMO began producing documents in response to Mr. Urvan’s demands pursuant to a Stipulation and Order Governing AMMO’s Document Productions. The court has not issued a post-trial ruling.

On January 18, 2024, Innovative Computer Professionals, Inc. d/b/a Digital Cash Processing (“DCP”) filed a civil action in Minnesota state court against Outdoors Online, LLC d/b/a GunBroker.com (“GunBroker.com”) for breach of contract (the “MN Action”). In the MN Action, DCP alleges that GunBroker.com breached a May 2021 contract, pursuant to which DCP was to provide specified digital payment processing services, and it alleges $100 million in damages. On February 7, 2024, GunBroker.com removed the MN Action to the United States District Court for the District of Minnesota. On February 14, 2024, GunBroker.com moved to dismiss the MN Action for lack of personal jurisdiction and for failure to adequately state a claim, or, in the alternative, to transfer the MN Action to the United States District Court for the District of Arizona (the “Motion”). As of March 31, 2024, the Motion had been fully briefed, argued, and submitted to the court. GunBroker.com denies the allegations , and it plans to vigorously defend the claims asserted against it and assert counterclaims against DCP if and when it is required to answer.

We have accrued for contingencies totaling approximately $1.4 million for the year ended March 31, 2024. There were no other known contingencies as of March 31, 2024, 2023 and 2022.

Recent Adopted Accounting Pronouncements

We adopted Accounting Standards Update (“ASU”) No. 2016-13, “Financial Instruments-Credit Losses (Topic 326) and ASU 2022-03, “Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions” in the current period. These policy changes did not result in a material effect on the Company’s financial statements.

Recent Accounting Pronouncements

In June 2022, the Financial Accounting Standards Board ("FASB") issued ASU 2022-03, “Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions” which clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance also clarifies that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction and requires specific disclosures for equity securities subject to contractual sale restrictions. For public business entities, the amendments in this ASU are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years.

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires that a public entity disclose, on an annual and interim basis, significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss. Additionally, it requires that a public entity (1) disclose an amount for “other segment items” by reportable segment, (2) provide all annual disclosures about a reportable segment’s profit or loss and assets currently required by Topic 280 in interim periods, and (3) requires that a public entity that has a single reportable segment provide all the disclosures required by the amendments in this proposed ASU and all existing segment disclosures in Topic 280. The new guidance is effective for annual periods beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. The amendments in this proposed ASU should be applied retrospectively to all prior periods presented in the financial statements. Early adoption is permitted. We are currently evaluating the potential impact of these changes.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which enhances the transparency and decision usefulness of income tax disclosures. The ASU requires that public business entities on an annual basis (1) disclose specific categories in the effective tax rate reconciliation and (2) provide additional information for reconciling items that meet or exceed a quantitative threshold. Additionally, it requires all entities disclose the following information about income taxes paid on an annual basis: (1) the year-to-date amounts of income taxes paid disaggregated by federal (national), state, and foreign taxes and (2) the amount of income taxes paid disaggregated by individual jurisdictions in which income taxes paid is equal to or greater than 5 percent of total income taxes paid. The amendments are effective for annual periods beginning after December 15, 2024. The amendments in this proposed ASU should be applied on a prospective basis, although retrospective application to all periods presented is permitted. Early adoption is permitted. We are currently evaluating the potential impact of these changes.

Management does not believe that any other recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

Reclassifications

Certain prior year amounts have been reclassified to conform to the current year's presentation. These reclassifications have no effect on the results of operations, stockholders' equity and cash flows as previously reported.

v3.25.1
RESTATEMENT OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS
12 Months Ended
Mar. 31, 2024
Prior Period Adjustment [Abstract]  
RESTATEMENT OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 3 – RESTATEMENT OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS

In September 2024, a Special Committee of the Board of Directors initiated the Special Committee Investigation through independent legal counsel and independent forensic accountants. During the course of the Special Committee Investigation, the Special Committee discovered accounting and financial reporting errors that required restatement resulting primarily from (i) inaccurate valuation of, and accounting for share-based compensation awards to employees, non-employee directors, and other service providers, and shares issued in exchange for goods and services, (ii) inappropriate capitalization of certain share issuance costs, and (iii) inappropriate accounting for certain convertible notes and warrants issued by the Company. During the course of the Special Committee Investigation, the Special Committee also found that the Company had not properly disclosed certain executive officers, executive compensation and related party transactions. In conjunction with the restatement of the items above, we also made corresponding income tax adjustments to our consolidated financial statements as these balances were impacted by the aforementioned adjustments.

The accounting and financial reporting errors identified as part of the Special Committee Investigation and subsequent restatement preparation are described and summarized as follows:

Stock-based payments

The valuation and amortization of expense related to stock-based payments to employees and non-employee directors and shares issued to service providers in exchange for goods and services were historically calculated incorrectly. The Company previously accounted for stock-based payments using a grant date fair value that was discounted from the fair value under the incorrect interpretation that the shares were restricted. In addition, the determination of the grant date was incorrectly determined with respect to historically issued stock-based payments. The Company re-evaluated the grant date fair value of stock-based payments under ASC 718. Under ASC 718, the grant date is the date at which the grantor and grantee have a mutual understanding of the key terms and conditions of the stock-based compensation agreement. The Company reviewed all stock-based payment awards to ensure the correct grant date was identified going back to the year ending December 31, 2017. The Company then evaluated the grant date fair value of all stock-based payment awards. The Company used the publicly available closing price of its stock on the date nearest the grant date as this is considered the best indicator of value. Additional expense of $2,422,490 for the years ended March 31, 2017 through 2021 has been recognized in opening retained earnings on the consolidated balance sheet as it occurred in a period prior to the restated period presented.

The following table summarizes the impact to the consolidated statement of operations of the change in stock-based compensation expense by fiscal year:

Year ended March 31, 2021 (unaudited)

 

$

 

4,192,414

 

 

Year ended March 31, 2022

 

 

 

1,422,138

 

 

Year ended March 31, 2023

 

 

 

4,141,364

 

 

Year Ended March 31, 2024

 

 

 

996,181

 

 

Equity issuance costs

In the fiscal years ending March 31, 2021 and 2022, the Company incorrectly capitalized costs associated with equity financings. The equity issuance costs did not meet the definition to be capitalized against proceeds. The Company determined that certain capitalized costs should have been expensed as incurred in general and administrative expenses in the consolidated statement of operations. After re-evaluation, the Company determined that the services provided by certain legal and investor relations service providers during financing events did not meet the definition of issuance costs as they were not specific incremental costs that were

directly attributable to the issuance of a debt or equity instrument. The Company recorded an adjustment to reclassify the issuance costs. The adjustment in the year ended March 31, 2021 has been recognized in opening retained earnings on the consolidated balance sheet as it occurred in a period prior to the restated period presented. The adjustment for the year ended March 31, 2022 is reflected as a reclassification from additional paid in capital on the consolidated balance sheet to corporate general and administrative expenses on the consolidated statement of operations.

The following table summarizes the impact to the consolidated statement of operations for the change in accounting for equity issuance costs:

Year ended March 31, 2021 (unaudited)

 

$

 

981,620

 

 

Year ended March 31, 2022

 

 

 

6,438,872

 

 

Warrants

In the year ended March 31, 2018, the Company issued warrants and the resulting value and recognition of expense for those warrants was accounted for incorrectly. The warrant values were recalculated using a Black-Scholes option pricing model using the relevant inputs based on the terms of the respective warrant. The resulting expense of $606,237 has been reflected in opening retained earnings on the consolidated balance sheet as it occurred in a period prior to the restated period presented.

With respect to warrants issued in December 2021, the Company recorded expense in the periods the warrant vested; however, upon further review, the total warrants were earned upon signing the services agreement. The full value of the warrants issued should have been recorded upon signing of the agreement in December 2021. In conjunction with the restatement, the warrant was re-valued based on the contract date fair value. The impact to the consolidated statement of operations for the year ended March 31, 2022 was $692,099.

Convertible Notes

Accounting for convertible notes was historically incorrect. Management reviewed all previously issued convertible notes and determined that, historically, conversion options within the convertible note agreements were not accounted for correctly.

As a result of analyzing the convertible notes issued in the year ended March 31, 2019, management determined that a beneficial conversion feature should have been recognized and amortized to interest expense over the term of the convertible notes. The expense would have been fully recognized in periods prior to the restatement and has been recognized in retained earnings on the consolidated balance sheet. In addition, an inducement offer was made to the note holders. After review of the accounting treatment initially recorded, management determined that the fair value of the inducement offer was not calculated correctly. The inducement offer was recalculated by determining the difference between the fair value of all securities and consideration transferred and the fair value of the consideration issuable under the original conversion terms. The resulting expense from the recalculation of the inducement offer has been recognized in retained earnings on the consolidated balance sheet as it occurred in a period prior to the restated periods presented.

Convertible notes and warrants issued in the year ended March 31, 2020 were also evaluated for proper accounting treatment. These convertible notes were not accounted for correctly as the Company did not account for the beneficial conversion feature within the convertible notes and did not allocate the consideration received upon issuance of the notes between the convertible notes and the stock purchase warrants. Under the terms on the convertible note, because the number of shares that would potentially be issued upon conversion were inversely indexed to the price of the Company's Common Stock, the conversion option should have been accounted for separately from the debt host agreement and recorded as a conversion option liability. In addition, the warrants should have been recorded as a liability until the exercise price was set due to the exercise price being indexed to a price upon a future event. In connection with the restatement, the warrants were calculated as a standard forward-start option with unit strike and initial price using a Black-Scholes model assuming constant volatility and rates. The proceeds from the issuance of the convertible notes was then allocated to the conversion option and the warrants at their fair values. The fair values exceeded the total proceeds, therefore no value would have been recorded for the notes and the Company would have recorded a loss on a derivative liability in the year ended March 31, 2020. In the year ended March 31, 2021, when the convertible note matured, the conversion price of the convertible notes as well as the exercise price of the warrants were set. The convertible notes and warrant fair values were calculated as of the date of conversion. The fair value resulted in an additional loss on a derivative liability then the liabilities were reclassified into equity upon conversion. The result of the transactions is accounted for as an adjustment to the opening retained earnings on the consolidated balance sheet.

During the year ended March 31, 2021, the Company entered into a promissory note that was subsequently partially paid by converting a portion of the principal balance into shares of the Company's Common Stock. The extinguishment of debt was recorded incorrectly. Under ASC 470, Debt, an early extinguishment of debt is accounted for by recognizing a gain or loss on the difference between the reacquisition price of the debt and the net carrying amount of the debt. The fair value of the Common Stock issued to extinguish the debt was greater than the principal balance being repaid resulting in a loss on extinguishment. This loss is reflected in the opening retained earnings on the consolidated balance sheet.

The total expense reflected in opening retained earnings on the consolidated balance sheet for all convertible note transactions is $6,024,240.

Related party transactions

Historically, the disclosure of related party transactions was omitted or not fully or accurately disclosed in the Company's financial statements. The Company performed an in-depth review and assessment of its related party transactions and the disclosure of such transactions in the affected periods. The Company determined that there were missing related party transaction disclosures which have been included in the related party footnotes (see Note 12, "Notes Payable - Related Party" and Note 18, "Related Party Transactions").

Summary of the Cumulative Effect of Restatement Adjustments to Previously Reported Beginning Retained Earnings

 

 

April 1,2021

 

Retained earnings, as previously reported

 

$

 

(41,819,539

)

Restatement adjustments:

 

 

 

 

Share-based compensation

 

 

 

(6,614,904

)

Warrants

 

 

 

(606,237

)

Convertible notes

 

 

 

(6,024,240

)

Other(1)

 

 

 

(6,478,136

)

Income taxes

 

 

 

 

Cumulative impact of restatement adjustments

 

 

 

(19,723,517

)

Retained earnings at March 31, 2021, as restated

 

$

 

(61,543,056

)

(1) Includes adjustments for licenses, patents, business acquisitions and equity issuance costs

 

Summary of the Effect of the Restatement of the Company’s Financial Statements

The following tables set forth the restatement of the Company’s consolidated balance sheets as of March 31, 2024, 2023, and 2022, and its consolidated statements of operations for the fiscal years ended March 31, 2024, 2023, and 2022:

Consolidated Balance Sheets

 

 

As of March 31, 2024

 

 

 

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

 

 

Stock Based
Payments

 

 

Equity Issuance
Costs

 

 

Convertible Notes

 

 

Warrants

 

 

Acquisition

 

 

Other

 

 

As Restated

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

 

55,586,441

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

 

55,586,441

 

 

Accounts receivable, net

 

 

 

28,221,321

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

28,221,321

 

 

Inventories

 

 

 

45,563,334

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

45,563,334

 

 

Prepaid expenses

 

 

 

2,154,170

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

2,154,170

 

 

Current portion of restricted cash

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

Total current assets

 

 

 

131,525,266

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

131,525,266

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equipment, net

 

 

 

58,082,040

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

58,082,040

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deposits

 

 

 

349,278

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

349,278

 

 

Patents, net

 

 

 

4,539,290

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

 

216,716

 

 

 

 

4,756,006

 

 

Other intangible assets, net

 

 

 

111,049,067

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

111,049,067

 

 

Goodwill

 

 

 

90,870,094

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

90,870,094

 

 

Right of use assets - operating leases

 

 

 

2,000,093

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

2,000,093

 

 

Deferred income tax asset

 

 

 

1,487,088

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

 

2,920,403

 

 

 

 

4,407,491

 

 

TOTAL ASSETS

 

$

 

399,902,216

 

 

$

0

 

 

$

0

 

 

$

0

 

 

$

0

 

 

$

0

 

 

$

3137119

 

 

$

 

403,039,335

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

$

 

23,156,495

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

 

23,156,495

 

 

Accrued liabilities

 

 

 

7,030,667

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

34,777

 

 

 

 

7,065,444

 

 

Current portion of operating lease liability

 

 

 

479,651

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

479,651

 

 

Note payable related party

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

Current portion of construction note payable

 

 

 

273,459

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

273,459

 

 

Insurance premium note payable

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

Total current liabilities

 

 

 

30,940,272

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

34,777.00

 

 

 

 

30,975,049

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long-term liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration payable

 

 

 

59,838

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

59,838

 

 

Income tax payable

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

1,609,520

 

 

 

 

1,609,520

 

 

Construction note payable, net of unamortized issuance costs

 

 

 

10,735,241

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

10,735,241

 

 

Operating lease liability, net of current portion

 

 

 

1,609,836

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

1,609,836

 

 

Deferred income tax liability

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

Total liabilities

 

 

 

43,345,187

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

1,644,297

 

 

 

 

44,989,484

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Series A cumulative perpetual preferred Stock

 

 

 

1,400

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

1,400

 

 

Common stock

 

 

 

119,181

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

119,181

 

 

Additional paid-in capital

 

 

 

396,730,170

 

 

 

 

13,174,586

 

 

 

 

7,420,492

 

 

 

 

6,024,240

 

 

 

 

1,298,336

 

 

 

 

5,225,000

 

 

 

 

653,000

 

 

 

 

430,525,824

 

 

Accumulated deficit

 

 

 

(37,620,566

)

 

 

 

(13,174,586

)

 

 

 

(7,420,492

)

 

 

 

(6,024,240

)

 

 

 

(1,298,336

)

 

 

 

(5,225,000

)

 

 

 

839,822

 

 

 

 

(69,923,398

)

 

Treasury stock

 

 

 

(2,673,156

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

(2,673,156

)

 

Total shareholders’ equity

 

 

 

356,557,029

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

1,492,822

 

 

 

 

358,049,851

 

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

 

$

 

399,902,216

 

 

$

 

-

 

 

$

 

-

 

 

$

 

-

 

 

$

 

-

 

 

$

 

-

 

 

$

 

3,137,119

 

 

$

 

403,039,335

 

 

 

 

 

 

As of March 31, 2023

 

 

 

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

 

 

Stock Based Payments

 

 

Equity
Issuance
Costs

 

 

Convertible Notes

 

 

Warrants

 

 

Acquisitions

 

 

Other

 

 

As Restated

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

 

39,134,027

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

 

39,134,027

 

 

Accounts receivable, net

 

 

 

29,346,380

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

29,346,380

 

 

Inventories

 

 

 

54,344,819

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

54,344,819

 

 

Prepaid expenses

 

 

 

5,126,667

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

5,126,667

 

 

Current portion of restricted cash

 

 

 

500,000

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

500,000

 

 

Total current assets

 

 

 

128,451,893

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

128,451,893

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equipment, net

 

 

 

55,963,255

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

55,963,255

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deposits

 

 

 

7,028,947

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

7,028,947

 

 

Patents, net

 

 

 

5,032,754

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

264,000

 

 

 

 

5,296,754

 

 

Other intangible assets, net

 

 

 

123,726,810

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

123,726,810

 

 

Goodwill

 

 

 

90,870,094

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

90,870,094

 

 

Right of use assets - operating leases

 

 

 

1,261,634

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

1,261,634

 

 

Deferred income tax asset

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

 

595,756

 

 

 

 

595,756

 

 

TOTAL ASSETS

 

$

 

412,335,387

 

 

$

 

-

 

 

$

 

-

 

 

$

 

-

 

 

$

 

-

 

 

$

 

-

 

 

$

 

859,756

 

 

$

 

413,195,143

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

$

 

18,079,397

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

 

18,079,397

 

 

Accrued liabilities

 

 

 

4,353,354

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

34,778

 

 

 

 

4,388,132

 

 

Current portion of operating lease liability

 

 

 

470,734

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

470,734

 

 

Note payable related party

 

 

 

180,850

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

180,850

 

 

Current portion of construction note payable

 

 

 

260,429

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

260,429

 

 

Insurance premium note payable

 

 

 

2,118,635

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

2,118,635

 

 

Total current liabilities

 

 

 

25,463,399

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

34,778

 

 

 

 

25,498,177

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long-term liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration payable

 

 

 

140,378

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

140,378

 

 

Income tax payable

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

1,609,520

 

 

 

 

1,609,520

 

 

Construction note payable, net of unamortized issuance costs

 

 

 

10,922,443

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

10,922,443

 

 

Operating lease liability, net of current portion

 

 

 

903,490

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

903,490

 

 

Deferred income tax liability

 

 

 

2,309,592

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

(2,309,592

)

 

 

 

-

 

 

Total liabilities

 

 

 

39,739,302

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

(665,294

)

 

 

 

39,074,008

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Series A cumulative perpetual preferred Stock

 

 

 

1,400

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

1,400

 

 

Common stock

 

 

 

118,294

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

118,294

 

 

Additional paid-in capital

 

 

 

391,940,374

 

 

 

 

12,178,405

 

 

 

 

7,420,492

 

 

 

 

6,024,240

 

 

 

 

1,298,336

 

 

 

 

5,225,000

 

 

 

 

653,000

 

 

 

 

424,739,847

 

 

Accumulated deficit

 

 

 

(18,941,825

)

 

 

 

(12,178,405

)

 

 

 

(7,420,492

)

 

 

 

(6,024,240

)

 

 

 

(1,298,336

)

 

 

 

(5,225,000

)

 

 

 

872,050

 

 

 

 

(50,216,248

)

 

Treasury stock

 

 

 

(522,158

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

(522,158

)

 

Total shareholders’ equity

 

 

 

372,596,085

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

1,525,050

 

 

 

 

374,121,135

 

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

 

$

 

412,335,387

 

 

$

 

-

 

 

$

 

-

 

 

$

 

-

 

 

$

 

-

 

 

$

 

-

 

 

$

 

859,756

 

 

$

 

413,195,143

 

 

 

 

 

 

As of March 31, 2022

 

 

 

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

 

 

Stock Based
Payments

 

 

Equity Issuance
Costs

 

 

Convertible Notes

 

 

Warrants

 

 

Acquisition

 

 

Other

 

 

As Restated

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

 

23,281,475

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

 

23,281,475

 

 

Accounts receivable, net

 

 

 

43,955,084

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

43,955,084

 

 

Due from related parties

 

 

 

15,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15,000

 

 

Inventories

 

 

 

59,016,152

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

59,016,152

 

 

Prepaid expenses

 

 

 

3,423,925

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

3,423,925

 

 

Current portion of restricted cash

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

Total current assets

 

 

 

129,691,636

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

129,691,636

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equipment, net

 

 

 

37,637,806

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

37,637,806

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

Other assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

Deposits

 

 

 

11,360,322

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

11,360,322

 

 

Patents, net

 

 

 

5,526,218

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

311,284

 

 

 

 

5,837,502

 

 

Other intangible assets, net

 

 

 

136,300,387

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

136,300,387

 

 

Goodwill

 

 

 

90,870,094

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

90,870,094

 

 

Right of use assets - operating leases

 

 

 

2,791,850

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

2,791,850

 

 

Deferred income tax asset

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

1,350,868

 

 

 

 

1,350,868

 

 

TOTAL ASSETS

 

$

 

414,178,313

 

 

$

 

-

 

 

$

 

-

 

 

$

 

-

 

 

$

 

-

 

 

$

 

-

 

 

$

 

1,662,152

 

 

$

 

415,840,465

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

$

 

26,817,083

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

 

26,817,083

 

 

Factoring liability

 

 

 

485,671

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

485,671

 

 

Accrued liabilities

 

 

 

6,178,814

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

34,778

 

 

 

 

6,213,592

 

 

Inventory credit facility

 

 

 

825,675

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

825,675

 

 

Current portion of operating lease liability

 

 

 

831,429

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

831,429

 

 

Current portion of note payable related party

 

 

 

684,639

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

684,639

 

 

Total current liabilities

 

 

 

35,823,311

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

34,778

 

 

 

 

35,858,089

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long-term liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration payable

 

 

 

204,142

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

204,142

 

 

Income tax payable

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

1,609,520

 

 

 

 

1,609,520

 

 

Notes payable related party, net of current portion

 

 

 

181,132

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

181,132

 

 

Construction note payable, net of unamortized issuance costs

 

 

 

38,330

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

38,330

 

 

Operating lease liability, net of current portion

 

 

 

2,091,351

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

2,091,351

 

 

Deferred income tax liability

 

 

 

1,536,481

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

(1,536,481

)

 

 

 

-

 

 

Total liabilities

 

 

 

39,874,747

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

107,817

 

 

 

 

39,982,564

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Series A cumulative perpetual preferred Stock

 

 

 

1,400

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

1,400

 

 

Common stock

 

 

 

116,487

 

 

 

0

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

116,487

 

 

Additional paid-in capital

 

 

 

385,426,431

 

 

 

 

8,037,042

 

 

 

 

7,420,492

 

 

 

 

6,024,240

 

 

 

 

1,298,336

 

 

 

 

5,225,000

 

 

 

 

653,000

 

 

 

 

414,084,541

 

 

Accumulated deficit

 

 

 

(11,240,752

)

 

 

 

(8,037,042

)

 

 

 

(7,420,492

)

 

 

 

(6,024,240

)

 

 

 

(1,298,336

)

 

 

 

(5,225,000

)

 

 

 

901,335

 

 

 

 

(38,344,527

)

 

Treasury stock

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

Total shareholders’ equity

 

 

 

374,303,566

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

1,554,335

 

 

 

 

375,857,901

 

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

 

$

 

414,178,313

 

 

$

 

-

 

 

 $

 

-

 

 

 $

 

-

 

 

 $

 

-

 

 

 $

 

-

 

 

$

 

1,662,152

 

 

$

 

415,840,465

 

 

 

Consolidated Statements of Operations

 

 

Fiscal Year Ended March 31, 2024

 

 

 

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

 

 

Stock Based
Payments

 

 

Other

 

 

As Restated

 

 

Net revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ammunition sales

 

$

 

69,390,801

 

 

 $

 

-

 

 

$

 

-

 

 

$

 

69,390,801

 

 

Marketplace revenue

 

 

 

53,942,076

 

 

 

 

-

 

 

 

 

-

 

 

 

 

53,942,076

 

 

Casing sales

 

 

 

21,721,695

 

 

 

 

-

 

 

 

 

-

 

 

 

 

21,721,695

 

 

Total revenues

 

 

 

145,054,572

 

 

 

 

-

 

 

 

 

-

 

 

 

 

145,054,572

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues

 

 

 

102,431,803

 

 

 

 

-

 

 

 

 

47,284

 

 

 

 

102,479,087

 

 

Gross profit

 

 

 

42,622,769

 

 

 

 

-

 

 

 

 

(47,284

)

 

 

 

42,575,485

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling and marketing

 

 

 

1,370,079

 

 

 

 

-

 

 

 

 

-

 

 

 

 

1,370,079

 

 

Corporate general and administrative

 

 

 

29,583,274

 

 

 

 

-

 

 

 

 

-

 

 

 

 

29,583,274

 

 

Employee salaries and related expenses

 

 

 

16,703,822

 

 

 

 

996,180

 

 

 

 

-

 

 

 

 

17,700,002

 

 

Depreciation and amortization expense

 

 

 

13,542,791

 

 

 

 

-

 

 

 

 

-

 

 

 

 

13,542,791

 

 

Total operating expenses

 

 

 

61,199,966

 

 

 

 

996,180

 

 

 

 

-

 

 

 

 

62,196,146

 

 

Loss from operations

 

 

 

(18,577,197

)

 

 

 

(996,180

)

 

 

 

(47,284

)

 

 

 

(19,620,661

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income

 

 

 

(332,593

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(332,593

)

 

Interest expense

 

 

 

(446,473

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(446,473

)

 

Total other expense

 

 

 

(779,066

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(779,066

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss before income taxes

 

 

 

(19,356,263

)

 

 

 

(996,180

)

 

 

 

(47,284

)

 

 

 

(20,399,727

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

 

(3,791,063

)

 

 

 

-

 

 

 

 

(15,055

)

 

 

 

(3,806,118

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

 

(15,565,200

)

 

 

 

(996,180

)

 

 

 

(32,229

)

 

 

 

(16,593,609

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock dividend

 

 

 

(3,122,049

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(3,122,049

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to common stock shareholders

 

$

 

(18,687,249

)

 

$

 

(996,180

)

 

$

 

(32,229

)

 

$

 

(19,715,658

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

 

(0.16

)

 

 

 

 

 

 

 

 

 

 $

 

(0.17

)

 

Diluted

 

$

 

(0.16

)

 

 

 

 

 

 

 

 

 

 $

 

(0.17

)

 

 

 

 

 

Fiscal Year Ended March 31, 2023

 

 

 

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

 

 

Stock Based
Payments

 

 

Other

 

 

As Restated

 

 

Net revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ammunition sales

 

$

 

114,116,044

 

 

$

 

-

 

 

$

 

-

 

 

$

 

114,116,044

 

 

Marketplace revenue

 

 

 

63,149,673

 

 

 

 

-

 

 

 

 

-

 

 

 

 

63,149,673

 

 

Casing sales

 

 

 

14,174,084

 

 

 

 

-

 

 

 

 

-

 

 

 

 

14,174,084

 

 

Total revenues

 

 

 

191,439,801

 

 

 

 

-

 

 

 

 

-

 

 

 

 

191,439,801

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues

 

 

 

136,031,204

 

 

 

 

-

 

 

 

 

47,284

 

 

 

 

136,078,488

 

 

Gross profit

 

 

 

55,408,597

 

 

 

 

-

 

 

 

 

(47,284

)

 

 

 

55,361,313

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling and marketing

 

 

 

4,729,540

 

 

 

 

-

 

 

 

 

-

 

 

 

 

4,729,540

 

 

Corporate general and administrative

 

 

 

24,980,079

 

 

 

 

-

 

 

 

 

-

 

 

 

 

24,980,079

 

 

Employee salaries and related expenses

 

 

 

15,679,135

 

 

 

 

4,141,363

 

 

 

 

-

 

 

 

 

19,820,498

 

 

Depreciation and amortization expense

 

 

 

13,278,762

 

 

 

 

-

 

 

 

 

-

 

 

 

 

13,278,762

 

 

Total operating expenses

 

 

 

58,667,516

 

 

 

 

4,141,363

 

 

 

 

-

 

 

 

 

62,808,879

 

 

Loss from operations

 

 

 

(3,258,919

)

 

 

 

(4,141,363

)

 

 

 

(47,284

)

 

 

 

(7,447,566

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income

 

 

 

25,181

 

 

 

 

-

 

 

 

 

-

 

 

 

 

25,181

 

 

Interest expense

 

 

 

(632,062

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(632,062

)

 

Total other expense

 

 

 

(606,881

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(606,881

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss before income taxes

 

 

 

(3,865,800

)

 

 

 

(4,141,363

)

 

 

 

(47,284

)

 

 

 

(8,054,447

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

 

730,238

 

 

 

 

-

 

 

 

 

(17,999

)

 

 

 

712,239

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

 

(4,596,038

)

 

 

 

(4,141,363

)

 

 

 

(29,285

)

 

 

 

(8,766,686

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock dividend

 

 

 

(3,105,034

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(3,105,034

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to common stock shareholders

 

$

 

(7,701,072

)

 

$

 

(4,141,363

)

 

$

 

(29,285

)

 

$

 

(11,871,720

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

 

(0.07

)

 

 

 

 

 

 

 

 

 

$

 

(0.10

)

 

Diluted

 

$

 

(0.07

)

 

 

 

 

 

 

 

 

 

$

 

(0.10

)

 

 

 

 

Fiscal Year Ended March 31, 2022

 

 

 

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

 

 

Stock Based
Payments

 

 

Equity Issuance
Costs

 

 

Warrants

 

 

Other

 

 

As Restated

 

 

Net revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ammunition sales

 

$

 

161,459,025

 

 

 $

 

-

 

 

$

 

-

 

 

$

 

-

 

 

$

 

-

 

 

$

 

161,459,025

 

 

Marketplace revenue

 

 

 

64,608,516

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

64,608,516

 

 

Casing sales

 

 

 

14,201,625

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

14,201,625

 

 

Total revenues

 

 

 

240,269,166

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

240,269,166

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues

 

 

 

151,505,657

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

47,284

 

 

 

 

151,552,941

 

 

Gross profit

 

 

 

88,763,509

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

(47,284

)

 

 

 

88,716,225

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling and marketing

 

 

 

7,310,216

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

7,310,216

 

 

Corporate general and administrative

 

 

 

16,986,344

 

 

 

 

3,168

 

 

 

 

6,438,872

 

 

 

 

692,099

 

 

 

 

-

 

 

 

 

24,120,483

 

 

Employee salaries and related expenses

 

 

 

13,615,439

 

 

 

 

1,418,969

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

15,034,408

 

 

Depreciation and amortization expense

 

 

 

13,702,148

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

22,917

 

 

 

 

13,725,065

 

 

Total operating expenses

 

 

 

51,614,147

 

 

 

 

1,422,137

 

 

 

 

6,438,872

 

 

 

 

692,099

 

 

 

 

22,917

 

 

 

 

60,190,172

 

 

Income/(loss) from operations

 

 

 

37,149,362

 

 

 

 

(1,422,137

)

 

 

 

(6,438,872

)

 

 

 

(692,099

)

 

 

 

(70,201

)

 

 

 

28,526,053

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income

 

 

 

21,840

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

21,840

 

 

Interest expense

 

 

 

(637,797

)

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

(637,797

)

 

Total other expense

 

 

 

(615,957

)

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

(615,957

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income/(loss) before income taxes

 

 

 

36,533,405

 

 

 

 

(1,422,137

)

 

 

 

(6,438,872

)

 

 

 

(692,099

)

 

 

 

(70,201

)

 

 

 

27,910,096

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

 

3,285,969

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

(1,243,051

)

 

 

 

2,042,918

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

 

 

33,247,436

 

 

 

 

(1,422,137

)

 

 

 

(6,438,872

)

 

 

 

(692,099

)

 

 

 

1,172,850

 

 

 

 

25,867,178

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock dividend

 

 

 

(2,668,649

)

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

(2,668,649

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) attributable to common stock shareholders

 

$

 

30,578,787

 

 

$

 

(1,422,137

)

 

$

 

(6,438,872

)

 

$

 

(692,099

)

 

$

 

1,172,850

 

 

$

 

23,198,529

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 $

 

0.27

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 $

 

0.21

 

 

Diluted

 

 $

 

0.27

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 $

 

0.20

 

 

 

Consolidated Statements of Stockholders' Equity

The following tables present the Additional Paid-In Capital ("APIC") as previously reported, restatement adjustments and the APIC as restated for the years ended March 31, 2024, 2023 and 2022.

 

 

 

 

 

 

As Previously
Reported

 

 

Reclassification

 

 

Current Period Adjustment

 

 

As Restated

 

 

 

 

 

 

 

 

 

 

 

 

 

Employee stock awards

 

$

4,080,170

 

 

$

203,000

 

 

$

996,181

 

 

$

5,279,351

 

Stock grants

 

 

203,000

 

 

 

(203,000

)

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

As Previously
Reported

 

 

Reclassification

 

 

Current Period Adjustment

 

 

As Restated

 

 

 

 

 

 

 

 

 

 

 

 

 

Employee stock awards

 

$

5,806,003

 

 

$

179,094

 

 

$

4,141,363

 

 

$

10,126,460

 

Stock grants

 

 

179,094

 

 

 

(179,094

)

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

As Previously
Reported

 

 

Reclassification

 

 

Current Period Adjustment

 

 

As Restated

 

 

 

 

 

 

 

 

 

 

 

 

 

Acquisition stock issuances

 

$

142,691,282

 

 

$

-

 

 

$

666,372

 

 

$

143,357,654

 

Common stock issued for services and equipment

 

 

1,631,701

 

 

 

-

 

 

 

3,854,895

 

 

 

5,486,596

 

Employee stock awards

 

 

5,759,000

 

 

 

252,488

 

 

 

1,417,162

 

 

 

7,428,650

 

Stock grants

 

 

252,488

 

 

 

(252,488

)

 

 

-

 

 

 

-

 

Issuance of Series A Preferred Stock, net of issuance costs

 

 

31,008,796

 

 

 

-

 

 

 

1,898,600

 

 

 

32,907,396

 

Warrants issued for services

 

 

1,090,076

 

 

 

-

 

 

 

692,099

 

 

 

1,782,175

 

 

Consolidated Statements of Cash Flow

 

 

For the Year Ended March 31, 2024

 

 

 

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

Stock Based
Payments

Other

 

 

As Restated

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

$

(15,565,200

)

 

$

(996,180

)

 

$

(32,229

)

 

$

(16,593,609

)

 

Adjustments to reconcile net loss to cash provided by operations:

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

18,813,897

 

 

 

-

 

 

 

47,284

 

 

 

18,861,181

 

 

Debt discount amortization

 

 

83,253

 

 

 

-

 

 

 

-

 

 

 

83,253

 

 

Employee stock awards

 

 

4,285,108

 

 

 

996,180

 

 

 

-

 

 

 

5,281,288

 

 

Common stock purchase options

 

 

430,457

 

 

 

-

 

 

 

-

 

 

 

430,457

 

 

Contingent consideration payable fair value

 

 

(80,540

)

 

 

-

 

 

 

-

 

 

 

(80,540

)

 

Allowance for doubtful accounts

 

 

419,527

 

 

 

-

 

 

 

-

 

 

 

419,527

 

 

(Gain)/loss on disposal of assets

 

 

259,540

 

 

 

-

 

 

 

-

 

 

 

259,540

 

 

Reduction in right of use asset

 

 

476,252

 

 

 

-

 

 

 

-

 

 

 

476,252

 

 

Deferred income taxes

 

 

(3,796,680

)

 

 

-

 

 

 

(15,055

)

 

 

(3,811,735

)

 

Changes in current assets and liabilities

 

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

Accounts receivable

 

 

705,532

 

 

 

-

 

 

 

-

 

 

 

705,532

 

 

Inventories

 

 

8,781,485

 

 

 

-

 

 

 

-

 

 

 

8,781,485

 

 

Prepaid expenses

 

 

4,028,696

 

 

 

-

 

 

 

-

 

 

 

4,028,696

 

 

Deposits

 

 

6,679,669

 

 

 

-

 

 

 

-

 

 

 

6,679,669

 

 

Accounts payable

 

 

5,077,098

 

 

 

-

 

 

 

-

 

 

 

5,077,098

 

 

Accrued liabilities

 

 

2,532,695

 

 

 

-

 

 

 

-

 

 

 

2,532,695

 

 

Operating lease liability

 

 

(499,448

)

 

 

-

 

 

 

-

 

 

 

(499,448

)

 

Net cash provided by operating activities

 

 

32,631,341

 

 

 

-

 

 

 

-

 

 

 

32,631,341

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Purchase of property, plant, and equipment

 

 

(8,024,765

)

 

 

-

 

 

 

-

 

 

 

(8,024,765

)

 

Proceeds from disposal of assets

 

 

3,750

 

 

 

-

 

 

 

-

 

 

 

3,750

 

 

Net cash used in investing activities

 

 

(8,021,015

)

 

 

-

 

 

 

-

 

 

 

(8,021,015

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from factoring liability

 

 

37,252,869

 

 

 

-

 

 

 

-

 

 

 

37,252,869

 

 

Payments on factoring liability

 

 

(37,252,869

)

 

 

-

 

 

 

-

 

 

 

(37,252,869

)

 

Payments on note payable - related party

 

 

(180,850

)

 

 

-

 

 

 

-

 

 

 

(180,850

)

 

Payments on insurance premium note payment

 

 

(3,174,834

)

 

 

-

 

 

 

-

 

 

 

(3,174,834

)

 

Payments on construction note payable

 

 

(257,425

)

 

 

-

 

 

 

-

 

 

 

(257,425

)

 

Common stock issued for exercised warrants

 

 

76,200

 

 

 

-

 

 

 

-

 

 

 

76,200

 

 

Preferred stock dividends paid

 

 

(2,968,923

)

 

 

-

 

 

 

-

 

 

 

(2,968,923

)

 

Common stock repurchase plan

 

 

(2,152,080

)

 

 

-

 

 

 

-

 

 

 

(2,152,080

)

 

Net cash used in financing activities

 

 

(8,657,912

)

 

 

-

 

 

 

-

 

 

 

(8,657,912

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net increase/(decrease) in cash

 

 

15,952,414

 

 

 

-

 

 

 

-

 

 

 

15,952,414

 

 

Cash, beginning of period

 

 

39,134,027

 

 

 

-

 

 

 

-

 

 

 

39,134,027

 

 

Restricted cash, beginning of period

 

 

500,000

 

 

 

-

 

 

 

-

 

 

 

500,000

 

 

Cash and restricted cash, end of period

 

$

55,586,441

 

 

$

-

 

 

$

-

 

 

$

55,586,441

 

 

Restricted cash, end of period

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

Cash, end of period

 

$

55,586,441

 

 

$

-

 

 

$

-

 

 

$

55,586,441

 

 

 

 

 

For the Year Ended March 31, 2023

 

 

 

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

Stock Based
Payments

Other

 

 

As Restated

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

$

(4,596,038

)

 

$

(4,141,363

)

 

$

(29,285

)

 

$

(8,766,686

)

 

Adjustments to reconcile net loss to cash provided by operations:

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

17,519,949

 

 

 

-

 

 

 

47,284

 

 

 

17,567,233

 

 

Debt discount amortization

 

 

83,253

 

 

 

-

 

 

 

-

 

 

 

83,253

 

 

Employee stock awards

 

 

5,986,873

 

 

 

4,141,363

 

 

 

-

 

 

 

10,128,236

 

 

Contingent consideration payable fair value

 

 

(63,764

)

 

 

-

 

 

 

-

 

 

 

(63,764

)

 

Allowance for doubtful accounts

 

 

191,299

 

 

 

-

 

 

 

-

 

 

 

191,299

 

 

Reduction in right of use asset

 

 

629,140

 

 

 

-

 

 

 

-

 

 

 

629,140

 

 

Warrants issued for services

 

 

213,819

 

 

 

-

 

 

 

-

 

 

 

213,819

 

 

Deferred income taxes

 

 

730,238

 

 

 

-

 

 

 

(17,999

)

 

 

712,239

 

 

Changes in current assets and liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

14,417,405

 

 

 

-

 

 

 

-

 

 

 

14,417,405

 

 

Due to related parties

 

 

15,000

 

 

 

-

 

 

 

-

 

 

 

15,000

 

 

Inventories

 

 

4,671,333

 

 

 

-

 

 

 

-

 

 

 

4,671,333

 

 

Prepaid expenses

 

 

2,763,855

 

 

 

-

 

 

 

-

 

 

 

2,763,855

 

 

Deposits

 

 

4,306,375

 

 

 

-

 

 

 

-

 

 

 

4,306,375

 

 

Accounts payable

 

 

(8,694,813

)

 

 

-

 

 

 

-

 

 

 

(8,694,813

)

 

Accrued liabilities

 

 

(1,970,078

)

 

 

-

 

 

 

-

 

 

 

(1,970,078

)

 

Operating lease liability

 

 

(647,480

)

 

 

-

 

 

 

-

 

 

 

(647,480

)

 

Net cash provided by operating activities

 

 

35,556,366

 

 

 

-

 

 

 

-

 

 

 

35,556,366

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Purchase of property, plant, and equipment

 

 

(12,541,325

)

 

 

-

 

 

 

-

 

 

 

(12,541,325

)

 

Net cash used in investing activities

 

 

(12,541,325

)

 

 

-

 

 

 

-

 

 

 

(12,541,325

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Payments on inventory facility, net

 

 

(825,675

)

 

 

-

 

 

 

-

 

 

 

(825,675

)

 

Proceeds from factoring liability

 

 

71,348,761

 

 

 

-

 

 

 

-

 

 

 

71,348,761

 

 

Payments on factoring liability

 

 

(71,834,432

)

 

 

-

 

 

 

-

 

 

 

(71,834,432

)

 

Payments on note payable - related party

 

 

(684,921

)

 

 

-

 

 

 

-

 

 

 

(684,921

)

 

Payments on insurance premium note payment

 

 

(2,134,143

)

 

 

-

 

 

 

-

 

 

 

(2,134,143

)

 

Proceeds from construction note payable

 

 

1,000,000

 

 

 

-

 

 

 

-

 

 

 

1,000,000

 

 

Payments on construction note payable

 

 

(150,743

)

 

 

-

 

 

 

-

 

 

 

(150,743

)

 

Common stock issued for exercised warrants

 

 

101,506

 

 

 

-

 

 

 

-

 

 

 

101,506

 

 

Preferred stock dividends paid

 

 

(2,960,416

)

 

 

-

 

 

 

-

 

 

 

(2,960,416

)

 

Common stock repurchase plan

 

 

(522,426

)

 

 

-

 

 

 

-

 

 

 

(522,426

)

 

Net cash used in financing activities

 

 

(6,662,489

)

 

 

-

 

 

 

-

 

 

 

(6,662,489

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net increase/(decrease) in cash

 

 

16,352,552

 

 

 

-

 

 

 

-

 

 

 

16,352,552

 

 

Cash, beginning of period

 

 

23,281,475

 

 

 

-

 

 

 

-

 

 

 

23,281,475

 

 

Restricted cash, beginning of period

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

Cash and restricted cash, end of period

 

$

39,634,027

 

 

$

-

 

 

$

-

 

 

$

39,634,027

 

 

Restricted cash, end of period

 

$

500,000

 

 

$

-

 

 

$

-

 

 

$

500,000

 

 

Cash, end of period

 

$

39,134,027

 

 

$

-

 

 

$

-

 

 

$

39,134,027

 

 

 

 

 

For the Year Ended March 31, 2022

 

 

 

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

Stock Based
Payments

 

 

Equity Issuance
Costs

Warrants

Other

 

 

As Restated

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

$

33,247,436

 

 

$

(1,422,137

)

 

$

(6,438,872

)

 

$

(692,099

)

 

$

1,172,850

 

 

$

25,867,178

 

 

Adjustments to reconcile net loss to cash provided by operations:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

17,339,093

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

70,201

 

 

 

17,409,294

 

 

Debt discount amortization

 

 

38,330

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

38,330

 

 

Employee stock awards

 

 

6,011,488

 

 

 

1,418,969

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

7,430,457

 

 

Stock for services

 

 

4,200

 

 

 

3,168

 

 

 

5,352,500

 

 

 

-

 

 

 

-

 

 

 

5,359,868

 

 

Contingent consideration payable fair value

 

 

(385,750

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(385,750

)

 

Allowance for doubtful accounts

 

 

2,748,250

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,748,250

 

 

(Gain)/loss on disposal of assets

 

 

(12,044

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(12,044

)

 

Reduction in right of use asset

 

 

720,491

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

720,491

 

 

Warrants issued for services

 

 

718,045

 

 

 

-

 

 

 

-

 

 

 

692,099

 

 

 

-

 

 

 

1,410,144

 

 

Deferred income taxes

 

 

1,536,481

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(1,243,051

)

 

 

293,430

 

 

Changes in current assets and liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(20,707,052

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(20,707,052

)

 

Due to related parties

 

 

657

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

657

 

 

Inventories

 

 

(43,149,234

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(43,149,234

)

 

Prepaid expenses

 

 

1,996,287

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,996,287

 

 

Deposits

 

 

(8,826,504

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(8,826,504

)

 

Accounts payable

 

 

9,930,191

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

9,930,191

 

 

Accrued liabilities

 

 

2,374,686

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,374,686

 

 

Operating lease liability

 

 

(732,468

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(732,468

)

 

Net cash provided by operating activities

 

 

2,852,583

 

 

 

-

 

 

 

(1,086,372

)

 

 

-

 

 

 

-

 

 

 

1,766,211

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gemini acquisition

 

 

(50,517,840

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(50,517,840

)

 

Purchase of property, plant, and equipment

 

 

(19,218,982

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(19,218,982

)

 

Proceeds from disposal of assets

 

 

59,800

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

59,800

 

 

Net cash used in investing activities

 

 

(69,677,022

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(69,677,022

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Payments on inventory facility, net

 

 

(265,422

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(265,422

)

 

Proceeds from factoring liability

 

 

121,488,045

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

121,488,045

 

 

Payments on factoring liability

 

 

(122,844,562

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(122,844,562

)

 

Payments on assumed debt from Gemini

 

 

(50,000,000

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(50,000,000

)

 

Payments on note payable - related party

 

 

(625,147

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(625,147

)

 

Payments on insurance premium note payment

 

 

(2,208,369

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(2,208,369

)

 

Payments on note payable

 

 

(4,000,000

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(4,000,000

)

 

Sale of preferred stock

 

 

35,000,000

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

35,000,000

 

 

Common stock issued for exercised warrants

 

 

943,907

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

943,907

 

 

Common stock issuance costs

 

 

(3,199,922

)

 

 

-

 

 

 

3,199,922

 

 

 

-

 

 

 

-

 

 

 

-

 

 

Preferred stock issuance costs

 

 

-

 

 

 

-

 

 

 

(2,113,550

)

 

 

-

 

 

 

-

 

 

 

(2,113,550

)

 

Preferred stock dividends paid

 

 

(2,524,087

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(2,524,087

)

 

Net cash used in financing activities

 

 

(28,235,557

)

 

 

-

 

 

 

1,086,372

 

 

 

-

 

 

 

-

 

 

 

(27,149,185

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net increase/(decrease) in cash

 

 

(95,059,996

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(95,059,996

)

 

Cash, beginning of period

 

 

118,341,471

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

118,341,471

 

 

Restricted cash, beginning of period

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

Cash and restricted cash, end of period

 

$

23,281,475

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

23,281,475

 

 

Restricted cash, end of period

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

Cash, end of period

 

$

23,281,475

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

23,281,475

 

 

v3.25.1
INCOME/(LOSS) PER COMMON SHARE
12 Months Ended
Mar. 31, 2024
Net Income/(Loss) per share  
INCOME/(LOSS) PER COMMON SHARE

NOTE 4 – INCOME/(LOSS) PER COMMON SHARE

We calculate basic income/(loss) per share using the weighted average number of common shares outstanding during each period. Diluted earnings per share assumes the conversion, exercise or issuance of all potential common stock equivalents unless the effect is to reduce a loss or increase the income per share. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options (using the treasury stock method), the exercise of warrants (using the if-converted method) and the vesting of restricted stock unit awards.

 

For the Year Ended March 31,

 

 

2024

 

 

2023

 

 

2022

 

 

 

(As Restated)

 

 

(As Restated)

 

 

(As Restated)

 

Numerator:

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

$

(16,593,609

)

 

$

(8,766,686

)

 

$

25,867,178

 

Less: Preferred stock dividends

 

 

(3,122,049

)

 

 

(3,105,034

)

 

 

(2,668,649

)

Net income/(loss) attributable to common stockholders

 

$

(19,715,658

)

 

$

(11,871,720

)

 

$

23,198,529

 

 

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

 

Weighted average shares of common stock - basic

 

 

118,249,486

 

 

 

117,177,885

 

 

 

112,328,680

 

Effect of dilutive common stock purchase warrants

 

 

-

 

 

 

-

 

 

 

2,121,302

 

Effect of dilutive equity incentive awards

 

 

-

 

 

 

-

 

 

 

375,853

 

 Weighted average shares of common stock - Diluted

 

 

118,249,486

 

 

 

117,177,885

 

 

 

114,825,835

 

 

 

 

 

 

 

 

 

 

 

Basic earnings per share:

 

 

 

 

 

 

 

 

 

Income/(loss) per share attributable to common stockholders - basic

 

$

(0.17

)

 

$

(0.10

)

 

$

0.21

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share:

 

 

 

 

 

 

 

 

 

Income/(loss) per share attributable to common stockholders - diluted

 

$

(0.17

)

 

$

(0.10

)

 

$

0.20

 

 

The following table presents the number of shares excluded from the calculation of diluted net loss per share attributable to common stockholders:

 

For the Year Ended March 31,

 

 

2024

 

 

2023

 

 

2022

 

 

 

(As Restated)

 

 

(As Restated)

 

 

(As Restated)

 

Common stock options

 

 

175,000

 

 

 

-

 

 

 

-

 

Non-vested stock awards

 

 

1,540,524

 

 

 

2,204,659

 

 

 

2,735,226

 

Warrants

 

 

1,808,870

 

 

 

2,560,986

 

 

 

150,000

 

Total shares excluded from net income (loss) per share attributable to common stockholders

 

 

3,524,394

 

 

 

4,765,645

 

 

 

2,885,226

 

v3.25.1
ACCOUNTS RECEIVABLE
12 Months Ended
Mar. 31, 2024
Credit Loss [Abstract]  
ACCOUNTS RECEIVABLE

NOTE 5 – ACCOUNTS RECEIVABLE

Our net accounts receivable are summarized as follows:

 

March 31,
2024

 

 

March 31,
2023

 

 

March 31,
2022

 

Accounts receivable

 

$

31,887,399

 

 

$

32,592,931

 

 

$

47,010,336

 

Less: allowance for credit losses

 

 

(3,666,078

)

 

 

(3,246,551

)

 

 

(3,055,252

)

 

 

$

28,221,321

 

 

$

29,346,380

 

 

$

43,955,084

 

 

The following presents a reconciliation of our allowance for credit losses for the periods presented:

March 31, 2021

 

$

148,540

 

Increase in allowance

 

 

2,903,304

 

Write-off of uncollectible amounts

 

 

(12,703

)

Purchase accounting

 

 

16,111

 

March 31, 2022

 

 

3,055,252

 

Increase in allowance

 

 

2,160,323

 

Write-off of uncollectible amounts

 

 

(1,969,024

)

March 31, 2023

 

 

3,246,551

 

Increase in allowance

 

 

1,530,891

 

Write-off of uncollectible amounts

 

 

(1,111,364

)

March 31, 2024

 

$

3,666,078

 

v3.25.1
INVENTORIES
12 Months Ended
Mar. 31, 2024
Inventory Disclosure [Abstract]  
INVENTORIES

NOTE 6 – INVENTORIES

At March 31, 2024, March 31, 2023, and March 31, 2022, the inventory balances are composed of:

 

 

March 31, 2024

 

 

March 31, 2023

 

 

March 31, 2022

 

Finished product

 

 

$

11,055,061

 

 

 

$

14,362,514

 

 

 

$

6,167,318

 

Raw materials

 

 

 

24,158,244

 

 

 

 

23,898,596

 

 

 

 

33,924,813

 

Work in process

 

 

 

10,350,029

 

 

 

 

16,083,709

 

 

 

 

18,924,021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

45,563,334

 

 

 

$

54,344,819

 

 

 

$

59,016,152

 

v3.25.1
PROPERTY, PLANT AND EQUIPMENT
12 Months Ended
Mar. 31, 2024
Property, Plant and Equipment [Abstract]  
PROPERTY, PLANT AND EQUIPMENT

NOTE 7 – PROPERTY, PLANT AND EQUIPMENT

Property and equipment consisted of the following at March 31, 2024, March 31, 2023, and March 31, 2022:

 

 

March 31, 2024

 

 

March 31, 2023

 

 

March 31, 2022

 

Leasehold Improvements

 

$

257,009

 

 

$

257,009

 

 

$

257,009

 

Building and Improvements

 

 

29,143,445

 

 

 

28,623,329

 

 

 

 

Furniture and Fixtures

 

 

439,990

 

 

 

384,650

 

 

 

343,014

 

Vehicles

 

 

153,254

 

 

 

153,254

 

 

 

153,254

 

Equipment

 

 

45,467,137

 

 

 

40,233,186

 

 

 

32,524,850

 

Tooling

 

 

143,710

 

 

 

143,710

 

 

 

143,710

 

Construction in Progress

 

 

2,785,616

 

 

 

734,781

 

 

 

14,335,371

 

Total property and equipment

 

$

78,390,161

 

 

$

70,529,919

 

 

$

47,757,208

 

Less accumulated depreciation

 

 

(20,308,121

)

 

 

(14,566,664

)

 

 

(10,119,402

)

Net property and equipment

 

$

58,082,040

 

 

$

55,963,255

 

 

$

37,637,806

 

 

Depreciation expense for the years ended March 31, 2024, 2023, and 2022 totaled $5,751,023, $4,452,908, and $4,266,126, respectively. Of these totals $4,777,642, $3,747,723, and $3,101,929 were included in cost of revenues for the years ending March 31, 2024, 2023, and 2022. Additionally, $973,381, $705,185, and $1,164,197, respectively were included in depreciation and amortization expenses in operating expenses.

v3.25.1
REVOLVING LOAN
12 Months Ended
Mar. 31, 2024
Revolving Loan  
REVOLVING LOAN

NOTE 8 – REVOLVING LOAN

On December 29, 2023, we entered into a Loan and Security Agreement (the “Sunflower Agreement”) by and among the Company and other borrowers party to the Agreement (collectively, the “Borrower”), the lenders party thereto (collectively, the “Lenders”) and Sunflower Bank, N.A., as administrative agent and collateral agent (the “Agent”). Capitalized terms used but not otherwise defined in this Note 8 have the same definitions given to such terms in the Sunflower Agreement under the terms of the Sunflower Agreement, the Lenders have provided to the Borrower a revolving loan in the principal amount of the lesser of (a) $20,000,000 (the “Total Commitment Amount”) and (b) the Borrowing Base (a formula based on certain amounts owed to Borrower for goods sold or services provided and eligible inventory) (the “Revolving Loan”). The proceeds of loans under the Sunflower Agreement may be used for working capital, general corporate purposes, Permitted Acquisitions, to pay fees and expenses incurred in

connection with the Revolving Loan, to facilitate Borrower’s stock repurchase program and to fund Borrower’s general business requirements.

The Revolving Loan bears interest at a rate of the greater of (x) 3.50% (the “Floor Rate”) and (y) Term SOFR, plus 3.00% (the “Revolving Facility Applicable Rate”) and is computed on the basis of a 360-day year for the actual number of days elapsed. Except in an Event of Default (as defined below), Advances under the Revolving Loan shall bear interest, on the outstanding Daily Balance thereof, at the Revolving Facility Applicable Rate. Interest is due and payable on the first calendar day of each month during the term of the Sunflower Agreement. The Borrower is also obligated to pay to the Agent, for the ratable benefit of Lenders, an origination fee, Prepayment Fee, unused facility fee, collateral monitoring fee and Lender Expenses.

The Borrower may borrow, repay and re-borrow under the Revolving Loan until December 29, 2026 (the “Maturity Date”), at which time the commitments will terminate and all outstanding loans, together with all accrued and unpaid interest, must be repaid. If the Revolving Loan is refinanced by another lender prior to the Maturity Date, an additional fee payable concurrently with such refinancing in an amount equal to (i) three percent (3.0%) of the Total Commitment Amount, if such financing occurs after the Closing Date but on or prior to the first anniversary of the Closing Date, (ii) two percent (2.0%) of the Total Commitment Amount, if such refinancing occurs after the first anniversary of the Closing Date but on or prior to the second anniversary of the Closing Date, and (iii) one percent (1.0%) of the Total Commitment Amount, if such refinancing occurs after the second anniversary of the Closing Date but on or prior to the third anniversary of the Closing Date (the “Prepayment Fee”).

The Sunflower Agreement contains customary affirmative and negative covenants, including covenants that limit or restrict the Borrower’s and the Borrower’ subsidiaries’ ability to, among other things, incur subsidiary indebtedness, grant liens, merge or consolidate, dispose of substantially all assets of the Borrower and its subsidiaries, taken as a whole, make investments, make acquisitions, enter into certain transactions with affiliates, pay dividends or make distributions, repurchase stock, and enter into restrictive agreements, in each case subject to customary exceptions.

The Sunflower Agreement includes customary events of default (each, an “Event of Default”) that include, among other things, non-payment defaults, inaccuracy of representations and warranties, covenant defaults, insolvency defaults, material judgment defaults, attachment defaults, subordinated debt default, guaranty defaults, and governmental approval defaults. Upon an Event of Default, all Obligations under the Sunflower Agreement shall bear interest at a rate equal to three (3.0) percentage points above the interest rate applicable immediately prior to the occurrence of the Event of Default.

We did not have an outstanding balance on our Revolving Loan as of March 31, 2024.

v3.25.1
FACTORING LIABILITY
12 Months Ended
Mar. 31, 2024
Factoring Liability  
FACTORING LIABILITY

NOTE 9 – FACTORING LIABILITY

On July 1, 2019, we entered into a Factoring and Security Agreement with Factors Southwest, LLC (“FSW”). FSW may purchase from time to time the Company’s Accounts Receivables with recourse on an account by account basis. The twenty-four month agreement contained a maximum advance amount of $5,000,000 on 85% of eligible accounts and had an annualized interest rate of the Prime Rate published from time to time by the Wall Street Journal plus 4.5%. The agreement provided for a fee of 3% ($150,000) of the Maximum Facility assessed to the Company. Our obligations under this agreement were secured by present and future accounts receivables and related assets, inventory, and equipment. The Company had the right to terminate the agreement, with 30 days written notice, upon obtaining a non-factoring credit facility. This agreement provided the Company with the ability to convert our account receivables into cash. We did not have an outstanding balance on our Factoring liability as of March 31, 2024 and March 31, 2023, and our balance was $485,671 as of March 31, 2022. Interest expense recognized on the Factoring Liability for the year ended March 31, 2024 was $185,319, including $62,500 of amortization of the commitment fee, for the year ended March 31, 2023, $153,646, including $37,500 of amortization of the commitment fee, for the year ended March 31, 2022, $327,746, including $100,000 of amortization of the commitment fee.

On June 17, 2021, this agreement was amended to extend the maturity date to June 17, 2025.

On November 29, 2023, we provided FSW notice of termination of the agreement. The agreement terminated on December 29, 2023. We recognized an expense of $281,108 in relation to the termination of the agreement with FSW.

v3.25.1
INVENTORY CREDIT FACILITY
12 Months Ended
Mar. 31, 2024
Inventory Credit Facility  
INVENTORY CREDIT FACILITY

NOTE 10 – INVENTORY CREDIT FACILITY

On June 17, 2020, we entered into a Revolving Inventory Loan and Security Agreement (the "Inventory Credit Agreement") with FSW. Pursuant to the Inventory Credit Agreement, FSW agreed to establish a revolving credit line, and make loans from time to time to the Company for the purpose of providing capital. The twenty-four month agreement secured by our inventory, among other assets, contained a maximum loan amount of $1,750,000 on eligible inventory and had an annualized interest rate of the greater of the three-month LIBOR rate plus 3.09% or 8%. The agreement contained a fee of 2% of the maximum loan amount ($35,000) assessed to the Company. On July 31, 2020, the Company amended the Revolving Loan and Security Agreement to increase the maximum inventory loan amount to $2,250,000. No outstanding balance remained as of March 31, 2024 and March 31, 2023. As of March 31, 2022, the outstanding balance of the Inventory Credit Facility was $825,675. There was no interest expense recognized on the Inventory Credit Facility for the year ended March 31, 2024. Interest expense for the year ended March 31, 2023 was $6,580, and for the year ended March 31, 2022 was $40,940, including $8,561 of amortization of the annual fee.

On November 29, 2023, we provided FSW notice of termination of the agreement. The agreement terminated on December 29, 2023.

v3.25.1
LEASES
12 Months Ended
Mar. 31, 2024
Leases  
LEASES

NOTE 11 – LEASES

We lease office, manufacturing, and warehouse space in Scottsdale, AZ, Atlanta and Marietta, GA, and Manitowoc, WI under contracts we classify as operating leases. None of our leases are financing leases. The Scottsdale lease has been extended through 2029 and does not include a renewal option. This extension resulted in an increase to our right of use assets on the consolidated balance sheet by $738,459.

In August of 2021, we extended the lease of our Atlanta offices through May of 2027, and as a result, we increased our right of use assets and operating lease liabilities on our consolidated balance sheet by $501,125 at September 30, 2021. In January of 2022, we extended the lease of our second Manitowoc, WI location and increased our right of use assets and operating lease liabilities on the consolidated balance sheet by $308,326.

We terminated our lease agreement in Marietta, GA during the year ended March 31, 2024 and decreased our right of use asset and operating lease liabilities on the consolidated balance sheet by $38,185. We also terminated our lease agreement in our first Manitowoc, WI location during the year ended March 31, 2023 and, accordingly, we decreased our right of use assets and operating lease liabilities on the consolidated balance sheet by $901,076.

Consolidated lease expense for the year ended March 31, 2024 was $663,826 including $642,105 of operating lease expense and $21,722 of other lease associated expenses such as association dues, taxes, utilities, and other month to month rentals. Consolidated lease expense for the year ended March 31, 2023 was $881,171 including $861,777 of operating lease expense and $19,394 of other lease associated expenses such as association dues, taxes, utilities, and other month to month rentals. Consolidated lease expense for the year ended March 31, 2022 was $1,221,473 including $1,177,589 of operating lease expense and $43,884 of other lease associated expenses such as association dues, taxes, utilities, and other month to month rentals.

The weighted average remaining lease term and weighted average discount rate for operating leases were 4.0 years and 10.0%, respectively at March 31, 2024, were 3.3 years and 10.0%, respectively at March 31, 2023, and were 3.5 years and 10.0%, respectively at March 31, 2022.

Future minimum lease payments under non-cancellable leases as of March 31, 2024 are as follows:

Years Ended March 31,

 

 

 

2025

 

$

666,233

 

2026

 

 

665,069

 

2027

 

 

581,574

 

2028

 

 

379,067

 

2029

 

 

258,102

 

Total minimum lease payments

 

 

2,550,045

 

Less: Amount Representing Interest

 

 

(460,558

)

Present value of minimum lease payments

 

$

2,089,487

 

v3.25.1
NOTES PAYABLE – RELATED PARTY
12 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
NOTES PAYABLE – RELATED PARTY

NOTE 12 – NOTES PAYABLE – RELATED PARTY

In connection with the acquisition of the casing division of Jagemann Stamping Company (“JSC”), a $10,400,000 promissory note was executed on March 14, 2019. The promissory note, under which $500,000 was paid on March 25, 2019 using funds raised for the acquisition, had a remaining balance at March 31, 2019 of $9,900,000. On April 30, 2019, the original due date of the note was subsequently extended to April 1, 2020. The note bears interest per annum at approximately 4.6% payable in arrears monthly. In May of 2019, the Company paid $1,500,000 on the balance of the note. The note is secured by all the equipment purchased from JSC. JSC owned at least five percent (5%) of our shares outstanding from March 2019 through March 16, 2021.

In October 2019, it was made apparent that certain equipment that was agreed to be delivered free and clear by the JSC was not achievable as JSC was not able to purchase equipment that JSC had leased. Accordingly, the remaining value of the promissory note was reduced by $2,596,200. As a result of the change to the purchase price of the transaction, the Company reduced equipment for a net value of $1,871,306, decreased other intangible assets by $766,068, increased accounts receivable by $31,924, and recorded an increase to deposits for $9,250 worth of equipment that the Company agreed to transfer back to JSC. Consequently, accumulated amortization has decreased by $159,530. Additionally, the Company entered into a lease to gain possession of the assets that were originally to be transferred.

On June 26, 2020, the Company, Enlight Group II, LLC (“Enlight”), the Company’s wholly owned subsidiary and JSC entered into a Settlement Agreement pursuant to which the parties mutually agreed to settle all disputes and mutually release each other from liabilities related to the Amended APA occurring prior to June 26, 2020. Pursuant to the Settlement Agreement, the Company shall pay JSC $1,269,977 and shall provide JSC with: (i) two new promissory notes, a note of $5,803,800 related to the Seller Note and note of $2,635,797 for inventory and services, which was reclassed from accounts payable, both with a maturity date of August 15, 2021, (ii) general business security agreements granting JSC a security interest in all personal property of the Company. Pursuant to the Notes, the Company is obligated to make monthly payments totaling $204,295 to JSC. In addition, the Notes have a mandatory prepayment provision that comes into effect if the Company conducts a publicly registered offering. Pursuant to such provision, the Company: (a) upon the closing of an Offering of less than $10,000,000 would be obligated to pay the lesser of ninety percent (90%) of the Offering proceeds or seventy (70%) of the then aggregate outstanding balance of the Notes; and (b) upon the closing of an Offering of more than $10,000,000 would be obligated to pay one hundred percent (100%) of the then aggregate outstanding balance of the Notes. The Company was granted an option to repurchase up to 1,000,000 of the shares of the Company’s Common Stock issued to JSC under the Amended APA at a price of $1.50 per share through April 1, 2021 so long as there are no defaults under the Settlement Agreement.

As a result of the Settlement Agreement, the Company agreed to forgo $1,000,000 in Construction in Progress that the parties had previously agreed to exchange. As a result, the Company recognized a loss in operating expenses for the year ended March 31, 2021.

On November 5, 2020, the Company paid $6,000,000 to JSC allocated as follows: (i) payment in full of Note A, representing the balance due from the Company to JSC relating to the acquisition of Jagemann Munition Components in March 2019 and (ii) $592,982 remitted in partial payment of Note B, resulting in the parties’ execution of Amended Note B which has a starting principal balance of $1,687,664 (“Amended Note B”). The Amended Note B principal balance carries a 9% per annum interest rate and is amortized equally over the thirty-six (36) month term. As a result of the payment in full of Note A JSC shall release the accompanying security interest in Company assets which secured Note A. Concurrently, upon entry into Amended Note B, JSC and the Company entered into the First Amendment to General Business Security Agreement to reflect a revised list of collateral in which JSC has a security interest. The total interest expense recognized on Note A was $216,160 for the year ended March 31, 2021. The total interest expense recognized on the original Note B was $62,876 for the year ended March 31, 2021.

The Company paid off the balance of Amended Note B during the year ended March 31, 2024 and there was a balance of $180,850 at March 31, 2023 and $865,771 at March 31, 2022. The Company recognized $1,788, $48,665, and $110,518, in interest expense on Amended Note B for the years ended March 31, 2024, 2023, and 2022, respectively.

On January 22, 2021, the Company repurchased 1,000,000 shares of the Company’s Common Stock issued to JSC at a price of $1.50 per share pursuant to the Amended APA.

On November 5, 2020, the Company, entered into a promissory note with Lisa Kay, an immediate family member of Fred Wagenhals, the Company's Chief Executive Officer and Chairman of the Board of Directors at the time, for the principal sum of $4.0 million, which accrued interest at 12 % per annum. The promissory note had a maturity date of November 5, 2023. The Company recognized $66,667 in interest expense related to the promissory note for the year ended March 31, 2022. On May 21, 2021, the Company repaid the principal of the promissory note in full.

v3.25.1
CONSTRUCTION NOTE PAYABLE
12 Months Ended
Mar. 31, 2024
Construction Note Payable  
CONSTRUCTION NOTE PAYABLE

NOTE 13 – CONSTRUCTION NOTE PAYABLE

On October 14, 2021, we entered into a Construction Loan Agreement (the “Hiawatha Loan Agreement”) with Hiawatha National Bank (“Hiawatha”). The Hiawatha Loan Agreement specifies that Hiawatha may lend up to $11,625,000 to us to pay a portion

of the construction costs of an approximately 185,000 square foot manufacturing facility to be constructed on our property (the “Construction Loan”). The first advance of Construction Loan funds by Hiawatha was made on October 14, 2021 in the amount of $329,843. We received advances of Construction Loan funds approximately every month as our “owner’s equity” was fully funded into the ongoing new plant construction project. The Construction Loan is an advancing term loan and not a revolving loan so any portion of the principal repaid cannot be re-borrowed.

Additionally, on October 14, 2021, we issued a Promissory Note in favor of Hiawatha (the “Hiawatha Note”) in the amount of up to $11,625,000 with an interest rate of 4.5%. The maturity date of the Hiawatha Note is October 14, 2026. Under the terms of the Hiawatha Loan Agreement, we are required to make monthly payments of $64,620 which consists of principal and interest until the maturity date, at which time the remaining principal balance of the Construction Loan would become due.

We can prepay the Hiawatha Note in whole or in part starting in July 2022 with a prepayment premium of 1% of the principal being prepaid.

The Hiawatha Loan Agreement contains customary events of default including, but not limited to, a failure to make any payments pursuant to the Hiawatha Loan Agreement or Hiawatha Note, a failure to complete construction of the project, a lien of $100,000 or more against the property, or a transfer of the property without Hiawatha’s consent. Upon the occurrence of an event of default, among other remedies, the amounts due pursuant to the Construction Loan can be accelerated, Hiawatha can foreclose on the property pursuant to the mortgage, and a late charge of 5% of the amount due will be owed with all amounts then owed pursuant to the Hiawatha Note bearing interest at an increased rate.

We are required to maintain a debt service coverage ratio, as defined in the terms of the Hiawatha Loan Agreement, of not less than 1.25 to 1.00 for the period defined below and continuing to and including the maturity date. The debt service coverage ratio shall be tested on an annual basis, as of July 1, for each previous year. We maintained compliance under the Loan Agreement since its inception.

During the year ended March 31, 2022 there was less than $1.0 million of Construction Loan funds advanced. During the year ended March 31, 2023, approximately $11.2 million of Construction Loan funds were advanced including $1.0 million of cash collateral or restricted cash as security for the Construction Loan. We made $257,425 and $150,743 in principal payments for the year ended March 31, 2024 and March 31, 2023, respectively. The restricted cash can be released per the terms documented in the Loan Agreement. During the year ended March 31, 2023, $500,000 of restricted cash was released with $500,000 remaining restricted. During the year ended March 31, 2024, the remaining $500,000 of restricted cash was released, resulting in a zero balance for restricted cash as of March 31, 2024.

v3.25.1
CAPITAL STOCK
12 Months Ended
Mar. 31, 2024
Equity [Abstract]  
CAPITAL STOCK

NOTE 15 – CAPITAL STOCK

Our authorized capital consists of 200,000,000 shares of Common Stock with a par value of $0.001 per share.

We issued 20,000,000 shares in connection with our merger of Gemini Direct Investments, LLC valued at $142,691,282 in the year ended March 31, 2022.

2017 Equity Incentive Plan

In October 2017, our board of directors approved the 2017 Equity Incentive Plan ("2017 Plan"). Our 2017 Plan initially permitted the issuance of equity-based instruments covering up to a total of 485,000 shares of Common Stock. Our board of directors and stockholders approved an increase of 4,515,000 shares in October 2020 an additional increase of 1,000,000 shares in March 2023, and an additional increase of 3,000,000 shares in February 2024, bringing the total shares allowed under the plan to 9,000,000. As of March 31, 2024, there were 2,791,492 shares available to be issued under the 2017 Plan.

Warrants

We issued 431,080 shares to investors for exercised warrants valued for $943,907 in the year ended March 31, 2022. In addition, 374,584 shares were issued for cashless exercise of 443,110 warrants.

We issued 200,003 shares to investors for exercised warrants valued for $101,506 in the year ended March 31, 2023. In addition, 99,762 shares were issued for cashless exercise of 100,000 warrants.

We issued 31,750 shares to investors for exercised warrants valued for $76,200 in the year ended March 31, 2024.

At March 31, 2024, 2023, and 2022, outstanding and exercisable stock purchase warrants consisted of the following (as restated):

 

Number of
Shares

 

 

Weighted
Averaged
Exercise
Price

 

 

Weighted
Average Life
Remaining
(Years)

 

Outstanding at March 31, 2021

 

 

3,607,945

 

 

$

2.31

 

 

 

3.24

 

Granted

 

 

300,000

 

 

 

0.01

 

 

 

3.92

 

Exercised

 

 

(874,190

)

 

 

1.76

 

 

 

-

 

Forfeited or cancelled

 

 

-

 

 

 

-

 

 

 

-

 

Outstanding at March 31, 2022

 

 

3,033,755

 

 

$

2.32

 

 

 

2.29

 

Exercisable at March 31, 2022

 

 

3,033,755

 

 

$

2.32

 

 

 

2.29

 

 

 

Number of
Shares

 

 

Weighted
Averaged
Exercise
Price

 

 

Weighted
Average Life
Remaining
(Years)

 

Outstanding at March 31, 2022

 

 

3,033,755

 

 

 

2.32

 

 

 

2.29

 

Granted

 

 

150,000

 

 

 

0.01

 

 

 

4.50

 

Exercised

 

 

(300,003

)

 

 

0.34

 

 

 

-

 

Forfeited or cancelled

 

 

(322,806

)

 

 

2.00

 

 

 

-

 

Outstanding at March 31, 2023

 

 

2,560,946

 

 

$

2.46

 

 

 

1.59

 

Exercisable at March 31, 2023

 

 

2,560,946

 

 

$

2.46

 

 

 

1.59

 

 

 

Number of
Shares

 

 

Weighted
Averaged
Exercise
Price

 

 

Weighted
Average Life
Remaining
(Years)

 

Outstanding at March 31, 2023

 

 

2,560,946

 

 

$

2.46

 

 

 

1.59

 

Exercised

 

 

(31,750

)

 

 

2.40

 

 

 

-

 

Forfeited or cancelled

 

 

(720,366

)

 

 

3.19

 

 

 

-

 

Outstanding at March 31, 2024

 

 

1,808,830

 

 

$

2.16

 

 

 

1.09

 

Exercisable at March 31, 2024

 

 

1,808,830

 

 

$

2.16

 

 

 

1.09

 

 

As of March 31, 2024, we had 1,808,830 warrants outstanding. Each warrant provides the holder the right to purchase up to one share of our Common Stock at a predetermined exercise price. The outstanding warrants consist of (1) warrants to purchase 100,000 shares of Common Stock at an exercise price of $0.01 per share until March 2027; (2) warrants to purchase 911 shares of Common Stock at an exercise price of $1.65 per share until April 2025; (3) warrants to purchase 1,244,108 shares of our Common Stock at an exercise price of $2.00 per share consisting of approximately 1% of the warrants until August 2024, and approximately 99% until February 2026; (4) warrants to purchase 77,500 shares of Common Stock at an exercise price of $2.40 until September 2024, and (5) warrants to purchase 386,311 shares of Common Stock at an exercise price of $2.63 until November 2025.

We valued warrants and Common Stock purchase options issued for services at their respective grants dates during the years ended March 31, 2024, 2023, and 2022 using valuation methods and assumptions that consider, among other factors, the fair value of the underlying stock, risk free interest rate, volatility, and expected life.

 

March 31,
2024

 

 

March 31,
2023

 

 

March 31,
2022

 

Risk free interest rate

 

 

4.1

%

 

 

3.9

%

 

 

1.2

%

Expected volatility

 

 

66.8

%

 

 

73.5

%

 

 

54.3

%

Expected term

 

5.8 years

 

 

5.0 years

 

 

5.0 years

 

Expected dividend yield

 

 

0.00

 

 

 

0.00

 

 

 

0.00

 

Options Granted

During the year ended March 31, 2023, we granted stock options (“Options”) to purchase 400,000 shares of our Common Stock to our Chief Executive Officer, of which (i) 100,000 Options vested on the July 24, 2023, and (ii) 300,000 Options shall vest in equal quarterly installments of 25,000 over three years beginning on September 30, 2023. The Options shall (a) be exercisable at an exercise price per share equal to the closing market price of the Company’s Common Stock on the date of the grant, (b) have a term of ten years, and (c) be on such other terms as shall be determined by the Board (or the Compensation Committee of the Board) and set forth in a customary form of stock option agreement under the 2017 Plan. We recognized $430,457 in expense related to the Options for year ended March 31, 2024.

Number of Options

 

 

400,000

 

Option Vesting Period

 

Up to 3 years

 

Per share grant price

 

$

2.08

 

Dividend yield

 

 

-

 

Expected volatility

 

 

83.5

%

Risk-free interest rate

 

 

4.13

%

Expected life (years)

 

 

5.75

 

Weighted average fair value

 

$

1.50

 

 

The following is a summary of our stock option activity during the year ended March 31, 2024:

 

Number of Options

 

 

Weighted Average Exercise Price

 

 

Weighted Average Grant Date Fair Value

 

 

Weighted Average Remaining Life in Years

 

Outstanding, April 1, 2023

 

 

 

-

 

 

$

 

-

 

 

$

 

-

 

 

 

 

-

 

Granted

 

 

 

400,000

 

 

 

 

2.08

 

 

 

 

1.50

 

 

 

 

10.00

 

Exercised

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

Canceled/Forfeited

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

Outstanding, March 31, 2024

 

 

 

400,000

 

 

$

2.08

 

 

$

1.5

 

 

 

 

9.32

 

 

As of March 31, 2024, there was $172,663 of unrecognized compensation expense related to unvested stock options, which is expected to be recognized over a weighted average vesting period of approximately 2.25 years. As of March 31, 2024, there were 225,000 unvested stock options with a grant date fair value of $1.50.

 

 

Stock Awards

We issued 772,450 shares valued at $1,631,701 for services and equipment provided to the Company in the year ended March 31, 2022.

A summary of stock award activity for the year ended March 31, 2024 is as follows:

 

 

Number of Shares

 

 

Weighted-Average Grant-Date Fair Value Per Share

 

Outstanding at April 1, 2023

 

 

2,204,659

 

 

$

 

3.68

 

Granted

 

 

2,579,901

 

 

 

 

2.22

 

Vested

 

 

(1,371,849

)

 

 

 

2.94

 

Forfeited

 

 

(1,872,186

)

 

 

 

2.82

 

Outstanding at March 31, 2024

 

 

1,540,525

 

 

$

 

2.93

 

A summary of stock award activity for the year ended March 31, 2023 is as follows:

 

 

Number of Shares

 

 

Weighted-Average Grant-Date Fair Value Per Share

 

Outstanding at April 1, 2022

 

 

2,795,017

 

 

$

 

5.79

 

Granted

 

 

2,102,840

 

 

 

 

2.93

 

Vested

 

 

(573,750

)

 

 

 

7.24

 

Forfeited

 

 

(2,119,448

)

 

 

 

4.76

 

Outstanding at March 31, 2023

 

 

2,204,659

 

 

$

 

3.68

 

A summary of stock award activity for the year ended March 31, 2022 is as follows:

 

 

Number of Shares

 

 

Weighted-Average Grant-Date Fair Value Per Share

 

Outstanding at April 1, 2021

 

 

1,973,004

 

 

$

 

3.94

 

Granted

 

 

3,347,200

 

 

 

 

6.56

 

Vested

 

 

(299,167

)

 

 

 

1.98

 

Forfeited

 

 

(2,226,020

)

 

 

 

5.82

 

Outstanding at March 31, 2022

 

 

2,795,017

 

 

$

 

5.79

 

As of March 31, 2024, there was $4,510,650 of unrecognized compensation expense related to unvested stock awards which is expected to be recognized over a weighted-average period of approximately 2.41 years.

As of March 31, 2023, there was $8,104,771 of unrecognized compensation expense related to unvested stock awards which is expected to be recognized over a weighted-average period of approximately 2.74 years.

As of March 31, 2022, there was $16,197,207 of unrecognized expense related to unvested stock awards which is expected to be recognized over a weighted-average period of approximately 2.40 years.

v3.25.1
PREFERRED STOCK
12 Months Ended
Mar. 31, 2024
Equity [Abstract]  
PREFERRED STOCK

NOTE 14 – PREFERRED STOCK

On May 18, 2021, the Company filed a Certificate of Designations (the “Certificate of Designations”) with the Secretary of State of the State of Delaware to establish the preferences, voting powers, limitations as to dividends or other distributions, qualifications, terms and conditions of redemption and other terms and conditions of the Series A Preferred Stock.

The Series A Cumulative Redeemable Perpetual Preferred Stock (“Series A Preferred Stock”), as to dividend rights and rights as to the distribution of assets upon the Company’s liquidation, dissolution or winding-up, ranks: (1) senior to all classes or series of Common Stock and to all other capital stock issued by the Company expressly designated as ranking junior to the Series A Preferred Stock; (2) on parity with any future class or series of the Company’s capital stock expressly designated as ranking on parity with the Series A Preferred Stock; (3) junior to any future class or series of the Company’s capital stock expressly designated as ranking senior to the Series A Preferred Stock; and (4) junior to all the Company’s existing and future indebtedness.

The Series A Preferred Stock has no stated maturity and is not subject to mandatory redemption or any sinking fund. In the event of the voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company, the holders of shares for the Series A Preferred Stock are entitled to be paid out of the Company’s assets legally available for distribution to its stockholders (i.e., after satisfaction of all the Company’s liabilities to creditors, if any) an amount equal to $25.00 per share of the Series A Preferred Stock, plus any amount equal to any accumulated and unpaid dividends to the date of payment before any distribution or payment may be made to holders of shares of Common Stock or any other class of or series of the Company’s capital stock ranking, as to rights to the distribution of assets upon any voluntary or involuntary liquidation, dissolution or winding up, junior to the Series A Preferred Stock.

The Company will pay cumulative cash dividends on the Series A Preferred Stock when, as and if declared by its Board of Directors (or a duly authorized committee of its Board of Directors), only out of funds legally available for payment of dividends. Dividends on the Series A Preferred Stock will accrue on the stated amount of $25.00 per share of the Series A Preferred Stock at a rate per annum equal to 8.75% (equivalent to $2.1875 per year), payable quarterly in arrears. Dividends on the Series A Preferred Stock declared by our Board of Directors (or a duly authorized committee of our Board of Directors) will be payable quarterly in arrears on March 15, June 15, September 15, and December 15.

Generally, the Series A Preferred Stock is not redeemable by the Company prior to May 18, 2026. However, upon a change of control or de-listing event (each as defined in the Certificate of Designations), the Company will have a special option to redeem the Series A Preferred Stock for a limited period of time.

On May 19, 2021, we entered into an underwriting agreement (the “Underwriting Agreement”) with Alexander Capital, L.P., as representative of several underwriters (collectively, the “Underwriters”), relating to a firm commitment public offering of 1,097,200 newly issued shares of our Series A Preferred Stock at a public offering price of $25.00 per share. Under the terms of the Underwriting Agreement, we granted the Underwriters a 45-day option to purchase up to an additional 164,580 shares of Series A Preferred Stock from us. The gross proceeds to us from the sale of 1,097,200 shares of Series A Preferred Stock, before deducting underwriting discounts and commissions and estimated offering expenses payable by us, was $27,430,000. The closing of the offering took place on May 21, 2021.

On May 25, 2021, we entered into an additional underwriting agreement with Alexander Capital, L.P. relating to a firm commitment public offering of 138,220 newly issued shares of our Series A Preferred Stock at a public offering price of $25.00 per share. The closing of the offering took place on May 27, 2021. The gross proceeds to us from the sale of 138,220 shares of Series A Preferred Stock, before deducting underwriting discounts and commissions and estimated offering expenses payable by us, were $3,455,500. Additionally, the Underwriters exercised its previously announced over-allotment option to purchase 164,580 shares of Series A Preferred Stock pursuant to the Underwriting Agreement. We closed the exercise of the over-allotment option on May 27, 2021. The gross proceeds from the exercise of the over-allotment option were $4,114,500, before deducting underwriting discounts and commissions.

The following is a summary of the dividends paid on the Series A Preferred Stock in the year ended March 31, 2024:

Dividend
Declaration
Date

 

Record
Date

 

Dividend
Period

 

Dividend
Payment
Date

 

Dividend
Amount

 

 

Per Share
Amount

 

May 15, 2023

 

May 31, 2023

 

March 15, 2023 - June 14, 2023

 

June 15, 2023

 

$

 

782,639

 

 

$

 

0.55902778

 

August 15, 2023

 

August 31, 2023

 

June 15, 2023 - September 14, 2023

 

September 15, 2023

 

 

 

782,639

 

 

 

 

0.55902778

 

November 15, 2023

 

November 30, 2023

 

September 15, 2023 - December 14, 2023

 

December 15, 2023

 

 

 

774,132

 

 

 

 

0.55295140

 

February 6, 2024

 

February 29, 2024

 

December 15, 2023 - March 14, 2024

 

March 15, 2024

 

 

 

774,132

 

 

 

 

0.55295140

 

Preferred dividends accumulated as of March 31, 2024 were $144,618.

The following is a summary of the dividends paid on the Series A Preferred Stock in the year ended March 31, 2023:

Dividend
Declaration
Date

 

Record
Date

 

Dividend
Period

 

Dividend
Payment
Date

 

Dividend
Amount

 

 

Per Share
Amount

 

May 12, 2022

 

May 31, 2022

 

March 15, 2022 - June 14, 2022

 

June 15, 2022

 

$

 

782,639

 

 

$

 

0.55902778

 

August 17, 2022

 

August 31, 2022

 

June 15, 2022 - September 14, 2022

 

September 15, 2022

 

 

 

782,639

 

 

 

 

0.55902778

 

November 18, 2022

 

November 30, 2022

 

September 15, 2022 - December 14, 2022

 

December 15, 2022

 

 

 

774,132

 

 

 

 

0.55295140

 

February 17, 2023

 

February 28, 2023

 

December 15, 2022 - March 14, 2023

 

March 15, 2023

 

 

 

765,625

 

 

 

 

0.54687500

 

Preferred dividends accumulated as of March 31, 2023 were $144,618.

The following is a summary of the dividends paid on the Series A Preferred Stock in the year ended March 31, 2022:

Dividend
Declaration
Date

 

Record
Date

 

Dividend
Period

 

Dividend
Payment
Date

 

Dividend
Amount

 

 

Per Share
Amount

 

August 17, 2021

 

August 31, 2021

 

May 21, 2021 - June 30, 2021

 

September 15, 2021

 

$

 

337,745

 

 

$

 

0.24124653

 

November 17, 2021

 

November 30, 2021

 

July 1, 2021 - December 14, 2021

 

December 15, 2021

 

 

 

1,420,700

 

 

 

 

1.01475694

 

February 18, 2022

 

February 28, 2022

 

December 15, 2021 - March 14, 2022

 

March 15, 2022

 

 

 

765,642

 

 

 

 

0.54687500

 

Preferred dividends accumulated as of March 31, 2022 were $144,562.

v3.25.1
ACQUISITIONS
12 Months Ended
Mar. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
ACQUISITIONS

NOTE 16 – ACQUISITIONS

Gemini Direct Investments, LLC

On April 30, 2021 (the “Merger Effective Date”) we entered into an agreement and plan of merger (the “Merger Agreement”), by and among the Company, SpeedLight Group I, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company (“Sub”), Gemini Direct Investments, LLC, a Nevada limited liability company (“Gemini”), and Steven F. Urvan, an individual (the “Seller”), whereby Sub merged with and into Gemini, with Sub surviving the merger as a wholly owned subsidiary of the Company (the “Merger”). At the time of the Merger, Gemini had nine (9) subsidiaries, all of which are related to Gemini’s ownership of the GunBroker business. GunBroker is an on-line auction marketplace dedicated to firearms, hunting, shooting, and related products. The Merger was completed on the Merger Effective Date.

In consideration of the Merger, on the terms and subject to the conditions set forth in the Merger Agreement, on the Merger Effective Date, (i) the Company assumed and repaid an aggregate amount of indebtedness of Gemini and its subsidiaries equal to $50,000,000 (the “Assumed Indebtedness”); and, (ii) the issued and outstanding membership interests in Gemini (the “Membership Interests”), held by the Seller, automatically converted into the right to receive (A) $50,000,000 (the “Cash Consideration”), and (B) 20,000,000 shares of Common Stock of the Company, $0.001 par value per share (the “Stock Consideration”).

In connection with the Merger Agreement, the Company and the Seller agreed that the Stock Consideration consisted of: (a) 14,500,000 shares issued without being held in escrow or requiring prior stockholder approval; (b) 4,000,000 shares issued subject to the Pledge and Escrow Agreement; and (c) 1,500,000 shares that will not be issued prior to the Company obtaining stockholder approval for the issuance (the “Additional Securities”).

The total estimated consideration consisted of cash payment of $50,000,000 less $1,350,046 of acquired cash, a working capital adjustment of $2,000,000, debt assumption and repayment upon closing of $50,000,000, contingent consideration of $10,755,000 for 1,500,000 Additional Securities, and 18,500,000 shares of Common Stock. The shares were valued at $7.17 per share, the five-day average closing price of the Company’s Common Stock immediately preceding the signing of the binding agreement.

Pursuant to the Merger Agreement, the Company completed a Post-Closing Adjustment following the close of the Merger equal to the Closing Working Capital minus the Estimated Working Capital at closing of the Merger. Accordingly, the Company received a cash payment of $129,114 and adjusted the $2,000,000 Estimated Working Capital Adjustment in the fair value of the consideration transferred to $1,870,886.

In accordance with the acquisition method of accounting for business combinations, the assets acquired, and the liabilities assumed have been recorded at their respective fair values. The consideration in excess of the fair values of assets acquired, and liabilities assumed are recorded as goodwill, which we expect to be deductible for tax purposes. The goodwill consists largely of the growth and profitability expected from this Merger.

The fair value of the consideration transferred was valued as follows:

 

Cash

 

$

48,649,954

 

Working capital adjustment

 

 

1,870,886

 

Contingent consideration

 

 

10,755,000

 

Common stock

 

 

132,645,000

 

Assumed debt

 

 

50,000,000

 

 

 

 

 

Fair value of consideration transferred

 

$

243,920,840

 

 

The allocation for the consideration recorded for the acquisition is as follows:

 

Accounts receivable, net

 

$

17,002,362

 

Prepaid expenses

 

 

478,963

 

Equipment

 

 

1,051,980

 

Deposits

 

 

703,389

 

Other intangible assets(1)

 

 

146,617,380

 

Goodwill

 

 

90,870,094

 

Right of use assets - operating leases

 

 

612,727

 

Accounts payable

 

 

(12,514,919

)

Accrued expenses

 

 

(196,780

)

Operating lease liability

 

 

(704,356

)

 

 

 

 

Total Consideration

 

$

243,920,840

 

(1)
Other intangible assets consist of Tradenames, Customer Relationships, Intellectual Property, and other tangible assets related to the acquired business.

We recorded approximately $1.3 million in transaction costs in the year ended March 31, 2022 related to the Merger.

Unaudited Pro Forma Results of Operations

These pro forma results of operations give effect to the Merger as if it had occurred on April 1, 2021. Material pro forma adjustments include the removal of approximately $1.8 million of interest expenses and debt discount amortization and the addition of approximately $0.9 million of depreciation and amortization expenses.

INCOME STATEMENT DATA

 

For the Year Ended March 31, 2022

 

Net revenues

 

$

248,314,587

 

Net income

 

$

37,793,924

 

The unaudited pro forma condensed combined financial information is presented for illustrative purposes only and is not necessarily indicative of the results of operations and financial position that would have been achieved had the Merger been completed and taken place on the dates indicated or the future consolidated results of operations or financial position of the Company.

v3.25.1
ACCRUED LIABILITIES
12 Months Ended
Mar. 31, 2024
Payables and Accruals [Abstract]  
ACCRUED LIABILITIES

NOTE 17 – ACCRUED LIABILITIES

At March 31, 2024, March 31, 2023, and March 31, 2022, accrued liabilities were as follows:

 

 

March 31, 2024

 

 

March 31,
2023

 

 

March 31,
2022

 

 

 

(Restated)

 

 

(Restated)

 

 

(Restated)

 

Accrued federal excise tax

 

$

 

1,145,937

 

 

$

 

1,808,065

 

 

$

 

2,408,318

 

Accrued bonus program

 

 

 

1,185,877

 

 

 

 

-

 

 

 

 

-

 

Accrued professional fees

 

 

 

1,134,368

 

 

 

 

736,323

 

 

 

 

66,000

 

Accrued payroll

 

 

 

964,661

 

 

 

 

430,344

 

 

 

 

458,027

 

Other accruals

 

 

 

417,496

 

 

 

 

618,243

 

 

 

 

357,616

 

Income taxes payable

 

 

 

394,133

 

 

 

 

438,517

 

 

 

 

1,784,266

 

Unearned revenue

 

 

 

1,822,972

 

 

 

 

101,593

 

 

 

 

201,891

 

Accrued sales commissions

 

 

 

-

 

 

 

 

252,366

 

 

 

 

932,712

 

Accrued interest

 

 

 

-

 

 

 

 

2,681

 

 

 

 

4,762

 

Accrued liabilities

 

$

 

7,065,444

 

 

$

 

4,388,132

 

 

$

 

6,213,592

 

v3.25.1
RELATED PARTY TRANSACTIONS (AS RESTATED)
12 Months Ended
Mar. 31, 2024
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS (AS RESTATED)

NOTE 18 – RELATED PARTY TRANSACTIONS (AS RESTATED)

During the year ended March 31, 2024, we paid $410,173 in service fees to two independent contractors consisting of a $244,640 payment due upon termination without cause. The two independent contractors were issued 168,581 shares of Common Stock for a total value of $449,370, which consisted of an issuance of 134,240 shares due upon termination without cause. We issued 25,000 shares in the aggregate to our advisory committee members for service for a total value of $43,240. Through our acquisition of Gemini, a related party relationship was created through one of our Members of the Board of Directors by ownership of entities that transacts with Gemini. There was $201,646 included in our Accounts Receivable at March 31, 2024 as a result of this relationship. Additionally, we owed $150,866 to Jagemann Precision Tooling, a division of JSC, at March 31, 2024.

On July 24, 2023, Fred Wagenhals departed as CEO and the Board appointed Mr. Wagenhals the Company’s Executive Chairman. Mr. Wagenhals received the following payments in connection with his transition from CEO to Executive Chairman: (i) total cash payments of $1,060,290; (ii) 300,000 shares of Common Stock for a total value of $639,000.

On July 26, 2023, we obtained a $1.6 million letter of credit with Northern Trust for collateral for a bond related to a judgment assessed to GunBroker. On July 17, 2023, we generated a $1.6 million certificate of deposit with Northern Trust for security on the letter of credit. The term of the certificate of deposit is twelve months and includes interest of approximately 5%. Per the terms of the Merger Agreement, the Seller is required to pay or be liable for these losses.

In July of 2023, the Company filed suit in the Delaware Chancery Court against director and the Company's largest shareholder Steve Urvan for claims arising out of the Company’s acquisition of certain companies referenced as the GunBroker family of companies. The Company alleges that Mr. Urvan’s repeatedly failed and refused to honor contractual defense and indemnification obligations arising under that certain Merger Agreement, along with alleged misrepresentations.

On November 3, 2022, the Company entered into a Settlement Agreement (the “2022 Urvan Settlement Agreement”) with Steven F. Urvan and Susan T. Lokey (collectively with each of their respective affiliates and associates, the “Urvan Group”).

Pursuant to the 2022 Urvan Settlement Agreement, the Urvan Group has agreed to withdraw its notice of stockholder nomination of its seven director candidates (the “Urvan Candidates”) and its demand to inspect books and records, pursuant to Section 220 of the General Corporation Law of the State of Delaware, and the Company agreed to immediately increase the size of the Board from seven to nine directors and appoint Christos Tsentas and Wayne Walker (each, a “New Director” and the New Directors together with Mr. Urvan, the “Urvan Group Directors”) to the Board to serve as directors with terms expiring at the 2022 Annual Meeting of Stockholders (the “2022 Annual Meeting”). The Company will include the Urvan Group Directors in its director candidates slate for the 2022 Annual Meeting and any subsequent Annual Meeting of Stockholders of the Company occurring prior to the Termination Date (as defined below). The Company has agreed to not increase the size of the Board above nine directors prior to the Termination Date unless the increase is approved by at least seven directors. Mr. Wagenhals will continue to serve as a director and Chairman of the Board.

Unless otherwise mutually agreed to in writing by each party, the 2022 Urvan Settlement Agreement will remain in effect until the date that is the earlier of (i) 30 days prior to the earlier of (A) the deadline set forth in the notice requirements of Federal “Universal Proxy Rules” promulgated under Rule 14a-19(a) and Rule 14a-19(b) under the Securities Exchange Act of 1934, as amended (the “UPR Deadline”) relating to the Company’s 2023 Annual Meeting of Stockholders (the “2023 Annual Meeting”) and (B) any deadline that may be set forth in the Company’s Amended and Restated Certificate of Incorporation (as amended from time to time, the “Certificate”) or Bylaws (the “Bylaws”) following the execution of the 2022 Urvan Settlement Agreement relating to the nomination of director candidates for election to the Board at the 2023 Annual Meeting, and (ii) 90 days prior to the first anniversary of the 2022 Annual Meeting (such date, the “Termination Date”). However, if the Company notifies Mr. Urvan in writing at least 15 days prior to such Termination Date that the Board irrevocably offers to re-nominate the Urvan Group Directors for election at the 2023 Annual Meeting and Mr. Urvan accepts such offer within 15 days of receipt of such notice, the Termination Date will be automatically extended until the earlier of (i) 30 days prior to the earlier of (A) the UPR Deadline relating to the Company’s 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”) and (B) any deadline that may be set forth in the Certificate or the Bylaws following execution of the 2022 Urvan Settlement Agreement relating to the nomination of director candidates for election to the Board at the 2024 Annual Meeting, and (ii) 90 days prior to the first anniversary of the 2023 Annual Meeting. Notwithstanding the foregoing, the “Termination Date” shall not occur prior to 20 days after Mr. Urvan’s departure from the Board. Pursuant to the 2022 Urvan Settlement Agreement, the Urvan Group agreed to certain standstill provisions effective during the period prior to the Termination Date. The Urvan Group agreed not to, among others, (i) nominate, recommend for nomination or give notice of an intent to nominate directors to be elected, (ii) seek to amend the certificate of incorporation or bylaws of the Company, (iii) demand an inspection of the Company’s books and records or (iv) knowingly initiate, make or in any way participate, directly or indirectly, incertain extraordinary transaction. The Company paid approximately $500,000 of the Urvan Group’s costs, fees and expenses per the terms of the 2022 Urvan Settlement Agreement.

Pursuant to the 2022 Urvan Settlement Agreement, the Company will agree to suspend the previously announced separation of Company into Action Outdoor Sports, Inc. and Outdoor Online, Inc., pending the further evaluation of strategic options by the Board. The Company paid approximately $500,000 of the Urvan Group’s costs, fees, and expenses per the terms of the 2022 Urvan Settlement Agreement. Additionally, the Company issued 125,000 shares of Common Stock for a total value of $777,500 to an employee and issued 110,000 shares of Common Stock for a total value of $259,000 to an independent contractor as a result of termination without cause per the terms of the 2022 Urvan Settlement Agreement.

The foregoing summary of the 2022 Urvan Settlement Agreement does not purport to be complete and is subject to, and qualified in its entirety, by reference to the full text of the 2022 Urvan Settlement Agreement, a copy of which was previously filed as Exhibit 10.1 in the Form 8-K filed with the SEC on November 7, 2022, and incorporated herein by reference.

During the year ended March 31, 2023, we paid $551,916 in service fees to two independent contractors of which $223,333 were created as a result of termination without cause as a result of our Proxy Settlement Agreement. The two independent contractors were issued 141,419 shares of our Common Stock for a total value of $791,384 in addition to the issuances described in the foregoing paragraphs. We issued 45,000 shares in the aggregate to its advisory committee members for service for a total value of $245,250.

During the year ended March 31, 2022, we paid $229,083 in service fees to an independent contractor and we issued 60,000 shares in the aggregate to its advisory committee members for service for a total value of $198,000. Through our acquisition of Gemini, a related party relationship was created through Mr. Urvan's ownership of an entity that transacts with Gemini. At March 31, 2022, 2023, and 2024 there $139,164, $182,344, and 201,646 respectively, included in the accounts receivable related to business included in our Accounts Receivable at March 31, 2022 as a result of this relationship.

During the year ended March 31, 2022, the Company paid $50,698 to a third-party service provider owned by an immediate family member of Fred Wagenhals, who was the Company's Chief Executive Officer and Chairman of the Board of Directors at the time, for services rendered.

In December 2020, the Company entered into an agreement with Larson Building to serve as the general contractor for the construction of its Manitowoc, WI manufacturing facility. Larson Building is wholly owned by the brother of Chris Larson, who was an executive officer of the Company at the time. During the years ended March 31, 2023 and 2022, the Company paid $14,584,805 and $11,221,738, respectively, to Larson Building in connection with this project.

After the initial filings of the Company’s Form 10-Ks for the years ended March 31, 2024, 2023 and 2022, the Company was made aware that Chris Larson had received undisclosed payments totaling $814,863 from a vendor from which the Company received services. The payments were made by a third-party service provider. This third-party made payments to Mr. Larson from approximately January 2022 through March 2024 based upon a percentage of revenue received in connection with services rendered to the Company. Mr. Larson separated as an employee from the Company effective November 4, 2022 and was later engaged as a contractor for approximately six months.

Through the Administrative and Management Services Agreement between the Company and JSC, the Company purchased approximately $2.0 million in inventory support services, and incurred $170,355 of rent expenses for the year ended March 31, 2023. The Company purchased approximately $1.7 million in inventory support services, and incurred $408,852 of rent expenses for the year ended March 31, 2022.

See Note 12 for further discussion of related party transactions with JSC.

v3.25.1
INCOME TAXES
12 Months Ended
Mar. 31, 2024
Income Tax Disclosure [Abstract]  
INCOME TAXES

NOTE 19 – INCOME TAXES

The income tax (provision) benefit for the periods shown consist of the following:

 

 

For the year ended March 31,

 

 

2024

 

 

2023

 

 

2022

 

 

 

(Restated)

 

 

(Restated)

 

 

(Restated)

 

Current

 

 

 

 

 

 

 

 

 

US Federal

 

$

-

 

 

$

-

 

 

$

(2,628,241

)

US State

 

 

-

 

 

 

-

 

 

 

(765,545

)

Total current provision

 

 

-

 

 

 

-

 

 

 

(3,393,786

)

Deferred

 

 

 

 

 

 

 

 

 

US Federal

 

 

2,986,152

 

 

 

(492,171

)

 

 

(6,675,540

)

US State

 

 

819,966

 

 

 

(220,068

)

 

 

(1,374,865

)

Total deferred benefit

 

 

3,806,118

 

 

 

(712,239

)

 

 

(8,050,405

)

Change in valuation allowance

 

 

-

 

 

 

-

 

 

 

9,401,273

 

Income tax (provision) benefit

 

$

3,806,118

 

 

$

(712,239

)

 

$

(2,042,918

)

The reconciliation of income tax expense computed at the U.S. federal statutory rate of 21% to the income tax provision is as follows:

 

For the Year Ended March 31,

 

 

2024

 

 

 

2023

 

 

 

2022

 

 

 

 

(Restated)

 

 

 

(Restated)

 

 

 

(Restated)

 

 

U.S. Federal

 

 

21.0

 

%

 

 

21.0

 

%

 

 

21.0

 

%

State taxes, net of Federal income tax benefit

 

 

5.6

 

%

 

 

6.0

 

%

 

 

5.7

 

%

Change in valuation allowance

 

 

0.0

 

%

 

 

0.0

 

%

 

 

(33.7

)

%

Employee stock awards

 

 

(7.4

)

%

 

 

(33.3

)

%

 

 

7.0

 

%

Equity issuance costs

 

 

0.0

 

%

 

 

0.0

 

%

 

 

6.2

 

%

Stock and warrants on note conversion

 

 

0.0

 

%

 

 

(1.9

)

%

 

 

1.4

 

%

Stock for services

 

 

0.0

 

%

 

 

0.0

 

%

 

 

0.0

 

%

Non-deductible meals and entertainment

 

 

(0.1

)

%

 

 

(0.4

)

%

 

 

0.1

 

%

Contingent consideration fair value

 

 

0.1

 

%

 

 

0.2

 

%

 

 

(0.4

)

%

Return to provision

 

 

0.0

 

%

 

 

0.0

 

%

 

 

0.0

 

%

Other

 

 

(0.4

)

%

 

 

(0.3

)

%

 

 

0.0

 

%

Total provision for income taxes

 

 

18.7

 

%

 

 

(8.8

)

%

 

 

7.3

 

%

 

The Company’s effective tax rates were 18.7%, (8.8%), and 7.3% for the years ended March 31, 2024, 2023 and 2022, respectively. Prior to the year ended March 31, 2022, we accumulated net operating losses in the amount of $61.5 million. These net operating losses created a deferred tax asset which carried a valuation allowance due to uncertainty regarding the timing and ability of the Company to utilize such losses against current income. During the year ended March 31, 2023, the Company generated significant taxable income which consumed $32.3 million of net operating loss carryforwards. This caused the release of the valuation allowance in the amount of $9.4 million. The release of the valuation allowance reduced tax expense and had a direct impact on the tax rate in the

year ended March 31, 2022. During the years ended March 31, 2024 and 2023, the effective tax rate differed from the U.S. federal statutory rate primarily due to employee stock awards.

Significant components of the Company’s deferred tax liabilities and assets are as follows:

 

As of March 31,

 

 

 

2024

 

 

2023

 

 

2022

 

Deferred tax assets

 

(Restated)

 

 

(Restated)

 

 

(Restated)

 

Net operating loss carryforward

 

$

5,229,409

 

 

$

731,597

 

 

$

 

Loss on purchase

 

 

2,215,611

 

 

 

2,210,878

 

 

 

2,225,477

 

Amortization

 

 

(1,029,565

)

 

 

(52,658

)

 

 

887,892

 

Bad debt allowance

 

 

973,565

 

 

 

860,314

 

 

 

814,967

 

Other

 

 

297,195

 

 

 

(137,835

)

 

 

(335,847

)

Total deferred tax assets

 

$

7,686,215

 

 

$

3,612,296

 

 

$

3,592,489

 

 

 

 

 

 

 

 

 

 

 

Deferred tax liabilities

 

 

 

 

 

 

 

 

 

Depreciation expense

 

$

(3,580,271

)

 

$

(3,510,041

)

 

$

(3,082,977

)

Sec 263A

 

$

1,001,457

 

 

$

1,191,918

 

 

$

1,302,919

 

True up

 

$

(699,910

)

 

$

(698,417

)

 

$

(461,563

)

Other

 

 

 

 

 

 

 

 

 

Total deferred tax liabilities

 

$

(3,278,724

)

 

$

(3,016,540

)

 

$

(2,241,621

)

Net deferred tax assets/(liabilities)

 

$

4,407,491

 

 

$

595,756

 

 

$

1,350,868

 

Valuation allowance

 

 

 

 

 

 

 

 

 

Net deferred tax assets/(liabilities)

 

$

4,407,491

 

 

$

595,756

 

 

$

1,350,868

 

 

The Company accounts for uncertain tax positions in accordance with ASC No. 740-10-25. ASC No. 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under ASC No. 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefit to be recognized is measured as the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. To the extent that the final tax outcome of these matters is different than the amount recorded, such differences impact income tax expense in the period in which such determination is made. Interest and penalties, if any, related to accrued liabilities for potential tax assessments are included in income tax expense. ASC No. 740-10-25 also requires management to evaluate tax positions taken by the Company and recognize a liability if the Company has taken uncertain tax positions that more likely than not would not be sustained upon examination by applicable taxing authorities.

The Company has evaluated tax positions taken by the Company as of March 31, 2024, 2023 and 2022 in accordance with the recognition and measurement framework within ASC No. 740-10, and has concluded that the benefits associated with certain tax positions should not be recognized on the financial statements. As such, the Company has recorded an additional income tax payable on the consolidated balance sheet of $1.6 million as of March 31, 2024, 2023 and 2022. Included within this amount is accrued penalties and interest of $0.3 million. The Company records penalties and interest associated with uncertain tax positions as a component of income tax expense.

 

The Company has never had an Internal Revenue Service audit; therefore, the tax periods ended December 31, 2016, December 31, 2017 and March 31, 2018, 2019, 2020, 2021, 2022, 2023, and 2024 are subject to audit.

v3.25.1
GOODWILL AND INTANGIBLE ASSETS
12 Months Ended
Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND INTANGIBLE ASSETS

NOTE 20 – GOODWILL AND INTANGIBLE ASSETS

During the year ended March 31, 2022, we recorded $90,870,094 of goodwill generated from our Merger with Gemini. The balance of goodwill at March 31, 2024 and 2023 was $90,870,094. We did not have any goodwill prior to the year ended March 31, 2022.

Total amortization expense of our intangible assets was $12,968,491, $13,114,325, and $13,143,168 for the years ended March 31, 2024, 2023, and 2022, respectively. During the year ended March 31, 2024, we disposed of an intangible asset resulting in a loss of $108,333, which is reflected in other (expense) income on the consolidated statement of operations.

Intangible assets consisted of the following:

 

 

 

March 31, 2024

 

 

Life

 

Licenses

 

 

Patent

 

 

Other
Intangible
Assets

 

 

 

 

 

(Restated)

 

 

(Restated)

 

 

(Restated)

 

Licensing Agreement – Jesse James

 

5

 

$

125,000

 

 

$

-

 

 

$

-

 

Licensing Agreement – Jeff Rann

 

5

 

 

250,000

 

 

 

-

 

 

 

-

 

Streak Visual Ammunition patent

 

11.2

 

 

-

 

 

 

950,000

 

 

 

-

 

SWK patent acquisition

 

15

 

 

-

 

 

 

6,652,005

 

 

 

-

 

Jagemann Munition Components:

 

 

 

 

 

 

 

 

 

 

 

Customer Relationships

 

3

 

 

-

 

 

 

-

 

 

 

1,450,613

 

Intellectual Property

 

3

 

 

-

 

 

 

-

 

 

 

1,543,548

 

Tradename

 

5

 

 

-

 

 

 

-

 

 

 

2,152,076

 

GDI Acquisition:

 

 

 

 

 

 

 

 

 

 

 

Tradename

 

15

 

 

-

 

 

 

-

 

 

 

76,532,389

 

Customer List

 

10

 

 

-

 

 

 

-

 

 

 

65,252,802

 

Intellectual Property

 

10

 

 

-

 

 

 

-

 

 

 

4,224,442

 

Other Intangible Assets

 

5

 

 

-

 

 

 

-

 

 

 

357,747

 

 

 

 

 

375,000

 

 

 

7,602,005

 

 

 

151,513,617

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated amortization – Licensing Agreements

 

 

 

 

(375,000

)

 

 

-

 

 

 

-

 

Accumulated amortization – Patents

 

 

 

 

-

 

 

 

(2,845,999

)

 

 

-

 

Accumulated amortization – Intangible Assets

 

 

 

 

-

 

 

 

-

 

 

 

(40,464,550

)

 

 

 

$

-

 

 

$

4,756,006

 

 

$

111,049,067

 

 

 

 

 

March 31, 2023

 

 

Life

 

Licenses

 

 

Patent

 

 

Other
Intangible
Assets

 

 

 

 

 

(Restated)

 

 

(Restated)

 

 

 

 

Licensing Agreement – Jesse James

 

5

 

$

125,000

 

 

$

-

 

 

$

-

 

Licensing Agreement – Jeff Rann

 

5

 

 

250,000

 

 

 

-

 

 

 

-

 

Streak Visual Ammunition patent

 

11.2

 

 

-

 

 

 

950,000

 

 

 

-

 

SWK patent acquisition

 

15

 

 

-

 

 

 

6,652,005

 

 

 

-

 

Jagemann Munition Components:

 

 

 

 

 

 

 

 

 

 

 

Customer Relationships

 

3

 

 

-

 

 

 

-

 

 

 

1,450,613

 

Intellectual Property

 

3

 

 

-

 

 

 

-

 

 

 

1,543,548

 

Tradename

 

5

 

 

-

 

 

 

-

 

 

 

2,152,076

 

GDI Acquisition:

 

 

 

 

 

 

 

 

 

 

 

Tradename

 

15

 

 

-

 

 

 

-

 

 

 

76,532,389

 

Customer List

 

10

 

 

-

 

 

 

-

 

 

 

65,252,802

 

Intellectual Property

 

10

 

 

-

 

 

 

-

 

 

 

4,224,442

 

Other Intangible Assets

 

5

 

 

-

 

 

 

-

 

 

 

607,747

 

 

 

 

 

375,000

 

 

 

7,602,005

 

 

 

151,763,617

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated amortization – Licensing Agreements

 

 

 

 

(375,000

)

 

 

 

 

 

-

 

Accumulated amortization – Patents

 

 

 

 

-

 

 

 

(2,305,251

)

 

 

-

 

Accumulated amortization – Intangible Assets

 

 

 

 

-

 

 

 

-

 

 

 

(28,036,807

)

 

 

 

$

-

 

 

$

5,296,754

 

 

$

123,726,810

 

 

 

 

 

 

March 31, 2022

 

 

Life

 

Licenses

 

 

Patent

 

 

Other
Intangible
Assets

 

 

 

 

 

(Restated)

 

 

(Restated)

 

 

 

 

Licensing Agreement – Jesse James

 

5

 

$

125,000

 

 

$

-

 

 

$

-

 

Licensing Agreement – Jeff Rann

 

5

 

 

250,000

 

 

 

-

 

 

 

-

 

Streak Visual Ammunition patent

 

11.2

 

 

-

 

 

 

950,000

 

 

 

-

 

SWK patent acquisition

 

15

 

 

-

 

 

 

6,652,005

 

 

 

-

 

Jagemann Munition Components:

 

 

 

 

 

 

 

 

 

 

 

Customer Relationships

 

3

 

 

-

 

 

 

-

 

 

 

1,450,613

 

Intellectual Property

 

3

 

 

-

 

 

 

-

 

 

 

1,543,548

 

Tradename

 

5

 

 

-

 

 

 

-

 

 

 

2,152,076

 

GDI Acquisition:

 

 

 

 

 

 

 

 

 

 

 

Tradename

 

15

 

 

-

 

 

 

-

 

 

 

76,532,389

 

Customer List

 

10

 

 

-

 

 

 

-

 

 

 

65,252,802

 

Intellectual Property

 

10

 

 

-

 

 

 

-

 

 

 

4,224,442

 

Other Intangible Assets

 

5

 

 

-

 

 

 

-

 

 

 

607,747

 

 

 

 

 

375,000

 

 

 

7,602,005

 

 

 

151,763,617

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated amortization – Licensing Agreements

 

 

 

 

(375,000

)

 

 

-

 

 

 

-

 

Accumulated amortization – Patents

 

 

 

 

-

 

 

 

(1,764,503

)

 

 

-

 

Accumulated amortization – Intangible Assets

 

 

 

 

-

 

 

 

-

 

 

 

(15,463,230

)

 

 

 

$

-

 

 

$

5,837,502

 

 

$

136,300,387

 

Annual estimated amortization of intangible assets for the next five fiscal years are as follows:

Years Ended March 31,

 

Estimates for
Fiscal Year

 

2025

 

$

12,697,926

 

2026

 

 

12,662,059

 

2027

 

 

12,596,472

 

2028

 

 

12,590,510

 

2029

 

 

12,555,076

 

Thereafter

 

 

52,703,030

 

 

 

$

115,805,073

 

v3.25.1
SEGMENTS
12 Months Ended
Mar. 31, 2024
Segment Reporting [Abstract]  
SEGMENTS

NOTE 21 – SEGMENTS

On April 30, 2021, the Company entered into the Merger Agreement with Gemini, which, along with its subsidiaries, engages primarily in the operation of an online marketplace dedicated to firearms, hunting, shooting and related products. As a result, at March 31, 2024, our Chief Executive Officer reviews financial performance based on two operating segments as follows:

Ammunition – which consists of our manufacturing business. The Ammunition segment engages in the design, production and marketing of ammunition, ammunition component and related products.
Marketplace – which consists of the GunBroker E-commerce marketplace. In its role as an auction site, GunBroker supports the lawful sale of firearms, ammunition, and hunting/shooting accessories.

The following tables set forth certain financial information utilized by management to evaluate our operating segments for the annual periods presented:

 

 

For the Year Ended March 31, 2024

 

 

Ammunition

 

 

Marketplace

 

 

Corporate
and other
expenses

 

 

Total

 

 

 

(As Restated)

 

Net Revenues

 

$

91,112,496

 

 

$

53,942,076

 

 

$

-

 

 

$

145,054,572

 

Cost of Revenues

 

 

94,818,546

 

 

 

7,660,541

 

 

 

-

 

 

 

102,479,087

 

General and administrative expense

 

 

8,967,456

 

 

 

9,885,131

 

 

 

29,800,768

 

 

 

48,653,355

 

Depreciation and amortization

 

 

508,485

 

 

 

13,034,306

 

 

 

-

 

 

 

13,542,791

 

Income/(Loss) from Operations

 

$

(13,181,991

)

 

$

23,362,098

 

 

$

(29,800,768

)

 

$

(19,620,661

)

 

 

For the Year Ended March 31, 2023

 

 

Ammunition

 

 

Marketplace

 

 

Corporate
and other
expenses

 

 

Total

 

 

 

(As Restated)

 

Net Revenues

 

$

128,290,128

 

 

$

63,149,673

 

 

$

-

 

 

$

191,439,801

 

Cost of Revenues

 

 

126,961,549

 

 

 

9,116,939

 

 

 

-

 

 

 

136,078,488

 

General and administrative expense

 

 

10,378,456

 

 

 

9,707,425

 

 

 

29,444,236

 

 

 

49,530,117

 

Depreciation and amortization

 

 

578,326

 

 

 

12,700,436

 

 

 

-

 

 

 

13,278,762

 

Income/(Loss) from Operations

 

$

(9,628,203

)

 

$

31,624,873

 

 

$

(29,444,236

)

 

$

(7,447,566

)

 

 

For the Year Ended March 31, 2022

 

 

Ammunition

 

 

Marketplace

 

 

Corporate
and other
expenses

 

 

Total

 

 

 

(As Restated)

 

Net Revenues

 

$

175,660,650

 

 

$

64,608,516

 

 

$

-

 

 

$

240,269,166

 

Cost of Revenues

 

 

142,820,590

 

 

 

8,732,351

 

 

 

-

 

 

 

151,552,941

 

General and administrative expense

 

 

11,932,720

 

 

 

8,434,308

 

 

 

26,098,079

 

 

 

46,465,107

 

Depreciation and amortization

 

 

1,602,695

 

 

 

12,122,370

 

 

 

-

 

 

 

13,725,065

 

Income/(Loss) from Operations

 

$

19,304,645

 

 

$

35,319,487

 

 

$

(26,098,079

)

 

$

28,526,053

 

 

Total assets by segment were as follows:

 

For the Year Ended

 

 

March 31,
2024

 

 

March 31,
2023

 

 

March 31,
2022

 

Ammunition

 

$

167,001,641

 

 

$

154,904,363

 

 

$

161,967,259

 

Marketplace

 

 

236,037,694

 

 

 

258,290,780

 

 

 

253,873,206

 

 

$

403,039,335

 

 

$

413,195,143

 

 

$

415,840,465

 

 

Total capital expenditures by segment were as follows:

 

For the Year Ended

 

 

March 31,
2024

 

 

March 31,
2023

 

 

March 31,
2022

 

Ammunition

 

$

5,519,135

 

 

$

10,819,177

 

 

$

17,728,023

 

Marketplace

 

 

2,505,630

 

 

 

1,722,148

 

 

 

1,490,959

 

 

$

8,024,765

 

 

$

12,541,325

 

 

$

19,218,982

 

v3.25.1
QUARTERLY RESULTS OF OPERATIONS
12 Months Ended
Mar. 31, 2024
Quarterly Financial Information Disclosure [Abstract]  
QUARTERLY RESULTS OF OPERATIONS

NOTE 22 – QUARTERLY RESULTS OF OPERATIONS (UNAUDITED)

Quarterly Statement of Operations Information

Unaudited interim consolidated results of operations for the fiscal year ended March 31, 2024 were as follows:

 

 

Quarter Ended

 

 

Fiscal 2024

 

June 30,

 

 

September 30,

 

 

December 31,

 

 

March 31,

 

 

(Unaudited)

 

2023

 

 

2023

 

 

2023

 

 

2024

 

 

 

 

(Restated)

 

 

(Restated)

 

 

(Restated)

 

 

(Restated)

 

 

Net revenues

 

$

 

34,254,575

 

 

$

 

34,372,386

 

 

$

 

36,006,464

 

 

$

 

40,421,147

 

 

Gross profit

 

 

 

14,012,719

 

 

 

 

8,276,445

 

 

 

 

10,898,555

 

 

 

 

9,387,766

 

 

Loss from operations

 

 

 

(1,998,400

)

 

 

 

(9,011,953

)

 

 

 

(2,576,497

)

 

 

 

(6,033,811

)

 

Net loss

 

 

 

(1,304,062

)

 

 

 

(7,665,967

)

 

 

 

(2,405,778

)

 

 

 

(5,217,802

)

 

Net loss attributable to common stock shareholders

 

 

 

(2,078,194

)

 

 

 

(8,448,606

)

 

 

 

(3,188,417

)

 

 

 

(6,000,441

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

 

(0.02

)

 

$

 

(0.07

)

 

$

 

(0.03

)

 

$

 

(0.05

)

 

Diluted

 

$

 

(0.02

)

 

$

 

(0.07

)

 

$

 

(0.03

)

 

$

 

(0.05

)

 

 

The following tables set for the restatement of the Company's unaudited interim consolidated results of operations for the three months ended June 30, 2023, three and six months ended September 30, 2023, the three and nine months ended December 31, 2023, and the three months ended March 31, 2024:

 

 

For the three months ended June 30, 2023

 

 

(Unaudited)

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

 

 

Stock Based
Payments

 

 

Other

 

 

As Restated

 

 

Net revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ammunition sales

 

 $

 

14,106,029

 

 

 $

 

-

 

 

 $

 

-

 

 

 $

 

14,106,029

 

 

Marketplace revenue

 

 

 

13,912,202

 

 

 

 

-

 

 

 

 

-

 

 

 

 

13,912,202

 

 

Casing sales

 

 

 

6,236,344

 

 

 

 

-

 

 

 

 

-

 

 

 

 

6,236,344

 

 

Total revenues

 

 

 

34,254,575

 

 

 

 

-

 

 

 

 

-

 

 

 

 

34,254,575

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues

 

 

 

20,230,035

 

 

 

 

-

 

 

 

 

11,821

 

 

 

 

20,241,856

 

 

Gross profit

 

 

 

14,024,540

 

 

 

 

-

 

 

 

 

(11,821

)

 

 

 

14,012,719

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling and marketing

 

 

 

295,581

 

 

 

 

-

 

 

 

 

-

 

 

 

 

295,581

 

 

Corporate general and administrative

 

 

 

7,947,563

 

 

 

 

-

 

 

 

 

-

 

 

 

 

7,947,563

 

 

Employee salaries and related expenses

 

 

 

4,116,280

 

 

 

 

307,652

 

 

 

 

-

 

 

 

 

4,423,932

 

 

Depreciation and amortization expense

 

 

 

3,344,043

 

 

 

 

-

 

 

 

 

-

 

 

 

 

3,344,043

 

 

Total operating expenses

 

 

 

15,703,467

 

 

 

 

307,652

 

 

 

 

-

 

 

 

 

16,011,119

 

 

Income/(loss) from operations

 

 

 

(1,678,927

)

 

 

 

(307,652

)

 

 

 

(11,821

)

 

 

 

(1,998,400

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income

 

 

 

692,951

 

 

 

 

-

 

 

 

 

-

 

 

 

 

692,951

 

 

Interest expense

 

 

 

(204,201

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(204,201

)

 

Total other expense

 

 

 

488,750

 

 

 

 

-

 

 

 

 

-

 

 

 

 

488,750

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income/(loss) before income taxes

 

 

 

(1,190,177

)

 

 

 

(307,652

)

 

 

 

(11,821

)

 

 

 

(1,509,650

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

 

(97,144

)

 

 

 

-

 

 

 

 

(108,444

)

 

 

 

(205,588

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

 

 

(1,093,033

)

 

 

 

(307,652

)

 

 

 

96,623

 

 

 

 

(1,304,062

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock dividend

 

 

 

(774,132

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(774,132

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) attributable to common stock shareholders

 

$

 

(1,867,165

)

 

$

 

(307,652

)

 

$

 

96,623

 

 

$

 

(2,078,194

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 $

 

(0.02

)

 

 

 

 

 

 

 

 

 

 $

 

(0.02

)

 

Diluted

 

 $

 

(0.02

)

 

 

 

 

 

 

 

 

 

 $

 

(0.02

)

 

 

 

 

 

For the three months ended September 30, 2023

 

 

(Unaudited)

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

 

 

Stock Based
Payments

 

 

Other

 

 

As Restated

 

 

Net revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ammunition sales

 

 $

 

15,516,589

 

 

 $

 

-

 

 

 $

 

-

 

 

 $

 

15,516,589

 

 

Marketplace revenue

 

 

 

12,474,716

 

 

 

 

-

 

 

 

 

-

 

 

 

 

12,474,716

 

 

Casing sales

 

 

 

6,381,081

 

 

 

 

-

 

 

 

 

-

 

 

 

 

6,381,081

 

 

Total revenues

 

 

 

34,372,386

 

 

 

 

-

 

 

 

 

-

 

 

 

 

34,372,386

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues

 

 

 

26,084,120

 

 

 

 

-

 

 

 

 

11,821

 

 

 

 

26,095,941

 

 

Gross profit

 

 

 

8,288,266

 

 

 

 

-

 

 

 

 

(11,821

)

 

 

 

8,276,445

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling and marketing

 

 

 

289,952

 

 

 

 

-

 

 

 

 

-

 

 

 

 

289,952

 

 

Corporate general and administrative

 

 

 

7,855,624

 

 

 

 

-

 

 

 

 

-

 

 

 

 

7,855,624

 

 

Employee salaries and related expenses

 

 

 

5,590,035

 

 

 

 

180,985

 

 

 

 

-

 

 

 

 

5,771,020

 

 

Depreciation and amortization expense

 

 

 

3,371,802

 

 

 

 

-

 

 

 

 

-

 

 

 

 

3,371,802

 

 

Total operating expenses

 

 

 

17,107,413

 

 

 

 

180,985

 

 

 

 

-

 

 

 

 

17,288,398

 

 

Income/(loss) from operations

 

 

 

(8,819,147

)

 

 

 

(180,985

)

 

 

 

(11,821

)

 

 

 

(9,011,953

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income

 

 

 

(321,341

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(321,341

)

 

Interest expense

 

 

 

(212,314

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(212,314

)

 

Total other expense

 

 

 

(533,655

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(533,655

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income/(loss) before income taxes

 

 

 

(9,352,802

)

 

 

 

(180,985

)

 

 

 

(11,821

)

 

 

 

(9,545,608

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

 

(1,857,505

)

 

 

 

-

 

 

 

 

(22,136

)

 

 

 

(1,879,641

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

 

 

(7,495,297

)

 

 

 

(180,985

)

 

 

 

10,315

 

 

 

 

(7,665,967

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock dividend

 

 

 

(782,639

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(782,639

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) attributable to common stock shareholders

 

$

 

(8,277,936

)

 

$

 

(180,985

)

 

$

 

10,315

 

 

$

 

(8,448,606

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 $

 

(0.07

)

 

 

 

 

 

 

 

 

 

 $

 

(0.07

)

 

Diluted

 

 $

 

(0.07

)

 

 

 

 

 

 

 

 

 

 $

 

(0.07

)

 

 

 

 

 

For the six months ended September 30, 2023

 

 

(Unaudited)

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

 

 

Stock Based
Payments

 

 

Other

 

 

As Restated

 

 

Net revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ammunition sales

 

 $

 

29,622,618

 

 

 $

 

-

 

 

 $

 

-

 

 

 $

 

29,622,618

 

 

Marketplace revenue

 

 

 

26,386,918

 

 

 

 

-

 

 

 

 

-

 

 

 

 

26,386,918

 

 

Casing sales

 

 

 

12,617,425

 

 

 

 

-

 

 

 

 

-

 

 

 

 

12,617,425

 

 

Total revenues

 

 

 

68,626,961

 

 

 

 

-

 

 

 

 

-

 

 

 

 

68,626,961

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues

 

 

 

46,314,155

 

 

 

 

-

 

 

 

 

23,642

 

 

 

 

46,337,797

 

 

Gross profit

 

 

 

22,312,806

 

 

 

 

-

 

 

 

 

(23,642

)

 

 

 

22,289,164

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling and marketing

 

 

 

585,533

 

 

 

 

-

 

 

 

 

-

 

 

 

 

585,533

 

 

Corporate general and administrative

 

 

 

15,803,187

 

 

 

 

-

 

 

 

 

-

 

 

 

 

15,803,187

 

 

Employee salaries and related expenses

 

 

 

9,706,315

 

 

 

 

488,637

 

 

 

 

-

 

 

 

 

10,194,952

 

 

Depreciation and amortization expense

 

 

 

6,715,845

 

 

 

 

-

 

 

 

 

-

 

 

 

 

6,715,845

 

 

Total operating expenses

 

 

 

32,810,880

 

 

 

 

488,637

 

 

 

 

-

 

 

 

 

33,299,517

 

 

Income/(loss) from operations

 

 

 

(10,498,074

)

 

 

 

(488,637

)

 

 

 

(23,642

)

 

 

 

(11,010,353

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income

 

 

 

371,610

 

 

 

 

-

 

 

 

 

-

 

 

 

 

371,610

 

 

Interest expense

 

 

 

(416,515

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(416,515

)

 

Total other expense

 

 

 

(44,905

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(44,905

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income/(loss) before income taxes

 

 

 

(10,542,979

)

 

 

 

(488,637

)

 

 

 

(23,642

)

 

 

 

(11,055,258

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

 

(1,954,649

)

 

 

 

-

 

 

 

 

(130,580

)

 

 

 

(2,085,229

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

 

 

(8,588,330

)

 

 

 

(488,637

)

 

 

 

106,938

 

 

 

 

(8,970,029

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock dividend

 

 

 

(1,556,771

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(1,556,771

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) attributable to common stock shareholders

 

$

 

(10,145,101

)

 

$

 

(488,637

)

 

$

 

106,938

 

 

$

 

(10,526,800

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 $

 

(0.09

)

 

 

 

 

 

 

 

 

 

 $

 

(0.09

)

 

Diluted

 

 $

 

(0.09

)

 

 

 

 

 

 

 

 

 

 $

 

(0.09

)

 

 

 

 

 

For the three months ended December 31, 2023

 

 

(Unaudited)

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

 

 

Stock Based
Payments

 

 

Other

 

 

As Restated

 

 

Net revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ammunition sales

 

 $

 

17,322,967

 

 

 $

 

-

 

 

 $

 

-

 

 

 $

 

17,322,967

 

 

Marketplace revenue

 

 

 

13,985,034

 

 

 

 

-

 

 

 

 

-

 

 

 

 

13,985,034

 

 

Casing sales

 

 

 

4,698,463

 

 

 

 

-

 

 

 

 

-

 

 

 

 

4,698,463

 

 

Total revenues

 

 

 

36,006,464

 

 

 

 

-

 

 

 

 

-

 

 

 

 

36,006,464

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues

 

 

 

25,096,088

 

 

 

 

-

 

 

 

 

11,821

 

 

 

 

25,107,909

 

 

Gross profit

 

 

 

10,910,376

 

 

 

 

-

 

 

 

 

(11,821

)

 

 

 

10,898,555

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling and marketing

 

 

 

236,565

 

 

 

 

-

 

 

 

 

-

 

 

 

 

236,565

 

 

Corporate general and administrative

 

 

 

5,803,255

 

 

 

 

-

 

 

 

 

-

 

 

 

 

5,803,255

 

 

Employee salaries and related expenses

 

 

 

3,390,153

 

 

 

 

643,923

 

 

 

 

-

 

 

 

 

4,034,076

 

 

Depreciation and amortization expense

 

 

 

3,401,156

 

 

 

 

-

 

 

 

 

-

 

 

 

 

3,401,156

 

 

Total operating expenses

 

 

 

12,831,129

 

 

 

 

643,923

 

 

 

 

-

 

 

 

 

13,475,052

 

 

Income/(loss) from operations

 

 

 

(1,920,753

)

 

 

 

(643,923

)

 

 

 

(11,821

)

 

 

 

(2,576,497

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income

 

 

 

4,576

 

 

 

 

-

 

 

 

 

-

 

 

 

 

4,576

 

 

Interest expense

 

 

 

(193,046

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(193,046

)

 

Total other expense

 

 

 

(188,470

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(188,470

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income/(loss) before income taxes

 

 

 

(2,109,223

)

 

 

 

(643,923

)

 

 

 

(11,821

)

 

 

 

(2,764,967

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

 

(465,234

)

 

 

 

-

 

 

 

 

106,045

 

 

 

 

(359,189

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

 

 

(1,643,989

)

 

 

 

(643,923

)

 

 

 

(117,866

)

 

 

 

(2,405,778

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock dividend

 

 

 

(782,639

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(782,639

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) attributable to common stock shareholders

 

$

 

(2,426,628

)

 

$

 

(643,923

)

 

$

 

(117,866

)

 

$

 

(3,188,417

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 $

 

(0.02

)

 

 

 

 

 

 

 

 

 

 $

 

(0.03

)

 

Diluted

 

 $

 

(0.02

)

 

 

 

 

 

 

 

 

 

 $

 

(0.03

)

 

 

 

 

 

 

For the nine months ended December 31, 2023

 

 

(Unaudited)

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

 

 

Stock Based
Payments

 

 

Other

 

 

As Restated

 

 

Net revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ammunition sales

 

 $

 

46,945,585

 

 

 $

 

-

 

 

 $

 

-

 

 

 $

 

46,945,585

 

 

Marketplace revenue

 

 

 

40,371,952

 

 

 

 

-

 

 

 

 

-

 

 

 

 

40,371,952

 

 

Casing sales

 

 

 

17,315,888

 

 

 

 

-

 

 

 

 

-

 

 

 

 

17,315,888

 

 

Total revenues

 

 

 

104,633,425

 

 

 

 

-

 

 

 

 

-

 

 

 

 

104,633,425

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues

 

 

 

71,410,243

 

 

 

 

-

 

 

 

 

35,463

 

 

 

 

71,445,706

 

 

Gross profit

 

 

 

33,223,182

 

 

 

 

-

 

 

 

 

(35,463

)

 

 

 

33,187,719

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling and marketing

 

 

 

822,098

 

 

 

 

-

 

 

 

 

-

 

 

 

 

822,098

 

 

Corporate general and administrative

 

 

 

21,606,442

 

 

 

 

-

 

 

 

 

-

 

 

 

 

21,606,442

 

 

Employee salaries and related expenses

 

 

 

13,096,468

 

 

 

 

1,132,560

 

 

 

 

-

 

 

 

 

14,229,028

 

 

Depreciation and amortization expense

 

 

 

10,117,001

 

 

 

 

-

 

 

 

 

-

 

 

 

 

10,117,001

 

 

Total operating expenses

 

 

 

45,642,009

 

 

 

 

1,132,560

 

 

 

 

-

 

 

 

 

46,774,569

 

 

Income/(loss) from operations

 

 

 

(12,418,827

)

 

 

 

(1,132,560

)

 

 

 

(35,463

)

 

 

 

(13,586,850

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income

 

 

 

376,186

 

 

 

 

-

 

 

 

 

-

 

 

 

 

376,186

 

 

Interest expense

 

 

 

(609,561

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(609,561

)

 

Total other expense

 

 

 

(233,375

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(233,375

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income/(loss) before income taxes

 

 

 

(12,652,202

)

 

 

 

(1,132,560

)

 

 

 

(35,463

)

 

 

 

(13,820,225

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

 

(2,419,883

)

 

 

 

-

 

 

 

 

(24,535

)

 

 

 

(2,444,418

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

 

 

(10,232,319

)

 

 

 

(1,132,560

)

 

 

 

(10,928

)

 

 

 

(11,375,807

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock dividend

 

 

 

(2,339,410

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(2,339,410

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) attributable to common stock shareholders

 

$

 

(12,571,729

)

 

$

 

(1,132,560

)

 

$

 

(10,928

)

 

$

 

(13,715,217

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 $

 

(0.11

)

 

 

 

 

 

 

 

 

 

 $

 

(0.12

)

 

Diluted

 

 $

 

(0.11

)

 

 

 

 

 

 

 

 

 

 $

 

(0.12

)

 

 

 

 

 

 

For the three months ended March 31, 2024

 

 

(Unaudited)

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

 

 

Stock Based
Payments

 

 

Other

 

 

As Restated

 

 

Net revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ammunition sales

 

 $

 

22,445,216

 

 

 $

 

-

 

 

 $

 

-

 

 

 $

 

22,445,216

 

 

Marketplace revenue

 

 

 

13,570,124

 

 

 

 

-

 

 

 

 

-

 

 

 

 

13,570,124

 

 

Casing sales

 

 

 

4,405,807

 

 

 

 

-

 

 

 

 

-

 

 

 

 

4,405,807

 

 

Total revenues

 

 

 

40,421,147

 

 

 

 

-

 

 

 

 

-

 

 

 

 

40,421,147

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues

 

 

 

31,021,560

 

 

 

 

-

 

 

 

 

11,821

 

 

 

 

31,033,381

 

 

Gross profit

 

 

 

9,399,587

 

 

 

 

-

 

 

 

 

(11,821

)

 

 

 

9,387,766

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling and marketing

 

 

 

547,981

 

 

 

 

-

 

 

 

 

-

 

 

 

 

547,981

 

 

Corporate general and administrative

 

 

 

7,976,832

 

 

 

 

-

 

 

 

 

-

 

 

 

 

7,976,832

 

 

Employee salaries and related expenses

 

 

 

3,607,354

 

 

 

 

(136,380

)

 

 

 

-

 

 

 

 

3,470,974

 

 

Depreciation and amortization expense

 

 

 

3,425,790

 

 

 

 

-

 

 

 

 

-

 

 

 

 

3,425,790

 

 

Total operating expenses

 

 

 

15,557,957

 

 

 

 

(136,380

)

 

 

 

-

 

 

 

 

15,421,577

 

 

Income/(loss) from operations

 

 

 

(6,158,370

)

 

 

 

136,380

 

 

 

 

(11,821

)

 

 

 

(6,033,811

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income

 

 

 

(708,779

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(708,779

)

 

Interest expense

 

 

 

163,088

 

 

 

 

-

 

 

 

 

-

 

 

 

 

163,088

 

 

Total other expense

 

 

 

(545,691

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(545,691

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income/(loss) before income taxes

 

 

 

(6,704,061

)

 

 

 

136,380

 

 

 

 

(11,821

)

 

 

 

(6,579,502

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

 

(1,371,180

)

 

 

 

-

 

 

 

 

9,480

 

 

 

 

(1,361,700

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

 

 

(5,332,881

)

 

 

 

136,380

 

 

 

 

(21,301

)

 

 

 

(5,217,802

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock dividend

 

 

 

(782,639

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(782,639

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) attributable to common stock shareholders

 

$

 

(6,115,520

)

 

$

 

136,380

 

 

$

 

(21,301

)

 

$

 

(6,000,441

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 $

 

(0.05

)

 

 

 

 

 

 

 

 

 

 $

 

(0.05

)

 

Diluted

 

 $

 

(0.05

)

 

 

 

 

 

 

 

 

 

 $

 

(0.05

)

 

 

Quarterly Balance Sheet Information

The unaudited interim consolidated balance sheets as of December 31, 2023, September 30, 2023, and June 30, 2023 are as follows:

 (Unaudited)

 

 

December 31,

 

 

 

September 30,

 

 

 

June 30,

 

 

 

 

 

2023

 

 

 

2023

 

 

 

2023

 

 

 

 

 

(Restated)

 

 

 

(Restated)

 

 

 

(Restated)

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

 $

 

54,679,868

 

 

 

 $

 

49,564,868

 

 

 

 $

 

47,505,047

 

 

Accounts receivable, net

 

 

 

 

21,121,450

 

 

 

 

 

23,030,851

 

 

 

 

 

21,348,226

 

 

Inventories

 

 

 

 

49,502,732

 

 

 

 

 

53,014,205

 

 

 

 

 

55,924,655

 

 

Prepaid expenses

 

 

 

 

3,708,865

 

 

 

 

 

3,920,007

 

 

 

 

 

5,294,454

 

 

Current portion of restricted cash

 

 

 

 

-

 

 

 

 

 

-

 

 

 

 

 

500,000

 

 

Total current assets

 

 

 

 

129,012,915

 

 

 

 

 

129,529,931

 

 

 

 

 

130,572,382

 

 

 

 

 

 

.

 

 

 

 

 

 

 

 

 

 

 

 

Equipment, net

 

 

 

 

57,278,603

 

 

 

 

 

55,821,414

 

 

 

 

 

55,923,867

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deposits

 

 

 

 

2,265,932

 

 

 

 

 

3,189,518

 

 

 

 

 

4,064,582

 

 

Patents, net

 

 

 

 

4,891,193

 

 

 

 

 

5,026,380

 

 

 

 

 

5,161,567

 

 

Other intangible assets, net

 

 

 

 

114,296,627

 

 

 

 

 

117,440,022

 

 

 

 

 

120,583,416

 

 

Goodwill

 

 

 

 

90,870,094

 

 

 

 

 

90,870,094

 

 

 

 

 

90,870,094

 

 

Right of use assets - operating leases

 

 

 

 

2,113,943

 

 

 

 

 

1,017,982

 

 

 

 

 

1,141,418

 

 

Deferred income tax asset

 

 

 

 

3,044,238

 

 

 

 

 

2,684,640

 

 

 

 

 

802,855

 

 

TOTAL ASSETS

 

 

$

 

403,773,545

 

 

 

 $

 

405,579,981

 

 

 

 $

 

409,120,181

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

 

$

 

19,146,138

 

 

 

 $

 

19,598,548

 

 

 

 $

 

16,356,614

 

 

Accrued liabilities

 

 

 

 

6,603,892

 

 

 

 

 

6,282,980

 

 

 

 

 

4,677,757

 

 

Current portion of operating lease liability

 

 

 

 

463,059

 

 

 

 

 

370,980

 

 

 

 

 

421,477

 

 

Note payable related party

 

 

 

 

-

 

 

 

 

 

-

 

 

 

 

 

-

 

 

Current portion of construction note payable

 

 

 

 

265,977

 

 

 

 

 

265,977

 

 

 

 

 

277,216

 

 

Insurance premium note payable

 

 

 

 

173,029

 

 

 

 

 

1,157,745

 

 

 

 

 

2,204,293

 

 

Total current liabilities

 

 

 

 

26,652,095

 

 

 

 

 

27,676,230

 

 

 

 

 

23,937,357

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long-term liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration payable

 

 

 

 

80,080

 

 

 

 

 

99,302

 

 

 

 

 

119,354

 

 

Income tax payable

 

 

 

 

1,609,520

 

 

 

 

 

1,609,520

 

 

 

 

 

1,609,520

 

 

Construction note payable, net of unamortized issuance costs

 

 

 

 

10,797,696

 

 

 

 

 

10,830,663

 

 

 

 

 

10,861,510

 

 

Operating lease liability, net of current portion

 

 

 

 

1,737,615

 

 

 

 

 

744,616

 

 

 

 

 

825,043

 

 

Deferred income tax liability

 

 

 

 

-

 

 

 

 

 

-

 

 

 

 

 

-

 

 

Total liabilities

 

 

 

 

40,877,006

 

 

 

 

 

40,960,331

 

 

 

 

 

37,352,784

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Series A cumulative perpetual preferred Stock

 

 

 

 

1,400

 

 

 

 

 

1,400

 

 

 

 

 

1,400

 

 

Common stock

 

 

 

 

118,644

 

 

 

 

 

118,461

 

 

 

 

 

117,946

 

 

Additional paid-in capital

 

 

 

 

429,381,115

 

 

 

 

 

427,619,626

 

 

 

 

 

425,920,655

 

 

Accumulated deficit

 

 

 

 

(63,931,464

)

 

 

 

 

(60,743,047

)

 

 

 

 

(52,294,441

)

 

Treasury stock

 

 

 

 

(2,673,156

)

 

 

 

 

(2,376,790

)

 

 

 

 

(1,978,163

)

 

Total shareholders’ equity

 

 

 

 

362,896,539

 

 

 

 

 

364,619,650

 

 

 

 

 

371,767,397

 

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

$

 

403,773,545

 

 

 

 $

 

405,579,981

 

 

 

 $

 

409,120,181

 

 

 

The following tables set forth the restatement of the Company's unaudited interim consolidated balance sheets as of June 30, 2023, September 30, 2023, and December 31, 2023:

 (Unaudited)

As of June 30, 2023

 

 

 

 

 

Adjustments

 

 

 

 

 

 

As Previously
Reported

 

 

 

Stock Based
Payments

 

 

Equity Issuance Costs

 

 

Convertible Notes

 

 

Warrants

 

 

Acquisition

 

 

Other

 

 

Restated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

47,505,047

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

47,505,047

 

Accounts receivable, net

 

 

21,348,226

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

21,348,226

 

Inventories

 

 

55,924,655

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

55,924,655

 

Prepaid expenses

 

 

5,294,454

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

5,294,454

 

Current portion of restricted cash

 

 

500,000

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

500,000

 

Total current assets

 

$

130,572,382

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

130,572,382

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equipment, net

 

 

55,923,867

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

55,923,867

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deposits

 

 

4,064,582

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

4,064,582

 

Patents, net

 

 

4,909,388

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

252,179

 

 

 

5,161,567

 

Other intangible assets, net

 

 

120,583,416

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

120,583,416

 

Goodwill

 

 

90,870,094

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

90,870,094

 

Right of use assets - operating leases

 

 

1,141,418

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,141,418

 

Deferred income tax asset

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

802,855

 

 

 

802,855

 

TOTAL ASSETS

 

$

408,065,147

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

1,055,034

 

 

$

409,120,181

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

$

16,356,614

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

16,356,614

 

Accrued liabilities

 

 

4,641,469

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

36,288

 

 

 

4,677,757

 

Current portion of operating lease liability

 

 

421,477

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

421,477

 

Note payable related party

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Current portion of construction note payable

 

 

277,216

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

277,216

 

Insurance premium note payable

 

 

2,204,293

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,204,293

 

Total current liabilities

 

 

23,901,069

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

36,288

 

 

 

23,937,357

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long-term liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration payable

 

 

119,354

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

119,354

 

Income tax payable

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,609,520

 

 

 

1,609,520

 

Construction note payable, net of unamortized issuance costs

 

 

10,861,510

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

10,861,510

 

Operating lease liability, net of current portion

 

 

825,043

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

825,043

 

Deferred income tax liability

 

 

2,212,448

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(2,212,448

)

 

 

-

 

Total liabilities

 

 

37,919,424

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(566,640

)

 

 

37,352,784

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Series A cumulative perpetual preferred Stock

 

 

1,400

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,400

 

Common stock

 

 

117,946

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

117,946

 

Additional paid-in capital

 

 

392,813,530

 

 

 

 

12,486,057

 

 

 

7,420,492

 

 

 

6,024,240

 

 

 

1,298,336

 

 

 

5,225,000

 

 

 

653,000

 

 

 

425,920,655

 

Accumulated deficit

 

 

(20,808,990

)

 

 

 

(12,486,057

)

 

 

(7,420,492

)

 

 

(6,024,240

)

 

 

(1,298,336

)

 

 

(5,225,000

)

 

 

968,674

 

 

 

(52,294,441

)

Treasury stock

 

 

(1,978,163

)

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(1,978,163

)

Total shareholders’ equity

 

 

370,145,723

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,621,674

 

 

 

371,767,397

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

 

$

408,065,147

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

1,055,034

 

 

$

409,120,181

 

 

 (Unaudited)

As of September 30, 2023

 

 

 

 

 

Adjustments

 

 

 

 

 

 

As Previously
Reported

 

 

 

Stock Based
Payments

 

 

Equity Issuance Costs

 

 

Convertible Notes

 

 

Warrants

 

 

Acquisition

 

 

Other

 

 

Restated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

49,564,868

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

49,564,868

 

Accounts receivable, net

 

 

23,030,851

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

23,030,851

 

Inventories

 

 

53,014,205

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

53,014,205

 

Prepaid expenses

 

 

3,920,007

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

3,920,007

 

Current portion of restricted cash

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Total current assets

 

$

129,529,931

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

129,529,931

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equipment, net

 

 

55,821,414

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

55,821,414

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deposits

 

 

3,189,518

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

3,189,518

 

Patents, net

 

 

4,786,022

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

240,358

 

 

 

5,026,380

 

Other intangible assets, net

 

 

117,440,022

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

117,440,022

 

Goodwill

 

 

90,870,094

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

90,870,094

 

Right of use assets - operating leases

 

 

1,017,982

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,017,982

 

Deferred income tax asset

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,684,640

 

 

 

2,684,640

 

TOTAL ASSETS

 

$

402,654,983

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

2,924,998

 

 

$

405,579,981

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

$

19,598,548

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

19,598,548

 

Accrued liabilities

 

 

6,250,164

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

32,816

 

 

 

6,282,980

 

Current portion of operating lease liability

 

 

370,980

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

370,980

 

Note payable related party

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Current portion of construction note payable

 

 

265,977

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

265,977

 

Insurance premium note payable

 

 

1,157,745

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,157,745

 

Total current liabilities

 

 

27,643,414

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

32,816

 

 

 

27,676,230

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long-term liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration payable

 

 

99,302

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

99,302

 

Income tax payable

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,609,520

 

 

 

1,609,520

 

Construction note payable, net of unamortized issuance costs

 

 

10,830,663

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

10,830,663

 

Operating lease liability, net of current portion

 

 

744,616

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

744,616

 

Deferred income tax liability

 

 

349,327

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(349,327

)

 

 

-

 

Total liabilities

 

 

39,667,322

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,293,009

 

 

 

40,960,331

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Series A cumulative perpetual preferred Stock

 

 

1,400

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,400

 

Common stock

 

 

118,461

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

118,461

 

Additional paid-in capital

 

 

394,331,516

 

 

 

 

12,667,042

 

 

 

7,420,492

 

 

 

6,024,240

 

 

 

1,298,336

 

 

 

5,225,000

 

 

 

653,000

 

 

 

427,619,626

 

Accumulated deficit

 

 

(29,086,926

)

 

 

 

(12,667,042

)

 

 

(7,420,492

)

 

 

(6,024,240

)

 

 

(1,298,336

)

 

 

(5,225,000

)

 

 

978,989

 

 

 

(60,743,047

)

Treasury stock

 

 

(2,376,790

)

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(2,376,790

)

Total shareholders’ equity

 

 

362,987,661

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,631,989

 

 

 

364,619,650

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

 

$

402,654,983

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

2,924,998

 

 

$

405,579,981

 

 

 

 (Unaudited)

As of December 31, 2023

 

 

 

 

 

Adjustments

 

 

 

 

 

 

As Previously
Reported

 

 

 

Stock Based
Payments

 

 

Equity Issuance Costs

 

 

Convertible Notes

 

 

Warrants

 

 

Acquisition

 

 

Other

 

 

Restated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

54,679,868

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

54,679,868

 

Accounts receivable, net

 

 

21,121,450

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

21,121,450

 

Inventories

 

 

49,502,732

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

49,502,732

 

Prepaid expenses

 

 

3,708,865

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

3,708,865

 

Current portion of restricted cash

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Total current assets

 

$

129,012,915

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

129,012,915

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equipment, net

 

 

57,278,603

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

57,278,603

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deposits

 

 

2,265,932

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,265,932

 

Patents, net

 

 

4,662,656

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

228,537

 

 

 

4,891,193

 

Other intangible assets, net

 

 

114,296,627

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

114,296,627

 

Goodwill

 

 

90,870,094

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

90,870,094

 

Right of use assets - operating leases

 

 

2,113,943

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,113,943

 

Deferred income tax asset

 

 

115,908

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,928,330

 

 

 

3,044,238

 

TOTAL ASSETS

 

$

400,616,678

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

3,156,867

 

 

$

403,773,545

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

$

19,146,138

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

19,146,138

 

Accrued liabilities

 

 

6,570,668

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

33,224

 

 

 

6,603,892

 

Current portion of operating lease liability

 

 

463,059

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

463,059

 

Note payable related party

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Current portion of construction note payable

 

 

265,977

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

265,977

 

Insurance premium note payable

 

 

173,029

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

173,029

 

Total current liabilities

 

 

26,618,871

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

33,224

 

 

 

26,652,095

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long-term liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration payable

 

 

80,080

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

80,080

 

Income tax payable

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,609,520

 

 

 

1,609,520

 

Construction note payable, net of unamortized issuance costs

 

 

10,797,696

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

10,797,696

 

Operating lease liability, net of current portion

 

 

1,737,615

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,737,615

 

Deferred income tax liability

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Total liabilities

 

 

39,234,262

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,642,744

 

 

 

40,877,006

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Series A cumulative perpetual preferred Stock

 

 

1,400

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,400

 

Common stock

 

 

118,644

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

118,644

 

Additional paid-in capital

 

 

395,449,082

 

 

 

 

13,310,965

 

 

 

7,420,492

 

 

 

6,024,240

 

 

 

1,298,336

 

 

 

5,225,000

 

 

 

653,000

 

 

 

429,381,115

 

Accumulated deficit

 

 

(31,513,554

)

 

 

 

(13,310,965

)

 

 

(7,420,492

)

 

 

(6,024,240

)

 

 

(1,298,336

)

 

 

(5,225,000

)

 

 

861,123

 

 

 

(63,931,464

)

Treasury stock

 

 

(2,673,156

)

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(2,673,156

)

Total shareholders’ equity

 

 

361,382,416

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,514,123

 

 

 

362,896,539

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

 

$

400,616,678

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

3,156,867

 

 

$

403,773,545

 

 

Quarterly Statements of Stockholders' Equity

The unaudited interim consolidated statements of stockholders' equity as of December 31, 2023, September 30, 2023, and June 30, 2023 are as follows:

 

 

Preferred Stock

 

 

Common Shares

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number

 

 

Par Value

 

 

Number

 

 

Par Value

 

 

Additional
Paid-In
Capital

 

 

Accumulated
(Deficit)

 

 

Treasury
Stock

 

 

Total

 

 

 

 

 

 

(Restated)

 

 

 

 

 

(Restated)

 

 

 

 

Balance as of March 31, 2023 (restated)

 

 

1,400,000

 

 

$

1,400

 

 

 

118,294,478

 

 

$

118,294

 

 

$

424,739,847

 

 

$

(50,216,248

)

 

$

(522,158

)

 

$

374,121,135

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Employee stock awards (Restated)

 

 

-

 

 

 

-

 

 

 

390,111

 

 

 

391

 

 

 

1,180,808

 

 

 

-

 

 

 

-

 

 

 

1,181,199

 

Preferred stock dividends declared

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(638,038

)

 

 

-

 

 

 

(638,038

)

Dividends accumulated on preferred stock

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(136,093

)

 

 

-

 

 

 

(136,093

)

Net loss (Restated)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(1,304,062

)

 

 

-

 

 

 

(1,304,062

)

Treasury shares purchased

 

 

-

 

 

 

-

 

 

 

(738,831

)

 

 

(739

)

 

 

-

 

 

 

-

 

 

 

(1,456,005

)

 

 

(1,456,744

)

Balance as of June 30, 2023 (restated)

 

 

1,400,000

 

 

$

1,400

 

 

 

117,945,758

 

 

$

117,946

 

 

$

425,920,655

 

 

$

(52,294,441

)

 

$

(1,978,163

)

 

$

371,767,397

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Employee stock awards (Restated)

 

 

-

 

 

 

-

 

 

 

712,783

 

 

 

713

 

 

 

1,698,971

 

 

 

-

 

 

 

-

 

 

 

1,699,684

 

Preferred stock dividends declared

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(646,545

)

 

 

-

 

 

 

(646,545

)

Dividends accumulated on preferred stock

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(136,094

)

 

 

-

 

 

 

(136,094

)

Net loss (restated)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(7,665,967

)

 

 

-

 

 

 

(7,665,967

)

Treasury shares purchased

 

 

-

 

 

 

-

 

 

 

(197,798

)

 

 

(198

)

 

 

-

 

 

 

-

 

 

 

(398,627

)

 

 

(398,825

)

Balance as of September 30, 2023 (restated)

 

 

1,400,000

 

 

$

1,400

 

 

 

118,460,743

 

 

$

118,461

 

 

$

427,619,626

 

 

$

(60,743,047

)

 

$

(2,376,790

)

 

$

364,619,650

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Employee stock awards (Restated)

 

 

-

 

 

 

-

 

 

 

328,333

 

 

 

328

 

 

 

1,381,444

 

 

 

-

 

 

 

-

 

 

 

1,381,772

 

Common stock purchase options

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

380,045

 

 

 

-

 

 

 

-

 

 

 

380,045

 

Preferred stock dividends declared

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(638,021

)

 

 

-

 

 

 

(638,021

)

Dividends accumulated on preferred stock

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(144,618

)

 

 

-

 

 

 

(144,618

)

Net loss (restated)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(2,405,778

)

 

 

-

 

 

 

(2,405,778

)

Treasury shares purchased

 

 

-

 

 

 

-

 

 

 

(145,483

)

 

 

(145

)

 

 

-

 

 

 

-

 

 

 

(296,366

)

 

 

(296,511

)

Balance as of December 31, 2023 (restated)

 

 

1,400,000

 

 

$

1,400

 

 

 

118,643,593

 

 

$

118,644

 

 

$

429,381,115

 

 

$

(63,931,464

)

 

$

(2,673,156

)

 

$

362,896,539

 

 

The following tables present the Additional Paid-In Capital ("APIC") as previously reported, restatement adjustments and the APIC as restated for the three months ended June 30, 2023, September 30, 2023, and December 31, 2023.

 

 

Three Months Ended June 30, 2023

 

 

 

 

As Previously
Reported

 

 

Reclassification

 

 

Current Period Adjustment

 

 

As Restated

 

 

 

 

(unaudited)

 

 

Employee stock awards

 

 $

 

822,406

 

 

 $

 

50,750

 

 

 $

 

307,652

 

 

 $

 

1,180,808

 

 

Stock grants

 

 

 

50,750

 

 

 

 

(50,750

)

 

 

 

-

 

 

 

 

-

 

 

 

 

 

 

Three Months Ended September 30, 2023

 

 

 

 

As Previously
Reported

 

 

Reclassification

 

 

Current Period Adjustment

 

 

As Restated

 

 

 

 

(unaudited)

 

 

Employee stock awards

 

 $

 

1,467,236

 

 

 $

 

50,750

 

 

 $

 

180,985

 

 

 $

 

1,698,971

 

 

Stock grants

 

 

 

50,750

 

 

 

 

(50,750

)

 

 

 

-

 

 

 

 

-

 

 

 

 

 

Three Months Ended December 31, 2023

 

 

 

 

As Previously
Reported

 

 

Reclassification

 

 

Current Period Adjustment

 

 

As Restated

 

 

 

 

(unaudited)

 

 

Employee stock awards

 

 $

 

686,771

 

 

 $

 

50,750

 

 

 $

 

643,923

 

 

 $

 

1,381,444

 

 

Stock grants

 

 

 

50,750

 

 

 

 

(50,750

)

 

 

 

-

 

 

 

 

-

 

 

 

Quarterly Statements of Cash Flows

The following tables set forth the restatement of the Company's unaudited interim consolidated statements of cash flow for the three months ended June 30, 2023, six months ended September 30, 2023, and nine months ended December 31, 2023 with the exception of the supplemental cash flows as there were no changes for the periods presented:

 

 

For the three months ended June 30, 2023

 

 

(Unaudited)

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

Stock Based
Payments

Other

 

 

As Restated

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

$

(1,093,033

)

 

$

(307,652

)

 

$

96,623

 

 

$

(1,304,062

)

 

Adjustments to reconcile net loss to cash provided by operations:

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

4,620,087

 

 

 

-

 

 

 

11,821

 

 

 

4,631,908

 

 

Debt discount amortization

 

 

20,813

 

 

 

-

 

 

 

-

 

 

 

20,813

 

 

Employee stock awards

 

 

873,547

 

 

 

307,652

 

 

 

-

 

 

 

1,181,199

 

 

Common stock purchase options

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

Contingent consideration payable fair value

 

 

(21,024

)

 

 

-

 

 

 

-

 

 

 

(21,024

)

 

Allowance for doubtful accounts

 

 

909,717

 

 

 

-

 

 

 

-

 

 

 

909,717

 

 

(Gain)/loss on disposal of assets

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

Reduction in right of use asset

 

 

120,216

 

 

 

-

 

 

 

-

 

 

 

120,216

 

 

Deferred income taxes

 

 

(97,144

)

 

 

-

 

 

 

(109,954

)

 

 

(207,098

)

 

Changes in current assets and liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

7,088,437

 

 

 

-

 

 

 

-

 

 

 

7,088,437

 

 

Inventories

 

 

(1,579,836

)

 

 

-

 

 

 

-

 

 

 

(1,579,836

)

 

Prepaid expenses

 

 

888,412

 

 

 

-

 

 

 

-

 

 

 

888,412

 

 

Deposits

 

 

2,964,365

 

 

 

-

 

 

 

-

 

 

 

2,964,365

 

 

Accounts payable

 

 

(1,722,783

)

 

 

-

 

 

 

-

 

 

 

(1,722,783

)

 

Accrued liabilities

 

 

152,021

 

 

 

-

 

 

 

1,510

 

 

 

153,531

 

 

Operating lease liability

 

 

(127,704

)

 

 

-

 

 

 

-

 

 

 

(127,704

)

 

Net cash provided by operating activities

 

 

12,996,091

 

 

 

-

 

 

 

-

 

 

 

12,996,091

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Purchase of property, plant, and equipment

 

 

(1,313,939

)

 

 

-

 

 

 

-

 

 

 

(1,313,939

)

 

Net cash used in investing activities

 

 

(1,313,939

)

 

 

-

 

 

 

-

 

 

 

(1,313,939

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Payments on inventory facility, net

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

Proceeds from factoring liability

 

 

14,610,314

 

 

 

-

 

 

 

-

 

 

 

14,610,314

 

 

Payments on factoring liability

 

 

(14,610,314

)

 

 

-

 

 

 

-

 

 

 

(14,610,314

)

 

Payments on note payable - related party

 

 

(180,850

)

 

 

-

 

 

 

-

 

 

 

(180,850

)

 

Payments on insurance premium note payment

 

 

(970,541

)

 

 

-

 

 

 

-

 

 

 

(970,541

)

 

Proceeds from construction note payable

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

Payments on construction note payable

 

 

(64,959

)

 

 

-

 

 

 

-

 

 

 

(64,959

)

 

Preferred stock dividends paid

 

 

(638,038

)

 

 

-

 

 

 

-

 

 

 

(638,038

)

 

Common stock repurchase plan

 

 

(1,456,744

)

 

 

-

 

 

 

-

 

 

 

(1,456,744

)

 

Net cash used in financing activities

 

 

(3,311,132

)

 

 

-

 

 

 

-

 

 

 

(3,311,132

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net increase/(decrease) in cash

 

 

8,371,020

 

 

 

-

 

 

 

-

 

 

 

8,371,020

 

 

Cash, beginning of period

 

 

39,134,027

 

 

 

-

 

 

 

-

 

 

 

39,134,027

 

 

Restricted cash, beginning of period

 

 

500,000

 

 

 

-

 

 

 

-

 

 

 

500,000

 

 

Cash and restricted cash, end of period

 

$

48,005,047

 

 

$

-

 

 

$

-

 

 

$

48,005,047

 

 

Restricted cash, end of period

 

$

500,000

 

 

$

-

 

 

$

-

 

 

 

500,000

 

 

Cash, end of period

 

$

47,505,047

 

 

$

-

 

 

$

-

 

 

$

47,505,047

 

 

 

 

 

 

For the six months ended September 30, 2023

 

 

(Unaudited)

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

Stock Based
Payments

Other

 

 

As Restated

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

$

(8,588,330

)

 

$

(488,637

)

 

$

106,938

 

 

$

(8,970,029

)

 

Adjustments to reconcile net loss to cash provided by operations:

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

9,293,566

 

 

 

-

 

 

 

23,642

 

 

 

9,317,208

 

 

Debt discount amortization

 

 

41,626

 

 

 

-

 

 

 

-

 

 

 

41,626

 

 

Employee stock awards

 

 

2,392,246

 

 

 

488,637

 

 

 

-

 

 

 

2,880,883

 

 

Common stock purchase options

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

Contingent consideration payable fair value

 

 

(41,076

)

 

 

-

 

 

 

-

 

 

 

(41,076

)

 

Allowance for doubtful accounts

 

 

1,047,587

 

 

 

-

 

 

 

-

 

 

 

1,047,587

 

 

(Gain)/loss on disposal of assets

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

Reduction in right of use asset

 

 

243,652

 

 

 

-

 

 

 

-

 

 

 

243,652

 

 

Deferred income taxes

 

 

(1,960,265

)

 

 

-

 

 

 

(128,618

)

 

 

(2,088,883

)

 

Changes in current assets and liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

5,267,942

 

 

 

-

 

 

 

-

 

 

 

5,267,942

 

 

Inventories

 

 

1,330,614

 

 

 

-

 

 

 

-

 

 

 

1,330,614

 

 

Prepaid expenses

 

 

2,262,859

 

 

 

-

 

 

 

-

 

 

 

2,262,859

 

 

Deposits

 

 

3,839,429

 

 

 

-

 

 

 

-

 

 

 

3,839,429

 

 

Accounts payable

 

 

1,519,151

 

 

 

-

 

 

 

-

 

 

 

1,519,151

 

 

Accrued liabilities

 

 

1,760,716

 

 

 

-

 

 

 

(1,962

)

 

 

1,758,754

 

 

Operating lease liability

 

 

(258,628

)

 

 

-

 

 

 

-

 

 

 

(258,628

)

 

Net cash provided by operating activities

 

 

18,151,089

 

 

 

-

 

 

 

-

 

 

 

18,151,089

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Purchase of property, plant, and equipment

 

 

(2,618,205

)

 

 

-

 

 

 

-

 

 

 

(2,618,205

)

 

Net cash used in investing activities

 

 

(2,618,205

)

 

 

-

 

 

 

-

 

 

 

(2,618,205

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Payments on inventory facility, net

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

Proceeds from factoring liability

 

 

26,047,370

 

 

 

-

 

 

 

-

 

 

 

26,047,370

 

 

Payments on factoring liability

 

 

(26,047,370

)

 

 

-

 

 

 

-

 

 

 

(26,047,370

)

 

Payments on note payable - related party

 

 

(180,850

)

 

 

-

 

 

 

-

 

 

 

(180,850

)

 

Payments on insurance premium note payment

 

 

(2,017,089

)

 

 

-

 

 

 

-

 

 

 

(2,017,089

)

 

Proceeds from construction note payable

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

Payments on construction note payable

 

 

(127,858

)

 

 

-

 

 

 

-

 

 

 

(127,858

)

 

Preferred stock dividends paid

 

 

(1,420,677

)

 

 

-

 

 

 

-

 

 

 

(1,420,677

)

 

Common stock repurchase plan

 

 

(1,855,569

)

 

 

-

 

 

 

-

 

 

 

(1,855,569

)

 

Net cash used in financing activities

 

 

(5,602,043

)

 

 

-

 

 

 

-

 

 

 

(5,602,043

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net increase/(decrease) in cash

 

 

9,930,841

 

 

 

-

 

 

 

-

 

 

 

9,930,841

 

 

Cash, beginning of period

 

 

39,134,027

 

 

 

-

 

 

 

-

 

 

 

39,134,027

 

 

Restricted cash, beginning of period

 

 

500,000

 

 

 

-

 

 

 

-

 

 

 

500,000

 

 

Cash and restricted cash, end of period

 

$

49,564,868

 

 

$

-

 

 

$

-

 

 

$

49,564,868

 

 

Restricted cash, end of period

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

Cash, end of period

 

$

49,564,868

 

 

$

-

 

 

$

-

 

 

$

49,564,868

 

 

 

 

 

 

 

For the nine months ended December 31, 2023

 

 

(Unaudited)

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

Stock Based
Payments

Other

 

 

As Restated

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

$

(10,232,319

)

 

$

(1,132,560

)

 

$

(10,928

)

 

$

(11,375,807

)

 

Adjustments to reconcile net loss to cash provided by operations:

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

14,047,216

 

 

 

-

 

 

 

35,463

 

 

 

14,082,679

 

 

Debt discount amortization

 

 

62,440

 

 

 

-

 

 

 

-

 

 

 

62,440

 

 

Employee stock awards

 

 

3,130,095

 

 

 

1,132,560

 

 

 

-

 

 

 

4,262,655

 

 

Common stock purchase options

 

 

380,045

 

 

 

-

 

 

 

-

 

 

 

380,045

 

 

Contingent consideration payable fair value

 

 

(60,298

)

 

 

-

 

 

 

-

 

 

 

(60,298

)

 

Allowance for doubtful accounts

 

 

1,117,565

 

 

 

-

 

 

 

-

 

 

 

1,117,565

 

 

(Gain)/loss on disposal of assets

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

Reduction in right of use asset

 

 

362,402

 

 

 

-

 

 

 

-

 

 

 

362,402

 

 

Deferred income taxes

 

 

(2,425,500

)

 

 

-

 

 

 

(22,981

)

 

 

(2,448,481

)

 

Changes in current assets and liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

7,107,365

 

 

 

-

 

 

 

-

 

 

 

7,107,365

 

 

Inventories

 

 

4,842,087

 

 

 

-

 

 

 

-

 

 

 

4,842,087

 

 

Prepaid expenses

 

 

2,474,001

 

 

 

-

 

 

 

-

 

 

 

2,474,001

 

 

Deposits

 

 

4,763,015

 

 

 

-

 

 

 

-

 

 

 

4,763,015

 

 

Accounts payable

 

 

1,066,741

 

 

 

-

 

 

 

-

 

 

 

1,066,741

 

 

Accrued liabilities

 

 

2,072,696

 

 

 

-

 

 

 

(1,554

)

 

 

2,071,142

 

 

Operating lease liability

 

 

(388,261

)

 

 

-

 

 

 

-

 

 

 

(388,261

)

 

Net cash provided by operating activities

 

 

28,319,290

 

 

 

-

 

 

 

-

 

 

 

28,319,290

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Purchase of property, plant, and equipment

 

 

(5,562,283

)

 

 

-

 

 

 

-

 

 

 

(5,562,283

)

 

Net cash used in investing activities

 

 

(5,562,283

)

 

 

-

 

 

 

-

 

 

 

(5,562,283

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Payments on inventory facility, net

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

Proceeds from factoring liability

 

 

37,252,869

 

 

 

-

 

 

 

-

 

 

 

37,252,869

 

 

Payments on factoring liability

 

 

(37,252,869

)

 

 

-

 

 

 

-

 

 

 

(37,252,869

)

 

Payments on note payable - related party

 

 

(180,850

)

 

 

-

 

 

 

-

 

 

 

(180,850

)

 

Payments on insurance premium note payment

 

 

(3,001,805

)

 

 

-

 

 

 

-

 

 

 

(3,001,805

)

 

Proceeds from construction note payable

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

Payments on construction note payable

 

 

(181,639

)

 

 

-

 

 

 

-

 

 

 

(181,639

)

 

Preferred stock dividends paid

 

 

(2,194,792

)

 

 

-

 

 

 

-

 

 

 

(2,194,792

)

 

Common stock repurchase plan

 

 

(2,152,080

)

 

 

-

 

 

 

-

 

 

 

(2,152,080

)

 

Net cash used in financing activities

 

 

(7,711,166

)

 

 

-

 

 

 

-

 

 

 

(7,711,166

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net increase/(decrease) in cash

 

 

15,045,841

 

 

 

-

 

 

 

-

 

 

 

15,045,841

 

 

Cash, beginning of period

 

 

39,134,027

 

 

 

-

 

 

 

-

 

 

 

39,134,027

 

 

Restricted cash, beginning of period

 

 

500,000

 

 

 

-

 

 

 

-

 

 

 

500,000

 

 

Cash and restricted cash, end of period

 

$

54,679,868

 

 

$

-

 

 

$

-

 

 

$

54,679,868

 

 

Restricted cash, end of period

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

Cash, end of period

 

$

54,679,868

 

 

$

-

 

 

$

-

 

 

$

54,679,868

 

 

v3.25.1
SUBSEQUENT EVENTS
12 Months Ended
Mar. 31, 2024
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 23 – SUBSEQUENT EVENTS

Related Party Transactions

Effective July 12, 2024, our $1.6 million letter of credit with Northern Trust for collateral for a bond related to a judgment assessed to GunBroker.com was extended until July 26, 2025. Effective July 26, 2024, our $1.6 million certificate of deposit with Northern Trust for security on the letter of credit was extended until July 28, 2025. The term of the certificate of deposit is twelve months and includes interest of approximately 5%. Per the terms of the Merger Agreement, which is filed with this Amendment as Exhibit 2.2, the Seller is required to pay or be liable for these losses (capitalized terms are defined in the Merger Agreement).

Settlement Agreement

On June 24, 2024 the Company entered into a Confidential Settlement Agreement and Mutual General Release (the “Settlement

Agreement”) with Triton Value Partners, LLC, Donald Gasgarth, Paul Freischlag, Jr., Jeff Zwitter (the “Plaintiffs,” and together with the Defendants and the Company, the “Parties” or, individually, “Party”), and Steven Urvan and TVP Investments LLC (the “Urvan Defendants”) and GunBroker.com, LLC, IA TECH, LLC, and GB Investments, Inc. (the “GunBroker Defendants,” and collectively with the Urvan Defendants, the “Defendants”) to fully resolve and settle all disputes and claims related to the litigation between the Defendants and Plaintiffs captioned Triton Value Partners, LLC et al. v. TVP Investments, LLC et al., Cobb County Superior Court, CAFN 18104869 (the “Action”). Pursuant to the Settlement Agreement, the GunBroker Defendants agreed to pay the Plaintiffs $8,000,000 (the “Settlement Amount”) in a single lump sum payment. AMMO agreed to tender the Settlement Amount to an escrow agent on behalf of the GunBroker Defendants within 45 days of the Settlement Agreement’s execution. Within five business days of the receipt of the Settlement Amount from the escrow agent, the Plaintiffs agreed to dismiss the Action with prejudice, and the Urvan Defendants agreed to dismiss all counterclaims against the Plaintiffs with prejudice. Pursuant to the Merger Agreement (as defined above), Urvan has the exclusive right to settle the Action on behalf of all Defendants and Urvan is obligated to indemnify the Company for certain liabilities, including certain liabilities incurred in connection with the Action. In connection with the Merger Agreement, on April 30, 2021, the Company and Urvan entered into a Pledge and Escrow Agreement (the “Pledge and Escrow Agreement”), pursuant to which ten stock certificates in the name of Urvan, with each certificate representing $2.8 million worth of shares of the Company’s common stock as of the date of the Pledge and Escrow Agreement (the “Pledged Securities”) were placed in escrow pending resolution of the Action. Pursuant to the Settlement Agreement, a portion of the Pledged Securities in the form of a stock certificate for 2,857,143 shares (“Stock Certificate”) were sent to the Company’s transfer agent for cancellation on September 30, 2024. Pursuant to the Settlement Agreement, each of the Plaintiffs and the Defendants provided mutual releases of all claims as of the Effective Date, arising from any allegations set forth in the Action. Notwithstanding the foregoing, the Company and the GunBroker Defendants do not release any claims asserted against Urvan, and Urvan did not release any claims asserted against the Company, the GunBroker Defendants or any individual or entity related to or affiliated with the Company. Upon the Stock Certificate’s cancellation on September 30, 2024, the Parties' payment obligations under the Settlement Agreement were complete.

On August 8, 2024, the Company paid $8.0 million to the escrow agent in connection with the Settlement Agreement. This resulted in $4.8 million recorded as a receivable that was reclassed to Treasury stock upon Mr. Urvan’s transfer of the shares related to the Settlement Payment to the Company on September 30, 2024.

Asset Purchase Agreement

On January 20, 2025, we entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”) with Olin Winchester, LLC (the “Buyer”), pursuant to which the Buyer agreed to (i) acquire all assets of our business of designing, manufacturing, marketing, distributing and selling ammunition and ammunition components (collectively, the “Ammunition Manufacturing Business”) along with certain assets related to the Ammunition Manufacturing Business, and (ii) assume certain liabilities related to the Ammunition Manufacturing Business, for a gross purchase price of $75.0 million, subject to customary adjustments for estimated net working capital and real property costs and pro-rations (the “Transaction”). The assets to be acquired, and the liabilities assumed by the Buyer were those primarily related to the Ammunition Manufacturing Business, including the Ammunition Manufacturing Business’ dedicated manufacturing facility in Manitowoc, Wisconsin.

The closing of the Transaction was subject to the satisfaction of customary closing conditions, including, among others, (i) the absence of any notice (whether temporary, preliminary or permanent) from a governmental authority or federal or state court of competent jurisdiction which is in effect and prevents or prohibits consummation of the Transaction, (ii) the accuracy of the representations and warranties of the parties, (iii) the parties’ compliance with their respective covenants in all material respects, (iv) the delivery by the Company to Buyer of certain consents and approvals, permits, and policies, surveys, and reports related to the owned real property used in the Ammunition Manufacturing Business, and (v) the release of all liens relating to the assets being purchased in the Transaction.

The Purchase Agreement contained customary representations, warranties and covenants as well as customary post-signing and post-Closing covenants.

On April 18, 2025, we entered into a First Amendment (the “First Amendment”) to the Asset Purchase Agreement. Pursuant to the First Amendment, the Company and Buyer agreed to, among other things: (i) the removal of the escrow mechanisms for the purchase price adjustments contemplated under the Asset Purchase Agreement; (ii) the addition of a pre-closing inventory count rather than a post-closing inventory count; (iii) the revision of the net working capital adjustment provisions to agree upon certain pre-determined assets and liabilities and remove deductions for certain types of inventory and account for inventory based on the Company’s historical accounting practices; (iv) the addition of a reserve to adjust for upgrades to equipment and inventory issues; and (v) the addition of a purchase price adjustment collar in the event the final net working capital amount is less the estimated net working capital exceeds, which entitles the Buyer to receive from the Company amounts in excess of the collar for such a shortfall.

The Company and the Buyer also entered into certain additional agreements, including, among other things: (a) the addition of a mutual non-disparagement provision; (b) the removal of the closing condition related to the process hazard analysis report and the

amendment of one of the representations to account for such report; (c) the addition of a mutual release related to certain disputed items; and (d) the addition of an indemnification related to an item excluded from coverage in the representations and warranties insurance policy.

The Transaction was completed on April 18, 2025.

In connection with the Transaction, we evaluated the Transaction in accordance with ASC Topic 205, "Presentation of Financial Statement" ("ASC 205") and concluded this was a triggering event to reassess the carrying value of the segment's assets. In accordance with ASC Topic 360, "Property, Plant, and Equipment" ("ASC 360"), we reassessed the carrying value of its assets and determined that an impairment of assets would be recorded in the year ended March 31, 2025 as follows:

 

 

 

Impairment
Amount

 

Inventory

 

 

$

17,129,874

 

Property, plant and equipment

 

 

 

25,381,646

 

Other assets

 

 

 

530,195

 

Intangible assets

 

 

 

2,805,715

 

Total Impairment

 

 

$

45,847,430

 

Separation Agreements

On September 19, 2024, we received a notice of resignation from its Chief Financial Officer, Rob Wiley, effective September 20, 2024. Pursuant to the Separation Agreement signed on September 19, 2024, Mr. Wiley will be entitled to separation compensation in the amount of $406,250.00 paid in equal bi-monthly installments over fifteen calendar months; 50,000 shares of Common Stock; a lump sum payment for accrued and unused vacation and paid time off; family health benefits under the Company’s employer sponsored plans until September 30, 2025; and unreimbursed expenses.

On April 8, 2025, in connection with Fred W. Wagenhals’ resignation from his position as the Executive Chairman of the Company and as Chairman of the Board on April 4, 2025, the Company and Mr. Wagenhals entered into an Executive Separation Agreement, effective April 4, 2025, pursuant to which Mr. Wagenhals is entitled to receive certain separation benefits, including: (i) payment of all compensation and benefits to which Mr. Wagenhals is legally entitled under the Wagenhals Employment Agreement through the Separation Date; (ii) a cash separation payment equal to $700,000, consisting of (a) a lump sum payment of $300,000 (an amount equal to nine months of Mr. Wagenhals’s annual base salary) and (b) an aggregate of $400,000 (an amount equal to 12 months of Mr. Wagenhals’s annual base salary) to be paid in substantially equal installments in accordance with the Company’s normal payroll practices; (iii) reimbursement for all reimbursable expenses due to Mr. Wagenhals under the Wagenhals Employment Agreement; and (iv) a lump sum payment equal to the value of Mr. Wagenhals’s accrued and unused vacation and paid time off balance.

Loan Amendment

On April 18, 2025, we entered into a Consent and Second Amendment to Loan and Security Agreement (the “Sunflower Loan Amendment”) by and among the Company and other borrowers party thereto (collectively, the “Borrower”), and Sunflower Bank, N.A., as administrative agent and collateral agent (the “Agent”). The Sunflower Loan Amendment amends that certain Loan and Security Agreement, dated as of December 29, 2019, by and among the Borrower, the Lenders and the Agent (as amended by the Sunflower Loan Amendment, the “Sunflower Loan Agreement”).

Pursuant to the Sunflower Loan Amendment, the Borrower and the Agent agreed to, among other things: (i) release the Agent’s security interest in all collateral securing the Borrower’s obligations under the Sunflower Loan Agreement upon consummation of the sale of the Ammunition Manufacturing Business; (ii) reduce all amounts available under the Revolving Loan to zero dollars as of the effective date of the Sunflower Loan Amendment; (iii) enter into an Amended and Restated Revolving Line Promissory Note in the amount of $5.0 million, representing 100% of the Revolving Line Commitment available under the Sunflower Loan Agreement, executed by Borrower in favor of Agent as of the effective date of the Sunflower Loan Amendment; and (iv) certain other amendments to Borrower’s customary covenants and obligations under the Sunflower Loan Agreement that only take effect in the event the Revolving Line Availability is greater than zero dollars.

Contingencies

On December 20, 2024, the Board of Directors held a meeting during which it voted to pursue a settlement in the Plenary Action between Ammo and Mr. Urvan (which is further described in Note 2 above) and voted to approve terms outlined in a non-binding term sheet. We recorded an estimated liability of $20.4 million in the year ended March 31, 2025.

Settlement negotiations between the Company and Mr. Urvan are ongoing. There can be no assurance that a final settlement

agreement will be reached. If an agreement is not reached, the Company intends to continue to vigorously defend against this litigation. On February 3, 2025, the Delaware Court granted a joint stipulated motion to postpone the five-day trial to April 27, 2026 and ordered a stay of litigation of approximately three months, during which all depositions and discovery is postponed.

The Company faces an inestimable loss contingency stemming from a pending investigation of the Staff of the Securities and Exchange Commission's ("SEC") Division of Enforcement (the "SEC Investigation"). The Company has produced documents responsive to document subpoenas and cooperated by, among other things, providing other information to the SEC Staff on a voluntary basis. The SEC Staff has significant discretion in conducting investigations, and therefore, the Company cannot predict the scope or outcome of the SEC Investigation. Based upon document subpoenas to the Company and other communications in January, 2025, it appears that the SEC Staff is investigating and will likely recommend that the SEC bring an enforcement action relating to the Company’s: (i) valuation of, and accounting for share-based compensation awards to employees, non-employee directors and other service providers, and issued in exchange for goods and services; (ii) capitalization of certain share issuance costs; (iii) disclosure of perquisites and the valuation of equity-based compensation paid to certain executives; (iv) disclosure of certain executive officers and related party transactions; and (v) disclosure concerning the calculation of Adjusted EBITDA. The SEC Staff have not issued a Wells Notice to the Company. If the SEC Staff issues a Wells Notice, the Company will have the opportunity to present factual evidence, legal arguments and mitigating circumstances to the SEC. If, notwithstanding the Company’s Wells submission, the SEC authorizes a civil enforcement action, the agency may seek injunctions, civil penalties or other relief, and the Company may incur additional legal and other professional fees in defending such action or negotiating a resolution. Given the ongoing nature and complexity of the SEC Investigation, we cannot yet reasonably estimate a loss or range of loss that may arise from its resolution. The Company will continue to evaluate information to determine when it is both probable that a loss has been incurred and the amount of the loss is reasonably estimable.

v3.25.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
12 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Principles of Consolidation

Principles of Consolidation

The consolidated financial statements include the accounts of AMMO, Inc. and its wholly owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires us to make estimates and assumptions that affect the amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates made in preparing the condensed consolidated financial statements include the valuation of allowances for credit losses, valuation of deferred tax assets, inventories, useful lives of assets, goodwill, intangible assets, stock-based compensation, and warrant-based compensation.

Goodwill

Goodwill

We evaluate goodwill for impairment annually or more frequently when an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. In testing for goodwill impairment, we may elect to utilize a qualitative assessment to evaluate whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If our qualitative assessment indicates that goodwill impairment is more likely than not, we perform a two-step impairment test. We test goodwill for impairment under the two-step impairment test by first comparing the book value of net assets to the fair value of the reporting unit. If the fair value is determined to be less than the book value or qualitative factors indicate that it is more likely than not that goodwill is impaired, a second step is performed to compute the amount of impairment as the difference between the estimated fair value of goodwill and the carrying value. We estimate the fair value of the reporting units using discounted cash flows. Forecasts of future cash flows are based on our best estimate of future net sales and operating expenses, based primarily on expected category expansion, pricing, market segment share, and general economic conditions. Due to the declines in the value of our stock price and market capitalization during the years ended March 31, 2024, 2023 and 2022, we assessed qualitative factors to determine if it is more likely than not that the fair value of the Marketplace segment is less than its carrying amount. Through our analysis we determined our stock price and market capitalization decline was not indicative of a decrease in the fair value of our Marketplace segment and a fair value calculation using the discounted cash flows was more appropriate due to the operational performance of the reporting segment. Accordingly, the impairment of Goodwill was not warranted for the year ended March 31, 2024. As of March 31, 2024, 2023 and 2022, the Company had a goodwill carrying value of $90,870,094, all of which was assigned to the Marketplace segment. However,

due to declines in the value of the Company’s Common Stock and market capitalization, it is possible that the book values of our Marketplace segment could exceed its fair value, which may result in the recognition of a material, noncash impairment of goodwill for the year ending March 31, 2025.

Accounts Receivable and Allowance for Credit Losses

Accounts Receivable and Allowance for Credit Losses

Our accounts receivable represents amounts due from customers for products sold and include an allowance for estimated credit losses which is estimated based on the collectability and age of the accounts receivable balances and categorization of customers with similar financial condition. At March 31, 2024, March 31, 2023, and March 31, 2022 we reserved $3,666,078, $3,246,551, and $3,055,252 respectively, of allowance for credit losses.

Cash and Cash Equivalents

Cash and Cash Equivalents

For purposes of the consolidated statements of cash flows, we consider highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents.

Restricted Cash

Restricted Cash

We consider cash to be restricted when withdrawal or general use is legally restricted. In the year ended March 31, 2023, our restricted cash balance was comprised of cash on deposit with banks to secure the Construction Loan Agreement as discussed in Note 13. During the year ended March 31, 2024, the remaining balance of our restricted cash was released. In the case that there is a balance, we report restricted cash in the consolidated balance sheets as current or non-current classification based on the expected duration of the restriction.

License Agreements

License Agreements

During the years ended March 31, 2024, 2023, and 2022 we were a party to a license agreement with Jesse James, a well-known motorcycle designer, and Jesse James Firearms, LLC, a Texas limited liability company. The license agreement grants us the exclusive worldwide rights through April 12, 2026 to Mr. James’ image rights and trademarks associated with him in connection with the marketing, promotion, advertising, sale, and commercial exploitation of Jesse James Branded Products. We agreed to pay Mr. James royalty fees on the sale of ammunition and non-ammunition Branded Products and to reimburse him for any out-of-pocket expenses and reasonable travel expenses.

We were a party to a license agreement with Jeff Rann, a well-known wild game hunter and spokesman for the firearm and ammunition industries. The license agreement, which expired February 2022, granted us the exclusive worldwide rights to Mr. Rann’s image rights and trademarks associated with him in connection with the marketing, promotion, advertising, sale, and commercial exploitation of all Jeff Rann Branded Products. We agreed to pay Mr. Rann royalty fees on the sale of ammunition and non-ammunition Branded Products and to reimburse him for any out-of-pocket expenses and reasonable travel expenses.

Patents

Patents

On September 28, 2017, AMMO Technologies Inc. (“ATI”), an Arizona corporation, which is 100% owned by us, merged with Hallam, Inc, a Texas corporation, with ATI being the survivor. The primary asset of Hallam, Inc. was an exclusive license to produce projectiles and ammunition using the Hybrid Luminescence Ammunition Technology under patent U.S. 8,402,896 B1 with a publication date of March 26, 2013 owned by University of Louisiana at Lafayette. The license was formally amended and assigned to ATI pursuant to an Assignment and First Amendment to Exclusive License Assumption Agreement dated to be effective as of August 22, 2017, the merger closing date. This asset will be amortized from September 2017, the first full month of the acquired rights, through October 29, 2028.

Under the terms of the Exclusive License Agreement, the Company is obligated to pay a royalty to the patent holder, based on a $0.01 per unit basis for each round of ammunition sold that incorporates this patented technology through October 29, 2028. For the years ended March 31, 2024, 2023, and 2022, the Company recognized royalty expenses of $22,754, $99,268, and $44,764 respectively under this agreement.

In August 2018, we applied for additional patent coverage for the manufacturing methods or application of the Hybrid Luminescence Ammunition Technology on a variety of projectile and ammunition types. The costs of filing this patent were expensed.

On October 5, 2018, we completed the acquisition of SW Kenetics, Inc. ATI succeeded all of the assets of SW Kenetics, Inc. and assumed all of the liabilities.

The primary asset of SW Kenetics, Inc. was a pending patent for modular projectiles. All rights to patent pending application were assigned and transferred to ATI pursuant to Intellectual Property Rights Agreement on September 27, 2018.

We intend to continue building our patent portfolio to protect our proprietary technologies and processes, and will file new applications where appropriate to preserve our rights to manufacture and sell our branded lines of ammunition.

Other Intangible Assets

Other Intangible Assets

On March 15, 2019, Enlight Group II, LLC d/b/a Jagemann Munition Components, a wholly owned subsidiary of AMMO, Inc., completed its acquisition of assets of Jagemann Stamping Company’s ammunition casing manufacturing and sales operations pursuant to the terms of the Amended and Restated Asset Purchase Agreement (See Note 20). The intangible assets acquired include a tradename, customer relationships, and intellectual property.

On April 30, 2021, we entered into an agreement and plan of merger (the “Merger Agreement”), by and among the Company, SpeedLight Group I, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company and Gemini Direct Investments, LLC, a Nevada limited liability company ("Gemini"), whereby SpeedLight Group I, LLC merged with and into Gemini, with SpeedLight Group I, LLC surviving the merger as a wholly owned subsidiary of the Company (the "Merger"). At the time of the Merger, Gemini had nine (9) subsidiaries, all of which are related to Gemini’s ownership of GunBroker, an online auction marketplace dedicated to firearms, hunting, shooting, and related products. The intangible assets acquired include a tradename, customer relationships, intellectual property, software, and domain names.

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

We continually monitor events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable. When such events or changes in circumstances are present, we assess the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, we recognize an impairment loss based on the excess of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or the fair value less costs to sell. No impairment expense was recognized for the years ended March 31, 2024, 2023, and 2022.

Revenue Recognition

Revenue Recognition

We generate revenue from the production and sale of ammunition, ammunition casings, and marketplace fee revenue, which includes auction revenue, payment processing revenue, and shipping income. We recognize revenue according to Accounting Standard Codification – Revenue from Contract with Customers (“ASC 606”). When the customer obtains control over the promised goods or services, we record revenue in the amount of consideration that we can expect to receive in exchange for those goods and services. We apply the following five-step model to determine revenue recognition:

Identification of a contract with a customer
Identification of the performance obligations in the contract
Determination of the transaction price
Allocation of the transaction price to the separate performance obligation
Recognition of revenue when performance obligations are satisfied

We only apply the five-step model when it is probable that we will collect the consideration we are entitled to in exchange for the goods or services we transfer to the customer. At contract inception and once the contract is determined to be within the scope of ASC 606, we assess the goods or services promised within each contract and determine those that are performance obligations, and assess whether each promised good or service is distinct.

For Ammunition Sales and Casing Sales, our contracts contain a single performance obligation and the entire transaction price is allocated to the single performance obligation. We recognize as revenues the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied. Accordingly, we recognize revenues (net) when the customer obtains control of our product, which typically occurs upon shipment of the product or the performance of the service. In the year ended March 31, 2021, we began accepting contract liabilities or deferred revenue. We included Deferred Revenue in our Accrued Liabilities. We will recognize revenue when the performance obligation is met.

For Marketplace revenue, the performance obligation is satisfied, and revenue is recognized, as follows:

Auction revenue consists of optional listing fees with variable pricing components based on customer options selected from the GunBroker website and final value fees based on a percentage of the final selling price of the listed item. The performance obligation is to process the transactions as initiated by the customer. Revenue is recognized at a point in time when the transaction is processed.

Compliance fee revenue consists of fees charged to customers based on a percentage of the final price of an item at the time of purchase. The performance obligation is to process the transactions as initiated by the customer. Revenue is recognized at a point in time when the transaction is processed.

Payment processing revenue consists of fees charged to customers on a transactional basis. The performance obligation is to process the transactions as initiated by the customer. The price is set by the GunBroker user agreement on the website based on stand-alone selling prices. Revenue is recognized at a point in time when the transaction is processed.

Shipping income consists of fees charged to customers for shipping of sold items listed on the GunBroker website. The performance obligation is to ship the item sold as initiated by the customer. The price is set based on the third-party service provider selected to be used by the customer as well as the speed and location of shipment. Revenue is recognized at a point in time when the shipping label is printed.

Banner Advertising Campaign Revenue consists of fees charged to customers for advertisement placement and impressions generated through the GunBroker website. The performance obligation is to generate the number of impressions specified by the customer on banner advertisements on the GunBroker website using the placement selected by the customer. The price is set by the GunBroker user agreement on the website based on standalone selling prices, or by advertising insertion order as negotiated by a media broker. If the number of impressions promised is not generated, the customer receives a refund and the refund is applied to the transaction price. Banner advertising campaigns generally run for one month, and revenue is recognized at a point in time at the end of the selected month.

Product Sales consists of fees charged for the liquidation of excess inventory for partner distributors. The performance obligation is to sell and ship the inventory item as initiated by the customer. The price depends on whether the inventory is a fixed price item or an auction item. For a fixed price item, the Company performs research to determine the current market rate for such an item, and the item is listed at that price. For an auction item, the price is set by what the buyer is willing to pay. The Company acts as a principal in these transactions due to the extent of control they have over the product prior to the sale. Due to the principal determination, gross revenue is recognized at a point in time when the item has been shipped.

Identity Verification consists of fees charged to customers for identity verification in order to gain access to the GunBroker website. The performance obligation is to process the identity verification as initiated by the customer. The price is set by the GunBroker user agreement on the website based on a stand-alone selling price. Revenue is recognized at a point in time when the identity verification is completed.

For the years ended March 31, 2024, 2023, and 2022, the Company’s customers that comprised more than ten percent (10%) of total revenues and accounts receivable were as follows:

 

For the Year Ended

 

 

For the Year Ended

 

 

For the Year Ended

 

 

 

March 31, 2024

 

 

March 31, 2023

 

 

March 31, 2022

 

PERCENTAGES

 

Revenues

 

 

Accounts
Receivable

 

 

Revenues

 

 

Accounts
Receivable

 

 

Revenues

 

 

Accounts
Receivable

 

Customers:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

A

 

 

-

 

 

 

11.8

%

 

 

12.2

%

 

 

-

 

 

 

-

 

 

 

-

 

B

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

11.8

%

 

 

-

 

 

 

11.8

%

 

 

12.2

%

 

 

-

 

 

 

-

 

 

 

11.8

%

 

Disaggregated Revenue Information

The following table presents a disaggregation of revenue from customers by category. We attribute net sales to categories by product or services types: ammunition, ammunition casings, and marketplace fees. The Company notes that revenue recognition processes are consistent between product and service type, however, the amount, timing and uncertainty of revenue and cash flows may vary by each product type due to the customers of each product and service type.

 

For the Year Ended

 

 

March 31,
2024

 

 

March 31,
2023

 

 

March 31,
2022

 

Ammunition Sales(1)

 

$

69,390,801

 

 

$

114,116,044

 

 

$

161,459,025

 

Marketplace Revenue

 

 

53,942,076

 

 

 

63,149,673

 

 

 

64,608,516

 

Casings Sales

 

 

21,721,695

 

 

 

14,174,084

 

 

 

14,201,625

 

Total Revenue

 

$

145,054,572

 

 

$

191,439,801

 

 

$

240,269,166

 

 

(1)
Included in revenue for the years ended March 31, 2024, 2023, and 2022 are excise taxes of $6,155,524, $9,789,897, and $14,646,983, respectively.

Ammunition products are sold through “Big Box” retailers, manufacturers, local ammunition stores, and shooting range operators. We also sell direct to customers online. In contrast, our ammunition casings products are sold to manufacturers. Marketplace fees are generated through our GunBroker online auction marketplace.

All ammunition product sales are recorded upon shipment and, depending on credit worthiness of customer, the payment terms will vary from thirty (30) to sixty (60) days. No refunds are allowed on any product shipped.

Each product manufactured by the Company has standard specifications and performance objectives. The Company has an extensive product testing program and, if the Company were given notice of a product defect by a customer, the Company would request the return of the product so that the manufacturing defect could be identified.

Contract Liabilities

Our contract liabilities consist of unearned revenue, which represents up front payments received from customers for product to be delivered at a future date. Contract liabilities are classified as current or long-term based on the timing of contract obligation. As of March 31, 2024, we had unearned revenue of $1.8 million, which is included in accrued liabilities on the consolidated balance sheet. Unearned revenue was $0.1 million and $0.2 million as of March 31, 2023 and 2022, respectively.
Advertising Costs

Advertising Costs

We expense advertising costs as they are incurred in selling and marketing expenses of operating expenses. Marketplace advertising costs are expensed as they are incurred and recorded in cost of revenues. For the years ended March 31, 2024, 2023, and 2022, we incurred advertising expenses of $1,149,596, $1,355,179, and $1,823,060, respectively, of which $384,002, $1,068,700, and $1,406,043 related to our ammunition segment. For the years ended March 31, 2024, 2023 and 2022 we incurred marketplace advertising expenses of $765,594, $286,479, and $417,017, respectively, in cost of revenues.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

We measure options and warrants at fair value in accordance with Accounting Standards Codification 820 – Fair Value Measurement (“ASC 820”). The objective of ASC 820 is to increase consistency and comparability in fair value measurements and to expand disclosures about fair value measurements. ASC 820 defines fair value, establishes a framework for measuring fair value in accordance with GAAP, and expands disclosures about fair value measurements. ASC 820 specifies a valuation hierarchy based on whether the inputs to those valuation techniques are observable or unobservable.

Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s own assumptions. These two types of inputs have created the following fair value hierarchy:

Level 1 – Quoted prices for identical instruments in active markets;

Level 2 – Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and

Level 3 – Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

This hierarchy requires us to minimize the use of unobservable inputs and to use observable market data, if available, when estimating fair value.

The carrying values of cash and cash equivalents, accounts receivable and accounts payable approximated fair values due to the short-term maturities of these instruments.

In connection with our acquisition of Gemini, we used the Level 2 inputs in estimating the fair value of the transaction. Please refer to Note 16.

Inventories

Inventories

We state inventories at the lower of cost or net realizable value. We determine cost using the average cost method. Our inventory consists of raw materials, work in progress, and finished goods. Cost of inventory includes cost of parts, labor, quality control, and all other costs incurred to bring our inventories to condition ready to be sold. We periodically evaluate and adjust inventories for obsolescence.

Property and Equipment

Property and Equipment

We state property and equipment at historical cost less accumulated depreciation. We compute depreciation using the straight-line method at rates intended to depreciate the cost of assets over their estimated useful lives, which are generally five to ten years. Upon retirement or sale of property and equipment, we remove the cost of the disposed assets and related accumulated depreciation from the accounts and any resulting gain or loss is credited or charged to other income or expenses. We charge expenditures for normal repairs and maintenance to expense as incurred.

We capitalize additions and expenditures for improving or rebuilding existing assets that extend the useful life. Leasehold improvements made either at the inception of the lease or during the lease term are amortized over the shorter of their economic lives or the lease term including any renewals that are reasonably assured.

Leases

Leases

We determine if an arrangement is a lease at inception of the contract. Operating lease assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease assets and liabilities are recognized at commencement date based on the present value of fixed lease payments over the lease term. Leases with an initial term of 12 months or less are not recorded on the balance sheet; instead, we recognize lease expense for these leases on a straight-line basis over the lease term. We do not account for lease components (e.g., fixed payments to use the underlying lease asset) separately from the non-lease components (e.g., fixed payments for common-area maintenance costs and other items that transfer a good or service). Some of our leases include variable lease payments, which primarily result from changes in consumer price and other market-based indices, which are generally updated annually, and maintenance and usage charges. These variable payments are excluded from the calculation of our lease assets and lease liabilities.

We utilize the interest rate implicit in the lease to determine the lease liability when the interest rate can be determined. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments.

Research and Development

Research and Development

To date, we have expensed all costs associated with developing our product specifications, manufacturing procedures, and products through our cost of revenues, as this work was done by the same employees who produced the finished product. We anticipate that it may become necessary to reclassify research and development costs into our operating expenses for reporting purposes as we begin to develop new technologies and lines of ammunition.

Excise Tax

Excise Tax

As a result of regulations imposed by the Federal Government for sales of ammunition to non-government U.S. entities, we charge and collect an 11% excise tax for all products sold into these channels. During the years ended March 31, 2024, 2023, and 2022, we recognized approximately $6.2 million, $9.8 million, and $14.6 million respectively, in excise taxes. For ease in selling to commercial markets, excise tax is included in our unit price for the products sold. We record this through net sales and expense the offsetting tax expense to cost of revenues on our consolidated statement of operations.

Stock-Based Compensation

Stock-Based Compensation

We account for stock-based compensation at fair value in accordance with Accounting Standards Codification 718 – Compensation – Stock Compensation (“ASC 718”), which requires the recognition of the cost of employee, director and non-employee services received in exchange for an award of equity over the period the employee, director or non-employee is required to perform the services in exchange for the award. Stock-based compensation is measured based on the grant-date fair value of the award. Stock-based compensation is recognized on a straight-line basis over the vesting periods and forfeitures are recognized in the periods they occur.

Concentrations of Credit Risk

Concentrations of Credit Risk

Accounts at banks are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. As of March 31, 2024, 2023 and 2022, our bank account balances exceeded federally insured limits, however, we have not incurred losses related to these deposits.

Income Taxes

Income Taxes

We file federal and state income tax returns in accordance with the applicable rules of each jurisdiction. We account for income taxes under the asset and liability method in accordance with Accounting Standards Codification 740 - Income Taxes (“ASC 740”). The provision for income taxes includes federal, state, and local income taxes currently payable, and deferred taxes. We recognize deferred tax assets and liabilities for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. We measure deferred tax assets and liabilities using enacted tax rates expected

to apply to taxable amounts in years in which those temporary differences are expected to be recovered or settled. If it is more likely than not that some portion or all of a deferred tax asset will not be realized, a valuation allowance is recognized. In accordance with ASC 740, we recognize the effect of income tax positions only if those positions are more likely than not of being sustained. We measure recognized income tax positions at the largest amount that is greater than 50% likely of being realized. We reflect changes in recognition or measurement in the period in which the change in judgment occurs.

Contingencies

Contingencies

Certain conditions may exist as of the date the consolidated financial statements are issued that may result in a loss to us but will only be resolved when one or more future events occur or fail to occur. We assess such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against us or unasserted claims that may result in such proceedings, we evaluate the perceived merits of any legal proceedings or unasserted claims and the perceived merits of the amount of relief sought or expected to be sought therein.

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability is reasonably estimated, the estimated liability would be accrued in our condensed consolidated financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of range of possible loss if determinable and material, would be disclosed.

On February 10, 2022, AMMO filed a Texas state court complaint against Expansion Industries pursing eight claims in pursuit of recovery of AMMO’s in primer acquisition deposit monies (i.e., Breach of Contract, Common Law Fraud, Violations of Texas Theft Liability Act, Conversion, Negligent Misrepresentation, Unjust Enrichment, Money Had and Received and Constructive Trust). AMMO moved aggressively to further the process, including successfully garnishing a portion of the deposit monies in Expansion bank accounts, filing a Motion for Summary Judgment, continuing to pursue written discovery, and amending the Complaint to add Expansion principal as an individual party. The putative primer manufacturer settled the two related lawsuits in September 2022 by repaying all deposit monies due AMMO, in addition to payment of principally all fees and costs incurred by us in pursuit of the resolution. The principal lawsuit and AMMO’s garnishment action against the defendant were dismissed with prejudice.

Along with countless other suppliers of Remington Outdoors, AMMO was served with an avoidance claim lawsuit by the bankruptcy trustee. AMMO presented substantial “ordinary course” defense evidence to the Trustee and the case was settled for a nominal sum in September 2022, with the lawsuit dismissed with prejudice.

AMMO was involved in three contract arbitration cases with adverse former employees. The first one involved an employee terminated for cause who was seeking contract wages and stock that was earned but clawed back upon his termination. In that case, the Company received a favorable ruling on a partial motion for summary judgment wherein the arbitrator ruled the employee had refused to return funds he received as reimbursement for invoices he never paid. The arbitrator granted the Company’s partially dispositive motion. The remaining claims went to an arbitration hearing in late September 2023. The arbitrator has entered an interim award as well as a supplemental briefing award fees. The parties have submitted their respective briefs on those issues. The arbitrator will enter the final award in June, 2024, which is not appealable.

 

The second case involved an employee who was terminated without cause wherein the former employee was seeking contract wages, commissions and allegedly earned common stock. The Company also received notice in October 2022 that an OSHA whistleblower complaint had been filed with the US Department of Labor by that same employee that had been terminated for cause. The regulatory filing was received after AMMO refused to capitulate to the former employee’s demands. AMMO has produced documents and submitted its position statement to OSHA and the matter is currently pending at the agency level. AMMO uncovered additional information through work with counsel and investigators and a supplemental response was provided to OHSA on or about July 10, 2023. The Company and the employee agreed to arbitrate the case. The parties reached a resolution of all outstanding claims in November 2023 and all claims have been dismissed.

The third case involved an employee who was terminated without cause wherein the former employee was seeking contract wages and commissions. The Company and the employee agreed to arbitrate the case in August 2023. The parties reached a resolution of all outstanding claims in January 2024 and all claims have been dismissed.

On April 30, 2023, director and stockholder Steve Urvan filed suit in the Delaware Court of Chancery (the"Delaware Court") against the Company, and certain AMMO directors, former directors, employees, former employees and consultants. Urvan’s claims include fraudulent inducement, unjust enrichment and violations of the Arizona Securities Act. The suit seeks a court order for partial rescission of the Merger and compensatory damages of not less than $140 million. The Company and named defendants are in alignment in all material respects and intend to vigorously defend Urvan’s claims. The Company has engaged Delaware Court litigation specialists to defend its interests in all respects in this case. The Company timely responded to the Urvan Complaint by filing a motion to dismiss.

On August 1, 2023, AMMO filed a separate lawsuit against Urvan in the Delaware Court alleging, among other things, that Urvan committed fraud in connection with the GunBroker.com sale, and that Urvan breached his indemnification obligations to AMMO after the sale. On September 11, 2023, the Delaware Court consolidated AMMO’s lawsuit against Urvan with Urvan’s lawsuit against AMMO and the individual defendants. On September 18, 2023, AMMO filed an amended complaint that added a claim against Urvan for breach of the Arizona Securities Act. Urvan moved to dismiss AMMO’s complaint in full. On December 18, 2023, the Delaware Court of heard argument on the parties’ motions to dismiss in the consolidated action. On February 27, 2024, the Delaware Court issued an opinion resolving all pending motions to dismiss. The Court dismissed Urvan’s aiding and abetting claims against the individual defendants, but it declined to dismiss Urvan’s other claims against the individuals and declined to dismiss Urvan’s claims against AMMO. The Delaware Court rejected Urvan’s motion to dismiss AMMO’s claims against him in its entirety. On May 8, 2024, the Delaware Court ordered a case schedule culminating in a five-day trial on July 28, 2025. For information about subsequent developments in this proceeding, see Note 23 "Subsequent Events."

On December 6, 2023, Steve Urvan initiated a separate action against the Company in his capacity as director under 8 Del. C. § 220(d) to inspect certain of the Company’s books and records (the “Books and Records Action”). In the Books and Records Action, Mr. Urvan alleges that the Company wrongfully refused to provide him with access to certain categories of documents following demands that he made on the Company on March 3, 2023 and November 9, 2023. The Company asserted as an affirmative defense that Mr. Urvan’s primary purpose for his demands is, among other things, to obtain documents to support his claims in the Delaware Plenary Litigation, in which discovery was then stayed. The court held a one-day trial on February 26, 2024 in Georgetown, Delaware. On February 27, 2024, the court in the Delaware Plenary Litigation issued an opinion that had the effect of lifting the discovery stay. On February 28, 2024, AMMO informed the judge presiding over the Books and Records Action that “[i]n AMMO’s view, the [Plenary Action] Opinion has effectively mooted this [Books and Records] action.” On April 9, 2024, AMMO began producing documents in response to Mr. Urvan’s demands pursuant to a Stipulation and Order Governing AMMO’s Document Productions. The court has not issued a post-trial ruling.

On January 18, 2024, Innovative Computer Professionals, Inc. d/b/a Digital Cash Processing (“DCP”) filed a civil action in Minnesota state court against Outdoors Online, LLC d/b/a GunBroker.com (“GunBroker.com”) for breach of contract (the “MN Action”). In the MN Action, DCP alleges that GunBroker.com breached a May 2021 contract, pursuant to which DCP was to provide specified digital payment processing services, and it alleges $100 million in damages. On February 7, 2024, GunBroker.com removed the MN Action to the United States District Court for the District of Minnesota. On February 14, 2024, GunBroker.com moved to dismiss the MN Action for lack of personal jurisdiction and for failure to adequately state a claim, or, in the alternative, to transfer the MN Action to the United States District Court for the District of Arizona (the “Motion”). As of March 31, 2024, the Motion had been fully briefed, argued, and submitted to the court. GunBroker.com denies the allegations , and it plans to vigorously defend the claims asserted against it and assert counterclaims against DCP if and when it is required to answer.

We have accrued for contingencies totaling approximately $1.4 million for the year ended March 31, 2024. There were no other known contingencies as of March 31, 2024, 2023 and 2022.

Recent Adopted Accounting Pronouncements

Recent Adopted Accounting Pronouncements

We adopted Accounting Standards Update (“ASU”) No. 2016-13, “Financial Instruments-Credit Losses (Topic 326) and ASU 2022-03, “Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions” in the current period. These policy changes did not result in a material effect on the Company’s financial statements.

Recent Accounting Pronouncements

In June 2022, the Financial Accounting Standards Board ("FASB") issued ASU 2022-03, “Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions” which clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance also clarifies that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction and requires specific disclosures for equity securities subject to contractual sale restrictions. For public business entities, the amendments in this ASU are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years.

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires that a public entity disclose, on an annual and interim basis, significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss. Additionally, it requires that a public entity (1) disclose an amount for “other segment items” by reportable segment, (2) provide all annual disclosures about a reportable segment’s profit or loss and assets currently required by Topic 280 in interim periods, and (3) requires that a public entity that has a single reportable segment provide all the disclosures required by the amendments in this proposed ASU and all existing segment disclosures in Topic 280. The new guidance is effective for annual periods beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. The amendments in this proposed ASU should be applied retrospectively to all prior periods presented in the financial statements. Early adoption is permitted. We are currently evaluating the potential impact of these changes.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which enhances the transparency and decision usefulness of income tax disclosures. The ASU requires that public business entities on an annual basis (1) disclose specific categories in the effective tax rate reconciliation and (2) provide additional information for reconciling items that meet or exceed a quantitative threshold. Additionally, it requires all entities disclose the following information about income taxes paid on an annual basis: (1) the year-to-date amounts of income taxes paid disaggregated by federal (national), state, and foreign taxes and (2) the amount of income taxes paid disaggregated by individual jurisdictions in which income taxes paid is equal to or greater than 5 percent of total income taxes paid. The amendments are effective for annual periods beginning after December 15, 2024. The amendments in this proposed ASU should be applied on a prospective basis, although retrospective application to all periods presented is permitted. Early adoption is permitted. We are currently evaluating the potential impact of these changes.

Management does not believe that any other recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

Reclassifications

Reclassifications

Certain prior year amounts have been reclassified to conform to the current year's presentation. These reclassifications have no effect on the results of operations, stockholders' equity and cash flows as previously reported.

v3.25.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
SCHEDULE OF CONCENTRATION RISK OF TOTAL REVENUES AND ACCOUNTS RECEIVABLE

 

For the Year Ended

 

 

For the Year Ended

 

 

For the Year Ended

 

 

 

March 31, 2024

 

 

March 31, 2023

 

 

March 31, 2022

 

PERCENTAGES

 

Revenues

 

 

Accounts
Receivable

 

 

Revenues

 

 

Accounts
Receivable

 

 

Revenues

 

 

Accounts
Receivable

 

Customers:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

A

 

 

-

 

 

 

11.8

%

 

 

12.2

%

 

 

-

 

 

 

-

 

 

 

-

 

B

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

11.8

%

 

 

-

 

 

 

11.8

%

 

 

12.2

%

 

 

-

 

 

 

-

 

 

 

11.8

%

SCHEDULE OF DISAGGREGATED REVENUE FROM CUSTOMERS BY SEGMENT

 

For the Year Ended

 

 

March 31,
2024

 

 

March 31,
2023

 

 

March 31,
2022

 

Ammunition Sales(1)

 

$

69,390,801

 

 

$

114,116,044

 

 

$

161,459,025

 

Marketplace Revenue

 

 

53,942,076

 

 

 

63,149,673

 

 

 

64,608,516

 

Casings Sales

 

 

21,721,695

 

 

 

14,174,084

 

 

 

14,201,625

 

Total Revenue

 

$

145,054,572

 

 

$

191,439,801

 

 

$

240,269,166

 

 

(1)
Included in revenue for the years ended March 31, 2024, 2023, and 2022 are excise taxes of $6,155,524, $9,789,897, and $14,646,983, respectively.
v3.25.1
RESTATEMENT OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS (Tables)
12 Months Ended
Mar. 31, 2024
Prior Period Adjustment [Abstract]  
SCHEDULE OF RESTATEMENT OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS

The following table summarizes the impact to the consolidated statement of operations of the change in stock-based compensation expense by fiscal year:

Year ended March 31, 2021 (unaudited)

 

$

 

4,192,414

 

 

Year ended March 31, 2022

 

 

 

1,422,138

 

 

Year ended March 31, 2023

 

 

 

4,141,364

 

 

Year Ended March 31, 2024

 

 

 

996,181

 

 

The following table summarizes the impact to the consolidated statement of operations for the change in accounting for equity issuance costs:

Year ended March 31, 2021 (unaudited)

 

$

 

981,620

 

 

Year ended March 31, 2022

 

 

 

6,438,872

 

 

Summary of the Cumulative Effect of Restatement Adjustments to Previously Reported Beginning Retained Earnings

 

 

April 1,2021

 

Retained earnings, as previously reported

 

$

 

(41,819,539

)

Restatement adjustments:

 

 

 

 

Share-based compensation

 

 

 

(6,614,904

)

Warrants

 

 

 

(606,237

)

Convertible notes

 

 

 

(6,024,240

)

Other(1)

 

 

 

(6,478,136

)

Income taxes

 

 

 

 

Cumulative impact of restatement adjustments

 

 

 

(19,723,517

)

Retained earnings at March 31, 2021, as restated

 

$

 

(61,543,056

)

(1) Includes adjustments for licenses, patents, business acquisitions and equity issuance costs

The following tables set forth the restatement of the Company’s consolidated balance sheets as of March 31, 2024, 2023, and 2022, and its consolidated statements of operations for the fiscal years ended March 31, 2024, 2023, and 2022:

Consolidated Balance Sheets

 

 

As of March 31, 2024

 

 

 

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

 

 

Stock Based
Payments

 

 

Equity Issuance
Costs

 

 

Convertible Notes

 

 

Warrants

 

 

Acquisition

 

 

Other

 

 

As Restated

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

 

55,586,441

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

 

55,586,441

 

 

Accounts receivable, net

 

 

 

28,221,321

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

28,221,321

 

 

Inventories

 

 

 

45,563,334

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

45,563,334

 

 

Prepaid expenses

 

 

 

2,154,170

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

2,154,170

 

 

Current portion of restricted cash

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

Total current assets

 

 

 

131,525,266

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

131,525,266

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equipment, net

 

 

 

58,082,040

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

58,082,040

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deposits

 

 

 

349,278

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

349,278

 

 

Patents, net

 

 

 

4,539,290

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

 

216,716

 

 

 

 

4,756,006

 

 

Other intangible assets, net

 

 

 

111,049,067

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

111,049,067

 

 

Goodwill

 

 

 

90,870,094

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

90,870,094

 

 

Right of use assets - operating leases

 

 

 

2,000,093

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

2,000,093

 

 

Deferred income tax asset

 

 

 

1,487,088

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

 

2,920,403

 

 

 

 

4,407,491

 

 

TOTAL ASSETS

 

$

 

399,902,216

 

 

$

0

 

 

$

0

 

 

$

0

 

 

$

0

 

 

$

0

 

 

$

3137119

 

 

$

 

403,039,335

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

$

 

23,156,495

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

 

23,156,495

 

 

Accrued liabilities

 

 

 

7,030,667

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

34,777

 

 

 

 

7,065,444

 

 

Current portion of operating lease liability

 

 

 

479,651

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

479,651

 

 

Note payable related party

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

Current portion of construction note payable

 

 

 

273,459

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

273,459

 

 

Insurance premium note payable

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

Total current liabilities

 

 

 

30,940,272

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

34,777.00

 

 

 

 

30,975,049

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long-term liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration payable

 

 

 

59,838

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

59,838

 

 

Income tax payable

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

1,609,520

 

 

 

 

1,609,520

 

 

Construction note payable, net of unamortized issuance costs

 

 

 

10,735,241

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

10,735,241

 

 

Operating lease liability, net of current portion

 

 

 

1,609,836

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

1,609,836

 

 

Deferred income tax liability

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

Total liabilities

 

 

 

43,345,187

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

1,644,297

 

 

 

 

44,989,484

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Series A cumulative perpetual preferred Stock

 

 

 

1,400

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

1,400

 

 

Common stock

 

 

 

119,181

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

119,181

 

 

Additional paid-in capital

 

 

 

396,730,170

 

 

 

 

13,174,586

 

 

 

 

7,420,492

 

 

 

 

6,024,240

 

 

 

 

1,298,336

 

 

 

 

5,225,000

 

 

 

 

653,000

 

 

 

 

430,525,824

 

 

Accumulated deficit

 

 

 

(37,620,566

)

 

 

 

(13,174,586

)

 

 

 

(7,420,492

)

 

 

 

(6,024,240

)

 

 

 

(1,298,336

)

 

 

 

(5,225,000

)

 

 

 

839,822

 

 

 

 

(69,923,398

)

 

Treasury stock

 

 

 

(2,673,156

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

(2,673,156

)

 

Total shareholders’ equity

 

 

 

356,557,029

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

1,492,822

 

 

 

 

358,049,851

 

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

 

$

 

399,902,216

 

 

$

 

-

 

 

$

 

-

 

 

$

 

-

 

 

$

 

-

 

 

$

 

-

 

 

$

 

3,137,119

 

 

$

 

403,039,335

 

 

 

 

 

 

As of March 31, 2023

 

 

 

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

 

 

Stock Based Payments

 

 

Equity
Issuance
Costs

 

 

Convertible Notes

 

 

Warrants

 

 

Acquisitions

 

 

Other

 

 

As Restated

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

 

39,134,027

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

 

39,134,027

 

 

Accounts receivable, net

 

 

 

29,346,380

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

29,346,380

 

 

Inventories

 

 

 

54,344,819

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

54,344,819

 

 

Prepaid expenses

 

 

 

5,126,667

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

5,126,667

 

 

Current portion of restricted cash

 

 

 

500,000

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

500,000

 

 

Total current assets

 

 

 

128,451,893

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

128,451,893

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equipment, net

 

 

 

55,963,255

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

55,963,255

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deposits

 

 

 

7,028,947

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

7,028,947

 

 

Patents, net

 

 

 

5,032,754

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

264,000

 

 

 

 

5,296,754

 

 

Other intangible assets, net

 

 

 

123,726,810

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

123,726,810

 

 

Goodwill

 

 

 

90,870,094

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

90,870,094

 

 

Right of use assets - operating leases

 

 

 

1,261,634

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

1,261,634

 

 

Deferred income tax asset

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

 

595,756

 

 

 

 

595,756

 

 

TOTAL ASSETS

 

$

 

412,335,387

 

 

$

 

-

 

 

$

 

-

 

 

$

 

-

 

 

$

 

-

 

 

$

 

-

 

 

$

 

859,756

 

 

$

 

413,195,143

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

$

 

18,079,397

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

 

18,079,397

 

 

Accrued liabilities

 

 

 

4,353,354

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

34,778

 

 

 

 

4,388,132

 

 

Current portion of operating lease liability

 

 

 

470,734

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

470,734

 

 

Note payable related party

 

 

 

180,850

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

180,850

 

 

Current portion of construction note payable

 

 

 

260,429

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

260,429

 

 

Insurance premium note payable

 

 

 

2,118,635

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

2,118,635

 

 

Total current liabilities

 

 

 

25,463,399

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

34,778

 

 

 

 

25,498,177

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long-term liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration payable

 

 

 

140,378

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

140,378

 

 

Income tax payable

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

1,609,520

 

 

 

 

1,609,520

 

 

Construction note payable, net of unamortized issuance costs

 

 

 

10,922,443

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

10,922,443

 

 

Operating lease liability, net of current portion

 

 

 

903,490

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

903,490

 

 

Deferred income tax liability

 

 

 

2,309,592

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

(2,309,592

)

 

 

 

-

 

 

Total liabilities

 

 

 

39,739,302

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

(665,294

)

 

 

 

39,074,008

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Series A cumulative perpetual preferred Stock

 

 

 

1,400

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

1,400

 

 

Common stock

 

 

 

118,294

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

118,294

 

 

Additional paid-in capital

 

 

 

391,940,374

 

 

 

 

12,178,405

 

 

 

 

7,420,492

 

 

 

 

6,024,240

 

 

 

 

1,298,336

 

 

 

 

5,225,000

 

 

 

 

653,000

 

 

 

 

424,739,847

 

 

Accumulated deficit

 

 

 

(18,941,825

)

 

 

 

(12,178,405

)

 

 

 

(7,420,492

)

 

 

 

(6,024,240

)

 

 

 

(1,298,336

)

 

 

 

(5,225,000

)

 

 

 

872,050

 

 

 

 

(50,216,248

)

 

Treasury stock

 

 

 

(522,158

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

(522,158

)

 

Total shareholders’ equity

 

 

 

372,596,085

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

1,525,050

 

 

 

 

374,121,135

 

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

 

$

 

412,335,387

 

 

$

 

-

 

 

$

 

-

 

 

$

 

-

 

 

$

 

-

 

 

$

 

-

 

 

$

 

859,756

 

 

$

 

413,195,143

 

 

 

 

 

 

As of March 31, 2022

 

 

 

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

 

 

Stock Based
Payments

 

 

Equity Issuance
Costs

 

 

Convertible Notes

 

 

Warrants

 

 

Acquisition

 

 

Other

 

 

As Restated

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

 

23,281,475

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

 

23,281,475

 

 

Accounts receivable, net

 

 

 

43,955,084

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

43,955,084

 

 

Due from related parties

 

 

 

15,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15,000

 

 

Inventories

 

 

 

59,016,152

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

59,016,152

 

 

Prepaid expenses

 

 

 

3,423,925

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

3,423,925

 

 

Current portion of restricted cash

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

Total current assets

 

 

 

129,691,636

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

129,691,636

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equipment, net

 

 

 

37,637,806

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

37,637,806

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

Other assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

Deposits

 

 

 

11,360,322

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

11,360,322

 

 

Patents, net

 

 

 

5,526,218

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

311,284

 

 

 

 

5,837,502

 

 

Other intangible assets, net

 

 

 

136,300,387

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

136,300,387

 

 

Goodwill

 

 

 

90,870,094

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

90,870,094

 

 

Right of use assets - operating leases

 

 

 

2,791,850

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

2,791,850

 

 

Deferred income tax asset

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

1,350,868

 

 

 

 

1,350,868

 

 

TOTAL ASSETS

 

$

 

414,178,313

 

 

$

 

-

 

 

$

 

-

 

 

$

 

-

 

 

$

 

-

 

 

$

 

-

 

 

$

 

1,662,152

 

 

$

 

415,840,465

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

$

 

26,817,083

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

 

26,817,083

 

 

Factoring liability

 

 

 

485,671

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

485,671

 

 

Accrued liabilities

 

 

 

6,178,814

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

34,778

 

 

 

 

6,213,592

 

 

Inventory credit facility

 

 

 

825,675

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

825,675

 

 

Current portion of operating lease liability

 

 

 

831,429

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

831,429

 

 

Current portion of note payable related party

 

 

 

684,639

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

684,639

 

 

Total current liabilities

 

 

 

35,823,311

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

34,778

 

 

 

 

35,858,089

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long-term liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration payable

 

 

 

204,142

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

204,142

 

 

Income tax payable

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

1,609,520

 

 

 

 

1,609,520

 

 

Notes payable related party, net of current portion

 

 

 

181,132

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

181,132

 

 

Construction note payable, net of unamortized issuance costs

 

 

 

38,330

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

38,330

 

 

Operating lease liability, net of current portion

 

 

 

2,091,351

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

2,091,351

 

 

Deferred income tax liability

 

 

 

1,536,481

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

(1,536,481

)

 

 

 

-

 

 

Total liabilities

 

 

 

39,874,747

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

107,817

 

 

 

 

39,982,564

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Series A cumulative perpetual preferred Stock

 

 

 

1,400

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

1,400

 

 

Common stock

 

 

 

116,487

 

 

 

0

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

116,487

 

 

Additional paid-in capital

 

 

 

385,426,431

 

 

 

 

8,037,042

 

 

 

 

7,420,492

 

 

 

 

6,024,240

 

 

 

 

1,298,336

 

 

 

 

5,225,000

 

 

 

 

653,000

 

 

 

 

414,084,541

 

 

Accumulated deficit

 

 

 

(11,240,752

)

 

 

 

(8,037,042

)

 

 

 

(7,420,492

)

 

 

 

(6,024,240

)

 

 

 

(1,298,336

)

 

 

 

(5,225,000

)

 

 

 

901,335

 

 

 

 

(38,344,527

)

 

Treasury stock

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

Total shareholders’ equity

 

 

 

374,303,566

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

1,554,335

 

 

 

 

375,857,901

 

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

 

$

 

414,178,313

 

 

$

 

-

 

 

 $

 

-

 

 

 $

 

-

 

 

 $

 

-

 

 

 $

 

-

 

 

$

 

1,662,152

 

 

$

 

415,840,465

 

 

 

Consolidated Statements of Operations

 

 

Fiscal Year Ended March 31, 2024

 

 

 

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

 

 

Stock Based
Payments

 

 

Other

 

 

As Restated

 

 

Net revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ammunition sales

 

$

 

69,390,801

 

 

 $

 

-

 

 

$

 

-

 

 

$

 

69,390,801

 

 

Marketplace revenue

 

 

 

53,942,076

 

 

 

 

-

 

 

 

 

-

 

 

 

 

53,942,076

 

 

Casing sales

 

 

 

21,721,695

 

 

 

 

-

 

 

 

 

-

 

 

 

 

21,721,695

 

 

Total revenues

 

 

 

145,054,572

 

 

 

 

-

 

 

 

 

-

 

 

 

 

145,054,572

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues

 

 

 

102,431,803

 

 

 

 

-

 

 

 

 

47,284

 

 

 

 

102,479,087

 

 

Gross profit

 

 

 

42,622,769

 

 

 

 

-

 

 

 

 

(47,284

)

 

 

 

42,575,485

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling and marketing

 

 

 

1,370,079

 

 

 

 

-

 

 

 

 

-

 

 

 

 

1,370,079

 

 

Corporate general and administrative

 

 

 

29,583,274

 

 

 

 

-

 

 

 

 

-

 

 

 

 

29,583,274

 

 

Employee salaries and related expenses

 

 

 

16,703,822

 

 

 

 

996,180

 

 

 

 

-

 

 

 

 

17,700,002

 

 

Depreciation and amortization expense

 

 

 

13,542,791

 

 

 

 

-

 

 

 

 

-

 

 

 

 

13,542,791

 

 

Total operating expenses

 

 

 

61,199,966

 

 

 

 

996,180

 

 

 

 

-

 

 

 

 

62,196,146

 

 

Loss from operations

 

 

 

(18,577,197

)

 

 

 

(996,180

)

 

 

 

(47,284

)

 

 

 

(19,620,661

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income

 

 

 

(332,593

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(332,593

)

 

Interest expense

 

 

 

(446,473

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(446,473

)

 

Total other expense

 

 

 

(779,066

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(779,066

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss before income taxes

 

 

 

(19,356,263

)

 

 

 

(996,180

)

 

 

 

(47,284

)

 

 

 

(20,399,727

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

 

(3,791,063

)

 

 

 

-

 

 

 

 

(15,055

)

 

 

 

(3,806,118

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

 

(15,565,200

)

 

 

 

(996,180

)

 

 

 

(32,229

)

 

 

 

(16,593,609

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock dividend

 

 

 

(3,122,049

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(3,122,049

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to common stock shareholders

 

$

 

(18,687,249

)

 

$

 

(996,180

)

 

$

 

(32,229

)

 

$

 

(19,715,658

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

 

(0.16

)

 

 

 

 

 

 

 

 

 

 $

 

(0.17

)

 

Diluted

 

$

 

(0.16

)

 

 

 

 

 

 

 

 

 

 $

 

(0.17

)

 

 

 

 

 

Fiscal Year Ended March 31, 2023

 

 

 

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

 

 

Stock Based
Payments

 

 

Other

 

 

As Restated

 

 

Net revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ammunition sales

 

$

 

114,116,044

 

 

$

 

-

 

 

$

 

-

 

 

$

 

114,116,044

 

 

Marketplace revenue

 

 

 

63,149,673

 

 

 

 

-

 

 

 

 

-

 

 

 

 

63,149,673

 

 

Casing sales

 

 

 

14,174,084

 

 

 

 

-

 

 

 

 

-

 

 

 

 

14,174,084

 

 

Total revenues

 

 

 

191,439,801

 

 

 

 

-

 

 

 

 

-

 

 

 

 

191,439,801

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues

 

 

 

136,031,204

 

 

 

 

-

 

 

 

 

47,284

 

 

 

 

136,078,488

 

 

Gross profit

 

 

 

55,408,597

 

 

 

 

-

 

 

 

 

(47,284

)

 

 

 

55,361,313

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling and marketing

 

 

 

4,729,540

 

 

 

 

-

 

 

 

 

-

 

 

 

 

4,729,540

 

 

Corporate general and administrative

 

 

 

24,980,079

 

 

 

 

-

 

 

 

 

-

 

 

 

 

24,980,079

 

 

Employee salaries and related expenses

 

 

 

15,679,135

 

 

 

 

4,141,363

 

 

 

 

-

 

 

 

 

19,820,498

 

 

Depreciation and amortization expense

 

 

 

13,278,762

 

 

 

 

-

 

 

 

 

-

 

 

 

 

13,278,762

 

 

Total operating expenses

 

 

 

58,667,516

 

 

 

 

4,141,363

 

 

 

 

-

 

 

 

 

62,808,879

 

 

Loss from operations

 

 

 

(3,258,919

)

 

 

 

(4,141,363

)

 

 

 

(47,284

)

 

 

 

(7,447,566

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income

 

 

 

25,181

 

 

 

 

-

 

 

 

 

-

 

 

 

 

25,181

 

 

Interest expense

 

 

 

(632,062

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(632,062

)

 

Total other expense

 

 

 

(606,881

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(606,881

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss before income taxes

 

 

 

(3,865,800

)

 

 

 

(4,141,363

)

 

 

 

(47,284

)

 

 

 

(8,054,447

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

 

730,238

 

 

 

 

-

 

 

 

 

(17,999

)

 

 

 

712,239

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

 

(4,596,038

)

 

 

 

(4,141,363

)

 

 

 

(29,285

)

 

 

 

(8,766,686

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock dividend

 

 

 

(3,105,034

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(3,105,034

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to common stock shareholders

 

$

 

(7,701,072

)

 

$

 

(4,141,363

)

 

$

 

(29,285

)

 

$

 

(11,871,720

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

 

(0.07

)

 

 

 

 

 

 

 

 

 

$

 

(0.10

)

 

Diluted

 

$

 

(0.07

)

 

 

 

 

 

 

 

 

 

$

 

(0.10

)

 

 

 

 

Fiscal Year Ended March 31, 2022

 

 

 

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

 

 

Stock Based
Payments

 

 

Equity Issuance
Costs

 

 

Warrants

 

 

Other

 

 

As Restated

 

 

Net revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ammunition sales

 

$

 

161,459,025

 

 

 $

 

-

 

 

$

 

-

 

 

$

 

-

 

 

$

 

-

 

 

$

 

161,459,025

 

 

Marketplace revenue

 

 

 

64,608,516

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

64,608,516

 

 

Casing sales

 

 

 

14,201,625

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

14,201,625

 

 

Total revenues

 

 

 

240,269,166

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

240,269,166

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues

 

 

 

151,505,657

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

47,284

 

 

 

 

151,552,941

 

 

Gross profit

 

 

 

88,763,509

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

(47,284

)

 

 

 

88,716,225

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling and marketing

 

 

 

7,310,216

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

7,310,216

 

 

Corporate general and administrative

 

 

 

16,986,344

 

 

 

 

3,168

 

 

 

 

6,438,872

 

 

 

 

692,099

 

 

 

 

-

 

 

 

 

24,120,483

 

 

Employee salaries and related expenses

 

 

 

13,615,439

 

 

 

 

1,418,969

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

15,034,408

 

 

Depreciation and amortization expense

 

 

 

13,702,148

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

22,917

 

 

 

 

13,725,065

 

 

Total operating expenses

 

 

 

51,614,147

 

 

 

 

1,422,137

 

 

 

 

6,438,872

 

 

 

 

692,099

 

 

 

 

22,917

 

 

 

 

60,190,172

 

 

Income/(loss) from operations

 

 

 

37,149,362

 

 

 

 

(1,422,137

)

 

 

 

(6,438,872

)

 

 

 

(692,099

)

 

 

 

(70,201

)

 

 

 

28,526,053

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income

 

 

 

21,840

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

21,840

 

 

Interest expense

 

 

 

(637,797

)

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

(637,797

)

 

Total other expense

 

 

 

(615,957

)

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

(615,957

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income/(loss) before income taxes

 

 

 

36,533,405

 

 

 

 

(1,422,137

)

 

 

 

(6,438,872

)

 

 

 

(692,099

)

 

 

 

(70,201

)

 

 

 

27,910,096

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

 

3,285,969

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

(1,243,051

)

 

 

 

2,042,918

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

 

 

33,247,436

 

 

 

 

(1,422,137

)

 

 

 

(6,438,872

)

 

 

 

(692,099

)

 

 

 

1,172,850

 

 

 

 

25,867,178

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock dividend

 

 

 

(2,668,649

)

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

(2,668,649

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) attributable to common stock shareholders

 

$

 

30,578,787

 

 

$

 

(1,422,137

)

 

$

 

(6,438,872

)

 

$

 

(692,099

)

 

$

 

1,172,850

 

 

$

 

23,198,529

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 $

 

0.27

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 $

 

0.21

 

 

Diluted

 

 $

 

0.27

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 $

 

0.20

 

 

 

Consolidated Statements of Stockholders' Equity

The following tables present the Additional Paid-In Capital ("APIC") as previously reported, restatement adjustments and the APIC as restated for the years ended March 31, 2024, 2023 and 2022.

 

 

 

 

 

 

As Previously
Reported

 

 

Reclassification

 

 

Current Period Adjustment

 

 

As Restated

 

 

 

 

 

 

 

 

 

 

 

 

 

Employee stock awards

 

$

4,080,170

 

 

$

203,000

 

 

$

996,181

 

 

$

5,279,351

 

Stock grants

 

 

203,000

 

 

 

(203,000

)

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

As Previously
Reported

 

 

Reclassification

 

 

Current Period Adjustment

 

 

As Restated

 

 

 

 

 

 

 

 

 

 

 

 

 

Employee stock awards

 

$

5,806,003

 

 

$

179,094

 

 

$

4,141,363

 

 

$

10,126,460

 

Stock grants

 

 

179,094

 

 

 

(179,094

)

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

As Previously
Reported

 

 

Reclassification

 

 

Current Period Adjustment

 

 

As Restated

 

 

 

 

 

 

 

 

 

 

 

 

 

Acquisition stock issuances

 

$

142,691,282

 

 

$

-

 

 

$

666,372

 

 

$

143,357,654

 

Common stock issued for services and equipment

 

 

1,631,701

 

 

 

-

 

 

 

3,854,895

 

 

 

5,486,596

 

Employee stock awards

 

 

5,759,000

 

 

 

252,488

 

 

 

1,417,162

 

 

 

7,428,650

 

Stock grants

 

 

252,488

 

 

 

(252,488

)

 

 

-

 

 

 

-

 

Issuance of Series A Preferred Stock, net of issuance costs

 

 

31,008,796

 

 

 

-

 

 

 

1,898,600

 

 

 

32,907,396

 

Warrants issued for services

 

 

1,090,076

 

 

 

-

 

 

 

692,099

 

 

 

1,782,175

 

 

Consolidated Statements of Cash Flow

 

 

For the Year Ended March 31, 2024

 

 

 

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

Stock Based
Payments

Other

 

 

As Restated

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

$

(15,565,200

)

 

$

(996,180

)

 

$

(32,229

)

 

$

(16,593,609

)

 

Adjustments to reconcile net loss to cash provided by operations:

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

18,813,897

 

 

 

-

 

 

 

47,284

 

 

 

18,861,181

 

 

Debt discount amortization

 

 

83,253

 

 

 

-

 

 

 

-

 

 

 

83,253

 

 

Employee stock awards

 

 

4,285,108

 

 

 

996,180

 

 

 

-

 

 

 

5,281,288

 

 

Common stock purchase options

 

 

430,457

 

 

 

-

 

 

 

-

 

 

 

430,457

 

 

Contingent consideration payable fair value

 

 

(80,540

)

 

 

-

 

 

 

-

 

 

 

(80,540

)

 

Allowance for doubtful accounts

 

 

419,527

 

 

 

-

 

 

 

-

 

 

 

419,527

 

 

(Gain)/loss on disposal of assets

 

 

259,540

 

 

 

-

 

 

 

-

 

 

 

259,540

 

 

Reduction in right of use asset

 

 

476,252

 

 

 

-

 

 

 

-

 

 

 

476,252

 

 

Deferred income taxes

 

 

(3,796,680

)

 

 

-

 

 

 

(15,055

)

 

 

(3,811,735

)

 

Changes in current assets and liabilities

 

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

Accounts receivable

 

 

705,532

 

 

 

-

 

 

 

-

 

 

 

705,532

 

 

Inventories

 

 

8,781,485

 

 

 

-

 

 

 

-

 

 

 

8,781,485

 

 

Prepaid expenses

 

 

4,028,696

 

 

 

-

 

 

 

-

 

 

 

4,028,696

 

 

Deposits

 

 

6,679,669

 

 

 

-

 

 

 

-

 

 

 

6,679,669

 

 

Accounts payable

 

 

5,077,098

 

 

 

-

 

 

 

-

 

 

 

5,077,098

 

 

Accrued liabilities

 

 

2,532,695

 

 

 

-

 

 

 

-

 

 

 

2,532,695

 

 

Operating lease liability

 

 

(499,448

)

 

 

-

 

 

 

-

 

 

 

(499,448

)

 

Net cash provided by operating activities

 

 

32,631,341

 

 

 

-

 

 

 

-

 

 

 

32,631,341

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Purchase of property, plant, and equipment

 

 

(8,024,765

)

 

 

-

 

 

 

-

 

 

 

(8,024,765

)

 

Proceeds from disposal of assets

 

 

3,750

 

 

 

-

 

 

 

-

 

 

 

3,750

 

 

Net cash used in investing activities

 

 

(8,021,015

)

 

 

-

 

 

 

-

 

 

 

(8,021,015

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from factoring liability

 

 

37,252,869

 

 

 

-

 

 

 

-

 

 

 

37,252,869

 

 

Payments on factoring liability

 

 

(37,252,869

)

 

 

-

 

 

 

-

 

 

 

(37,252,869

)

 

Payments on note payable - related party

 

 

(180,850

)

 

 

-

 

 

 

-

 

 

 

(180,850

)

 

Payments on insurance premium note payment

 

 

(3,174,834

)

 

 

-

 

 

 

-

 

 

 

(3,174,834

)

 

Payments on construction note payable

 

 

(257,425

)

 

 

-

 

 

 

-

 

 

 

(257,425

)

 

Common stock issued for exercised warrants

 

 

76,200

 

 

 

-

 

 

 

-

 

 

 

76,200

 

 

Preferred stock dividends paid

 

 

(2,968,923

)

 

 

-

 

 

 

-

 

 

 

(2,968,923

)

 

Common stock repurchase plan

 

 

(2,152,080

)

 

 

-

 

 

 

-

 

 

 

(2,152,080

)

 

Net cash used in financing activities

 

 

(8,657,912

)

 

 

-

 

 

 

-

 

 

 

(8,657,912

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net increase/(decrease) in cash

 

 

15,952,414

 

 

 

-

 

 

 

-

 

 

 

15,952,414

 

 

Cash, beginning of period

 

 

39,134,027

 

 

 

-

 

 

 

-

 

 

 

39,134,027

 

 

Restricted cash, beginning of period

 

 

500,000

 

 

 

-

 

 

 

-

 

 

 

500,000

 

 

Cash and restricted cash, end of period

 

$

55,586,441

 

 

$

-

 

 

$

-

 

 

$

55,586,441

 

 

Restricted cash, end of period

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

Cash, end of period

 

$

55,586,441

 

 

$

-

 

 

$

-

 

 

$

55,586,441

 

 

 

 

 

For the Year Ended March 31, 2023

 

 

 

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

Stock Based
Payments

Other

 

 

As Restated

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

$

(4,596,038

)

 

$

(4,141,363

)

 

$

(29,285

)

 

$

(8,766,686

)

 

Adjustments to reconcile net loss to cash provided by operations:

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

17,519,949

 

 

 

-

 

 

 

47,284

 

 

 

17,567,233

 

 

Debt discount amortization

 

 

83,253

 

 

 

-

 

 

 

-

 

 

 

83,253

 

 

Employee stock awards

 

 

5,986,873

 

 

 

4,141,363

 

 

 

-

 

 

 

10,128,236

 

 

Contingent consideration payable fair value

 

 

(63,764

)

 

 

-

 

 

 

-

 

 

 

(63,764

)

 

Allowance for doubtful accounts

 

 

191,299

 

 

 

-

 

 

 

-

 

 

 

191,299

 

 

Reduction in right of use asset

 

 

629,140

 

 

 

-

 

 

 

-

 

 

 

629,140

 

 

Warrants issued for services

 

 

213,819

 

 

 

-

 

 

 

-

 

 

 

213,819

 

 

Deferred income taxes

 

 

730,238

 

 

 

-

 

 

 

(17,999

)

 

 

712,239

 

 

Changes in current assets and liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

14,417,405

 

 

 

-

 

 

 

-

 

 

 

14,417,405

 

 

Due to related parties

 

 

15,000

 

 

 

-

 

 

 

-

 

 

 

15,000

 

 

Inventories

 

 

4,671,333

 

 

 

-

 

 

 

-

 

 

 

4,671,333

 

 

Prepaid expenses

 

 

2,763,855

 

 

 

-

 

 

 

-

 

 

 

2,763,855

 

 

Deposits

 

 

4,306,375

 

 

 

-

 

 

 

-

 

 

 

4,306,375

 

 

Accounts payable

 

 

(8,694,813

)

 

 

-

 

 

 

-

 

 

 

(8,694,813

)

 

Accrued liabilities

 

 

(1,970,078

)

 

 

-

 

 

 

-

 

 

 

(1,970,078

)

 

Operating lease liability

 

 

(647,480

)

 

 

-

 

 

 

-

 

 

 

(647,480

)

 

Net cash provided by operating activities

 

 

35,556,366

 

 

 

-

 

 

 

-

 

 

 

35,556,366

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Purchase of property, plant, and equipment

 

 

(12,541,325

)

 

 

-

 

 

 

-

 

 

 

(12,541,325

)

 

Net cash used in investing activities

 

 

(12,541,325

)

 

 

-

 

 

 

-

 

 

 

(12,541,325

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Payments on inventory facility, net

 

 

(825,675

)

 

 

-

 

 

 

-

 

 

 

(825,675

)

 

Proceeds from factoring liability

 

 

71,348,761

 

 

 

-

 

 

 

-

 

 

 

71,348,761

 

 

Payments on factoring liability

 

 

(71,834,432

)

 

 

-

 

 

 

-

 

 

 

(71,834,432

)

 

Payments on note payable - related party

 

 

(684,921

)

 

 

-

 

 

 

-

 

 

 

(684,921

)

 

Payments on insurance premium note payment

 

 

(2,134,143

)

 

 

-

 

 

 

-

 

 

 

(2,134,143

)

 

Proceeds from construction note payable

 

 

1,000,000

 

 

 

-

 

 

 

-

 

 

 

1,000,000

 

 

Payments on construction note payable

 

 

(150,743

)

 

 

-

 

 

 

-

 

 

 

(150,743

)

 

Common stock issued for exercised warrants

 

 

101,506

 

 

 

-

 

 

 

-

 

 

 

101,506

 

 

Preferred stock dividends paid

 

 

(2,960,416

)

 

 

-

 

 

 

-

 

 

 

(2,960,416

)

 

Common stock repurchase plan

 

 

(522,426

)

 

 

-

 

 

 

-

 

 

 

(522,426

)

 

Net cash used in financing activities

 

 

(6,662,489

)

 

 

-

 

 

 

-

 

 

 

(6,662,489

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net increase/(decrease) in cash

 

 

16,352,552

 

 

 

-

 

 

 

-

 

 

 

16,352,552

 

 

Cash, beginning of period

 

 

23,281,475

 

 

 

-

 

 

 

-

 

 

 

23,281,475

 

 

Restricted cash, beginning of period

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

Cash and restricted cash, end of period

 

$

39,634,027

 

 

$

-

 

 

$

-

 

 

$

39,634,027

 

 

Restricted cash, end of period

 

$

500,000

 

 

$

-

 

 

$

-

 

 

$

500,000

 

 

Cash, end of period

 

$

39,134,027

 

 

$

-

 

 

$

-

 

 

$

39,134,027

 

 

 

 

 

For the Year Ended March 31, 2022

 

 

 

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

Stock Based
Payments

 

 

Equity Issuance
Costs

Warrants

Other

 

 

As Restated

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

$

33,247,436

 

 

$

(1,422,137

)

 

$

(6,438,872

)

 

$

(692,099

)

 

$

1,172,850

 

 

$

25,867,178

 

 

Adjustments to reconcile net loss to cash provided by operations:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

17,339,093

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

70,201

 

 

 

17,409,294

 

 

Debt discount amortization

 

 

38,330

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

38,330

 

 

Employee stock awards

 

 

6,011,488

 

 

 

1,418,969

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

7,430,457

 

 

Stock for services

 

 

4,200

 

 

 

3,168

 

 

 

5,352,500

 

 

 

-

 

 

 

-

 

 

 

5,359,868

 

 

Contingent consideration payable fair value

 

 

(385,750

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(385,750

)

 

Allowance for doubtful accounts

 

 

2,748,250

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,748,250

 

 

(Gain)/loss on disposal of assets

 

 

(12,044

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(12,044

)

 

Reduction in right of use asset

 

 

720,491

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

720,491

 

 

Warrants issued for services

 

 

718,045

 

 

 

-

 

 

 

-

 

 

 

692,099

 

 

 

-

 

 

 

1,410,144

 

 

Deferred income taxes

 

 

1,536,481

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(1,243,051

)

 

 

293,430

 

 

Changes in current assets and liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(20,707,052

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(20,707,052

)

 

Due to related parties

 

 

657

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

657

 

 

Inventories

 

 

(43,149,234

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(43,149,234

)

 

Prepaid expenses

 

 

1,996,287

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,996,287

 

 

Deposits

 

 

(8,826,504

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(8,826,504

)

 

Accounts payable

 

 

9,930,191

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

9,930,191

 

 

Accrued liabilities

 

 

2,374,686

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,374,686

 

 

Operating lease liability

 

 

(732,468

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(732,468

)

 

Net cash provided by operating activities

 

 

2,852,583

 

 

 

-

 

 

 

(1,086,372

)

 

 

-

 

 

 

-

 

 

 

1,766,211

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gemini acquisition

 

 

(50,517,840

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(50,517,840

)

 

Purchase of property, plant, and equipment

 

 

(19,218,982

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(19,218,982

)

 

Proceeds from disposal of assets

 

 

59,800

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

59,800

 

 

Net cash used in investing activities

 

 

(69,677,022

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(69,677,022

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Payments on inventory facility, net

 

 

(265,422

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(265,422

)

 

Proceeds from factoring liability

 

 

121,488,045

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

121,488,045

 

 

Payments on factoring liability

 

 

(122,844,562

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(122,844,562

)

 

Payments on assumed debt from Gemini

 

 

(50,000,000

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(50,000,000

)

 

Payments on note payable - related party

 

 

(625,147

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(625,147

)

 

Payments on insurance premium note payment

 

 

(2,208,369

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(2,208,369

)

 

Payments on note payable

 

 

(4,000,000

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(4,000,000

)

 

Sale of preferred stock

 

 

35,000,000

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

35,000,000

 

 

Common stock issued for exercised warrants

 

 

943,907

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

943,907

 

 

Common stock issuance costs

 

 

(3,199,922

)

 

 

-

 

 

 

3,199,922

 

 

 

-

 

 

 

-

 

 

 

-

 

 

Preferred stock issuance costs

 

 

-

 

 

 

-

 

 

 

(2,113,550

)

 

 

-

 

 

 

-

 

 

 

(2,113,550

)

 

Preferred stock dividends paid

 

 

(2,524,087

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(2,524,087

)

 

Net cash used in financing activities

 

 

(28,235,557

)

 

 

-

 

 

 

1,086,372

 

 

 

-

 

 

 

-

 

 

 

(27,149,185

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net increase/(decrease) in cash

 

 

(95,059,996

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(95,059,996

)

 

Cash, beginning of period

 

 

118,341,471

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

118,341,471

 

 

Restricted cash, beginning of period

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

Cash and restricted cash, end of period

 

$

23,281,475

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

23,281,475

 

 

Restricted cash, end of period

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

Cash, end of period

 

$

23,281,475

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

23,281,475

 

 

v3.25.1
INCOME/(LOSS) PER COMMON SHARE (Tables)
12 Months Ended
Mar. 31, 2024
Net Income/(Loss) per share  
SCHEDULE OF INCOME/(LOSS) PER COMMON SHARE

 

For the Year Ended March 31,

 

 

2024

 

 

2023

 

 

2022

 

 

 

(As Restated)

 

 

(As Restated)

 

 

(As Restated)

 

Numerator:

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

$

(16,593,609

)

 

$

(8,766,686

)

 

$

25,867,178

 

Less: Preferred stock dividends

 

 

(3,122,049

)

 

 

(3,105,034

)

 

 

(2,668,649

)

Net income/(loss) attributable to common stockholders

 

$

(19,715,658

)

 

$

(11,871,720

)

 

$

23,198,529

 

 

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

 

Weighted average shares of common stock - basic

 

 

118,249,486

 

 

 

117,177,885

 

 

 

112,328,680

 

Effect of dilutive common stock purchase warrants

 

 

-

 

 

 

-

 

 

 

2,121,302

 

Effect of dilutive equity incentive awards

 

 

-

 

 

 

-

 

 

 

375,853

 

 Weighted average shares of common stock - Diluted

 

 

118,249,486

 

 

 

117,177,885

 

 

 

114,825,835

 

 

 

 

 

 

 

 

 

 

 

Basic earnings per share:

 

 

 

 

 

 

 

 

 

Income/(loss) per share attributable to common stockholders - basic

 

$

(0.17

)

 

$

(0.10

)

 

$

0.21

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share:

 

 

 

 

 

 

 

 

 

Income/(loss) per share attributable to common stockholders - diluted

 

$

(0.17

)

 

$

(0.10

)

 

$

0.20

 

SCHEDULE OF DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS

The following table presents the number of shares excluded from the calculation of diluted net loss per share attributable to common stockholders:

 

For the Year Ended March 31,

 

 

2024

 

 

2023

 

 

2022

 

 

 

(As Restated)

 

 

(As Restated)

 

 

(As Restated)

 

Common stock options

 

 

175,000

 

 

 

-

 

 

 

-

 

Non-vested stock awards

 

 

1,540,524

 

 

 

2,204,659

 

 

 

2,735,226

 

Warrants

 

 

1,808,870

 

 

 

2,560,986

 

 

 

150,000

 

Total shares excluded from net income (loss) per share attributable to common stockholders

 

 

3,524,394

 

 

 

4,765,645

 

 

 

2,885,226

 

v3.25.1
ACCOUNTS RECEIVABLE (Tables)
12 Months Ended
Mar. 31, 2024
Credit Loss [Abstract]  
SCHEDULE OF ACCOUNTS RECEIVABLE

Our net accounts receivable are summarized as follows:

 

March 31,
2024

 

 

March 31,
2023

 

 

March 31,
2022

 

Accounts receivable

 

$

31,887,399

 

 

$

32,592,931

 

 

$

47,010,336

 

Less: allowance for credit losses

 

 

(3,666,078

)

 

 

(3,246,551

)

 

 

(3,055,252

)

 

 

$

28,221,321

 

 

$

29,346,380

 

 

$

43,955,084

 

 

The following presents a reconciliation of our allowance for credit losses for the periods presented:

March 31, 2021

 

$

148,540

 

Increase in allowance

 

 

2,903,304

 

Write-off of uncollectible amounts

 

 

(12,703

)

Purchase accounting

 

 

16,111

 

March 31, 2022

 

 

3,055,252

 

Increase in allowance

 

 

2,160,323

 

Write-off of uncollectible amounts

 

 

(1,969,024

)

March 31, 2023

 

 

3,246,551

 

Increase in allowance

 

 

1,530,891

 

Write-off of uncollectible amounts

 

 

(1,111,364

)

March 31, 2024

 

$

3,666,078

 

v3.25.1
INVENTORIES (Tables)
12 Months Ended
Mar. 31, 2024
Inventory Disclosure [Abstract]  
SCHEDULE OF INVENTORIES

At March 31, 2024, March 31, 2023, and March 31, 2022, the inventory balances are composed of:

 

 

March 31, 2024

 

 

March 31, 2023

 

 

March 31, 2022

 

Finished product

 

 

$

11,055,061

 

 

 

$

14,362,514

 

 

 

$

6,167,318

 

Raw materials

 

 

 

24,158,244

 

 

 

 

23,898,596

 

 

 

 

33,924,813

 

Work in process

 

 

 

10,350,029

 

 

 

 

16,083,709

 

 

 

 

18,924,021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

45,563,334

 

 

 

$

54,344,819

 

 

 

$

59,016,152

 

v3.25.1
PROPERTY, PLANT AND EQUIPMENT (Tables)
12 Months Ended
Mar. 31, 2024
Property, Plant and Equipment [Abstract]  
SCHEDULE OF PROPERTY AND EQUIPMENT

Property and equipment consisted of the following at March 31, 2024, March 31, 2023, and March 31, 2022:

 

 

March 31, 2024

 

 

March 31, 2023

 

 

March 31, 2022

 

Leasehold Improvements

 

$

257,009

 

 

$

257,009

 

 

$

257,009

 

Building and Improvements

 

 

29,143,445

 

 

 

28,623,329

 

 

 

 

Furniture and Fixtures

 

 

439,990

 

 

 

384,650

 

 

 

343,014

 

Vehicles

 

 

153,254

 

 

 

153,254

 

 

 

153,254

 

Equipment

 

 

45,467,137

 

 

 

40,233,186

 

 

 

32,524,850

 

Tooling

 

 

143,710

 

 

 

143,710

 

 

 

143,710

 

Construction in Progress

 

 

2,785,616

 

 

 

734,781

 

 

 

14,335,371

 

Total property and equipment

 

$

78,390,161

 

 

$

70,529,919

 

 

$

47,757,208

 

Less accumulated depreciation

 

 

(20,308,121

)

 

 

(14,566,664

)

 

 

(10,119,402

)

Net property and equipment

 

$

58,082,040

 

 

$

55,963,255

 

 

$

37,637,806

 

v3.25.1
LEASES (Tables)
12 Months Ended
Mar. 31, 2024
Leases  
SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES

Future minimum lease payments under non-cancellable leases as of March 31, 2024 are as follows:

Years Ended March 31,

 

 

 

2025

 

$

666,233

 

2026

 

 

665,069

 

2027

 

 

581,574

 

2028

 

 

379,067

 

2029

 

 

258,102

 

Total minimum lease payments

 

 

2,550,045

 

Less: Amount Representing Interest

 

 

(460,558

)

Present value of minimum lease payments

 

$

2,089,487

 

v3.25.1
CAPITAL STOCK (Tables)
12 Months Ended
Mar. 31, 2024
Class of Stock [Line Items]  
SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK PURCHASE WARRANTS

At March 31, 2024, 2023, and 2022, outstanding and exercisable stock purchase warrants consisted of the following (as restated):

 

Number of
Shares

 

 

Weighted
Averaged
Exercise
Price

 

 

Weighted
Average Life
Remaining
(Years)

 

Outstanding at March 31, 2021

 

 

3,607,945

 

 

$

2.31

 

 

 

3.24

 

Granted

 

 

300,000

 

 

 

0.01

 

 

 

3.92

 

Exercised

 

 

(874,190

)

 

 

1.76

 

 

 

-

 

Forfeited or cancelled

 

 

-

 

 

 

-

 

 

 

-

 

Outstanding at March 31, 2022

 

 

3,033,755

 

 

$

2.32

 

 

 

2.29

 

Exercisable at March 31, 2022

 

 

3,033,755

 

 

$

2.32

 

 

 

2.29

 

 

 

Number of
Shares

 

 

Weighted
Averaged
Exercise
Price

 

 

Weighted
Average Life
Remaining
(Years)

 

Outstanding at March 31, 2022

 

 

3,033,755

 

 

 

2.32

 

 

 

2.29

 

Granted

 

 

150,000

 

 

 

0.01

 

 

 

4.50

 

Exercised

 

 

(300,003

)

 

 

0.34

 

 

 

-

 

Forfeited or cancelled

 

 

(322,806

)

 

 

2.00

 

 

 

-

 

Outstanding at March 31, 2023

 

 

2,560,946

 

 

$

2.46

 

 

 

1.59

 

Exercisable at March 31, 2023

 

 

2,560,946

 

 

$

2.46

 

 

 

1.59

 

 

 

Number of
Shares

 

 

Weighted
Averaged
Exercise
Price

 

 

Weighted
Average Life
Remaining
(Years)

 

Outstanding at March 31, 2023

 

 

2,560,946

 

 

$

2.46

 

 

 

1.59

 

Exercised

 

 

(31,750

)

 

 

2.40

 

 

 

-

 

Forfeited or cancelled

 

 

(720,366

)

 

 

3.19

 

 

 

-

 

Outstanding at March 31, 2024

 

 

1,808,830

 

 

$

2.16

 

 

 

1.09

 

Exercisable at March 31, 2024

 

 

1,808,830

 

 

$

2.16

 

 

 

1.09

 

SCHEDULE OF WARRANTS AND COMMON STOCK PURCHASE OPTIONS USING VALUATION METHODS AND ASSUMPTIONS

We valued warrants and Common Stock purchase options issued for services at their respective grants dates during the years ended March 31, 2024, 2023, and 2022 using valuation methods and assumptions that consider, among other factors, the fair value of the underlying stock, risk free interest rate, volatility, and expected life.

 

March 31,
2024

 

 

March 31,
2023

 

 

March 31,
2022

 

Risk free interest rate

 

 

4.1

%

 

 

3.9

%

 

 

1.2

%

Expected volatility

 

 

66.8

%

 

 

73.5

%

 

 

54.3

%

Expected term

 

5.8 years

 

 

5.0 years

 

 

5.0 years

 

Expected dividend yield

 

 

0.00

 

 

 

0.00

 

 

 

0.00

 

SCHEDULE OF SHARE BASED COMPENSATION ARRANGEMENTS

Number of Options

 

 

400,000

 

Option Vesting Period

 

Up to 3 years

 

Per share grant price

 

$

2.08

 

Dividend yield

 

 

-

 

Expected volatility

 

 

83.5

%

Risk-free interest rate

 

 

4.13

%

Expected life (years)

 

 

5.75

 

Weighted average fair value

 

$

1.50

 

 

Stock Option Activity [Member]  
Class of Stock [Line Items]  
SUMMARY OF STOCK ACTIVITY

The following is a summary of our stock option activity during the year ended March 31, 2024:

 

Number of Options

 

 

Weighted Average Exercise Price

 

 

Weighted Average Grant Date Fair Value

 

 

Weighted Average Remaining Life in Years

 

Outstanding, April 1, 2023

 

 

 

-

 

 

$

 

-

 

 

$

 

-

 

 

 

 

-

 

Granted

 

 

 

400,000

 

 

 

 

2.08

 

 

 

 

1.50

 

 

 

 

10.00

 

Exercised

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

Canceled/Forfeited

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

Outstanding, March 31, 2024

 

 

 

400,000

 

 

$

2.08

 

 

$

1.5

 

 

 

 

9.32

 

 

Stock Award Activity [Member]  
Class of Stock [Line Items]  
SUMMARY OF STOCK ACTIVITY

A summary of stock award activity for the year ended March 31, 2024 is as follows:

 

 

Number of Shares

 

 

Weighted-Average Grant-Date Fair Value Per Share

 

Outstanding at April 1, 2023

 

 

2,204,659

 

 

$

 

3.68

 

Granted

 

 

2,579,901

 

 

 

 

2.22

 

Vested

 

 

(1,371,849

)

 

 

 

2.94

 

Forfeited

 

 

(1,872,186

)

 

 

 

2.82

 

Outstanding at March 31, 2024

 

 

1,540,525

 

 

$

 

2.93

 

A summary of stock award activity for the year ended March 31, 2023 is as follows:

 

 

Number of Shares

 

 

Weighted-Average Grant-Date Fair Value Per Share

 

Outstanding at April 1, 2022

 

 

2,795,017

 

 

$

 

5.79

 

Granted

 

 

2,102,840

 

 

 

 

2.93

 

Vested

 

 

(573,750

)

 

 

 

7.24

 

Forfeited

 

 

(2,119,448

)

 

 

 

4.76

 

Outstanding at March 31, 2023

 

 

2,204,659

 

 

$

 

3.68

 

A summary of stock award activity for the year ended March 31, 2022 is as follows:

 

 

Number of Shares

 

 

Weighted-Average Grant-Date Fair Value Per Share

 

Outstanding at April 1, 2021

 

 

1,973,004

 

 

$

 

3.94

 

Granted

 

 

3,347,200

 

 

 

 

6.56

 

Vested

 

 

(299,167

)

 

 

 

1.98

 

Forfeited

 

 

(2,226,020

)

 

 

 

5.82

 

Outstanding at March 31, 2022

 

 

2,795,017

 

 

$

 

5.79

 

v3.25.1
ACQUISITIONS (Tables)
12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]    
SCHEDULE OF FAIR VALUE OF CONSIDERATION TRANSFERRED  

The fair value of the consideration transferred was valued as follows:

 

Cash

 

$

48,649,954

 

Working capital adjustment

 

 

1,870,886

 

Contingent consideration

 

 

10,755,000

 

Common stock

 

 

132,645,000

 

Assumed debt

 

 

50,000,000

 

 

 

 

 

Fair value of consideration transferred

 

$

243,920,840

 

SCHEDULE OF ALLOCATION FOR CONSIDERATION

The allocation for the consideration recorded for the acquisition is as follows:

 

Accounts receivable, net

 

$

17,002,362

 

Prepaid expenses

 

 

478,963

 

Equipment

 

 

1,051,980

 

Deposits

 

 

703,389

 

Other intangible assets(1)

 

 

146,617,380

 

Goodwill

 

 

90,870,094

 

Right of use assets - operating leases

 

 

612,727

 

Accounts payable

 

 

(12,514,919

)

Accrued expenses

 

 

(196,780

)

Operating lease liability

 

 

(704,356

)

 

 

 

 

Total Consideration

 

$

243,920,840

 

(1)
Other intangible assets consist of Tradenames, Customer Relationships, Intellectual Property, and other tangible assets related to the acquired business.
 
SCHEDULE OF UNAUDITED PRO FORMA RESULTS OF OPERATIONS

INCOME STATEMENT DATA

 

For the Year Ended March 31, 2022

 

Net revenues

 

$

248,314,587

 

Net income

 

$

37,793,924

 

 
v3.25.1
ACCRUED LIABILITIES (Tables)
12 Months Ended
Mar. 31, 2024
Payables and Accruals [Abstract]  
SCHEDULE OF ACCRUED LIABILITIES

At March 31, 2024, March 31, 2023, and March 31, 2022, accrued liabilities were as follows:

 

 

March 31, 2024

 

 

March 31,
2023

 

 

March 31,
2022

 

 

 

(Restated)

 

 

(Restated)

 

 

(Restated)

 

Accrued federal excise tax

 

$

 

1,145,937

 

 

$

 

1,808,065

 

 

$

 

2,408,318

 

Accrued bonus program

 

 

 

1,185,877

 

 

 

 

-

 

 

 

 

-

 

Accrued professional fees

 

 

 

1,134,368

 

 

 

 

736,323

 

 

 

 

66,000

 

Accrued payroll

 

 

 

964,661

 

 

 

 

430,344

 

 

 

 

458,027

 

Other accruals

 

 

 

417,496

 

 

 

 

618,243

 

 

 

 

357,616

 

Income taxes payable

 

 

 

394,133

 

 

 

 

438,517

 

 

 

 

1,784,266

 

Unearned revenue

 

 

 

1,822,972

 

 

 

 

101,593

 

 

 

 

201,891

 

Accrued sales commissions

 

 

 

-

 

 

 

 

252,366

 

 

 

 

932,712

 

Accrued interest

 

 

 

-

 

 

 

 

2,681

 

 

 

 

4,762

 

Accrued liabilities

 

$

 

7,065,444

 

 

$

 

4,388,132

 

 

$

 

6,213,592

 

v3.25.1
INCOME TAXES (Tables)
12 Months Ended
Mar. 31, 2024
Income Tax Disclosure [Abstract]  
SCHEDULE OF INCOME TAX PROVISION BENEFIT

The income tax (provision) benefit for the periods shown consist of the following:

 

 

For the year ended March 31,

 

 

2024

 

 

2023

 

 

2022

 

 

 

(Restated)

 

 

(Restated)

 

 

(Restated)

 

Current

 

 

 

 

 

 

 

 

 

US Federal

 

$

-

 

 

$

-

 

 

$

(2,628,241

)

US State

 

 

-

 

 

 

-

 

 

 

(765,545

)

Total current provision

 

 

-

 

 

 

-

 

 

 

(3,393,786

)

Deferred

 

 

 

 

 

 

 

 

 

US Federal

 

 

2,986,152

 

 

 

(492,171

)

 

 

(6,675,540

)

US State

 

 

819,966

 

 

 

(220,068

)

 

 

(1,374,865

)

Total deferred benefit

 

 

3,806,118

 

 

 

(712,239

)

 

 

(8,050,405

)

Change in valuation allowance

 

 

-

 

 

 

-

 

 

 

9,401,273

 

Income tax (provision) benefit

 

$

3,806,118

 

 

$

(712,239

)

 

$

(2,042,918

)

SCHEDULE OF RECONCILIATION OF INCOME TAX

The reconciliation of income tax expense computed at the U.S. federal statutory rate of 21% to the income tax provision is as follows:

 

For the Year Ended March 31,

 

 

2024

 

 

 

2023

 

 

 

2022

 

 

 

 

(Restated)

 

 

 

(Restated)

 

 

 

(Restated)

 

 

U.S. Federal

 

 

21.0

 

%

 

 

21.0

 

%

 

 

21.0

 

%

State taxes, net of Federal income tax benefit

 

 

5.6

 

%

 

 

6.0

 

%

 

 

5.7

 

%

Change in valuation allowance

 

 

0.0

 

%

 

 

0.0

 

%

 

 

(33.7

)

%

Employee stock awards

 

 

(7.4

)

%

 

 

(33.3

)

%

 

 

7.0

 

%

Equity issuance costs

 

 

0.0

 

%

 

 

0.0

 

%

 

 

6.2

 

%

Stock and warrants on note conversion

 

 

0.0

 

%

 

 

(1.9

)

%

 

 

1.4

 

%

Stock for services

 

 

0.0

 

%

 

 

0.0

 

%

 

 

0.0

 

%

Non-deductible meals and entertainment

 

 

(0.1

)

%

 

 

(0.4

)

%

 

 

0.1

 

%

Contingent consideration fair value

 

 

0.1

 

%

 

 

0.2

 

%

 

 

(0.4

)

%

Return to provision

 

 

0.0

 

%

 

 

0.0

 

%

 

 

0.0

 

%

Other

 

 

(0.4

)

%

 

 

(0.3

)

%

 

 

0.0

 

%

Total provision for income taxes

 

 

18.7

 

%

 

 

(8.8

)

%

 

 

7.3

 

%

SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES

Significant components of the Company’s deferred tax liabilities and assets are as follows:

 

As of March 31,

 

 

 

2024

 

 

2023

 

 

2022

 

Deferred tax assets

 

(Restated)

 

 

(Restated)

 

 

(Restated)

 

Net operating loss carryforward

 

$

5,229,409

 

 

$

731,597

 

 

$

 

Loss on purchase

 

 

2,215,611

 

 

 

2,210,878

 

 

 

2,225,477

 

Amortization

 

 

(1,029,565

)

 

 

(52,658

)

 

 

887,892

 

Bad debt allowance

 

 

973,565

 

 

 

860,314

 

 

 

814,967

 

Other

 

 

297,195

 

 

 

(137,835

)

 

 

(335,847

)

Total deferred tax assets

 

$

7,686,215

 

 

$

3,612,296

 

 

$

3,592,489

 

 

 

 

 

 

 

 

 

 

 

Deferred tax liabilities

 

 

 

 

 

 

 

 

 

Depreciation expense

 

$

(3,580,271

)

 

$

(3,510,041

)

 

$

(3,082,977

)

Sec 263A

 

$

1,001,457

 

 

$

1,191,918

 

 

$

1,302,919

 

True up

 

$

(699,910

)

 

$

(698,417

)

 

$

(461,563

)

Other

 

 

 

 

 

 

 

 

 

Total deferred tax liabilities

 

$

(3,278,724

)

 

$

(3,016,540

)

 

$

(2,241,621

)

Net deferred tax assets/(liabilities)

 

$

4,407,491

 

 

$

595,756

 

 

$

1,350,868

 

Valuation allowance

 

 

 

 

 

 

 

 

 

Net deferred tax assets/(liabilities)

 

$

4,407,491

 

 

$

595,756

 

 

$

1,350,868

 

v3.25.1
GOODWILL AND INTANGIBLE ASSETS (Tables)
12 Months Ended
Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
SCHEDULE OF INTANGIBLE ASSETS

Intangible assets consisted of the following:

 

 

 

March 31, 2024

 

 

Life

 

Licenses

 

 

Patent

 

 

Other
Intangible
Assets

 

 

 

 

 

(Restated)

 

 

(Restated)

 

 

(Restated)

 

Licensing Agreement – Jesse James

 

5

 

$

125,000

 

 

$

-

 

 

$

-

 

Licensing Agreement – Jeff Rann

 

5

 

 

250,000

 

 

 

-

 

 

 

-

 

Streak Visual Ammunition patent

 

11.2

 

 

-

 

 

 

950,000

 

 

 

-

 

SWK patent acquisition

 

15

 

 

-

 

 

 

6,652,005

 

 

 

-

 

Jagemann Munition Components:

 

 

 

 

 

 

 

 

 

 

 

Customer Relationships

 

3

 

 

-

 

 

 

-

 

 

 

1,450,613

 

Intellectual Property

 

3

 

 

-

 

 

 

-

 

 

 

1,543,548

 

Tradename

 

5

 

 

-

 

 

 

-

 

 

 

2,152,076

 

GDI Acquisition:

 

 

 

 

 

 

 

 

 

 

 

Tradename

 

15

 

 

-

 

 

 

-

 

 

 

76,532,389

 

Customer List

 

10

 

 

-

 

 

 

-

 

 

 

65,252,802

 

Intellectual Property

 

10

 

 

-

 

 

 

-

 

 

 

4,224,442

 

Other Intangible Assets

 

5

 

 

-

 

 

 

-

 

 

 

357,747

 

 

 

 

 

375,000

 

 

 

7,602,005

 

 

 

151,513,617

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated amortization – Licensing Agreements

 

 

 

 

(375,000

)

 

 

-

 

 

 

-

 

Accumulated amortization – Patents

 

 

 

 

-

 

 

 

(2,845,999

)

 

 

-

 

Accumulated amortization – Intangible Assets

 

 

 

 

-

 

 

 

-

 

 

 

(40,464,550

)

 

 

 

$

-

 

 

$

4,756,006

 

 

$

111,049,067

 

 

 

 

 

March 31, 2023

 

 

Life

 

Licenses

 

 

Patent

 

 

Other
Intangible
Assets

 

 

 

 

 

(Restated)

 

 

(Restated)

 

 

 

 

Licensing Agreement – Jesse James

 

5

 

$

125,000

 

 

$

-

 

 

$

-

 

Licensing Agreement – Jeff Rann

 

5

 

 

250,000

 

 

 

-

 

 

 

-

 

Streak Visual Ammunition patent

 

11.2

 

 

-

 

 

 

950,000

 

 

 

-

 

SWK patent acquisition

 

15

 

 

-

 

 

 

6,652,005

 

 

 

-

 

Jagemann Munition Components:

 

 

 

 

 

 

 

 

 

 

 

Customer Relationships

 

3

 

 

-

 

 

 

-

 

 

 

1,450,613

 

Intellectual Property

 

3

 

 

-

 

 

 

-

 

 

 

1,543,548

 

Tradename

 

5

 

 

-

 

 

 

-

 

 

 

2,152,076

 

GDI Acquisition:

 

 

 

 

 

 

 

 

 

 

 

Tradename

 

15

 

 

-

 

 

 

-

 

 

 

76,532,389

 

Customer List

 

10

 

 

-

 

 

 

-

 

 

 

65,252,802

 

Intellectual Property

 

10

 

 

-

 

 

 

-

 

 

 

4,224,442

 

Other Intangible Assets

 

5

 

 

-

 

 

 

-

 

 

 

607,747

 

 

 

 

 

375,000

 

 

 

7,602,005

 

 

 

151,763,617

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated amortization – Licensing Agreements

 

 

 

 

(375,000

)

 

 

 

 

 

-

 

Accumulated amortization – Patents

 

 

 

 

-

 

 

 

(2,305,251

)

 

 

-

 

Accumulated amortization – Intangible Assets

 

 

 

 

-

 

 

 

-

 

 

 

(28,036,807

)

 

 

 

$

-

 

 

$

5,296,754

 

 

$

123,726,810

 

 

 

 

 

 

March 31, 2022

 

 

Life

 

Licenses

 

 

Patent

 

 

Other
Intangible
Assets

 

 

 

 

 

(Restated)

 

 

(Restated)

 

 

 

 

Licensing Agreement – Jesse James

 

5

 

$

125,000

 

 

$

-

 

 

$

-

 

Licensing Agreement – Jeff Rann

 

5

 

 

250,000

 

 

 

-

 

 

 

-

 

Streak Visual Ammunition patent

 

11.2

 

 

-

 

 

 

950,000

 

 

 

-

 

SWK patent acquisition

 

15

 

 

-

 

 

 

6,652,005

 

 

 

-

 

Jagemann Munition Components:

 

 

 

 

 

 

 

 

 

 

 

Customer Relationships

 

3

 

 

-

 

 

 

-

 

 

 

1,450,613

 

Intellectual Property

 

3

 

 

-

 

 

 

-

 

 

 

1,543,548

 

Tradename

 

5

 

 

-

 

 

 

-

 

 

 

2,152,076

 

GDI Acquisition:

 

 

 

 

 

 

 

 

 

 

 

Tradename

 

15

 

 

-

 

 

 

-

 

 

 

76,532,389

 

Customer List

 

10

 

 

-

 

 

 

-

 

 

 

65,252,802

 

Intellectual Property

 

10

 

 

-

 

 

 

-

 

 

 

4,224,442

 

Other Intangible Assets

 

5

 

 

-

 

 

 

-

 

 

 

607,747

 

 

 

 

 

375,000

 

 

 

7,602,005

 

 

 

151,763,617

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated amortization – Licensing Agreements

 

 

 

 

(375,000

)

 

 

-

 

 

 

-

 

Accumulated amortization – Patents

 

 

 

 

-

 

 

 

(1,764,503

)

 

 

-

 

Accumulated amortization – Intangible Assets

 

 

 

 

-

 

 

 

-

 

 

 

(15,463,230

)

 

 

 

$

-

 

 

$

5,837,502

 

 

$

136,300,387

 

SCHEDULE OF ANNUAL AMORTIZATION OF INTANGIBLE ASSET

Annual estimated amortization of intangible assets for the next five fiscal years are as follows:

Years Ended March 31,

 

Estimates for
Fiscal Year

 

2025

 

$

12,697,926

 

2026

 

 

12,662,059

 

2027

 

 

12,596,472

 

2028

 

 

12,590,510

 

2029

 

 

12,555,076

 

Thereafter

 

 

52,703,030

 

 

 

$

115,805,073

 

v3.25.1
SEGMENTS (Tables)
12 Months Ended
Mar. 31, 2024
Segment Reporting [Abstract]  
SCHEDULE OF OPERATING SEGMENTS

 

For the Year Ended March 31, 2024

 

 

Ammunition

 

 

Marketplace

 

 

Corporate
and other
expenses

 

 

Total

 

 

 

(As Restated)

 

Net Revenues

 

$

91,112,496

 

 

$

53,942,076

 

 

$

-

 

 

$

145,054,572

 

Cost of Revenues

 

 

94,818,546

 

 

 

7,660,541

 

 

 

-

 

 

 

102,479,087

 

General and administrative expense

 

 

8,967,456

 

 

 

9,885,131

 

 

 

29,800,768

 

 

 

48,653,355

 

Depreciation and amortization

 

 

508,485

 

 

 

13,034,306

 

 

 

-

 

 

 

13,542,791

 

Income/(Loss) from Operations

 

$

(13,181,991

)

 

$

23,362,098

 

 

$

(29,800,768

)

 

$

(19,620,661

)

 

 

For the Year Ended March 31, 2023

 

 

Ammunition

 

 

Marketplace

 

 

Corporate
and other
expenses

 

 

Total

 

 

 

(As Restated)

 

Net Revenues

 

$

128,290,128

 

 

$

63,149,673

 

 

$

-

 

 

$

191,439,801

 

Cost of Revenues

 

 

126,961,549

 

 

 

9,116,939

 

 

 

-

 

 

 

136,078,488

 

General and administrative expense

 

 

10,378,456

 

 

 

9,707,425

 

 

 

29,444,236

 

 

 

49,530,117

 

Depreciation and amortization

 

 

578,326

 

 

 

12,700,436

 

 

 

-

 

 

 

13,278,762

 

Income/(Loss) from Operations

 

$

(9,628,203

)

 

$

31,624,873

 

 

$

(29,444,236

)

 

$

(7,447,566

)

 

 

For the Year Ended March 31, 2022

 

 

Ammunition

 

 

Marketplace

 

 

Corporate
and other
expenses

 

 

Total

 

 

 

(As Restated)

 

Net Revenues

 

$

175,660,650

 

 

$

64,608,516

 

 

$

-

 

 

$

240,269,166

 

Cost of Revenues

 

 

142,820,590

 

 

 

8,732,351

 

 

 

-

 

 

 

151,552,941

 

General and administrative expense

 

 

11,932,720

 

 

 

8,434,308

 

 

 

26,098,079

 

 

 

46,465,107

 

Depreciation and amortization

 

 

1,602,695

 

 

 

12,122,370

 

 

 

-

 

 

 

13,725,065

 

Income/(Loss) from Operations

 

$

19,304,645

 

 

$

35,319,487

 

 

$

(26,098,079

)

 

$

28,526,053

 

 

Total assets by segment were as follows:

 

For the Year Ended

 

 

March 31,
2024

 

 

March 31,
2023

 

 

March 31,
2022

 

Ammunition

 

$

167,001,641

 

 

$

154,904,363

 

 

$

161,967,259

 

Marketplace

 

 

236,037,694

 

 

 

258,290,780

 

 

 

253,873,206

 

 

$

403,039,335

 

 

$

413,195,143

 

 

$

415,840,465

 

 

Total capital expenditures by segment were as follows:

 

For the Year Ended

 

 

March 31,
2024

 

 

March 31,
2023

 

 

March 31,
2022

 

Ammunition

 

$

5,519,135

 

 

$

10,819,177

 

 

$

17,728,023

 

Marketplace

 

 

2,505,630

 

 

 

1,722,148

 

 

 

1,490,959

 

 

$

8,024,765

 

 

$

12,541,325

 

 

$

19,218,982

 

v3.25.1
QUARTERLY RESULTS OF OPERATIONS (Tables)
12 Months Ended
Mar. 31, 2024
Quarterly Financial Information Disclosure [Abstract]  
SCHEDULE OF QUARTERLY STATEMENT OF OPERATIONS, BALANCE SHEET INFORMATION, STOCKHOLDERS' EQUITY AND CASH FLOWS

Unaudited interim consolidated results of operations for the fiscal year ended March 31, 2024 were as follows:

 

 

Quarter Ended

 

 

Fiscal 2024

 

June 30,

 

 

September 30,

 

 

December 31,

 

 

March 31,

 

 

(Unaudited)

 

2023

 

 

2023

 

 

2023

 

 

2024

 

 

 

 

(Restated)

 

 

(Restated)

 

 

(Restated)

 

 

(Restated)

 

 

Net revenues

 

$

 

34,254,575

 

 

$

 

34,372,386

 

 

$

 

36,006,464

 

 

$

 

40,421,147

 

 

Gross profit

 

 

 

14,012,719

 

 

 

 

8,276,445

 

 

 

 

10,898,555

 

 

 

 

9,387,766

 

 

Loss from operations

 

 

 

(1,998,400

)

 

 

 

(9,011,953

)

 

 

 

(2,576,497

)

 

 

 

(6,033,811

)

 

Net loss

 

 

 

(1,304,062

)

 

 

 

(7,665,967

)

 

 

 

(2,405,778

)

 

 

 

(5,217,802

)

 

Net loss attributable to common stock shareholders

 

 

 

(2,078,194

)

 

 

 

(8,448,606

)

 

 

 

(3,188,417

)

 

 

 

(6,000,441

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

 

(0.02

)

 

$

 

(0.07

)

 

$

 

(0.03

)

 

$

 

(0.05

)

 

Diluted

 

$

 

(0.02

)

 

$

 

(0.07

)

 

$

 

(0.03

)

 

$

 

(0.05

)

 

The following tables set for the restatement of the Company's unaudited interim consolidated results of operations for the three months ended June 30, 2023, three and six months ended September 30, 2023, the three and nine months ended December 31, 2023, and the three months ended March 31, 2024:

 

 

For the three months ended June 30, 2023

 

 

(Unaudited)

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

 

 

Stock Based
Payments

 

 

Other

 

 

As Restated

 

 

Net revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ammunition sales

 

 $

 

14,106,029

 

 

 $

 

-

 

 

 $

 

-

 

 

 $

 

14,106,029

 

 

Marketplace revenue

 

 

 

13,912,202

 

 

 

 

-

 

 

 

 

-

 

 

 

 

13,912,202

 

 

Casing sales

 

 

 

6,236,344

 

 

 

 

-

 

 

 

 

-

 

 

 

 

6,236,344

 

 

Total revenues

 

 

 

34,254,575

 

 

 

 

-

 

 

 

 

-

 

 

 

 

34,254,575

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues

 

 

 

20,230,035

 

 

 

 

-

 

 

 

 

11,821

 

 

 

 

20,241,856

 

 

Gross profit

 

 

 

14,024,540

 

 

 

 

-

 

 

 

 

(11,821

)

 

 

 

14,012,719

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling and marketing

 

 

 

295,581

 

 

 

 

-

 

 

 

 

-

 

 

 

 

295,581

 

 

Corporate general and administrative

 

 

 

7,947,563

 

 

 

 

-

 

 

 

 

-

 

 

 

 

7,947,563

 

 

Employee salaries and related expenses

 

 

 

4,116,280

 

 

 

 

307,652

 

 

 

 

-

 

 

 

 

4,423,932

 

 

Depreciation and amortization expense

 

 

 

3,344,043

 

 

 

 

-

 

 

 

 

-

 

 

 

 

3,344,043

 

 

Total operating expenses

 

 

 

15,703,467

 

 

 

 

307,652

 

 

 

 

-

 

 

 

 

16,011,119

 

 

Income/(loss) from operations

 

 

 

(1,678,927

)

 

 

 

(307,652

)

 

 

 

(11,821

)

 

 

 

(1,998,400

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income

 

 

 

692,951

 

 

 

 

-

 

 

 

 

-

 

 

 

 

692,951

 

 

Interest expense

 

 

 

(204,201

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(204,201

)

 

Total other expense

 

 

 

488,750

 

 

 

 

-

 

 

 

 

-

 

 

 

 

488,750

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income/(loss) before income taxes

 

 

 

(1,190,177

)

 

 

 

(307,652

)

 

 

 

(11,821

)

 

 

 

(1,509,650

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

 

(97,144

)

 

 

 

-

 

 

 

 

(108,444

)

 

 

 

(205,588

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

 

 

(1,093,033

)

 

 

 

(307,652

)

 

 

 

96,623

 

 

 

 

(1,304,062

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock dividend

 

 

 

(774,132

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(774,132

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) attributable to common stock shareholders

 

$

 

(1,867,165

)

 

$

 

(307,652

)

 

$

 

96,623

 

 

$

 

(2,078,194

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 $

 

(0.02

)

 

 

 

 

 

 

 

 

 

 $

 

(0.02

)

 

Diluted

 

 $

 

(0.02

)

 

 

 

 

 

 

 

 

 

 $

 

(0.02

)

 

 

 

 

 

For the three months ended September 30, 2023

 

 

(Unaudited)

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

 

 

Stock Based
Payments

 

 

Other

 

 

As Restated

 

 

Net revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ammunition sales

 

 $

 

15,516,589

 

 

 $

 

-

 

 

 $

 

-

 

 

 $

 

15,516,589

 

 

Marketplace revenue

 

 

 

12,474,716

 

 

 

 

-

 

 

 

 

-

 

 

 

 

12,474,716

 

 

Casing sales

 

 

 

6,381,081

 

 

 

 

-

 

 

 

 

-

 

 

 

 

6,381,081

 

 

Total revenues

 

 

 

34,372,386

 

 

 

 

-

 

 

 

 

-

 

 

 

 

34,372,386

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues

 

 

 

26,084,120

 

 

 

 

-

 

 

 

 

11,821

 

 

 

 

26,095,941

 

 

Gross profit

 

 

 

8,288,266

 

 

 

 

-

 

 

 

 

(11,821

)

 

 

 

8,276,445

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling and marketing

 

 

 

289,952

 

 

 

 

-

 

 

 

 

-

 

 

 

 

289,952

 

 

Corporate general and administrative

 

 

 

7,855,624

 

 

 

 

-

 

 

 

 

-

 

 

 

 

7,855,624

 

 

Employee salaries and related expenses

 

 

 

5,590,035

 

 

 

 

180,985

 

 

 

 

-

 

 

 

 

5,771,020

 

 

Depreciation and amortization expense

 

 

 

3,371,802

 

 

 

 

-

 

 

 

 

-

 

 

 

 

3,371,802

 

 

Total operating expenses

 

 

 

17,107,413

 

 

 

 

180,985

 

 

 

 

-

 

 

 

 

17,288,398

 

 

Income/(loss) from operations

 

 

 

(8,819,147

)

 

 

 

(180,985

)

 

 

 

(11,821

)

 

 

 

(9,011,953

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income

 

 

 

(321,341

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(321,341

)

 

Interest expense

 

 

 

(212,314

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(212,314

)

 

Total other expense

 

 

 

(533,655

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(533,655

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income/(loss) before income taxes

 

 

 

(9,352,802

)

 

 

 

(180,985

)

 

 

 

(11,821

)

 

 

 

(9,545,608

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

 

(1,857,505

)

 

 

 

-

 

 

 

 

(22,136

)

 

 

 

(1,879,641

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

 

 

(7,495,297

)

 

 

 

(180,985

)

 

 

 

10,315

 

 

 

 

(7,665,967

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock dividend

 

 

 

(782,639

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(782,639

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) attributable to common stock shareholders

 

$

 

(8,277,936

)

 

$

 

(180,985

)

 

$

 

10,315

 

 

$

 

(8,448,606

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 $

 

(0.07

)

 

 

 

 

 

 

 

 

 

 $

 

(0.07

)

 

Diluted

 

 $

 

(0.07

)

 

 

 

 

 

 

 

 

 

 $

 

(0.07

)

 

 

 

 

 

For the six months ended September 30, 2023

 

 

(Unaudited)

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

 

 

Stock Based
Payments

 

 

Other

 

 

As Restated

 

 

Net revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ammunition sales

 

 $

 

29,622,618

 

 

 $

 

-

 

 

 $

 

-

 

 

 $

 

29,622,618

 

 

Marketplace revenue

 

 

 

26,386,918

 

 

 

 

-

 

 

 

 

-

 

 

 

 

26,386,918

 

 

Casing sales

 

 

 

12,617,425

 

 

 

 

-

 

 

 

 

-

 

 

 

 

12,617,425

 

 

Total revenues

 

 

 

68,626,961

 

 

 

 

-

 

 

 

 

-

 

 

 

 

68,626,961

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues

 

 

 

46,314,155

 

 

 

 

-

 

 

 

 

23,642

 

 

 

 

46,337,797

 

 

Gross profit

 

 

 

22,312,806

 

 

 

 

-

 

 

 

 

(23,642

)

 

 

 

22,289,164

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling and marketing

 

 

 

585,533

 

 

 

 

-

 

 

 

 

-

 

 

 

 

585,533

 

 

Corporate general and administrative

 

 

 

15,803,187

 

 

 

 

-

 

 

 

 

-

 

 

 

 

15,803,187

 

 

Employee salaries and related expenses

 

 

 

9,706,315

 

 

 

 

488,637

 

 

 

 

-

 

 

 

 

10,194,952

 

 

Depreciation and amortization expense

 

 

 

6,715,845

 

 

 

 

-

 

 

 

 

-

 

 

 

 

6,715,845

 

 

Total operating expenses

 

 

 

32,810,880

 

 

 

 

488,637

 

 

 

 

-

 

 

 

 

33,299,517

 

 

Income/(loss) from operations

 

 

 

(10,498,074

)

 

 

 

(488,637

)

 

 

 

(23,642

)

 

 

 

(11,010,353

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income

 

 

 

371,610

 

 

 

 

-

 

 

 

 

-

 

 

 

 

371,610

 

 

Interest expense

 

 

 

(416,515

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(416,515

)

 

Total other expense

 

 

 

(44,905

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(44,905

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income/(loss) before income taxes

 

 

 

(10,542,979

)

 

 

 

(488,637

)

 

 

 

(23,642

)

 

 

 

(11,055,258

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

 

(1,954,649

)

 

 

 

-

 

 

 

 

(130,580

)

 

 

 

(2,085,229

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

 

 

(8,588,330

)

 

 

 

(488,637

)

 

 

 

106,938

 

 

 

 

(8,970,029

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock dividend

 

 

 

(1,556,771

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(1,556,771

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) attributable to common stock shareholders

 

$

 

(10,145,101

)

 

$

 

(488,637

)

 

$

 

106,938

 

 

$

 

(10,526,800

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 $

 

(0.09

)

 

 

 

 

 

 

 

 

 

 $

 

(0.09

)

 

Diluted

 

 $

 

(0.09

)

 

 

 

 

 

 

 

 

 

 $

 

(0.09

)

 

 

 

 

 

For the three months ended December 31, 2023

 

 

(Unaudited)

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

 

 

Stock Based
Payments

 

 

Other

 

 

As Restated

 

 

Net revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ammunition sales

 

 $

 

17,322,967

 

 

 $

 

-

 

 

 $

 

-

 

 

 $

 

17,322,967

 

 

Marketplace revenue

 

 

 

13,985,034

 

 

 

 

-

 

 

 

 

-

 

 

 

 

13,985,034

 

 

Casing sales

 

 

 

4,698,463

 

 

 

 

-

 

 

 

 

-

 

 

 

 

4,698,463

 

 

Total revenues

 

 

 

36,006,464

 

 

 

 

-

 

 

 

 

-

 

 

 

 

36,006,464

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues

 

 

 

25,096,088

 

 

 

 

-

 

 

 

 

11,821

 

 

 

 

25,107,909

 

 

Gross profit

 

 

 

10,910,376

 

 

 

 

-

 

 

 

 

(11,821

)

 

 

 

10,898,555

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling and marketing

 

 

 

236,565

 

 

 

 

-

 

 

 

 

-

 

 

 

 

236,565

 

 

Corporate general and administrative

 

 

 

5,803,255

 

 

 

 

-

 

 

 

 

-

 

 

 

 

5,803,255

 

 

Employee salaries and related expenses

 

 

 

3,390,153

 

 

 

 

643,923

 

 

 

 

-

 

 

 

 

4,034,076

 

 

Depreciation and amortization expense

 

 

 

3,401,156

 

 

 

 

-

 

 

 

 

-

 

 

 

 

3,401,156

 

 

Total operating expenses

 

 

 

12,831,129

 

 

 

 

643,923

 

 

 

 

-

 

 

 

 

13,475,052

 

 

Income/(loss) from operations

 

 

 

(1,920,753

)

 

 

 

(643,923

)

 

 

 

(11,821

)

 

 

 

(2,576,497

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income

 

 

 

4,576

 

 

 

 

-

 

 

 

 

-

 

 

 

 

4,576

 

 

Interest expense

 

 

 

(193,046

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(193,046

)

 

Total other expense

 

 

 

(188,470

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(188,470

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income/(loss) before income taxes

 

 

 

(2,109,223

)

 

 

 

(643,923

)

 

 

 

(11,821

)

 

 

 

(2,764,967

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

 

(465,234

)

 

 

 

-

 

 

 

 

106,045

 

 

 

 

(359,189

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

 

 

(1,643,989

)

 

 

 

(643,923

)

 

 

 

(117,866

)

 

 

 

(2,405,778

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock dividend

 

 

 

(782,639

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(782,639

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) attributable to common stock shareholders

 

$

 

(2,426,628

)

 

$

 

(643,923

)

 

$

 

(117,866

)

 

$

 

(3,188,417

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 $

 

(0.02

)

 

 

 

 

 

 

 

 

 

 $

 

(0.03

)

 

Diluted

 

 $

 

(0.02

)

 

 

 

 

 

 

 

 

 

 $

 

(0.03

)

 

 

 

 

 

 

For the nine months ended December 31, 2023

 

 

(Unaudited)

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

 

 

Stock Based
Payments

 

 

Other

 

 

As Restated

 

 

Net revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ammunition sales

 

 $

 

46,945,585

 

 

 $

 

-

 

 

 $

 

-

 

 

 $

 

46,945,585

 

 

Marketplace revenue

 

 

 

40,371,952

 

 

 

 

-

 

 

 

 

-

 

 

 

 

40,371,952

 

 

Casing sales

 

 

 

17,315,888

 

 

 

 

-

 

 

 

 

-

 

 

 

 

17,315,888

 

 

Total revenues

 

 

 

104,633,425

 

 

 

 

-

 

 

 

 

-

 

 

 

 

104,633,425

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues

 

 

 

71,410,243

 

 

 

 

-

 

 

 

 

35,463

 

 

 

 

71,445,706

 

 

Gross profit

 

 

 

33,223,182

 

 

 

 

-

 

 

 

 

(35,463

)

 

 

 

33,187,719

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling and marketing

 

 

 

822,098

 

 

 

 

-

 

 

 

 

-

 

 

 

 

822,098

 

 

Corporate general and administrative

 

 

 

21,606,442

 

 

 

 

-

 

 

 

 

-

 

 

 

 

21,606,442

 

 

Employee salaries and related expenses

 

 

 

13,096,468

 

 

 

 

1,132,560

 

 

 

 

-

 

 

 

 

14,229,028

 

 

Depreciation and amortization expense

 

 

 

10,117,001

 

 

 

 

-

 

 

 

 

-

 

 

 

 

10,117,001

 

 

Total operating expenses

 

 

 

45,642,009

 

 

 

 

1,132,560

 

 

 

 

-

 

 

 

 

46,774,569

 

 

Income/(loss) from operations

 

 

 

(12,418,827

)

 

 

 

(1,132,560

)

 

 

 

(35,463

)

 

 

 

(13,586,850

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income

 

 

 

376,186

 

 

 

 

-

 

 

 

 

-

 

 

 

 

376,186

 

 

Interest expense

 

 

 

(609,561

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(609,561

)

 

Total other expense

 

 

 

(233,375

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(233,375

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income/(loss) before income taxes

 

 

 

(12,652,202

)

 

 

 

(1,132,560

)

 

 

 

(35,463

)

 

 

 

(13,820,225

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

 

(2,419,883

)

 

 

 

-

 

 

 

 

(24,535

)

 

 

 

(2,444,418

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

 

 

(10,232,319

)

 

 

 

(1,132,560

)

 

 

 

(10,928

)

 

 

 

(11,375,807

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock dividend

 

 

 

(2,339,410

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(2,339,410

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) attributable to common stock shareholders

 

$

 

(12,571,729

)

 

$

 

(1,132,560

)

 

$

 

(10,928

)

 

$

 

(13,715,217

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 $

 

(0.11

)

 

 

 

 

 

 

 

 

 

 $

 

(0.12

)

 

Diluted

 

 $

 

(0.11

)

 

 

 

 

 

 

 

 

 

 $

 

(0.12

)

 

 

 

 

 

 

For the three months ended March 31, 2024

 

 

(Unaudited)

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

 

 

Stock Based
Payments

 

 

Other

 

 

As Restated

 

 

Net revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ammunition sales

 

 $

 

22,445,216

 

 

 $

 

-

 

 

 $

 

-

 

 

 $

 

22,445,216

 

 

Marketplace revenue

 

 

 

13,570,124

 

 

 

 

-

 

 

 

 

-

 

 

 

 

13,570,124

 

 

Casing sales

 

 

 

4,405,807

 

 

 

 

-

 

 

 

 

-

 

 

 

 

4,405,807

 

 

Total revenues

 

 

 

40,421,147

 

 

 

 

-

 

 

 

 

-

 

 

 

 

40,421,147

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues

 

 

 

31,021,560

 

 

 

 

-

 

 

 

 

11,821

 

 

 

 

31,033,381

 

 

Gross profit

 

 

 

9,399,587

 

 

 

 

-

 

 

 

 

(11,821

)

 

 

 

9,387,766

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling and marketing

 

 

 

547,981

 

 

 

 

-

 

 

 

 

-

 

 

 

 

547,981

 

 

Corporate general and administrative

 

 

 

7,976,832

 

 

 

 

-

 

 

 

 

-

 

 

 

 

7,976,832

 

 

Employee salaries and related expenses

 

 

 

3,607,354

 

 

 

 

(136,380

)

 

 

 

-

 

 

 

 

3,470,974

 

 

Depreciation and amortization expense

 

 

 

3,425,790

 

 

 

 

-

 

 

 

 

-

 

 

 

 

3,425,790

 

 

Total operating expenses

 

 

 

15,557,957

 

 

 

 

(136,380

)

 

 

 

-

 

 

 

 

15,421,577

 

 

Income/(loss) from operations

 

 

 

(6,158,370

)

 

 

 

136,380

 

 

 

 

(11,821

)

 

 

 

(6,033,811

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income

 

 

 

(708,779

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(708,779

)

 

Interest expense

 

 

 

163,088

 

 

 

 

-

 

 

 

 

-

 

 

 

 

163,088

 

 

Total other expense

 

 

 

(545,691

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(545,691

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income/(loss) before income taxes

 

 

 

(6,704,061

)

 

 

 

136,380

 

 

 

 

(11,821

)

 

 

 

(6,579,502

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

 

(1,371,180

)

 

 

 

-

 

 

 

 

9,480

 

 

 

 

(1,361,700

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

 

 

(5,332,881

)

 

 

 

136,380

 

 

 

 

(21,301

)

 

 

 

(5,217,802

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock dividend

 

 

 

(782,639

)

 

 

 

-

 

 

 

 

-

 

 

 

 

(782,639

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) attributable to common stock shareholders

 

$

 

(6,115,520

)

 

$

 

136,380

 

 

$

 

(21,301

)

 

$

 

(6,000,441

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss) per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 $

 

(0.05

)

 

 

 

 

 

 

 

 

 

 $

 

(0.05

)

 

Diluted

 

 $

 

(0.05

)

 

 

 

 

 

 

 

 

 

 $

 

(0.05

)

 

 

Quarterly Balance Sheet Information

The unaudited interim consolidated balance sheets as of December 31, 2023, September 30, 2023, and June 30, 2023 are as follows:

 (Unaudited)

 

 

December 31,

 

 

 

September 30,

 

 

 

June 30,

 

 

 

 

 

2023

 

 

 

2023

 

 

 

2023

 

 

 

 

 

(Restated)

 

 

 

(Restated)

 

 

 

(Restated)

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

 $

 

54,679,868

 

 

 

 $

 

49,564,868

 

 

 

 $

 

47,505,047

 

 

Accounts receivable, net

 

 

 

 

21,121,450

 

 

 

 

 

23,030,851

 

 

 

 

 

21,348,226

 

 

Inventories

 

 

 

 

49,502,732

 

 

 

 

 

53,014,205

 

 

 

 

 

55,924,655

 

 

Prepaid expenses

 

 

 

 

3,708,865

 

 

 

 

 

3,920,007

 

 

 

 

 

5,294,454

 

 

Current portion of restricted cash

 

 

 

 

-

 

 

 

 

 

-

 

 

 

 

 

500,000

 

 

Total current assets

 

 

 

 

129,012,915

 

 

 

 

 

129,529,931

 

 

 

 

 

130,572,382

 

 

 

 

 

 

.

 

 

 

 

 

 

 

 

 

 

 

 

Equipment, net

 

 

 

 

57,278,603

 

 

 

 

 

55,821,414

 

 

 

 

 

55,923,867

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deposits

 

 

 

 

2,265,932

 

 

 

 

 

3,189,518

 

 

 

 

 

4,064,582

 

 

Patents, net

 

 

 

 

4,891,193

 

 

 

 

 

5,026,380

 

 

 

 

 

5,161,567

 

 

Other intangible assets, net

 

 

 

 

114,296,627

 

 

 

 

 

117,440,022

 

 

 

 

 

120,583,416

 

 

Goodwill

 

 

 

 

90,870,094

 

 

 

 

 

90,870,094

 

 

 

 

 

90,870,094

 

 

Right of use assets - operating leases

 

 

 

 

2,113,943

 

 

 

 

 

1,017,982

 

 

 

 

 

1,141,418

 

 

Deferred income tax asset

 

 

 

 

3,044,238

 

 

 

 

 

2,684,640

 

 

 

 

 

802,855

 

 

TOTAL ASSETS

 

 

$

 

403,773,545

 

 

 

 $

 

405,579,981

 

 

 

 $

 

409,120,181

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

 

$

 

19,146,138

 

 

 

 $

 

19,598,548

 

 

 

 $

 

16,356,614

 

 

Accrued liabilities

 

 

 

 

6,603,892

 

 

 

 

 

6,282,980

 

 

 

 

 

4,677,757

 

 

Current portion of operating lease liability

 

 

 

 

463,059

 

 

 

 

 

370,980

 

 

 

 

 

421,477

 

 

Note payable related party

 

 

 

 

-

 

 

 

 

 

-

 

 

 

 

 

-

 

 

Current portion of construction note payable

 

 

 

 

265,977

 

 

 

 

 

265,977

 

 

 

 

 

277,216

 

 

Insurance premium note payable

 

 

 

 

173,029

 

 

 

 

 

1,157,745

 

 

 

 

 

2,204,293

 

 

Total current liabilities

 

 

 

 

26,652,095

 

 

 

 

 

27,676,230

 

 

 

 

 

23,937,357

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long-term liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration payable

 

 

 

 

80,080

 

 

 

 

 

99,302

 

 

 

 

 

119,354

 

 

Income tax payable

 

 

 

 

1,609,520

 

 

 

 

 

1,609,520

 

 

 

 

 

1,609,520

 

 

Construction note payable, net of unamortized issuance costs

 

 

 

 

10,797,696

 

 

 

 

 

10,830,663

 

 

 

 

 

10,861,510

 

 

Operating lease liability, net of current portion

 

 

 

 

1,737,615

 

 

 

 

 

744,616

 

 

 

 

 

825,043

 

 

Deferred income tax liability

 

 

 

 

-

 

 

 

 

 

-

 

 

 

 

 

-

 

 

Total liabilities

 

 

 

 

40,877,006

 

 

 

 

 

40,960,331

 

 

 

 

 

37,352,784

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Series A cumulative perpetual preferred Stock

 

 

 

 

1,400

 

 

 

 

 

1,400

 

 

 

 

 

1,400

 

 

Common stock

 

 

 

 

118,644

 

 

 

 

 

118,461

 

 

 

 

 

117,946

 

 

Additional paid-in capital

 

 

 

 

429,381,115

 

 

 

 

 

427,619,626

 

 

 

 

 

425,920,655

 

 

Accumulated deficit

 

 

 

 

(63,931,464

)

 

 

 

 

(60,743,047

)

 

 

 

 

(52,294,441

)

 

Treasury stock

 

 

 

 

(2,673,156

)

 

 

 

 

(2,376,790

)

 

 

 

 

(1,978,163

)

 

Total shareholders’ equity

 

 

 

 

362,896,539

 

 

 

 

 

364,619,650

 

 

 

 

 

371,767,397

 

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

$

 

403,773,545

 

 

 

 $

 

405,579,981

 

 

 

 $

 

409,120,181

 

 

 

The following tables set forth the restatement of the Company's unaudited interim consolidated balance sheets as of June 30, 2023, September 30, 2023, and December 31, 2023:

 (Unaudited)

As of June 30, 2023

 

 

 

 

 

Adjustments

 

 

 

 

 

 

As Previously
Reported

 

 

 

Stock Based
Payments

 

 

Equity Issuance Costs

 

 

Convertible Notes

 

 

Warrants

 

 

Acquisition

 

 

Other

 

 

Restated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

47,505,047

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

47,505,047

 

Accounts receivable, net

 

 

21,348,226

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

21,348,226

 

Inventories

 

 

55,924,655

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

55,924,655

 

Prepaid expenses

 

 

5,294,454

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

5,294,454

 

Current portion of restricted cash

 

 

500,000

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

500,000

 

Total current assets

 

$

130,572,382

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

130,572,382

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equipment, net

 

 

55,923,867

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

55,923,867

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deposits

 

 

4,064,582

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

4,064,582

 

Patents, net

 

 

4,909,388

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

252,179

 

 

 

5,161,567

 

Other intangible assets, net

 

 

120,583,416

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

120,583,416

 

Goodwill

 

 

90,870,094

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

90,870,094

 

Right of use assets - operating leases

 

 

1,141,418

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,141,418

 

Deferred income tax asset

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

802,855

 

 

 

802,855

 

TOTAL ASSETS

 

$

408,065,147

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

1,055,034

 

 

$

409,120,181

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

$

16,356,614

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

16,356,614

 

Accrued liabilities

 

 

4,641,469

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

36,288

 

 

 

4,677,757

 

Current portion of operating lease liability

 

 

421,477

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

421,477

 

Note payable related party

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Current portion of construction note payable

 

 

277,216

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

277,216

 

Insurance premium note payable

 

 

2,204,293

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,204,293

 

Total current liabilities

 

 

23,901,069

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

36,288

 

 

 

23,937,357

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long-term liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration payable

 

 

119,354

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

119,354

 

Income tax payable

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,609,520

 

 

 

1,609,520

 

Construction note payable, net of unamortized issuance costs

 

 

10,861,510

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

10,861,510

 

Operating lease liability, net of current portion

 

 

825,043

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

825,043

 

Deferred income tax liability

 

 

2,212,448

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(2,212,448

)

 

 

-

 

Total liabilities

 

 

37,919,424

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(566,640

)

 

 

37,352,784

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Series A cumulative perpetual preferred Stock

 

 

1,400

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,400

 

Common stock

 

 

117,946

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

117,946

 

Additional paid-in capital

 

 

392,813,530

 

 

 

 

12,486,057

 

 

 

7,420,492

 

 

 

6,024,240

 

 

 

1,298,336

 

 

 

5,225,000

 

 

 

653,000

 

 

 

425,920,655

 

Accumulated deficit

 

 

(20,808,990

)

 

 

 

(12,486,057

)

 

 

(7,420,492

)

 

 

(6,024,240

)

 

 

(1,298,336

)

 

 

(5,225,000

)

 

 

968,674

 

 

 

(52,294,441

)

Treasury stock

 

 

(1,978,163

)

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(1,978,163

)

Total shareholders’ equity

 

 

370,145,723

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,621,674

 

 

 

371,767,397

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

 

$

408,065,147

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

1,055,034

 

 

$

409,120,181

 

 

 (Unaudited)

As of September 30, 2023

 

 

 

 

 

Adjustments

 

 

 

 

 

 

As Previously
Reported

 

 

 

Stock Based
Payments

 

 

Equity Issuance Costs

 

 

Convertible Notes

 

 

Warrants

 

 

Acquisition

 

 

Other

 

 

Restated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

49,564,868

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

49,564,868

 

Accounts receivable, net

 

 

23,030,851

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

23,030,851

 

Inventories

 

 

53,014,205

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

53,014,205

 

Prepaid expenses

 

 

3,920,007

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

3,920,007

 

Current portion of restricted cash

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Total current assets

 

$

129,529,931

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

129,529,931

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equipment, net

 

 

55,821,414

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

55,821,414

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deposits

 

 

3,189,518

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

3,189,518

 

Patents, net

 

 

4,786,022

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

240,358

 

 

 

5,026,380

 

Other intangible assets, net

 

 

117,440,022

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

117,440,022

 

Goodwill

 

 

90,870,094

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

90,870,094

 

Right of use assets - operating leases

 

 

1,017,982

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,017,982

 

Deferred income tax asset

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,684,640

 

 

 

2,684,640

 

TOTAL ASSETS

 

$

402,654,983

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

2,924,998

 

 

$

405,579,981

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

$

19,598,548

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

19,598,548

 

Accrued liabilities

 

 

6,250,164

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

32,816

 

 

 

6,282,980

 

Current portion of operating lease liability

 

 

370,980

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

370,980

 

Note payable related party

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Current portion of construction note payable

 

 

265,977

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

265,977

 

Insurance premium note payable

 

 

1,157,745

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,157,745

 

Total current liabilities

 

 

27,643,414

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

32,816

 

 

 

27,676,230

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long-term liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration payable

 

 

99,302

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

99,302

 

Income tax payable

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,609,520

 

 

 

1,609,520

 

Construction note payable, net of unamortized issuance costs

 

 

10,830,663

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

10,830,663

 

Operating lease liability, net of current portion

 

 

744,616

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

744,616

 

Deferred income tax liability

 

 

349,327

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(349,327

)

 

 

-

 

Total liabilities

 

 

39,667,322

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,293,009

 

 

 

40,960,331

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Series A cumulative perpetual preferred Stock

 

 

1,400

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,400

 

Common stock

 

 

118,461

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

118,461

 

Additional paid-in capital

 

 

394,331,516

 

 

 

 

12,667,042

 

 

 

7,420,492

 

 

 

6,024,240

 

 

 

1,298,336

 

 

 

5,225,000

 

 

 

653,000

 

 

 

427,619,626

 

Accumulated deficit

 

 

(29,086,926

)

 

 

 

(12,667,042

)

 

 

(7,420,492

)

 

 

(6,024,240

)

 

 

(1,298,336

)

 

 

(5,225,000

)

 

 

978,989

 

 

 

(60,743,047

)

Treasury stock

 

 

(2,376,790

)

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(2,376,790

)

Total shareholders’ equity

 

 

362,987,661

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,631,989

 

 

 

364,619,650

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

 

$

402,654,983

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

2,924,998

 

 

$

405,579,981

 

 

 

 (Unaudited)

As of December 31, 2023

 

 

 

 

 

Adjustments

 

 

 

 

 

 

As Previously
Reported

 

 

 

Stock Based
Payments

 

 

Equity Issuance Costs

 

 

Convertible Notes

 

 

Warrants

 

 

Acquisition

 

 

Other

 

 

Restated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

54,679,868

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

54,679,868

 

Accounts receivable, net

 

 

21,121,450

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

21,121,450

 

Inventories

 

 

49,502,732

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

49,502,732

 

Prepaid expenses

 

 

3,708,865

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

3,708,865

 

Current portion of restricted cash

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Total current assets

 

$

129,012,915

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

129,012,915

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equipment, net

 

 

57,278,603

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

57,278,603

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deposits

 

 

2,265,932

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,265,932

 

Patents, net

 

 

4,662,656

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

228,537

 

 

 

4,891,193

 

Other intangible assets, net

 

 

114,296,627

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

114,296,627

 

Goodwill

 

 

90,870,094

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

90,870,094

 

Right of use assets - operating leases

 

 

2,113,943

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,113,943

 

Deferred income tax asset

 

 

115,908

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,928,330

 

 

 

3,044,238

 

TOTAL ASSETS

 

$

400,616,678

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

3,156,867

 

 

$

403,773,545

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

$

19,146,138

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

19,146,138

 

Accrued liabilities

 

 

6,570,668

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

33,224

 

 

 

6,603,892

 

Current portion of operating lease liability

 

 

463,059

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

463,059

 

Note payable related party

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Current portion of construction note payable

 

 

265,977

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

265,977

 

Insurance premium note payable

 

 

173,029

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

173,029

 

Total current liabilities

 

 

26,618,871

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

33,224

 

 

 

26,652,095

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long-term liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration payable

 

 

80,080

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

80,080

 

Income tax payable

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,609,520

 

 

 

1,609,520

 

Construction note payable, net of unamortized issuance costs

 

 

10,797,696

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

10,797,696

 

Operating lease liability, net of current portion

 

 

1,737,615

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,737,615

 

Deferred income tax liability

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Total liabilities

 

 

39,234,262

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,642,744

 

 

 

40,877,006

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Series A cumulative perpetual preferred Stock

 

 

1,400

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,400

 

Common stock

 

 

118,644

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

118,644

 

Additional paid-in capital

 

 

395,449,082

 

 

 

 

13,310,965

 

 

 

7,420,492

 

 

 

6,024,240

 

 

 

1,298,336

 

 

 

5,225,000

 

 

 

653,000

 

 

 

429,381,115

 

Accumulated deficit

 

 

(31,513,554

)

 

 

 

(13,310,965

)

 

 

(7,420,492

)

 

 

(6,024,240

)

 

 

(1,298,336

)

 

 

(5,225,000

)

 

 

861,123

 

 

 

(63,931,464

)

Treasury stock

 

 

(2,673,156

)

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(2,673,156

)

Total shareholders’ equity

 

 

361,382,416

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,514,123

 

 

 

362,896,539

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

 

$

400,616,678

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

3,156,867

 

 

$

403,773,545

 

 

The unaudited interim consolidated statements of stockholders' equity as of December 31, 2023, September 30, 2023, and June 30, 2023 are as follows:

 

 

Preferred Stock

 

 

Common Shares

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number

 

 

Par Value

 

 

Number

 

 

Par Value

 

 

Additional
Paid-In
Capital

 

 

Accumulated
(Deficit)

 

 

Treasury
Stock

 

 

Total

 

 

 

 

 

 

(Restated)

 

 

 

 

 

(Restated)

 

 

 

 

Balance as of March 31, 2023 (restated)

 

 

1,400,000

 

 

$

1,400

 

 

 

118,294,478

 

 

$

118,294

 

 

$

424,739,847

 

 

$

(50,216,248

)

 

$

(522,158

)

 

$

374,121,135

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Employee stock awards (Restated)

 

 

-

 

 

 

-

 

 

 

390,111

 

 

 

391

 

 

 

1,180,808

 

 

 

-

 

 

 

-

 

 

 

1,181,199

 

Preferred stock dividends declared

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(638,038

)

 

 

-

 

 

 

(638,038

)

Dividends accumulated on preferred stock

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(136,093

)

 

 

-

 

 

 

(136,093

)

Net loss (Restated)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(1,304,062

)

 

 

-

 

 

 

(1,304,062

)

Treasury shares purchased

 

 

-

 

 

 

-

 

 

 

(738,831

)

 

 

(739

)

 

 

-

 

 

 

-

 

 

 

(1,456,005

)

 

 

(1,456,744

)

Balance as of June 30, 2023 (restated)

 

 

1,400,000

 

 

$

1,400

 

 

 

117,945,758

 

 

$

117,946

 

 

$

425,920,655

 

 

$

(52,294,441

)

 

$

(1,978,163

)

 

$

371,767,397

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Employee stock awards (Restated)

 

 

-

 

 

 

-

 

 

 

712,783

 

 

 

713

 

 

 

1,698,971

 

 

 

-

 

 

 

-

 

 

 

1,699,684

 

Preferred stock dividends declared

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(646,545

)

 

 

-

 

 

 

(646,545

)

Dividends accumulated on preferred stock

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(136,094

)

 

 

-

 

 

 

(136,094

)

Net loss (restated)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(7,665,967

)

 

 

-

 

 

 

(7,665,967

)

Treasury shares purchased

 

 

-

 

 

 

-

 

 

 

(197,798

)

 

 

(198

)

 

 

-

 

 

 

-

 

 

 

(398,627

)

 

 

(398,825

)

Balance as of September 30, 2023 (restated)

 

 

1,400,000

 

 

$

1,400

 

 

 

118,460,743

 

 

$

118,461

 

 

$

427,619,626

 

 

$

(60,743,047

)

 

$

(2,376,790

)

 

$

364,619,650

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Employee stock awards (Restated)

 

 

-

 

 

 

-

 

 

 

328,333

 

 

 

328

 

 

 

1,381,444

 

 

 

-

 

 

 

-

 

 

 

1,381,772

 

Common stock purchase options

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

380,045

 

 

 

-

 

 

 

-

 

 

 

380,045

 

Preferred stock dividends declared

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(638,021

)

 

 

-

 

 

 

(638,021

)

Dividends accumulated on preferred stock

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(144,618

)

 

 

-

 

 

 

(144,618

)

Net loss (restated)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(2,405,778

)

 

 

-

 

 

 

(2,405,778

)

Treasury shares purchased

 

 

-

 

 

 

-

 

 

 

(145,483

)

 

 

(145

)

 

 

-

 

 

 

-

 

 

 

(296,366

)

 

 

(296,511

)

Balance as of December 31, 2023 (restated)

 

 

1,400,000

 

 

$

1,400

 

 

 

118,643,593

 

 

$

118,644

 

 

$

429,381,115

 

 

$

(63,931,464

)

 

$

(2,673,156

)

 

$

362,896,539

 

 

The following tables present the Additional Paid-In Capital ("APIC") as previously reported, restatement adjustments and the APIC as restated for the three months ended June 30, 2023, September 30, 2023, and December 31, 2023.

 

 

Three Months Ended June 30, 2023

 

 

 

 

As Previously
Reported

 

 

Reclassification

 

 

Current Period Adjustment

 

 

As Restated

 

 

 

 

(unaudited)

 

 

Employee stock awards

 

 $

 

822,406

 

 

 $

 

50,750

 

 

 $

 

307,652

 

 

 $

 

1,180,808

 

 

Stock grants

 

 

 

50,750

 

 

 

 

(50,750

)

 

 

 

-

 

 

 

 

-

 

 

 

 

 

 

Three Months Ended September 30, 2023

 

 

 

 

As Previously
Reported

 

 

Reclassification

 

 

Current Period Adjustment

 

 

As Restated

 

 

 

 

(unaudited)

 

 

Employee stock awards

 

 $

 

1,467,236

 

 

 $

 

50,750

 

 

 $

 

180,985

 

 

 $

 

1,698,971

 

 

Stock grants

 

 

 

50,750

 

 

 

 

(50,750

)

 

 

 

-

 

 

 

 

-

 

 

 

 

 

Three Months Ended December 31, 2023

 

 

 

 

As Previously
Reported

 

 

Reclassification

 

 

Current Period Adjustment

 

 

As Restated

 

 

 

 

(unaudited)

 

 

Employee stock awards

 

 $

 

686,771

 

 

 $

 

50,750

 

 

 $

 

643,923

 

 

 $

 

1,381,444

 

 

Stock grants

 

 

 

50,750

 

 

 

 

(50,750

)

 

 

 

-

 

 

 

 

-

 

 

The following tables set forth the restatement of the Company's unaudited interim consolidated statements of cash flow for the three months ended June 30, 2023, six months ended September 30, 2023, and nine months ended December 31, 2023 with the exception of the supplemental cash flows as there were no changes for the periods presented:

 

 

For the three months ended June 30, 2023

 

 

(Unaudited)

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

Stock Based
Payments

Other

 

 

As Restated

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

$

(1,093,033

)

 

$

(307,652

)

 

$

96,623

 

 

$

(1,304,062

)

 

Adjustments to reconcile net loss to cash provided by operations:

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

4,620,087

 

 

 

-

 

 

 

11,821

 

 

 

4,631,908

 

 

Debt discount amortization

 

 

20,813

 

 

 

-

 

 

 

-

 

 

 

20,813

 

 

Employee stock awards

 

 

873,547

 

 

 

307,652

 

 

 

-

 

 

 

1,181,199

 

 

Common stock purchase options

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

Contingent consideration payable fair value

 

 

(21,024

)

 

 

-

 

 

 

-

 

 

 

(21,024

)

 

Allowance for doubtful accounts

 

 

909,717

 

 

 

-

 

 

 

-

 

 

 

909,717

 

 

(Gain)/loss on disposal of assets

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

Reduction in right of use asset

 

 

120,216

 

 

 

-

 

 

 

-

 

 

 

120,216

 

 

Deferred income taxes

 

 

(97,144

)

 

 

-

 

 

 

(109,954

)

 

 

(207,098

)

 

Changes in current assets and liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

7,088,437

 

 

 

-

 

 

 

-

 

 

 

7,088,437

 

 

Inventories

 

 

(1,579,836

)

 

 

-

 

 

 

-

 

 

 

(1,579,836

)

 

Prepaid expenses

 

 

888,412

 

 

 

-

 

 

 

-

 

 

 

888,412

 

 

Deposits

 

 

2,964,365

 

 

 

-

 

 

 

-

 

 

 

2,964,365

 

 

Accounts payable

 

 

(1,722,783

)

 

 

-

 

 

 

-

 

 

 

(1,722,783

)

 

Accrued liabilities

 

 

152,021

 

 

 

-

 

 

 

1,510

 

 

 

153,531

 

 

Operating lease liability

 

 

(127,704

)

 

 

-

 

 

 

-

 

 

 

(127,704

)

 

Net cash provided by operating activities

 

 

12,996,091

 

 

 

-

 

 

 

-

 

 

 

12,996,091

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Purchase of property, plant, and equipment

 

 

(1,313,939

)

 

 

-

 

 

 

-

 

 

 

(1,313,939

)

 

Net cash used in investing activities

 

 

(1,313,939

)

 

 

-

 

 

 

-

 

 

 

(1,313,939

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Payments on inventory facility, net

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

Proceeds from factoring liability

 

 

14,610,314

 

 

 

-

 

 

 

-

 

 

 

14,610,314

 

 

Payments on factoring liability

 

 

(14,610,314

)

 

 

-

 

 

 

-

 

 

 

(14,610,314

)

 

Payments on note payable - related party

 

 

(180,850

)

 

 

-

 

 

 

-

 

 

 

(180,850

)

 

Payments on insurance premium note payment

 

 

(970,541

)

 

 

-

 

 

 

-

 

 

 

(970,541

)

 

Proceeds from construction note payable

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

Payments on construction note payable

 

 

(64,959

)

 

 

-

 

 

 

-

 

 

 

(64,959

)

 

Preferred stock dividends paid

 

 

(638,038

)

 

 

-

 

 

 

-

 

 

 

(638,038

)

 

Common stock repurchase plan

 

 

(1,456,744

)

 

 

-

 

 

 

-

 

 

 

(1,456,744

)

 

Net cash used in financing activities

 

 

(3,311,132

)

 

 

-

 

 

 

-

 

 

 

(3,311,132

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net increase/(decrease) in cash

 

 

8,371,020

 

 

 

-

 

 

 

-

 

 

 

8,371,020

 

 

Cash, beginning of period

 

 

39,134,027

 

 

 

-

 

 

 

-

 

 

 

39,134,027

 

 

Restricted cash, beginning of period

 

 

500,000

 

 

 

-

 

 

 

-

 

 

 

500,000

 

 

Cash and restricted cash, end of period

 

$

48,005,047

 

 

$

-

 

 

$

-

 

 

$

48,005,047

 

 

Restricted cash, end of period

 

$

500,000

 

 

$

-

 

 

$

-

 

 

 

500,000

 

 

Cash, end of period

 

$

47,505,047

 

 

$

-

 

 

$

-

 

 

$

47,505,047

 

 

 

 

 

 

For the six months ended September 30, 2023

 

 

(Unaudited)

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

Stock Based
Payments

Other

 

 

As Restated

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

$

(8,588,330

)

 

$

(488,637

)

 

$

106,938

 

 

$

(8,970,029

)

 

Adjustments to reconcile net loss to cash provided by operations:

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

9,293,566

 

 

 

-

 

 

 

23,642

 

 

 

9,317,208

 

 

Debt discount amortization

 

 

41,626

 

 

 

-

 

 

 

-

 

 

 

41,626

 

 

Employee stock awards

 

 

2,392,246

 

 

 

488,637

 

 

 

-

 

 

 

2,880,883

 

 

Common stock purchase options

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

Contingent consideration payable fair value

 

 

(41,076

)

 

 

-

 

 

 

-

 

 

 

(41,076

)

 

Allowance for doubtful accounts

 

 

1,047,587

 

 

 

-

 

 

 

-

 

 

 

1,047,587

 

 

(Gain)/loss on disposal of assets

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

Reduction in right of use asset

 

 

243,652

 

 

 

-

 

 

 

-

 

 

 

243,652

 

 

Deferred income taxes

 

 

(1,960,265

)

 

 

-

 

 

 

(128,618

)

 

 

(2,088,883

)

 

Changes in current assets and liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

5,267,942

 

 

 

-

 

 

 

-

 

 

 

5,267,942

 

 

Inventories

 

 

1,330,614

 

 

 

-

 

 

 

-

 

 

 

1,330,614

 

 

Prepaid expenses

 

 

2,262,859

 

 

 

-

 

 

 

-

 

 

 

2,262,859

 

 

Deposits

 

 

3,839,429

 

 

 

-

 

 

 

-

 

 

 

3,839,429

 

 

Accounts payable

 

 

1,519,151

 

 

 

-

 

 

 

-

 

 

 

1,519,151

 

 

Accrued liabilities

 

 

1,760,716

 

 

 

-

 

 

 

(1,962

)

 

 

1,758,754

 

 

Operating lease liability

 

 

(258,628

)

 

 

-

 

 

 

-

 

 

 

(258,628

)

 

Net cash provided by operating activities

 

 

18,151,089

 

 

 

-

 

 

 

-

 

 

 

18,151,089

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Purchase of property, plant, and equipment

 

 

(2,618,205

)

 

 

-

 

 

 

-

 

 

 

(2,618,205

)

 

Net cash used in investing activities

 

 

(2,618,205

)

 

 

-

 

 

 

-

 

 

 

(2,618,205

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Payments on inventory facility, net

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

Proceeds from factoring liability

 

 

26,047,370

 

 

 

-

 

 

 

-

 

 

 

26,047,370

 

 

Payments on factoring liability

 

 

(26,047,370

)

 

 

-

 

 

 

-

 

 

 

(26,047,370

)

 

Payments on note payable - related party

 

 

(180,850

)

 

 

-

 

 

 

-

 

 

 

(180,850

)

 

Payments on insurance premium note payment

 

 

(2,017,089

)

 

 

-

 

 

 

-

 

 

 

(2,017,089

)

 

Proceeds from construction note payable

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

Payments on construction note payable

 

 

(127,858

)

 

 

-

 

 

 

-

 

 

 

(127,858

)

 

Preferred stock dividends paid

 

 

(1,420,677

)

 

 

-

 

 

 

-

 

 

 

(1,420,677

)

 

Common stock repurchase plan

 

 

(1,855,569

)

 

 

-

 

 

 

-

 

 

 

(1,855,569

)

 

Net cash used in financing activities

 

 

(5,602,043

)

 

 

-

 

 

 

-

 

 

 

(5,602,043

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net increase/(decrease) in cash

 

 

9,930,841

 

 

 

-

 

 

 

-

 

 

 

9,930,841

 

 

Cash, beginning of period

 

 

39,134,027

 

 

 

-

 

 

 

-

 

 

 

39,134,027

 

 

Restricted cash, beginning of period

 

 

500,000

 

 

 

-

 

 

 

-

 

 

 

500,000

 

 

Cash and restricted cash, end of period

 

$

49,564,868

 

 

$

-

 

 

$

-

 

 

$

49,564,868

 

 

Restricted cash, end of period

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

Cash, end of period

 

$

49,564,868

 

 

$

-

 

 

$

-

 

 

$

49,564,868

 

 

 

 

 

 

 

For the nine months ended December 31, 2023

 

 

(Unaudited)

 

 

 

 

Adjustments

 

 

 

 

 

 

 

As Previously
Reported

Stock Based
Payments

Other

 

 

As Restated

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

$

(10,232,319

)

 

$

(1,132,560

)

 

$

(10,928

)

 

$

(11,375,807

)

 

Adjustments to reconcile net loss to cash provided by operations:

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

14,047,216

 

 

 

-

 

 

 

35,463

 

 

 

14,082,679

 

 

Debt discount amortization

 

 

62,440

 

 

 

-

 

 

 

-

 

 

 

62,440

 

 

Employee stock awards

 

 

3,130,095

 

 

 

1,132,560

 

 

 

-

 

 

 

4,262,655

 

 

Common stock purchase options

 

 

380,045

 

 

 

-

 

 

 

-

 

 

 

380,045

 

 

Contingent consideration payable fair value

 

 

(60,298

)

 

 

-

 

 

 

-

 

 

 

(60,298

)

 

Allowance for doubtful accounts

 

 

1,117,565

 

 

 

-

 

 

 

-

 

 

 

1,117,565

 

 

(Gain)/loss on disposal of assets

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

Reduction in right of use asset

 

 

362,402

 

 

 

-

 

 

 

-

 

 

 

362,402

 

 

Deferred income taxes

 

 

(2,425,500

)

 

 

-

 

 

 

(22,981

)

 

 

(2,448,481

)

 

Changes in current assets and liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

7,107,365

 

 

 

-

 

 

 

-

 

 

 

7,107,365

 

 

Inventories

 

 

4,842,087

 

 

 

-

 

 

 

-

 

 

 

4,842,087

 

 

Prepaid expenses

 

 

2,474,001

 

 

 

-

 

 

 

-

 

 

 

2,474,001

 

 

Deposits

 

 

4,763,015

 

 

 

-

 

 

 

-

 

 

 

4,763,015

 

 

Accounts payable

 

 

1,066,741

 

 

 

-

 

 

 

-

 

 

 

1,066,741

 

 

Accrued liabilities

 

 

2,072,696

 

 

 

-

 

 

 

(1,554

)

 

 

2,071,142

 

 

Operating lease liability

 

 

(388,261

)

 

 

-

 

 

 

-

 

 

 

(388,261

)

 

Net cash provided by operating activities

 

 

28,319,290

 

 

 

-

 

 

 

-

 

 

 

28,319,290

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Purchase of property, plant, and equipment

 

 

(5,562,283

)

 

 

-

 

 

 

-

 

 

 

(5,562,283

)

 

Net cash used in investing activities

 

 

(5,562,283

)

 

 

-

 

 

 

-

 

 

 

(5,562,283

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Payments on inventory facility, net

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

Proceeds from factoring liability

 

 

37,252,869

 

 

 

-

 

 

 

-

 

 

 

37,252,869

 

 

Payments on factoring liability

 

 

(37,252,869

)

 

 

-

 

 

 

-

 

 

 

(37,252,869

)

 

Payments on note payable - related party

 

 

(180,850

)

 

 

-

 

 

 

-

 

 

 

(180,850

)

 

Payments on insurance premium note payment

 

 

(3,001,805

)

 

 

-

 

 

 

-

 

 

 

(3,001,805

)

 

Proceeds from construction note payable

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

Payments on construction note payable

 

 

(181,639

)

 

 

-

 

 

 

-

 

 

 

(181,639

)

 

Preferred stock dividends paid

 

 

(2,194,792

)

 

 

-

 

 

 

-

 

 

 

(2,194,792

)

 

Common stock repurchase plan

 

 

(2,152,080

)

 

 

-

 

 

 

-

 

 

 

(2,152,080

)

 

Net cash used in financing activities

 

 

(7,711,166

)

 

 

-

 

 

 

-

 

 

 

(7,711,166

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net increase/(decrease) in cash

 

 

15,045,841

 

 

 

-

 

 

 

-

 

 

 

15,045,841

 

 

Cash, beginning of period

 

 

39,134,027

 

 

 

-

 

 

 

-

 

 

 

39,134,027

 

 

Restricted cash, beginning of period

 

 

500,000

 

 

 

-

 

 

 

-

 

 

 

500,000

 

 

Cash and restricted cash, end of period

 

$

54,679,868

 

 

$

-

 

 

$

-

 

 

$

54,679,868

 

 

Restricted cash, end of period

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

Cash, end of period

 

$

54,679,868

 

 

$

-

 

 

$

-

 

 

$

54,679,868

 

 

v3.25.1
SUBSEQUENT EVENTS (Tables)
12 Months Ended
Mar. 31, 2024
Subsequent Events [Abstract]  
Schedule of Impairment of Assets impairment of assets would be recorded in the year ended March 31, 2025 as follows:

 

 

 

Impairment
Amount

 

Inventory

 

 

$

17,129,874

 

Property, plant and equipment

 

 

 

25,381,646

 

Other assets

 

 

 

530,195

 

Intangible assets

 

 

 

2,805,715

 

Total Impairment

 

 

$

45,847,430

 

v3.25.1
ORGANIZATION AND BUSINESS ACTIVITY (Details Narrative) - shares
Mar. 17, 2017
Dec. 15, 2016
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Number of shares sold   475,681      
Number of shares issued for pre-split   11,891,976      
Reverse stock split   1-for-25 reverse stock split of the issued and outstanding shares of the common stock of the Company ("Common Stock"). As a result of the reverse split, the previous issued and outstanding shares of Common Stock became 580,052 shares; no shareholder was reversed below 100 shares, and all fractional shares resulting from the reverse split were rounded up to the next whole share      
Common stock, shares issued   580,052 120,531,507 118,562,806 116,485,747
Common stock, shares outstanding   580,052 119,181,067 118,294,478 116,485,747
Definitive Agreement [Member] | PRIVCO [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Number of common stock shares issued 17,285,800        
Number of shares retired 475,681        
Number of shares issued to satisfy issuance commitment 500,000        
Shares equivalent to issuance recapitalization 604,371        
v3.25.1
SCHEDULE OF CONCENTRATION RISK OF TOTAL REVENUES AND ACCOUNTS RECEIVABLE (Details) - Customer Concentration Risk [Member]
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Revenue Benchmark [Member] | Customer A [Member]      
Product Information [Line Items]      
Concentration risk, percentage 0.00% 12.20% 0.00%
Revenue Benchmark [Member] | Customer B [Member]      
Product Information [Line Items]      
Concentration risk, percentage 0.00% 0.00% 0.00%
Revenue Benchmark [Member] | Customer [Member]      
Product Information [Line Items]      
Concentration risk, percentage 0.00% 12.20% 0.00%
Accounts Receivable [Member] | Customer A [Member]      
Product Information [Line Items]      
Concentration risk, percentage 11.80% 0.00% 0.00%
Accounts Receivable [Member] | Customer B [Member]      
Product Information [Line Items]      
Concentration risk, percentage 0.00% 0.00% 11.80%
Accounts Receivable [Member] | Customer [Member]      
Product Information [Line Items]      
Concentration risk, percentage 11.80% 0.00% 11.80%
v3.25.1
SCHEDULE OF DISAGGREGATED REVENUE FROM CUSTOMERS BY SEGMENT (Details) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Sep. 30, 2023
Dec. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Product Information [Line Items]                  
Total revenues $ 40,421,147 $ 36,006,464 $ 34,372,386 $ 34,254,575 $ 68,626,961 $ 104,633,425 $ 145,054,572 $ 191,439,801 $ 240,269,166
Ammunition Sales [Member]                  
Product Information [Line Items]                  
Total revenues $ 22,445,216 $ 17,322,967 $ 15,516,589 $ 14,106,029 $ 29,622,618 $ 46,945,585 69,390,801 [1],[2] 114,116,044 [1],[2] 161,459,025 [1],[2]
Marketplace Revenue [Member]                  
Product Information [Line Items]                  
Total revenues             53,942,076 63,149,673 64,608,516
Casings Sales [Member]                  
Product Information [Line Items]                  
Total revenues             $ 21,721,695 $ 14,174,084 $ 14,201,625
[1]
(1)
Included in revenue for the years ended March 31, 2024, 2023, and 2022 are excise taxes of $6,155,524, $9,789,897, and $14,646,983, respectively.
[2] Included in revenue for the years ended March 31, 2024, 2023, and 2022 are excises taxes of $6,155,524, $9,789,897, and $14,646,983, respectively.
v3.25.1
SCHEDULE OF DISAGGREGATED REVENUE FROM CUSTOMERS BY SEGMENT (Details) (Parenthetical) - USD ($)
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Accounting Policies [Abstract]      
Excise tax $ 6,155,524 $ 9,789,897 $ 14,646,983
v3.25.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
12 Months Ended
Jan. 18, 2024
Apr. 30, 2023
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Apr. 30, 2021
Apr. 01, 2021
Mar. 31, 2021
Goodwill     $ 90,870,094 $ 90,870,094 $ 90,870,094 $ 90,870,094 $ 90,870,094 $ 90,870,094 $ 90,870,094    
Allowance for credit loss     3,666,078 3,246,551 3,055,252           $ 148,540
Impairment expense     0 0 0            
Unearned revenue     $ 1,822,972 101,593 201,891         $ 400,000  
Excise tax percentage     11.00%                
Excise taxes     $ 6,155,524 9,789,897 14,646,983            
Cash, FDIC insured amount     $ 250,000 250,000 250,000            
Income tax examination, description     We measure recognized income tax positions at the largest amount that is greater than 50% likely of being realized. We reflect changes in recognition or measurement in the period in which the change in judgment occurs.                
Compensatory damages $ 100,000,000 $ 140,000,000                  
Accrued contingencies     $ 1,400,000                
Other contingencies     0 0 0            
Ammunition Segment [Member]                      
Advertising expenses     384,002 1,068,700 1,406,043            
Selling and Marketing Expense [Member]                      
Advertising expenses     1,149,596 1,355,179 1,823,060            
Cost of Sales [Member] | Marketplace [Member]                      
Advertising expenses     $ 765,594 286,479 417,017            
Patents [Member] | Exclusive License Agreement [Member]                      
Royalty rate on per unit basis     $ 0.01                
Royalty expenses     $ 22,754 $ 99,268 $ 44,764            
v3.25.1
RESTATEMENT OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS (Details Narrative) - USD ($)
12 Months Ended 48 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2018
Mar. 31, 2021
Error Corrections and Prior Period Adjustments Restatement [Line Items]            
Warrants issued   $ 427,639 $ 1,782,175      
Restatement Adjustments [Member]            
Error Corrections and Prior Period Adjustments Restatement [Line Items]            
Stock-based compensation expense $ 996,181 $ 4,141,364 1,422,138 $ 4,192,414   $ 2,422,490
Warrants issued     $ 692,099   $ 606,237  
Expense on convertible note transactions       $ 6,024,240    
v3.25.1
SCHEDULE OF IMPACT TO CONSOLIDATED STATEMENT OF OPERATIONS OF CHANGE IN STOCK-BASED COMPENSATION EXPENSE (Details) - USD ($)
12 Months Ended 48 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2021
Restatement Adjustments [Member]          
Error Corrections and Prior Period Adjustments Restatement [Line Items]          
Stock-based compensation expense $ 996,181 $ 4,141,364 $ 1,422,138 $ 4,192,414 $ 2,422,490
v3.25.1
SCHEDULE OF IMPACT TO CONSOLIDATED STATEMENT OF OPERATIONS OF CHANGE IN ACCOUNTING OF EQUITY ISSUANCE COSTS (Details) - USD ($)
12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Restatement Adjustments [Member]    
Error Corrections and Prior Period Adjustments Restatement [Line Items]    
Equity issuance costs $ 6,438,872 $ 981,620
v3.25.1
SCHEDULE OF CUMULATIVE EFFECT OF RESTATEMENT ADJUSTMENTS TO PREVIOUSLY REPORTED BEGINNING RETAINED EARNINGS (Details) - USD ($)
12 Months Ended
Mar. 31, 2021
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Mar. 31, 2022
Error Corrections and Prior Period Adjustments Restatement [Line Items]              
Retained earnings $ (61,543,056) $ (69,923,398) $ (63,931,464) $ (60,743,047) $ (52,294,441) $ (50,216,248) $ (38,344,527)
As Previously Reported [Member]              
Error Corrections and Prior Period Adjustments Restatement [Line Items]              
Retained earnings (41,819,539) (37,620,566) $ (31,513,554) $ (29,086,926) $ (20,808,990) (18,941,825) (11,240,752)
Restatement Adjustments [Member]              
Error Corrections and Prior Period Adjustments Restatement [Line Items]              
Cumulative impact of restatement adjustments (19,723,517)            
Restatement Adjustments [Member] | Restatement Adjustment on Share-Based Compensation [Member]              
Error Corrections and Prior Period Adjustments Restatement [Line Items]              
Cumulative impact of restatement adjustments (6,614,904)            
Restatement Adjustments [Member] | Restatement Adjustment on Warrants [Member]              
Error Corrections and Prior Period Adjustments Restatement [Line Items]              
Retained earnings   (6,024,240)       (6,024,240) (6,024,240)
Cumulative impact of restatement adjustments (606,237)            
Restatement Adjustments [Member] | Restatement Adjustment on Convertible Notes [Member]              
Error Corrections and Prior Period Adjustments Restatement [Line Items]              
Retained earnings   (1,298,336)       (1,298,336) (1,298,336)
Cumulative impact of restatement adjustments (6,024,240)            
Restatement Adjustments [Member] | Restatement Adjustment Other [Member]              
Error Corrections and Prior Period Adjustments Restatement [Line Items]              
Retained earnings   $ 839,822       $ 872,050 $ 901,335
Cumulative impact of restatement adjustments (6,478,136)            
Restatement Adjustments [Member] | Restatement Adjustment on Income Taxes [Member]              
Error Corrections and Prior Period Adjustments Restatement [Line Items]              
Cumulative impact of restatement adjustments $ 0            
v3.25.1
SCHEDULE OF EFFECT OF RESTATEMENT OF CONSOLIDATED BALANCE SHEETS (Details) - USD ($)
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Mar. 31, 2022
Apr. 30, 2021
Mar. 31, 2021
Current Assets:                  
Cash and cash equivalents   $ 55,586,441 $ 54,679,868 $ 49,564,868 $ 47,505,047 $ 39,134,027 $ 23,281,475   $ 118,341,471
Accounts receivable, net   28,221,321 21,121,450 23,030,851 21,348,226 29,346,380 43,955,084    
Due from related parties             15,000    
Inventories   45,563,334 49,502,732 53,014,205 55,924,655 54,344,819 59,016,152    
Prepaid expenses   2,154,170 3,708,865 3,920,007 5,294,454 5,126,667 3,423,925    
Current portion of restricted cash         500,000 500,000 0    
Total Current Assets   131,525,266 129,012,915 129,529,931 130,572,382 128,451,893 129,691,636    
Equipment, net   58,082,040 57,278,603 55,821,414 55,923,867 55,963,255 37,637,806    
Other Assets:                  
Deposits   349,278 2,265,932 3,189,518 4,064,582 7,028,947 11,360,322    
Intangible assets, net   115,805,073              
Other intangible assets, net     114,296,627 117,440,022 120,583,416        
Goodwill   90,870,094 90,870,094 90,870,094 90,870,094 90,870,094 90,870,094 $ 90,870,094  
Right of use assets - operating leases   2,000,093 2,113,943 1,017,982 1,141,418 1,261,634 2,791,850    
Deferred income tax asset   4,407,491 3,044,238 2,684,640 802,855 595,756 1,350,868    
TOTAL ASSETS   403,039,335 403,773,545 405,579,981 409,120,181 413,195,143 415,840,465    
Current Liabilities:                  
Accounts payable   23,156,495 19,146,138 19,598,548 16,356,614 18,079,397 26,817,083    
Factoring liability   0       0 485,671    
Accrued liabilities   7,065,444 6,603,892 6,282,980 4,677,757 4,388,132 6,213,592    
Inventory credit facility             825,675    
Current portion of operating lease liability   479,651 463,059 370,980 421,477 470,734 831,429    
Current portion of note payable related party           180,850 684,639    
Current portion of construction note payable   273,459 265,977 265,977 277,216 260,429      
Insurance premium note payable     173,029 1,157,745 2,204,293 2,118,635      
Total Current Liabilities   30,975,049 26,652,095 27,676,230 23,937,357 25,498,177 35,858,089    
Long-term Liabilities:                  
Contingent consideration payable   59,838 80,080 99,302 119,354 140,378 204,142    
Income tax payable   1,609,520 1,609,520 1,609,520 1,609,520 1,609,520 1,609,520    
Notes payable related party, net of current portion             181,132    
Construction note payable, net of unamortized issuance costs   10,735,241 10,797,696 10,830,663 10,861,510 10,922,443 38,330    
Operating lease liability, net of current portion   1,609,836 1,737,615 744,616 825,043 903,490 2,091,351    
Deferred income tax liability       0 0 0      
Total Liabilities   44,989,484 40,877,006 40,960,331 37,352,784 39,074,008 39,982,564    
Shareholders’ Equity:                  
Series A cumulative perpetual preferred Stock   1,400 1,400 1,400 1,400 1,400 1,400    
Common stock   119,181 118,644 118,461 117,946 118,294 116,487    
Additional paid-in capital   430,525,824 429,381,115 427,619,626 425,920,655 424,739,847 414,084,541    
Accumulated deficit   (69,923,398) (63,931,464) (60,743,047) (52,294,441) (50,216,248) (38,344,527)   (61,543,056)
Treasury Stock   (2,673,156) (2,673,156) (2,376,790) (1,978,163) (522,158)      
Total Shareholders’ Equity   358,049,851 362,896,539 364,619,650 371,767,397 374,121,135 375,857,901   160,729,013
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY   403,039,335 403,773,545 405,579,981 409,120,181 413,195,143 415,840,465    
Patents [Member]                  
Other Assets:                  
Intangible assets, net   4,756,006 4,891,193 5,026,380 5,161,567 5,296,754 5,837,502    
Other Intangible Assets [Member]                  
Other Assets:                  
Intangible assets, net   111,049,067       123,726,810 136,300,387    
Related Party [Member]                  
Current Assets:                  
Accounts receivable, net   201,646       182,344 139,164    
Long-term Liabilities:                  
Notes payable related party, net of current portion             181,132    
As Previously Reported [Member]                  
Current Assets:                  
Cash and cash equivalents   55,586,441 54,679,868 49,564,868 47,505,047 39,134,027 23,281,475   118,341,471
Accounts receivable, net   28,221,321 21,121,450 23,030,851 21,348,226 29,346,380 43,955,084    
Inventories   45,563,334 49,502,732 53,014,205 55,924,655 54,344,819 59,016,152    
Prepaid expenses   2,154,170 3,708,865 3,920,007 5,294,454 5,126,667 3,423,925    
Current portion of restricted cash         500,000 500,000      
Total Current Assets   131,525,266 129,012,915 129,529,931 130,572,382 128,451,893 129,691,636    
Equipment, net   58,082,040 57,278,603 55,821,414 55,923,867 55,963,255 37,637,806    
Other Assets:                  
Deposits   349,278 2,265,932 3,189,518 4,064,582 7,028,947 11,360,322    
Other intangible assets, net     114,296,627 117,440,022 120,583,416        
Goodwill   90,870,094 90,870,094 90,870,094 90,870,094 90,870,094 90,870,094    
Right of use assets - operating leases   2,000,093 2,113,943 1,017,982 1,141,418 1,261,634 2,791,850    
Deferred income tax asset   1,487,088 115,908            
TOTAL ASSETS   399,902,216 400,616,678 402,654,983 408,065,147 412,335,387 414,178,313    
Current Liabilities:                  
Accounts payable   23,156,495 19,146,138 19,598,548 16,356,614 18,079,397 26,817,083    
Factoring liability             485,671    
Accrued liabilities   7,030,667 6,570,668 6,250,164 4,641,469 4,353,354 6,178,814    
Inventory credit facility             825,675    
Current portion of operating lease liability   479,651 463,059 370,980 421,477 470,734 831,429    
Current portion of note payable related party           180,850 684,639    
Current portion of construction note payable   273,459 265,977 265,977 277,216 260,429      
Insurance premium note payable     173,029 1,157,745 2,204,293 2,118,635      
Total Current Liabilities   30,940,272 26,618,871 27,643,414 23,901,069 25,463,399 35,823,311    
Long-term Liabilities:                  
Contingent consideration payable   59,838 80,080 99,302 119,354 140,378 204,142    
Notes payable related party, net of current portion             181,132    
Construction note payable, net of unamortized issuance costs   10,735,241 10,797,696 10,830,663 10,861,510 10,922,443 38,330    
Operating lease liability, net of current portion   1,609,836 1,737,615 744,616 825,043 903,490 2,091,351    
Deferred income tax liability       349,327 2,212,448 2,309,592 1,536,481    
Total Liabilities   43,345,187 39,234,262 39,667,322 37,919,424 39,739,302 39,874,747    
Shareholders’ Equity:                  
Series A cumulative perpetual preferred Stock   1,400 1,400 1,400 1,400 1,400 1,400    
Common stock   119,181 118,644 118,461 117,946 118,294 116,487    
Additional paid-in capital   396,730,170 395,449,082 394,331,516 392,813,530 391,940,374 385,426,431    
Accumulated deficit   (37,620,566) (31,513,554) (29,086,926) (20,808,990) (18,941,825) (11,240,752)   (41,819,539)
Treasury Stock   (2,673,156) (2,673,156) (2,376,790) (1,978,163) (522,158)      
Total Shareholders’ Equity   356,557,029 361,382,416 362,987,661 370,145,723 372,596,085 374,303,566   $ 160,347,529
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY   399,902,216 400,616,678 402,654,983 408,065,147 412,335,387 414,178,313    
As Previously Reported [Member] | Patents [Member]                  
Other Assets:                  
Intangible assets, net   4,539,290 $ 4,662,656 $ 4,786,022 $ 4,909,388 5,032,754 5,526,218    
As Previously Reported [Member] | Other Intangible Assets [Member]                  
Other Assets:                  
Intangible assets, net   111,049,067       123,726,810 136,300,387    
As Previously Reported [Member] | Related Party [Member]                  
Current Assets:                  
Due from related parties             15,000    
Restatement Adjustments [Member] | Restatement Adjustment on Stock-Based Compensation [Member]                  
Other Assets:                  
TOTAL ASSETS   0              
Shareholders’ Equity:                  
Common stock             0    
Additional paid-in capital   13,174,586       12,178,405 8,037,042    
Accumulated deficit   (13,174,586)       (12,178,405) (8,037,042)    
Restatement Adjustments [Member] | Restatement Adjustment on Equity Issuance Costs [Member]                  
Other Assets:                  
TOTAL ASSETS   0              
Shareholders’ Equity:                  
Additional paid-in capital   7,420,492       7,420,492 7,420,492    
Accumulated deficit   (7,420,492)       (7,420,492) (7,420,492)    
Restatement Adjustments [Member] | Restatement Adjustment on Warrants [Member]                  
Other Assets:                  
TOTAL ASSETS   0              
Shareholders’ Equity:                  
Additional paid-in capital   6,024,240       6,024,240 6,024,240    
Accumulated deficit   (6,024,240)       (6,024,240) (6,024,240)    
Restatement Adjustments [Member] | Restatement Adjustment on Convertible Notes [Member]                  
Other Assets:                  
TOTAL ASSETS   0              
Shareholders’ Equity:                  
Additional paid-in capital   1,298,336       1,298,336 1,298,336    
Accumulated deficit   (1,298,336)       (1,298,336) (1,298,336)    
Restatement Adjustments [Member] | Restatement Adjustment on Acquisition [Member]                  
Other Assets:                  
TOTAL ASSETS   0              
Shareholders’ Equity:                  
Additional paid-in capital   5,225,000       5,225,000 5,225,000    
Accumulated deficit   (5,225,000)       (5,225,000) (5,225,000)    
Restatement Adjustments [Member] | Restatement Adjustment Other [Member]                  
Other Assets:                  
Deferred income tax asset   2,920,403       595,756 1,350,868    
TOTAL ASSETS   3,137,119       859,756 1,662,152    
Current Liabilities:                  
Accrued liabilities $ 20.4 34,777       34,778 34,778    
Total Current Liabilities   34,777       34,778 34,778    
Long-term Liabilities:                  
Income tax payable   1,609,520       1,609,520 1,609,520    
Deferred income tax liability           (2,309,592) (1,536,481)    
Total Liabilities   1,644,297       (665,294) 107,817    
Shareholders’ Equity:                  
Additional paid-in capital   653,000       653,000 653,000    
Accumulated deficit   839,822       872,050 901,335    
Total Shareholders’ Equity   1,492,822       1,525,050 1,554,335    
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY   3,137,119       859,756 1,662,152    
Restatement Adjustments [Member] | Restatement Adjustment Other [Member] | Patents [Member]                  
Other Assets:                  
Intangible assets, net   $ 216,716       $ 264,000 $ 311,284    
v3.25.1
SCHEDULE OF EFFECT OF RESTATEMENT OF CONSOLIDATED STATEMENTS OF OPERATIONS (Details) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Sep. 30, 2023
Dec. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Net Revenues                  
Total Revenues $ 40,421,147 $ 36,006,464 $ 34,372,386 $ 34,254,575 $ 68,626,961 $ 104,633,425 $ 145,054,572 $ 191,439,801 $ 240,269,166
Cost of Revenues 31,033,381 25,107,909 26,095,941 20,241,856 46,337,797 71,445,706 102,479,087 136,078,488 151,552,941
Gross profit 9,387,766 10,898,555 8,276,445 14,012,719 22,289,164 33,187,719 42,575,485 55,361,313 88,716,225
Operating Expenses                  
Selling and marketing 547,981 236,565 289,952 295,581 585,533 822,098 1,370,079 4,729,540 7,310,216
Corporate general and administrative 7,976,832 5,803,255 7,855,624 7,947,563 15,803,187 21,606,442 29,583,274 24,980,079 24,120,483
Employee salaries and related expenses 3,470,974 4,034,076 5,771,020 4,423,932 10,194,952 14,229,028 17,700,002 19,820,498 15,034,408
Depreciation and amortization expense 3,425,790 3,401,156 3,371,802 3,344,043 6,715,845 10,117,001 13,542,791 13,278,762 13,725,065
Total operating expenses 15,421,577 13,475,052 17,288,398 16,011,119 33,299,517 46,774,569 62,196,146 62,808,879 60,190,172
Income/(Loss) from Operations (6,033,811) (2,576,497) (9,011,953) (1,998,400) (11,010,353) (13,586,850) (19,620,661) (7,447,566) 28,526,053
Other Expenses                  
Other (expense) income (708,779) 4,576 (321,341) 692,951 371,610 376,186 (332,593) 25,181 21,840
Interest expense 163,088 (193,046) (212,314) (204,201) (416,515) (609,561) (446,473) (632,062) (637,797)
Total other expense (545,691) (188,470) (533,655) 488,750 (44,905) (233,375) (779,066) (606,881) (615,957)
Income/(Loss) before Income Taxes (6,579,502) (2,764,967) (9,545,608) (1,509,650) (11,055,258) (13,820,225) (20,399,727) (8,054,447) 27,910,096
Provision for income taxes (1,361,700) (359,189) (1,879,641) (205,588) (2,085,229) (2,444,418) (3,806,118) 712,239 2,042,918
Net income/(loss) (5,217,802) (2,405,778) (7,665,967) (1,304,062) (8,970,029) (11,375,807) (16,593,609) (8,766,686) 25,867,178
Preferred stock dividend (782,639) (782,639) (782,639) (774,132) (1,556,771) (2,339,410) (3,122,049) (3,105,034) (2,668,649)
Net Income/(Loss) Attributable to Common Stock Shareholders $ (6,000,441) $ (3,188,417) $ (8,448,606) $ (2,078,194) $ (10,526,800) $ (13,715,217) $ (19,715,658) $ (11,871,720) $ 23,198,529
Net Income/(Loss) per share                  
Basic $ (0.05) $ (0.03) $ (0.07) $ (0.02) $ (0.09) $ (0.12) $ (0.17) $ (0.1) $ 0.21
Diluted $ (0.05) $ (0.03) $ (0.07) $ (0.02) $ (0.09) $ (0.12) $ (0.17) $ (0.1) $ 0.2
Ammunition Sales [Member]                  
Net Revenues                  
Total Revenues $ 22,445,216 $ 17,322,967 $ 15,516,589 $ 14,106,029 $ 29,622,618 $ 46,945,585 $ 69,390,801 [1],[2] $ 114,116,044 [1],[2] $ 161,459,025 [1],[2]
Marketplace Fee Revenue [Member]                  
Net Revenues                  
Total Revenues 13,570,124 13,985,034 12,474,716 13,912,202 26,386,918 40,371,952 53,942,076 63,149,673 64,608,516
Ammunition Casings Sales [Member]                  
Net Revenues                  
Total Revenues 4,405,807 4,698,463 6,381,081 6,236,344 12,617,425 17,315,888 21,721,695 14,174,084 14,201,625
As Previously Reported [Member]                  
Net Revenues                  
Total Revenues 40,421,147 36,006,464 34,372,386 34,254,575 68,626,961 104,633,425 145,054,572 191,439,801 240,269,166
Cost of Revenues 31,021,560 25,096,088 26,084,120 20,230,035 46,314,155 71,410,243 102,431,803 136,031,204 151,505,657
Gross profit 9,399,587 10,910,376 8,288,266 14,024,540 22,312,806 33,223,182 42,622,769 55,408,597 88,763,509
Operating Expenses                  
Selling and marketing 547,981 236,565 289,952 295,581 585,533 822,098 1,370,079 4,729,540 7,310,216
Corporate general and administrative 7,976,832 5,803,255 7,855,624 7,947,563 15,803,187 21,606,442 29,583,274 24,980,079 16,986,344
Employee salaries and related expenses 3,607,354 3,390,153 5,590,035 4,116,280 9,706,315 13,096,468 16,703,822 15,679,135 13,615,439
Depreciation and amortization expense 3,425,790 3,401,156 3,371,802 3,344,043 6,715,845 10,117,001 13,542,791 13,278,762 13,702,148
Total operating expenses 15,557,957 12,831,129 17,107,413 15,703,467 32,810,880 45,642,009 61,199,966 58,667,516 51,614,147
Income/(Loss) from Operations (6,158,370) (1,920,753) (8,819,147) (1,678,927) (10,498,074) (12,418,827) (18,577,197) (3,258,919) 37,149,362
Other Expenses                  
Other (expense) income (708,779) 4,576 (321,341) 692,951 371,610 376,186 (332,593) 25,181 21,840
Interest expense 163,088 (193,046) (212,314) (204,201) (416,515) (609,561) (446,473) (632,062) (637,797)
Total other expense (545,691) (188,470) (533,655) 488,750 (44,905) (233,375) (779,066) (606,881) (615,957)
Income/(Loss) before Income Taxes (6,704,061) (2,109,223) (9,352,802) (1,190,177) (10,542,979) (12,652,202) (19,356,263) (3,865,800) 36,533,405
Provision for income taxes (1,371,180) (465,234) (1,857,505) (97,144) (1,954,649) (2,419,883) (3,791,063) 730,238 3,285,969
Net income/(loss) (5,332,881) (1,643,989) (7,495,297) (1,093,033) (8,588,330) (10,232,319) (15,565,200) (4,596,038) 33,247,436
Preferred stock dividend (782,639) (782,639) (782,639) (774,132) (1,556,771) (2,339,410) (3,122,049) (3,105,034) (2,668,649)
Net Income/(Loss) Attributable to Common Stock Shareholders $ (6,115,520) $ (2,426,628) $ (8,277,936) $ (1,867,165) $ (10,145,101) $ (12,571,729) $ (18,687,249) $ (7,701,072) $ 30,578,787
Net Income/(Loss) per share                  
Basic $ (0.05) $ (0.02) $ (0.07) $ (0.02) $ (0.09) $ (0.11) $ (0.16) $ (0.07) $ 0.27
Diluted $ (0.05) $ (0.02) $ (0.07) $ (0.02) $ (0.09) $ (0.11) $ (0.16) $ (0.07) $ 0.27
As Previously Reported [Member] | Ammunition Sales [Member]                  
Net Revenues                  
Total Revenues $ 22,445,216 $ 17,322,967 $ 15,516,589 $ 14,106,029 $ 29,622,618 $ 46,945,585 $ 69,390,801 $ 114,116,044 $ 161,459,025
As Previously Reported [Member] | Marketplace Fee Revenue [Member]                  
Net Revenues                  
Total Revenues 13,570,124 13,985,034 12,474,716 13,912,202 26,386,918 40,371,952 53,942,076 63,149,673 64,608,516
As Previously Reported [Member] | Ammunition Casings Sales [Member]                  
Net Revenues                  
Total Revenues $ 4,405,807 $ 4,698,463 $ 6,381,081 $ 6,236,344 $ 12,617,425 $ 17,315,888 21,721,695 14,174,084 14,201,625
Restatement Adjustments [Member] | Restatement Adjustment on Share-Based Compensation [Member]                  
Other Expenses                  
Net Income/(Loss) Attributable to Common Stock Shareholders                 (1,422,137)
Restatement Adjustments [Member] | Restatement Adjustment On Stock Based Compensation [Member]                  
Operating Expenses                  
Corporate general and administrative                 3,168
Employee salaries and related expenses             996,180 4,141,363 1,418,969
Total operating expenses             996,180 4,141,363 1,422,137
Income/(Loss) from Operations             (996,180) (4,141,363) (1,422,137)
Other Expenses                  
Income/(Loss) before Income Taxes             (996,180) (4,141,363) (1,422,137)
Net income/(loss)             (996,180) (4,141,363) (1,422,137)
Net Income/(Loss) Attributable to Common Stock Shareholders             (996,180) (4,141,363)  
Restatement Adjustments [Member] | Restatement Adjustment on Equity Issuance Costs [Member]                  
Operating Expenses                  
Corporate general and administrative                 6,438,872
Total operating expenses                 6,438,872
Income/(Loss) from Operations                 (6,438,872)
Other Expenses                  
Income/(Loss) before Income Taxes                 (6,438,872)
Net income/(loss)                 (6,438,872)
Net Income/(Loss) Attributable to Common Stock Shareholders                 (6,438,872)
Restatement Adjustments [Member] | Restatement Adjustment on Warrants [Member]                  
Operating Expenses                  
Corporate general and administrative                 692,099
Total operating expenses                 692,099
Income/(Loss) from Operations                 (692,099)
Other Expenses                  
Income/(Loss) before Income Taxes                 (692,099)
Net income/(loss)                 (692,099)
Net Income/(Loss) Attributable to Common Stock Shareholders                 (692,099)
Restatement Adjustments [Member] | Restatement Adjustment Other [Member]                  
Net Revenues                  
Cost of Revenues             47,284 47,284 47,284
Gross profit             (47,284) (47,284) (47,284)
Operating Expenses                  
Depreciation and amortization expense                 22,917
Total operating expenses                 22,917
Income/(Loss) from Operations             (47,284) (47,284) (70,201)
Other Expenses                  
Income/(Loss) before Income Taxes             (47,284) (47,284) (70,201)
Provision for income taxes             (15,055) (17,999) (1,243,051)
Net income/(loss)             (32,229) (29,285) 1,172,850
Net Income/(Loss) Attributable to Common Stock Shareholders             $ (32,229) $ (29,285) $ 1,172,850
[1]
(1)
Included in revenue for the years ended March 31, 2024, 2023, and 2022 are excise taxes of $6,155,524, $9,789,897, and $14,646,983, respectively.
[2] Included in revenue for the years ended March 31, 2024, 2023, and 2022 are excises taxes of $6,155,524, $9,789,897, and $14,646,983, respectively.
v3.25.1
SCHEDULE OF EFFECT OF RESTATEMENT OF CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Details) - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Error Corrections and Prior Period Adjustments Restatement [Line Items]            
Employee stock awards $ 1,381,772 $ 1,699,684 $ 1,181,199      
Acquisition stock issuances           $ 143,377,654
Common stock issued for services and equipment           5,487,369
Warrants issued for services         $ 427,639 1,782,175
Additional Paid-in Capital [Member]            
Error Corrections and Prior Period Adjustments Restatement [Line Items]            
Employee stock awards 1,381,444 1,698,971 1,180,808 $ 5,279,351 10,126,460 7,428,650
Acquisition stock issuances           143,357,654
Common stock issued for services and equipment           5,486,596
Issuance of Series A Preferred Stock, net of issuance costs           32,907,396
Warrants issued for services         427,639 1,782,175
Previously Reported [Member] | Additional Paid-in Capital [Member]            
Error Corrections and Prior Period Adjustments Restatement [Line Items]            
Employee stock awards 686,771 1,467,236 822,406 4,080,170 5,806,003 5,759,000
Stock grants       203,000 179,094 252,488
Acquisition stock issuances           142,691,282
Common stock issued for services and equipment           1,631,701
Issuance of Series A Preferred Stock, net of issuance costs           31,008,796
Warrants issued for services           1,090,076
Reclassification [Member] | Additional Paid-in Capital [Member]            
Error Corrections and Prior Period Adjustments Restatement [Line Items]            
Employee stock awards $ 50,750 $ 50,750 $ 50,750 203,000 179,094 252,488
Stock grants       (203,000) (179,094) (252,488)
Current Period Adjustment [Member] | Additional Paid-in Capital [Member]            
Error Corrections and Prior Period Adjustments Restatement [Line Items]            
Employee stock awards       $ 996,181 $ 4,141,363 1,417,162
Acquisition stock issuances           666,372
Common stock issued for services and equipment           3,854,895
Issuance of Series A Preferred Stock, net of issuance costs           1,898,600
Warrants issued for services           $ 692,099
v3.25.1
SCHEDULE OF EFFECT OF RESTATEMENT OF CONSOLIDATED STATEMENTS OF CASH FLOW (Details) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Sep. 30, 2023
Dec. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:                  
Net income/(loss) $ (5,217,802) $ (2,405,778) $ (7,665,967) $ (1,304,062) $ (8,970,029) $ (11,375,807) $ (16,593,609) $ (8,766,686) $ 25,867,178
Adjustments to reconcile net loss to cash provided by operations:                  
Depreciation and amortization       4,631,908 9,317,208 14,082,679 18,861,181 17,567,233 17,409,294
Debt discount amortization       20,813 41,626 62,440 83,253 83,253 38,330
Employee stock awards       1,181,199 2,880,883 4,262,655 5,281,288 10,128,236 7,430,457
Common stock purchase options           380,045 430,457
Stock for services                 5,359,868
Contingent consideration payable fair value       (21,024) (41,076) (60,298) (80,540) (63,764) (385,750)
Allowance for doubtful accounts         1,047,587 1,117,565 419,527 191,299 2,748,250
(Gain)/loss on disposal of assets             259,540 (12,044)
Reduction in right of use asset       120,216 243,652 362,402 476,252 629,140 720,491
Warrants issued for services               213,819 1,410,144
Deferred income taxes       (207,098) (2,088,883) (2,448,481) (3,811,735) 712,239 293,430
Accounts receivable       7,088,437 5,267,942 7,107,365 705,532 14,417,405 (20,707,052)
Due to related parties             15,000 657
Inventories       (1,579,836) 1,330,614 4,842,087 8,781,485 4,671,333 (43,149,234)
Prepaid expenses       888,412 2,262,859 2,474,001 4,028,696 2,763,855 1,996,287
Deposits       2,964,365 3,839,429 4,763,015 6,679,669 4,306,375 (8,826,504)
Accounts payable       (1,722,783) 1,519,151 1,066,741 5,077,098 (8,694,813) 9,930,191
Accrued liabilities       153,531 1,758,754 2,071,142 2,532,695 (1,970,078) 2,374,686
Operating lease liability       (127,704) (258,628) (388,261) (499,448) (647,480) (732,468)
Net cash provided by operating activities       12,996,091 18,151,089 28,319,290 32,631,341 35,556,366 1,766,211
Cash flows from investing activities:                  
Gemini acquisition             (50,517,840)
Purchase of property, plant, and equipment       (1,313,939) (2,618,205) (5,562,283) (8,024,765) (12,541,325) (19,218,982)
Proceeds from disposal of assets             3,750   59,800
Net cash used in investing activities       (1,313,939) (2,618,205) (5,562,283) (8,021,015) (12,541,325) (69,677,022)
Cash flows from financing activities:                  
Payments on inventory facility, net             (825,675) (265,422)
Proceeds from factoring liability       14,610,314 26,047,370 37,252,869 37,252,869 71,348,761 121,488,045
Payments on factoring liability       (14,610,314) (26,047,370) (37,252,869) (37,252,869) (71,834,432) (122,844,562)
Payments on assumed debt from Gemini             (50,000,000)
Payments on note payable - related party       (180,850) (180,850) (180,850) (180,850) (684,921) (625,147)
Payments on insurance premium note payment       (970,541) (2,017,089) (3,001,805) (3,174,834) (2,134,143) (2,208,369)
Proceeds from construction note payable             1,000,000
Payments on construction note payable       (64,959) (127,858) (181,639) (257,425) (150,743)
Payments on note payable             (4,000,000)
Sale of preferred stock             35,000,000
Common stock issued for exercised warrants             76,200 101,506 943,907
Common stock issuance costs                 0
Preferred stock issuance costs             (2,113,550)
Preferred stock dividends paid       (638,038) (1,420,677) (2,194,792) (2,968,923) (2,960,416) (2,524,087)
Common stock repurchase plan       (1,456,744) (1,855,569) (2,152,080) (2,152,080) (522,426)
Net cash used in financing activities       (3,311,132) (5,602,043) (7,711,166) (8,657,912) (6,662,489) (27,149,185)
Net increase/(decrease) in cash       8,371,020 9,930,841 15,045,841 15,952,414 16,352,552 (95,059,996)
Cash, beginning of period 54,679,868 49,564,868 47,505,047 39,134,027 39,134,027 39,134,027 39,134,027 23,281,475 118,341,471
Restricted cash, beginning of period     500,000 500,000 500,000 500,000 500,000  
Cash and restricted cash, end of period 55,586,441 54,679,868 49,564,868 48,005,047 49,564,868 54,679,868 55,586,441 39,634,027 23,281,475
Restricted cash, end of period 0     500,000     0 500,000
Cash, end of period 55,586,441 54,679,868 49,564,868 47,505,047 49,564,868 54,679,868 55,586,441 39,134,027 23,281,475
As Previously Reported [Member]                  
Cash flows from operating activities:                  
Net income/(loss) (5,332,881) (1,643,989) (7,495,297) (1,093,033) (8,588,330) (10,232,319) (15,565,200) (4,596,038) 33,247,436
Adjustments to reconcile net loss to cash provided by operations:                  
Depreciation and amortization       4,620,087 9,293,566 14,047,216 18,813,897 17,519,949 17,339,093
Debt discount amortization       20,813 41,626 62,440 83,253 83,253 38,330
Employee stock awards       873,547 2,392,246 3,130,095 4,285,108 5,986,873 6,011,488
Common stock purchase options           380,045 430,457    
Stock for services                 4,200
Contingent consideration payable fair value       (21,024) (41,076) (60,298) (80,540) (63,764) (385,750)
Allowance for doubtful accounts         1,047,587 1,117,565 419,527 191,299 2,748,250
(Gain)/loss on disposal of assets             259,540   (12,044)
Reduction in right of use asset       120,216 243,652 362,402 476,252 629,140 720,491
Warrants issued for services               213,819 718,045
Deferred income taxes       (97,144) (1,960,265) (2,425,500) (3,796,680) 730,238 1,536,481
Accounts receivable       7,088,437 5,267,942 7,107,365 705,532 14,417,405 (20,707,052)
Due to related parties               15,000 657
Inventories       (1,579,836) 1,330,614 4,842,087 8,781,485 4,671,333 (43,149,234)
Prepaid expenses       888,412 2,262,859 2,474,001 4,028,696 2,763,855 1,996,287
Deposits       2,964,365 3,839,429 4,763,015 6,679,669 4,306,375 (8,826,504)
Accounts payable       (1,722,783) 1,519,151 1,066,741 5,077,098 (8,694,813) 9,930,191
Accrued liabilities       152,021 1,760,716 2,072,696 2,532,695 (1,970,078) 2,374,686
Operating lease liability       (127,704) (258,628) (388,261) (499,448) (647,480) (732,468)
Net cash provided by operating activities       12,996,091 18,151,089 28,319,290 32,631,341 35,556,366 2,852,583
Cash flows from investing activities:                  
Gemini acquisition                 (50,517,840)
Purchase of property, plant, and equipment       (1,313,939) (2,618,205) (5,562,283) (8,024,765) (12,541,325) (19,218,982)
Proceeds from disposal of assets             3,750   59,800
Net cash used in investing activities       (1,313,939) (2,618,205) (5,562,283) (8,021,015) (12,541,325) (69,677,022)
Cash flows from financing activities:                  
Payments on inventory facility, net               (825,675) (265,422)
Proceeds from factoring liability       14,610,314 26,047,370 37,252,869 37,252,869 71,348,761 121,488,045
Payments on factoring liability       (14,610,314) (26,047,370) (37,252,869) (37,252,869) (71,834,432) (122,844,562)
Payments on assumed debt from Gemini                 (50,000,000)
Payments on note payable - related party       (180,850) (180,850) (180,850) (180,850) (684,921) (625,147)
Payments on insurance premium note payment       (970,541) (2,017,089) (3,001,805) (3,174,834) (2,134,143) (2,208,369)
Proceeds from construction note payable               1,000,000  
Payments on construction note payable       (64,959) (127,858) (181,639) (257,425) (150,743)  
Payments on note payable                 (4,000,000)
Sale of preferred stock                 35,000,000
Common stock issued for exercised warrants             76,200 101,506 943,907
Common stock issuance costs                 (3,199,922)
Preferred stock dividends paid       (638,038) (1,420,677) (2,194,792) (2,968,923) (2,960,416) (2,524,087)
Common stock repurchase plan       (1,456,744) (1,855,569) (2,152,080) (2,152,080) (522,426)  
Net cash used in financing activities       (3,311,132) (5,602,043) (7,711,166) (8,657,912) (6,662,489) (28,235,557)
Net increase/(decrease) in cash       8,371,020 9,930,841 15,045,841 15,952,414 16,352,552 (95,059,996)
Cash, beginning of period 54,679,868 49,564,868 47,505,047 39,134,027 39,134,027 39,134,027 39,134,027 23,281,475 118,341,471
Restricted cash, beginning of period     500,000 500,000 500,000 500,000 500,000    
Cash and restricted cash, end of period 55,586,441 54,679,868 49,564,868 48,005,047 49,564,868 54,679,868 55,586,441 39,634,027 23,281,475
Restricted cash, end of period       500,000       500,000  
Cash, end of period $ 55,586,441 $ 54,679,868 $ 49,564,868 $ 47,505,047 $ 49,564,868 $ 54,679,868 55,586,441 39,134,027 23,281,475
Restatement Adjustments [Member] | Restatement Adjustment on Stock-Based Compensation [Member]                  
Cash flows from operating activities:                  
Net income/(loss)             (996,180) (4,141,363) (1,422,137)
Adjustments to reconcile net loss to cash provided by operations:                  
Employee stock awards             996,180 4,141,363 1,418,969
Stock for services                 3,168
Restatement Adjustments [Member] | Restatement Adjustment on Equity Issuance Costs [Member]                  
Cash flows from operating activities:                  
Net income/(loss)                 (6,438,872)
Adjustments to reconcile net loss to cash provided by operations:                  
Stock for services                 5,352,500
Net cash provided by operating activities                 (1,086,372)
Cash flows from financing activities:                  
Common stock issuance costs                 (3,199,922)
Preferred stock issuance costs                 (2,113,550)
Net cash used in financing activities                 1,086,372
Restatement Adjustments [Member] | Restatement Adjustment on Warrants [Member]                  
Cash flows from operating activities:                  
Net income/(loss)                 (692,099)
Adjustments to reconcile net loss to cash provided by operations:                  
Warrants issued for services                 692,099
Restatement Adjustments [Member] | Restatement Adjustment Other [Member]                  
Cash flows from operating activities:                  
Net income/(loss)             (32,229) (29,285) 1,172,850
Adjustments to reconcile net loss to cash provided by operations:                  
Depreciation and amortization             47,284 47,284 70,201
Deferred income taxes             $ (15,055) $ (17,999) $ (1,243,051)
v3.25.1
SCHEDULE OF INCOME/(LOSS) PER COMMON SHARE (Details) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Sep. 30, 2023
Dec. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Net Income/(Loss) per share                  
Net Income (Loss) $ (5,217,802) $ (2,405,778) $ (7,665,967) $ (1,304,062) $ (8,970,029) $ (11,375,807) $ (16,593,609) $ (8,766,686) $ 25,867,178
Less: Preferred stock dividends             (3,122,049) (3,105,034) (2,668,649)
Net income/(loss) attributable to common stockholders             $ (19,715,658) $ (11,871,720) $ 23,198,529
Weighted average shares of common stock - basic             118,249,486 117,177,885 112,328,680
Effect of dilutive common stock purchase warrants             2,121,302
Effect of dilutive equity incentive awards             375,853
Weighted average shares of common stock - Diluted             118,249,486 117,177,885 114,825,835
Income/(loss) per share attributable to common stockholders - basic $ (0.05) $ (0.03) $ (0.07) $ (0.02) $ (0.09) $ (0.12) $ (0.17) $ (0.1) $ 0.21
Income/(loss) per share attributable to common stockholders - diluted $ (0.05) $ (0.03) $ (0.07) $ (0.02) $ (0.09) $ (0.12) $ (0.17) $ (0.1) $ 0.2
v3.25.1
SCHEDULE OF DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS (Details) - shares
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Total shares excluded from net income (loss) per share attributable to common stockholders 3,524,394 4,765,645 2,885,226
Common Stock Options [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Total shares excluded from net income (loss) per share attributable to common stockholders 175,000    
Non-vested stock awards [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Total shares excluded from net income (loss) per share attributable to common stockholders 1,540,524 2,204,659 2,735,226
Warrant [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Total shares excluded from net income (loss) per share attributable to common stockholders 1,808,870 2,560,986 150,000
v3.25.1
SCHEDULE OF ACCOUNTS RECEIVABLE (Details) - USD ($)
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Credit Loss [Abstract]            
Accounts receivable $ 31,887,399 $ 32,592,931 $ 47,010,336      
Less: allowance for credit losses (3,666,078) (3,246,551) (3,055,252)      
Accounts receivable, net 28,221,321 29,346,380 43,955,084 $ 21,121,450 $ 23,030,851 $ 21,348,226
Allowance for credit losses, beginning balance 3,246,551 3,055,252 148,540      
Increase in allowance 1,530,891 2,160,323 2,903,304      
Write-off of uncollectible amounts (1,111,364) (1,969,024) (12,703)      
Purchase accounting     16,111      
Allowance for credit losses, ending balance $ 3,666,078 $ 3,246,551 $ 3,055,252      
v3.25.1
SCHEDULE OF INVENTORIES (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Mar. 31, 2022
Inventory Disclosure [Abstract]            
Finished product $ 11,055,061       $ 14,362,514 $ 6,167,318
Raw materials 24,158,244       23,898,596 33,924,813
Work in process 10,350,029       16,083,709 18,924,021
Inventory net $ 45,563,334 $ 49,502,732 $ 53,014,205 $ 55,924,655 $ 54,344,819 $ 59,016,152
v3.25.1
SCHEDULE OF PROPERTY AND EQUIPMENT (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Mar. 31, 2022
Property, Plant and Equipment [Line Items]            
Total property and equipment $ 78,390,161       $ 70,529,919 $ 47,757,208
Less accumulated depreciation (20,308,121)       (14,566,664) (10,119,402)
Net property and equipment 58,082,040 $ 57,278,603 $ 55,821,414 $ 55,923,867 55,963,255 37,637,806
Leasehold Improvements [Member]            
Property, Plant and Equipment [Line Items]            
Total property and equipment 257,009       257,009 257,009
Building Improvements [Member]            
Property, Plant and Equipment [Line Items]            
Total property and equipment 29,143,445       28,623,329  
Furniture and Fixtures [Member]            
Property, Plant and Equipment [Line Items]            
Total property and equipment 439,990       384,650 343,014
Vehicles [Member]            
Property, Plant and Equipment [Line Items]            
Total property and equipment 153,254       153,254 153,254
Equipment [Member]            
Property, Plant and Equipment [Line Items]            
Total property and equipment 45,467,137       40,233,186 32,524,850
Tooling [Member]            
Property, Plant and Equipment [Line Items]            
Total property and equipment 143,710       143,710 143,710
Construction in Progress [Member]            
Property, Plant and Equipment [Line Items]            
Total property and equipment $ 2,785,616       $ 734,781 $ 14,335,371
v3.25.1
PROPERTY, PLANT AND EQUIPMENT (Details Narrative) - USD ($)
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Impaired Assets to be Disposed of by Method Other than Sale [Line Items]      
Depreciation expense $ 5,751,023 $ 4,452,908 $ 4,266,126
Cost of Sales [Member]      
Impaired Assets to be Disposed of by Method Other than Sale [Line Items]      
Depreciation expense 4,777,642 3,747,723 3,101,929
Operating Expense [Member]      
Impaired Assets to be Disposed of by Method Other than Sale [Line Items]      
Depreciation expense $ 973,381 $ 705,185 $ 1,164,197
v3.25.1
REVOLVING LOAN (Details Narrative) - USD ($)
12 Months Ended
Mar. 31, 2024
Dec. 29, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Total commitment amount   $ 20,000,000
Revolving loan description December 29, 2026 (the “Maturity Date”), at which time the commitments will terminate and all outstanding loans, together with all accrued and unpaid interest, must be repaid. If the Revolving Loan is refinanced by another lender prior to the Maturity Date, an additional fee payable concurrently with such refinancing in an amount equal to (i) three percent (3.0%) of the Total Commitment Amount, if such financing occurs after the Closing Date but on or prior to the first anniversary of the Closing Date, (ii) two percent (2.0%) of the Total Commitment Amount, if such refinancing occurs after the first anniversary of the Closing Date but on or prior to the second anniversary of the Closing Date, and (iii) one percent (1.0%) of the Total Commitment Amount, if such refinancing occurs after the second anniversary of the Closing Date but on or prior to the third anniversary of the Closing Date (the “Prepayment Fee”).  
Sunflower Agreement [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Revolving loan description The Revolving Loan bears interest at a rate of the greater of (x) 3.50% (the “Floor Rate”) and (y) Term SOFR, plus 3.00% (the “Revolving Facility Applicable Rate”) and is computed on the basis of a 360-day year for the actual number of days elapsed. Except in an Event of Default (as defined below), Advances under the Revolving Loan shall bear interest, on the outstanding Daily Balance thereof, at the Revolving Facility Applicable Rate. Interest is due and payable on the first calendar day of each month during the term of the Sunflower Agreement. The Borrower is also obligated to pay to the Agent, for the ratable benefit of Lenders, an origination fee, Prepayment Fee, unused facility fee, collateral monitoring fee and Lender Expenses.  
v3.25.1
FACTORING LIABILITY (Details Narrative) - USD ($)
12 Months Ended
Dec. 29, 2023
Jun. 17, 2021
Jul. 01, 2019
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Factoring liability       $ 0 $ 0 $ 485,671
Interest expenses on factoring liability       185,319 153,646 327,746
Amortization of commitment fee       $ 62,500 $ 37,500 $ 100,000
Maturity date   Jun. 17, 2025        
Termination agreement expenses $ 281,108          
Factoring and Security Agreement [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Maximum advance amount     $ 5,000,000      
Line of credit facility interest rate during period     85.00%      
Fee percentage     3.00%      
Line of credit facility commitment fee amount     $ 150,000      
Factoring and Security Agreement [Member] | Prime Rate [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Line of credit facility interest rate during period     4.50%      
v3.25.1
INVENTORY CREDIT FACILITY (Details Narrative) - USD ($)
12 Months Ended
Jun. 17, 2020
Jun. 17, 2020
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Jul. 31, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Outstanding balance of the Inventory Credit Facility         $ 825,675  
Inventory Credit Facility [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Interest expense on factoring liability     $ 0 $ 6,580 40,940  
Amortization of annual fee         $ 8,561  
Revolving Inventory Loan and Security Agreement [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Maximum loan amount           $ 2,250,000
Maximum loan amount   $ 35,000        
Line of credit interest rate description annualized interest rate of the greater of the three-month LIBOR rate plus 3.09% or 8%          
Commitment fee percentage 2.00%          
Revolving Inventory Loan and Security Agreement [Member] | Eligible Inventory [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Maximum loan amount $ 1,750,000 $ 1,750,000        
v3.25.1
SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES (Details)
Mar. 31, 2024
USD ($)
Leases  
2025 $ 666,233
2026 665,069
2027 581,574
2028 379,067
2029 258,102
Total minimum lease payments 2,550,045
Less: Amount Representing Interest (460,558)
Present value of minimum lease payments $ 2,089,487
v3.25.1
LEASES (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2023
Sep. 30, 2023
Dec. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Jan. 31, 2022
Sep. 30, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Operating lease, liability       $ 2,089,487        
Right use of asset $ 1,141,418 $ 1,017,982 $ 2,113,943 2,000,093 $ 1,261,634 $ 2,791,850    
Operating lease liability $ (127,704) $ (258,628) $ (388,261) (499,448) (647,480) (732,468)    
Consolidated lease expense       663,826 881,171 1,221,473    
Operating lease expense       642,105 861,777 1,177,589    
Other lease expenses       $ 21,722 $ 19,394 $ 43,884    
Weighted average remaining lease term       4 years 3 years 3 months 18 days 3 years 6 months    
Weighted average discount rate for operating leases       10.00% 10.00% 10.00%    
Scottsdale Lease [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Operating lease, liability               $ 501,125
Right use of asset       $ 738,459       $ 501,125
Operating lease liability       38,185        
Marietta Lease [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Operating lease, liability             $ 308,326  
Right use of asset             $ 308,326  
Lease Agreement [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Operating lease liability       $ 901,076        
v3.25.1
NOTES PAYABLE – RELATED PARTY (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Dec. 29, 2023
Jun. 17, 2021
Jan. 22, 2021
Nov. 05, 2020
Jun. 26, 2020
Mar. 14, 2020
Mar. 31, 2019
Mar. 25, 2019
Oct. 30, 2019
May 31, 2019
Apr. 30, 2019
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Short-Term Debt [Line Items]                              
Payment of note payable related party                       $ 4,000,000  
Debt description                     The note bears interest per annum at approximately 4.6% payable in arrears monthly.        
Principal payments                       257,425 150,743    
Debt instrument maturity date   Jun. 17, 2025                          
Loss on contract termination $ 281,108                            
Settlement Agreement [Member]                              
Short-Term Debt [Line Items]                              
Payment of note payable related party       $ 6,000,000                      
Debt description         Pursuant to the Settlement Agreement, the Company shall pay JSC $1,269,977 and shall provide JSC with: (i) two new promissory notes, a note of $5,803,800 related to the Seller Note and note of $2,635,797 for inventory and services, which was reclassed from accounts payable, both with a maturity date of August 15, 2021, (ii) general business security agreements granting JSC a security interest in all personal property of the Company. Pursuant to the Notes, the Company is obligated to make monthly payments totaling $204,295 to JSC. In addition, the Notes have a mandatory prepayment provision that comes into effect if the Company conducts a publicly registered offering.                    
Principal payments         $ 1,269,977                    
Debt instrument maturity date         Aug. 15, 2021                    
Loss on contract termination         $ 1,000,000                    
Post Closing Transaction Note Reduction [Member]                              
Short-Term Debt [Line Items]                              
Post-closing changes to the purchase price of transaction                 $ 2,596,200            
Decreased Equipment Net [Member]                              
Short-Term Debt [Line Items]                              
Post-closing changes to the purchase price of transaction                 1,871,306            
Reduction in Other Intangible Assets [Member]                              
Short-Term Debt [Line Items]                              
Post-closing changes to the purchase price of transaction                 766,068            
Increased Accounts Receivable [Member]                              
Short-Term Debt [Line Items]                              
Post-closing changes to the purchase price of transaction                 31,924            
Increase to Deposits [Member]                              
Short-Term Debt [Line Items]                              
Post-closing changes to the purchase price of transaction                 9,250            
Decreased Accumulated Amortization [Member]                              
Short-Term Debt [Line Items]                              
Post-closing changes to the purchase price of transaction                 $ 159,530            
Inventory and Services [Member] | Settlement Agreement [Member]                              
Short-Term Debt [Line Items]                              
Payment of note payable related party         2,635,797                    
Promissory Note [Member] | Settlement Agreement [Member]                              
Short-Term Debt [Line Items]                              
Payment of note payable related party         $ 5,803,800                    
Note B [Member] | Settlement Agreement [Member]                              
Short-Term Debt [Line Items]                              
Payment of note payable related party       $ 592,982                      
Interest expenses                             $ 62,876
Amended Note B [Member]                              
Short-Term Debt [Line Items]                              
Interest expenses                       $ 1,788 48,665 110,518  
Amended Note B [Member] | Related Party [Member]                              
Short-Term Debt [Line Items]                              
Notes payable related party                         $ 180,850 $ 865,771  
Amended Note B [Member] | Settlement Agreement [Member]                              
Short-Term Debt [Line Items]                              
Debt interest rate       9.00%                      
Amended Note B [Member] | Settlement Agreement [Member] | Related Party [Member]                              
Short-Term Debt [Line Items]                              
Notes payable related party       $ 1,687,664                      
Note A [Member] | Settlement Agreement [Member]                              
Short-Term Debt [Line Items]                              
Interest expenses                             $ 216,160
Fred Wagenhals [Member]                              
Short-Term Debt [Line Items]                              
Principal Amount       4,000,000                      
Interest expense       $ 66,667                      
Debt interest rate       12.00%                      
Jagemann Stamping Company [Member]                              
Short-Term Debt [Line Items]                              
Debt description         . Pursuant to such provision, the Company: (a) upon the closing of an Offering of less than $10,000,000 would be obligated to pay the lesser of ninety percent (90%) of the Offering proceeds or seventy (70%) of the then aggregate outstanding balance of the Notes; and (b) upon the closing of an Offering of more than $10,000,000 would be obligated to pay one hundred percent (100%) of the then aggregate outstanding balance of the Notes. The Company was granted an option to repurchase up to 1,000,000 of the shares of the Company’s Common Stock issued to JSC under the Amended APA at a price of $1.50 per share through April 1, 2021 so long as there are no defaults under the Settlement Agreement.                    
Debt monthly payments         $ 204,295                    
Jagemann Stamping Company [Member] | Settlement Agreement [Member]                              
Short-Term Debt [Line Items]                              
Debt description         upon the closing of an Offering of less than $10,000,000 would be obligated to pay the lesser of ninety percent (90%) of the Offering proceeds or seventy (70%) of the then aggregate outstanding balance of the Notes; and (b) upon the closing of an Offering of more than $10,000,000 would be obligated to pay one hundred percent (100%) of the then aggregate outstanding balance of the Notes. The Company was granted an option to repurchase up to 1,000,000 of the shares of the Company’s Common Stock issued to JSC under the Amended APA at a price of $1.50 per share through April 1, 2021 so long as there are no defaults under the Settlement Agreement                    
Option termination date         Apr. 01, 2021                    
Jagemann Stamping Company [Member] | Amended APA [Member]                              
Short-Term Debt [Line Items]                              
Stock repurchased during period, shares     1,000,000                        
Shares issued, price per share     $ 1.5                        
Jagemann Stamping Company [Member] | Promissory Note [Member]                              
Short-Term Debt [Line Items]                              
Payment of note payable related party           $ 10,400,000 $ 9,900,000 $ 500,000   $ 1,500,000          
Jagemann Stamping Company [Member] | Equity Option [Member] | Settlement Agreement [Member] | Maximum                              
Short-Term Debt [Line Items]                              
Option granted to repurchase         1,000,000                    
v3.25.1
CONSTRUCTION NOTE PAYABLE (Details Narrative)
12 Months Ended
Oct. 14, 2021
USD ($)
ft²
Jun. 17, 2021
Mar. 31, 2024
USD ($)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
USD ($)
Jun. 30, 2023
USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Debt maturity date   Jun. 17, 2025        
Debt instrument principal payment     $ 257,425 $ 150,743    
Restricted cash     $ 0 500,000 $ 500,000
Hiawatha National Bank [Member] | Promissory Note [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Debt interest rate 4.50%          
Debt maturity date Oct. 14, 2026          
Hiawatha National Bank [Member] | Maximum [Member] | Promissory Note [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Debt face amount $ 11,625,000          
Debt periodic payment $ 64,620          
Construction Loan Agreement [Member] | Hiawatha National Bank [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Area of land | ft² 185,000          
Proceeds from notes payable       11,200,000    
Prepayment premium of note amount, percentage 1.00%          
Debt default, description The Hiawatha Loan Agreement contains customary events of default including, but not limited to, a failure to make any payments pursuant to the Hiawatha Loan Agreement or Hiawatha Note, a failure to complete construction of the project, a lien of $100,000 or more against the property, or a transfer of the property without Hiawatha’s consent. Upon the occurrence of an event of default, among other remedies, the amounts due pursuant to the Construction Loan can be accelerated, Hiawatha can foreclose on the property pursuant to the mortgage, and a late charge of 5% of the amount due will be owed with all amounts then owed pursuant to the Hiawatha Note bearing interest at an increased rate          
Debt instrument, covenant description     We are required to maintain a debt service coverage ratio, as defined in the terms of the Hiawatha Loan Agreement, of not less than 1.25 to 1.00 for the period defined below and continuing to and including the maturity date.      
Cash collateral or restricted cash       $ 1,000,000    
Construction Loan Agreement [Member] | Hiawatha National Bank [Member] | First Advance [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Proceeds from notes payable $ 329,843          
Construction Loan Agreement [Member] | Hiawatha National Bank [Member] | Maximum [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Debt face amount $ 11,625,000          
Proceeds from notes payable         $ 1,000,000  
Debt covenant ratio 1.25          
Construction Loan Agreement [Member] | Hiawatha National Bank [Member] | Minimum [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Debt covenant ratio 1          
v3.25.1
CAPITAL STOCK (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Jul. 14, 2023
Oct. 31, 2017
Sep. 30, 2023
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Common stock, shares authorized       200,000,000 200,000,000 200,000,000
Common stock, par value       $ 0.001 $ 0.001 $ 0.001
Number of shares issued for merger, value           $ 143,377,654
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross       400,000    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares 100,000   300,000      
Expenses related to options       $ 430,457    
Unvested stock options       225,000    
Unvested stock options, grant date fair value       $ 1.5    
Stock Option Activity [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross       400,000    
Unrecognized compensation expense related to unvested stock options       $ 172,663    
Unrecognized compensation expense recognized over a weighted average vesting period       2 years 3 months    
Stock Award Activity [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares issued for services and equipment, shares           772,450
Number of shares issued for services and equipment, value           $ 1,631,701
Unrecognized compensation expense related to unvested stock options       $ 4,510,650 $ 8,104,771 $ 16,197,207
Unrecognized compensation expense recognized over a weighted average vesting period       2 years 4 months 28 days 2 years 8 months 26 days 2 years 4 months 24 days
Share-Based Payment Arrangement, Tranche One [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares     25,000      
2017 Equity Incentive Plan [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of common stock shares issued   9,000,000        
Shares available to be issued       2,791,492    
2017 Equity Incentive Plan [Member] | October 2020 [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Increase in issuance of equity-based instruments   4,515,000        
2017 Equity Incentive Plan [Member] | March 2023 [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Increase in issuance of equity-based instruments   1,000,000        
2017 Equity Incentive Plan [Member] | February 2024 [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Increase in issuance of equity-based instruments   3,000,000        
Common Stock [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares issued for merger, shares           20,000,000
Number of shares issued for merger, value           $ 20,000
Common Stock [Member] | 2017 Equity Incentive Plan [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of common stock shares issued   485,000        
Warrant [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Shares issued cashless exercise of warrants         99,762 374,584
Cashless exercise of warrants         100,000 443,110
Warrants outstanding       1,808,830    
Issuance of warrants, description       Each warrant provides the holder the right to purchase up to one share of our Common Stock at a predetermined exercise price. The outstanding warrants consist of (1) warrants to purchase 100,000 shares of Common Stock at an exercise price of $0.01 per share until March 2027; (2) warrants to purchase 911 shares of Common Stock at an exercise price of $1.65 per share until April 2025; (3) warrants to purchase 1,244,108 shares of our Common Stock at an exercise price of $2.00 per share consisting of approximately 1% of the warrants until August 2024, and approximately 99% until February 2026; (4) warrants to purchase 77,500 shares of Common Stock at an exercise price of $2.40 until September 2024, and (5) warrants to purchase 386,311 shares of Common Stock at an exercise price of $2.63 until November 2025.    
Warrant One [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Warrants issued to purchase common stock       100,000    
Warrants exercise price       $ 0.01    
Warrant Two [Member] | Until April 2025 [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Warrants issued to purchase common stock       911    
Warrants exercise price       $ 1.65    
Warrant Three [Member] | Until August 2024 [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Warrants issued to purchase common stock       1,244,108    
Warrants exercise price       $ 2    
Warrant Four [Member] | Until September 2024 [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Warrants issued to purchase common stock       77,500    
Warrants exercise price       $ 2.4    
Warrant Five [Member] | Until November 2025 [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Warrants issued to purchase common stock       386,311    
Warrants exercise price       $ 2.63    
Gemini Direct Investments LLC [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares issued for merger, shares           20,000,000
Number of shares issued for merger, value           $ 142,691,282
Investors [Member] | Warrant [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Stock issued during period shares warrants exercised, shares       31,750 200,003 431,080
Stock issued during period value warrants exercised, value       $ 76,200 $ 101,506 $ 943,907
v3.25.1
SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK PURCHASE WARRANTS (Details) - Warrant [Member] - $ / shares
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Number of shares, outstanding beginning 2,560,946 3,033,755 3,607,945
Number of shares, granted   150,000 300,000
Number of shares, exercised (31,750) (300,003) (874,190)
Number of shares, forfeited or cancelled (720,366) (322,806)
Number of shares, outstanding ending 1,808,830 2,560,946 3,033,755
Number of shares, exercisable 1,808,830 2,560,946 3,033,755
Weighted average exercise price, outstanding beginning $ 2.46 $ 2.32 $ 2.31
Weighted average exercise price, granted   0.01 0.01
Weighted average exercise price, exercised 2.4 0.34 1.76
Weighted average exercise price, forfeited or cancelled 3.19 2
Weighted average exercise price, outstanding ending 2.16 2.46 2.32
Weighted average exercise price, exercisable $ 2.16 $ 2.46 $ 2.32
Weighted average life remaining years, outstanding beginning 1 year 7 months 2 days 2 years 3 months 14 days 3 years 2 months 26 days
Weighted average life remaining years, outstanding granted   4 years 6 months 3 years 11 months 1 day
Weighted average life remaining years, outstanding ending 1 year 1 month 2 days 1 year 7 months 2 days 2 years 3 months 14 days
Weighted average life remaining years, exercisable 1 year 1 month 2 days 1 year 7 months 2 days 2 years 3 months 14 days
v3.25.1
SCHEDULE OF WARRANTS AND COMMON STOCK PURCHASE OPTIONS USING VALUATION METHODS AND ASSUMPTIONS (Details) - Employee Stock Option
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Risk Free Interest Rate [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Fair value measurement input 4.1 3.9 1.2
Expected Volatility [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Fair value measurement input 66.8 73.5 54.3
Expected Term [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Fair value measurement input, term 5 years 9 months 18 days 5 years 5 years
Expected Dividend Yield [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Fair value measurement input 0 0 0
v3.25.1
SCHEDULE OF SHARE BASED COMPENSATION ARRANGEMENTS (Details)
12 Months Ended
Mar. 31, 2024
$ / shares
shares
Equity [Abstract]  
Number of options | shares 400,000
Vesting period 3 years
Grant price (per share) $ 2.08
Expected dividend yields
Expected volatility 83.50%
Risk-free interest rates 4.13%
Expected lives 5 years 9 months
Weighted average fair value per share $ 1.5
v3.25.1
SUMMARY OF STOCK OPTION ACTIVITY (Details)
12 Months Ended
Mar. 31, 2024
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Options, Granted | shares 400,000
Weighted Average Grant Date Fair Value, Granted $ 1.5
Stock Option Activity [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Option Outstandings, Beginning Balance | shares 0
Number of Options, Granted | shares 400,000
Number of Options, Exercised | shares 0
Number of Options, Canceled/Forfeited | shares 0
Number of Option Outstandings, Ending Balance | shares 400,000
Weighted Average Exercise Price Outstanding, Beginning Balance $ 0
Weighted Average Exercise Price Outstanding, Granted 2.08
Weighted Average Exercise Price Outstanding, Exercised 0
Weighted Average Exercise Price Outstanding, Canceled/Forfeited 0
Weighted Average Exercise Price Outstanding, Ending Balance 2.08
Weighted Average Grant Date Fair Value, Granted 1.5
Weighted Average Grant Date Fair Value, Outstanding $ 1.5
Weighted Average Remaining Life in Years, Granted 10 years
Weighted Average Remaining Life in Years, Outstanding 9 years 3 months 25 days
v3.25.1
SUMMARY OF STOCK AWARD ACTIVITY (Details) - Stock Award Activity [Member] - $ / shares
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Number of Shares Outstanding, Beginning Balance 2,204,659 2,795,017 1,973,004
Number of Shares Outstanding, Granted 2,579,901 2,102,840 3,347,200
Number of Shares Outstanding, Vested (1,371,849) (573,750) (299,167)
Number of Shares Outstanding, Forfeited (1,872,186) (2,119,448) (2,226,020)
Number of Shares Outstanding, Ending Balance 1,540,525 2,204,659 2,795,017
Weighted-Average Grant-Date Fair Value Per Share, Beginning Balance $ 3.68 $ 5.79 $ 3.94
Weighted-Average Grant-Date Fair Value Per Share, Granted 2.22 2.93 6.56
Weighted-Average Grant-Date Fair Value Per Share, Vested 2.94 7.24 1.98
Weighted-Average Grant-Date Fair Value Per Share, Forfeited 2.82 4.76 5.82
Weighted-Average Grant-Date Fair Value Per Share, Ending Balance $ 2.93 $ 3.68 $ 5.79
v3.25.1
PREFERRED STOCK (Details Narrative) - USD ($)
12 Months Ended
May 25, 2021
May 19, 2021
May 18, 2021
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Class of Stock [Line Items]            
Dividend rate       8.75% 8.75% 8.75%
Series A Preferred Stock [Member]            
Class of Stock [Line Items]            
Preferred Stock share price     $ 25      
Dividend rate     8.75%      
Preferred stock dividend rate per annum     $ 2.1875      
Dividend payment terms     payable quarterly in arrears on March 15, June 15, September 15, and December 15.      
Proceeds from offering           $ 32,908,796
Series A Preferred Stock [Member] | May 15, 2023 [Member]            
Class of Stock [Line Items]            
Accumulated preferred dividends       $ 144,618    
Series A Preferred Stock [Member] | August 27, 2021 [Member]            
Class of Stock [Line Items]            
Accumulated preferred dividends           $ 144,562
Series A Preferred Stock [Member] | February 17. 2023 [Member]            
Class of Stock [Line Items]            
Accumulated preferred dividends         $ 144,618  
Series A Preferred Stock [Member] | Underwriting Agreement [Member]            
Class of Stock [Line Items]            
Share price $ 25 $ 25        
Number of common stock shares issued 138,220 1,097,200        
Proceeds from offering $ 3,455,500 $ 27,430,000        
Series A Preferred Stock [Member] | Underwriting Agreement [Member] | Over-Allotment Option [Member]            
Class of Stock [Line Items]            
Number of common stock shares issued 164,580          
Proceeds from offering $ 4,114,500          
Series A Preferred Stock [Member] | Underwriting Agreement [Member] | Underwriters [Member]            
Class of Stock [Line Items]            
Number of common stock shares issued   164,580        
v3.25.1
SUMMARY OF DIVIDENDS PAID ON SERIES A PREFERRED STOCK (Details) - Series A Preferred Stock [Member] - USD ($)
12 Months Ended
May 18, 2021
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Class of Stock [Line Items]        
Per Share Amount $ 2.1875      
May 15, 2023 [Member]        
Class of Stock [Line Items]        
Dividend Declaration Date   May 15, 2023    
Record Date   May 31, 2023    
Dividend Period   March 15, 2023 - June 14, 2023    
Dividend Payment Date   Jun. 15, 2023    
Dividend Amount   $ 782,639    
Per Share Amount   $ 0.55902778    
August 15, 2023 [Member]        
Class of Stock [Line Items]        
Dividend Declaration Date   Aug. 15, 2023    
Record Date   Aug. 31, 2023    
Dividend Period   June 15, 2023 - September 14, 2023    
Dividend Payment Date   Sep. 15, 2023    
Dividend Amount   $ 782,639    
Per Share Amount   $ 0.55902778    
November 15, 2023 [Member]        
Class of Stock [Line Items]        
Dividend Declaration Date   Nov. 15, 2023    
Record Date   Nov. 30, 2023    
Dividend Period   September 15, 2023 - December 14, 2023    
Dividend Payment Date   Dec. 15, 2023    
Dividend Amount   $ 774,132    
Per Share Amount   $ 0.5529514    
February 6, 2024 [Member]        
Class of Stock [Line Items]        
Dividend Declaration Date   Feb. 06, 2024    
Record Date   Feb. 29, 2024    
Dividend Period   December 15, 2023 - March 14, 2024    
Dividend Payment Date   Mar. 15, 2024    
Dividend Amount   $ 774,132    
Per Share Amount   $ 0.5529514    
May 12, 2022 [Member]        
Class of Stock [Line Items]        
Dividend Declaration Date     May 12, 2022  
Record Date     May 31, 2022  
Dividend Period     March 15, 2022 - June 14, 2022  
Dividend Payment Date     Jun. 15, 2022  
Dividend Amount     $ 782,639  
Per Share Amount     $ 0.55902778  
August 17, 2022 [Member]        
Class of Stock [Line Items]        
Dividend Declaration Date     Aug. 17, 2022  
Record Date     Aug. 31, 2022  
Dividend Period     June 15, 2022 - September 14, 2022  
Dividend Payment Date     Sep. 15, 2022  
Dividend Amount     $ 782,639  
Per Share Amount     $ 0.55902778  
November 18, 2022 [Member]        
Class of Stock [Line Items]        
Dividend Declaration Date     Nov. 18, 2022  
Record Date     Nov. 30, 2022  
Dividend Period     September 15, 2022 - December 14, 2022  
Dividend Payment Date     Dec. 15, 2022  
Dividend Amount     $ 774,132  
Per Share Amount     $ 0.5529514  
February 17, 2023 [Member]        
Class of Stock [Line Items]        
Dividend Declaration Date     Feb. 17, 2023  
Record Date     Feb. 28, 2023  
Dividend Period     December 15, 2022 - March 14, 2023  
Dividend Payment Date     Mar. 15, 2023  
Dividend Amount     $ 765,625  
Per Share Amount     $ 0.546875  
August 17, 2021 [Member]        
Class of Stock [Line Items]        
Dividend Declaration Date       Aug. 17, 2021
Record Date       Aug. 31, 2021
Dividend Period       May 21, 2021 - June 30, 2021
Dividend Payment Date       Sep. 15, 2021
Dividend Amount       $ 337,745
Per Share Amount       $ 0.24124653
November 17, 2021 [Member]        
Class of Stock [Line Items]        
Dividend Declaration Date       Nov. 17, 2021
Record Date       Nov. 30, 2021
Dividend Period       July 1, 2021 - December 14, 2021
Dividend Payment Date       Dec. 15, 2021
Dividend Amount       $ 1,420,700
Per Share Amount       $ 1.01475694
February 18, 2022 [Member]        
Class of Stock [Line Items]        
Dividend Declaration Date       Feb. 18, 2022
Record Date       Feb. 28, 2022
Dividend Period       December 15, 2021 - March 14, 2022
Dividend Payment Date       Mar. 15, 2022
Dividend Amount       $ 765,642
Per Share Amount       $ 0.546875
v3.25.1
SCHEDULE OF FAIR VALUE OF CONSIDERATION TRANSFERRED (Details)
Apr. 30, 2021
USD ($)
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
Cash $ 48,649,954
Working capital adjustment 1,870,886
Contingent consideration 10,755,000
Common stock 132,645,000
Assumed debt 50,000,000
Fair value of consideration transferred   $ 243,920,840
v3.25.1
SCHEDULE OF ALLOCATION FOR CONSIDERATION (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Mar. 31, 2022
Apr. 30, 2021
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]              
Accounts receivable, net             $ 17,002,362
Prepaid expenses             478,963
Equipment             1,051,980
Deposits             703,389
Other intangible assets [1]             146,617,380
Goodwill $ 90,870,094 $ 90,870,094 $ 90,870,094 $ 90,870,094 $ 90,870,094 $ 90,870,094 90,870,094
Right of use assets - operating leases             612,727
Accounts payable             (12,514,919)
Accrued expenses             (196,780)
Operating lease liability             (704,356)
Total Consideration             $ 243,920,840
[1] Other intangible assets consist of Tradenames, Customer Relationships, Intellectual Property, and other tangible assets related to the acquired business.
v3.25.1
SCHEDULE OF UNAUDITED PRO FORMA RESULTS OF OPERATIONS (Details)
12 Months Ended
Mar. 31, 2022
USD ($)
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
Net revenues $ 248,314,587
Net income $ 37,793,924
v3.25.1
ACQUISITIONS (Details Narrative) - USD ($)
12 Months Ended
Apr. 30, 2021
Apr. 30, 2021
Apr. 01, 2021
Mar. 31, 2022
Mar. 31, 2024
Mar. 31, 2023
Business Acquisition [Line Items]            
Common stock, par value       $ 0.001 $ 0.001 $ 0.001
Contingent consideration, amount $ 10,755,000 $ 10,755,000        
Working capital adjustments   $ 2,000,000        
Transaction cost       $ 1,300,000    
Business acquisitions pro form a interest and debt expense     $ 1,800,000      
Business acquisitions pro form a depreciation and amortization     $ 900,000      
Gemini Direct Investments LLC [Member]            
Business Acquisition [Line Items]            
Business acquisition, share price $ 7.17 $ 7.17        
Company received a cash payment   $ 50,000,000        
Business acquisition, cash acquired   1,350,046        
Estimated working capital adjustment $ 2,000,000 2,000,000        
Contingent consideration payable, net of current portion 50,000,000          
Contingent consideration, amount 10,755,000 $ 10,755,000        
Shares issued prior stockholder   1,500,000        
Business combination additional securities of common stock   18,500,000        
Merger Agreement [Member] | Gemini Direct Investments LLC [Member]            
Business Acquisition [Line Items]            
Business acquisition, amount $ 50,000,000 $ 50,000,000        
Business acquisition, shares   20,000,000        
Common stock, par value $ 0.001 $ 0.001        
Company received a cash payment   $ 129,114        
Consideration transferred   $ 1,870,886        
Without Being Held in Escrow or Requiring Prior Stockholder Approval [Member]            
Business Acquisition [Line Items]            
Issuance of Series A Preferred Stock, net of issuance costs, shares   14,500,000        
Pledge and Escrow Agreement [Member]            
Business Acquisition [Line Items]            
Issuance of Series A Preferred Stock, net of issuance costs, shares 2,857,143 4,000,000        
Will Not Be Issued Prior to The Stockholder Approval [Member]            
Business Acquisition [Line Items]            
Issuance of Series A Preferred Stock, net of issuance costs, shares   1,500,000        
v3.25.1
SCHEDULE OF ACCRUED LIABILITIES (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Mar. 31, 2022
Apr. 01, 2021
Payables and Accruals [Abstract]              
Accrued federal excise tax $ 1,145,937       $ 1,808,065 $ 2,408,318  
Accrued bonus program 1,185,877       0 0  
Accrued professional fees 1,134,368       736,323 66,000  
Accrued payroll 458,027       430,344 964,661  
Other accruals 417,496       618,243 357,616  
Income taxes payable 394,133       438,517 1,784,266  
Unearned revenue 1,822,972       101,593 201,891 $ 400,000
Accrued sales commissions 0       252,366 932,712  
Accrued interest 0       2,681 4,762  
Accrued liabilities $ 7,065,444 $ 6,603,892 $ 6,282,980 $ 4,677,757 $ 4,388,132 $ 6,213,592  
v3.25.1
RELATED PARTY TRANSACTIONS (AS RESTATED) (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Jul. 24, 2023
Jul. 17, 2023
Nov. 03, 2022
Jun. 17, 2021
Jan. 22, 2021
Nov. 05, 2020
Jun. 26, 2020
Oct. 30, 2019
Apr. 30, 2019
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Sep. 30, 2023
Dec. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Jul. 26, 2023
Service payment due amount                   $ 1,134,368           $ 1,134,368 $ 736,323 $ 66,000    
Letter of credit                                       $ 1,600,000
Certificate of deposit   $ 1,600,000                                    
Description of line of credit facility   The term of the certificate of deposit is twelve months and includes interest of approximately 5%. Per the terms of the Merger Agreement, the Seller is required to pay or be liable for these losses.                                    
Revenues                   40,421,147 $ 36,006,464 $ 34,372,386 $ 34,254,575 $ 68,626,961 $ 104,633,425 145,054,572 191,439,801 240,269,166    
Accounts receivable                   28,221,321 $ 21,121,450 $ 23,030,851 $ 21,348,226 $ 23,030,851 $ 21,121,450 28,221,321 29,346,380 43,955,084    
Debt instrument, description                 The note bears interest per annum at approximately 4.6% payable in arrears monthly.                      
Rent paid                               663,826 881,171 1,221,473    
Principal payments                               257,425 150,743      
Payment of note payable related party                               4,000,000    
Debt maturity date       Jun. 17, 2025                                
Amended Note B [Member]                                        
Interest expenses                               1,788 48,665 110,518    
Post Closing Transaction Note Reduction [Member]                                        
Post-closing changes to the purchase price of transaction               $ 2,596,200                        
Decreased Equipment Net [Member]                                        
Post-closing changes to the purchase price of transaction               1,871,306                        
Reduction in Other Intangible Assets [Member]                                        
Post-closing changes to the purchase price of transaction               766,068                        
Increased Accounts Receivable [Member]                                        
Post-closing changes to the purchase price of transaction               31,924                        
Increase to Deposits [Member]                                        
Post-closing changes to the purchase price of transaction               9,250                        
Decreased Accumulated Amortization [Member]                                        
Post-closing changes to the purchase price of transaction               $ 159,530                        
Jagemann Stamping Company [Member]                                        
Debt instrument, description             . Pursuant to such provision, the Company: (a) upon the closing of an Offering of less than $10,000,000 would be obligated to pay the lesser of ninety percent (90%) of the Offering proceeds or seventy (70%) of the then aggregate outstanding balance of the Notes; and (b) upon the closing of an Offering of more than $10,000,000 would be obligated to pay one hundred percent (100%) of the then aggregate outstanding balance of the Notes. The Company was granted an option to repurchase up to 1,000,000 of the shares of the Company’s Common Stock issued to JSC under the Amended APA at a price of $1.50 per share through April 1, 2021 so long as there are no defaults under the Settlement Agreement.                          
Marketplace Revenue [Member]                                        
Revenues                               53,942,076 63,149,673 64,608,516    
Settlement Agreement [Member]                                        
Debt instrument, description             Pursuant to the Settlement Agreement, the Company shall pay JSC $1,269,977 and shall provide JSC with: (i) two new promissory notes, a note of $5,803,800 related to the Seller Note and note of $2,635,797 for inventory and services, which was reclassed from accounts payable, both with a maturity date of August 15, 2021, (ii) general business security agreements granting JSC a security interest in all personal property of the Company. Pursuant to the Notes, the Company is obligated to make monthly payments totaling $204,295 to JSC. In addition, the Notes have a mandatory prepayment provision that comes into effect if the Company conducts a publicly registered offering.                          
Principal payments             $ 1,269,977                          
Payment of note payable related party           $ 6,000,000                            
Debt maturity date             Aug. 15, 2021                          
Settlement Agreement [Member] | Note B [Member]                                        
Payment of note payable related party           $ 592,982                            
Interest expenses                                     $ 62,876  
Settlement Agreement [Member] | Amended Note B [Member]                                        
Debt interest rate           9.00%                            
Settlement Agreement [Member] | Inventory and Services [Member]                                        
Payment of note payable related party             $ 2,635,797                          
Settlement Agreement [Member] | Jagemann Stamping Company [Member]                                        
Debt instrument, description             upon the closing of an Offering of less than $10,000,000 would be obligated to pay the lesser of ninety percent (90%) of the Offering proceeds or seventy (70%) of the then aggregate outstanding balance of the Notes; and (b) upon the closing of an Offering of more than $10,000,000 would be obligated to pay one hundred percent (100%) of the then aggregate outstanding balance of the Notes. The Company was granted an option to repurchase up to 1,000,000 of the shares of the Company’s Common Stock issued to JSC under the Amended APA at a price of $1.50 per share through April 1, 2021 so long as there are no defaults under the Settlement Agreement                          
2022 Urvan Settlement Agreement [Member]                                        
Issuance of Series A Preferred Stock, net of issuance costs, shares     110,000                                  
Common stock shares issued, value     $ 259,000                                  
Costs, fees and expenses     $ 500,000                                  
2022 Urvan Settlement Agreement [Member] | Common Stock [Member]                                        
Issuance of Series A Preferred Stock, net of issuance costs, shares     125,000                                  
Common stock shares issued, value     $ 777,500                                  
Administrative and Management Services [Member]                                        
Purchased inventory support services                                 2,000,000 1,700,000    
Rent paid                                 170,355 408,852    
Amended APA [Member] | Jagemann Stamping Company [Member]                                        
Share price per share         $ 1.5                              
Shares repurchase         1,000,000                              
Related Party [Member]                                        
Service fees                               410,173 551,916      
Service payment due upon termination amount                               $ 244,640 $ 223,333      
Shares for service                                 141,419      
Service paid                                 $ 791,384      
Issuance of Series A Preferred Stock, net of issuance costs, shares                               134,240        
Accounts receivable                   201,646           $ 201,646        
Accounts receivable                               150,866        
Accounts receivable                   $ 201,646           201,646 182,344 139,164    
Related Party [Member] | Amended Note B [Member]                                        
Notes payable related party                                 180,850 865,771    
Related Party [Member] | Settlement Agreement [Member] | Amended Note B [Member]                                        
Notes payable related party           $ 1,687,664                            
Larson Building [Member]                                        
Payment of note payable related party                                 $ 14,584,805 $ 11,221,738    
Undisclosed payment from vendor                               814,863        
Foregoing [Member]                                        
Service paid                               $ 449,370        
Advisory Committee [Member]                                        
Shares for service                               168,581 45,000 60,000    
Service paid                               $ 43,240 $ 245,250 $ 198,000    
Fred Wagenhals [Member]                                        
Issuance of Series A Preferred Stock, net of issuance costs, shares 300,000                                      
Payments to Employees $ 1,060,290                                      
Common stock shares issued, value $ 639,000                                      
Debt interest rate           12.00%                            
Fred Wagenhals [Member] | Third-party Service Provider [Member]                                        
Payment of note payable related party                                   50,698    
Independent Contractor [Member]                                        
Service fees                                   $ 229,083    
v3.25.1
SCHEDULE OF INCOME TAX PROVISION BENEFIT (Details) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Sep. 30, 2023
Dec. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Income Tax Disclosure [Abstract]                  
US Federal             $ (2,628,241)
US State             (765,545)
Total current provision             (3,393,786)
US Federal             2,986,152 (492,171) (6,675,540)
US State             819,966 (220,068) (1,374,865)
Total deferred benefit             3,806,118 (712,239) (8,050,405)
Change in valuation allowance                 9,401,273
Income tax (provision) benefit $ 1,361,700 $ 359,189 $ 1,879,641 $ 205,588 $ 2,085,229 $ 2,444,418 $ 3,806,118 $ (712,239) $ (2,042,918)
v3.25.1
SCHEDULE OF RECONCILIATION OF INCOME TAX (Details)
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Income Tax Disclosure [Abstract]      
U.S. Federal 21.00% 21.00% 21.00%
State taxes, net of federal income tax benefit 5.60% 6.00% 5.70%
Change in valuation allowance 0.00% 0.00% (33.70%)
Employee stock awards (7.40%) (33.30%) 7.00%
Equity issuance costs 0.00% 0.00% 6.20%
Stock and warrants on note conversion 0.00% (1.90%) 1.40%
Stock for services 0.00% 0.00% 0.00%
Non-deductible meals and entertainment (0.10%) (0.40%) 0.10%
Contingent consideration fair value 0.10% 0.20% (0.40%)
Return to provision 0.00% 0.00% 0.00%
Other (0.40%) (0.30%) 0.00%
Total provision for income taxes 18.70% (8.80%) 7.30%
v3.25.1
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($)
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Income Tax Disclosure [Abstract]      
Net operating loss carryforward $ 5,229,409 $ 731,597 $ 0
Loss on purchase 2,215,611 2,210,878 2,225,477
Amortization (1,029,565) (52,658) 887,892
Bad debt allowance 973,565 860,314 814,967
Other 297,195 (137,835) (335,847)
Total deferred tax assets 7,686,215 3,612,296 3,592,489
Depreciation expense (3,580,271) (3,510,041) (3,082,977)
Sec 263A 1,001,457 1,191,918 1,302,919
True up (699,910) (698,417) (461,563)
Other 0 0 0
Total deferred tax liabilities (3,278,724) (3,016,540) (2,241,621)
Net deferred tax assets/(liabilities) 4,407,491 595,756 1,350,868
Valuation allowance 0 0 0
Net deferred tax assets/(liabilities) $ 4,407,491 $ 595,756 $ 1,350,868
v3.25.1
INCOME TAXES (Details Narrative) - USD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Income Tax Disclosure [Abstract]      
Effective income tax percentage 18.70% (8.80%) 7.30%
Accumulated net operating losses   $ 32.3 $ 61.5
Operating loss carryforwards valuation allowance   9.4  
Additional income tax payable $ 1.6 1.6 1.6
Accrued penalties and interest $ 0.3 $ 0.3 $ 0.3
v3.25.1
SCHEDULE OF INTANGIBLE ASSETS (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Mar. 31, 2022
Finite-Lived Intangible Assets [Line Items]            
Intangible assets, net $ 115,805,073          
Licensing Agreement - Jesse James [Member]            
Finite-Lived Intangible Assets [Line Items]            
Licensing agreement, life 5 years       5 years 5 years
Intangible assets, gross $ 125,000       $ 125,000 $ 125,000
Licensing Agreement - Jeff Rann [Member]            
Finite-Lived Intangible Assets [Line Items]            
Licensing agreement, life 5 years       5 years 5 years
Intangible assets, gross $ 250,000       $ 250,000 $ 250,000
Streak Visual Ammunition Patent [Member]            
Finite-Lived Intangible Assets [Line Items]            
Licensing agreement, life 11 years 2 months 12 days       11 years 2 months 12 days 11 years 2 months 12 days
Intangible assets, gross $ 950,000       $ 950,000 $ 950,000
SWK Patent Acquisition [Member]            
Finite-Lived Intangible Assets [Line Items]            
Licensing agreement, life 15 years       15 years 15 years
Intangible assets, gross $ 6,652,005       $ 6,652,005 $ 6,652,005
Customer Relationships [Member] | Jagemann Munition Components [Member]            
Finite-Lived Intangible Assets [Line Items]            
Licensing agreement, life 3 years       3 years 3 years
Intangible assets, gross $ 1,450,613       $ 1,450,613 $ 1,450,613
Intellectual Property [Member] | GDI Acquisition [Member]            
Finite-Lived Intangible Assets [Line Items]            
Licensing agreement, life 10 years       10 years 10 years
Intangible assets, gross $ 4,224,442       $ 4,224,442 $ 4,224,442
Intellectual Property [Member] | Jagemann Munition Components [Member]            
Finite-Lived Intangible Assets [Line Items]            
Licensing agreement, life 3 years       3 years 3 years
Intangible assets, gross $ 1,543,548       $ 1,543,548 $ 1,543,548
Trade Names [Member] | GDI Acquisition [Member]            
Finite-Lived Intangible Assets [Line Items]            
Licensing agreement, life 15 years       15 years 15 years
Intangible assets, gross $ 76,532,389       $ 76,532,389 $ 76,532,389
Trade Names [Member] | Jagemann Munition Components [Member]            
Finite-Lived Intangible Assets [Line Items]            
Licensing agreement, life 5 years       5 years 5 years
Intangible assets, gross $ 2,152,076       $ 2,152,076 $ 2,152,076
Customer Lists [Member] | GDI Acquisition [Member]            
Finite-Lived Intangible Assets [Line Items]            
Licensing agreement, life 10 years       10 years 10 years
Intangible assets, gross $ 65,252,802       $ 65,252,802 $ 65,252,802
Other Intangible Assets [Member]            
Finite-Lived Intangible Assets [Line Items]            
Intangible assets, gross 151,513,617       151,763,617 151,763,617
Accumulated amortization (40,464,550)       (28,036,807) (15,463,230)
Intangible assets, net $ 111,049,067       $ 123,726,810 $ 136,300,387
Other Intangible Assets [Member] | GDI Acquisition [Member]            
Finite-Lived Intangible Assets [Line Items]            
Licensing agreement, life 5 years       5 years 5 years
Intangible assets, gross $ 357,747       $ 607,747 $ 607,747
Licensing Agreements [Member]            
Finite-Lived Intangible Assets [Line Items]            
Intangible assets, gross 375,000       375,000 375,000
Accumulated amortization (375,000)       (375,000) (375,000)
Intangible assets, net      
Patents [Member]            
Finite-Lived Intangible Assets [Line Items]            
Intangible assets, gross 7,602,005       7,602,005 7,602,005
Accumulated amortization (2,845,999)       (2,305,251) (1,764,503)
Intangible assets, net $ 4,756,006 $ 4,891,193 $ 5,026,380 $ 5,161,567 $ 5,296,754 $ 5,837,502
v3.25.1
SCHEDULE OF ANNUAL AMORTIZATION OF INTANGIBLE ASSET (Details) - USD ($)
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Finite-Lived Intangible Assets [Line Items]      
2025 $ 12,697,926    
2026 12,662,059    
2027 12,596,472    
2028 12,590,510    
2029 12,555,076    
Thereafter 52,703,030    
Annual amortization of intangible assets 115,805,073    
Other Intangible Assets [Member]      
Finite-Lived Intangible Assets [Line Items]      
Annual amortization of intangible assets $ 111,049,067 $ 123,726,810 $ 136,300,387
v3.25.1
GOODWILL AND INTANGIBLE ASSETS (Details Narrative) - USD ($)
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Apr. 30, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Goodwill $ 90,870,094 $ 90,870,094 $ 90,870,094 $ 90,870,094 $ 90,870,094 $ 90,870,094 $ 90,870,094
Amortization of intangible assets 12,968,491 $ 13,114,325 13,143,168        
Loss on disposal of intangible assets $ (108,333)            
Merger Agreement [Member] | Gemini Direct Investments LLC [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Goodwill     $ 90,870,094        
v3.25.1
SCHEDULE OF OPERATING SEGMENTS (Details) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Sep. 30, 2023
Dec. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Revenue from External Customer [Line Items]                  
Total Revenues $ 40,421,147 $ 36,006,464 $ 34,372,386 $ 34,254,575 $ 68,626,961 $ 104,633,425 $ 145,054,572 $ 191,439,801 $ 240,269,166
Cost of Revenues             102,479,087 136,078,488 151,552,941
General and administrative expense             48,653,355 49,530,117 46,465,107
Depreciation and amortization 3,425,790 3,401,156 3,371,802 3,344,043 6,715,845 10,117,001 13,542,791 13,278,762 13,725,065
Income/(Loss) from Operations $ (6,033,811) $ (2,576,497) $ (9,011,953) $ (1,998,400) $ (11,010,353) $ (13,586,850) (19,620,661) (7,447,566) 28,526,053
Ammunition [Member]                  
Revenue from External Customer [Line Items]                  
Total Revenues             91,112,496 128,290,128 175,660,650
Cost of Revenues             94,818,546 126,961,549 142,820,590
General and administrative expense             8,967,456 10,378,456 11,932,720
Depreciation and amortization             508,485 578,326 1,602,695
Income/(Loss) from Operations             (13,181,991) (9,628,203) 19,304,645
Marketplace [Member]                  
Revenue from External Customer [Line Items]                  
Total Revenues             53,942,076 63,149,673 64,608,516
Cost of Revenues             7,660,541 9,116,939 8,732,351
General and administrative expense             9,885,131 9,707,425 8,434,308
Depreciation and amortization             13,034,306 12,700,436 12,122,370
Income/(Loss) from Operations             23,362,098 31,624,873 35,319,487
Corporate and Other Expenses [Member]                  
Revenue from External Customer [Line Items]                  
Total Revenues            
Cost of Revenues            
General and administrative expense             29,800,768 29,444,236 26,098,079
Depreciation and amortization              
Income/(Loss) from Operations             $ (29,800,768) $ (29,444,236) $ (26,098,079)
v3.25.1
SCHEDULE OF TOTAL ASSETS SEGMENTS (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Mar. 31, 2022
Segment Reporting Information [Line Items]            
Total assets $ 403,039,335 $ 403,773,545 $ 405,579,981 $ 409,120,181 $ 413,195,143 $ 415,840,465
Ammunition [Member]            
Segment Reporting Information [Line Items]            
Total assets 167,001,641       154,904,363 161,967,259
Marketplace [Member]            
Segment Reporting Information [Line Items]            
Total assets $ 236,037,694       $ 258,290,780 $ 253,873,206
v3.25.1
SCHEDULE OF CAPITAL EXPENDITURE SEGMENT (Details) - USD ($)
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Segment Reporting Information [Line Items]      
Payment to acquire property and plant equipment $ 8,024,765 $ 12,541,325 $ 19,218,982
Ammunition [Member]      
Segment Reporting Information [Line Items]      
Payment to acquire property and plant equipment 5,519,135 10,819,177 17,728,023
Marketplace [Member]      
Segment Reporting Information [Line Items]      
Payment to acquire property and plant equipment $ 2,505,630 $ 1,722,148 $ 1,490,959
v3.25.1
SCHEDULE OF QUARTERLY STATEMENT OF OPERATIONS (Details) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Sep. 30, 2023
Dec. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Net revenues                  
Total revenues $ 40,421,147 $ 36,006,464 $ 34,372,386 $ 34,254,575 $ 68,626,961 $ 104,633,425 $ 145,054,572 $ 191,439,801 $ 240,269,166
Cost of revenues 31,033,381 25,107,909 26,095,941 20,241,856 46,337,797 71,445,706 102,479,087 136,078,488 151,552,941
Gross Profit 9,387,766 10,898,555 8,276,445 14,012,719 22,289,164 33,187,719 42,575,485 55,361,313 88,716,225
Operating expenses                  
Selling and marketing 547,981 236,565 289,952 295,581 585,533 822,098 1,370,079 4,729,540 7,310,216
Corporate general and administrative 7,976,832 5,803,255 7,855,624 7,947,563 15,803,187 21,606,442 29,583,274 24,980,079 24,120,483
Employee salaries and related expenses 3,470,974 4,034,076 5,771,020 4,423,932 10,194,952 14,229,028 17,700,002 19,820,498 15,034,408
Depreciation and amortization expense 3,425,790 3,401,156 3,371,802 3,344,043 6,715,845 10,117,001 13,542,791 13,278,762 13,725,065
Total operating expenses 15,421,577 13,475,052 17,288,398 16,011,119 33,299,517 46,774,569 62,196,146 62,808,879 60,190,172
Income/(Loss) from Operations (6,033,811) (2,576,497) (9,011,953) (1,998,400) (11,010,353) (13,586,850) (19,620,661) (7,447,566) 28,526,053
Other expenses                  
Other income (708,779) 4,576 (321,341) 692,951 371,610 376,186 (332,593) 25,181 21,840
Interest expense 163,088 (193,046) (212,314) (204,201) (416,515) (609,561) (446,473) (632,062) (637,797)
Total other expense (545,691) (188,470) (533,655) 488,750 (44,905) (233,375) (779,066) (606,881) (615,957)
Income/(Loss) before Income Taxes (6,579,502) (2,764,967) (9,545,608) (1,509,650) (11,055,258) (13,820,225) (20,399,727) (8,054,447) 27,910,096
Provision for income taxes 1,361,700 359,189 1,879,641 205,588 2,085,229 2,444,418 3,806,118 (712,239) (2,042,918)
Net Income/(Loss) (5,217,802) (2,405,778) (7,665,967) (1,304,062) (8,970,029) (11,375,807) (16,593,609) (8,766,686) 25,867,178
Preferred Stock Dividend (782,639) (782,639) (782,639) (774,132) (1,556,771) (2,339,410) (3,122,049) (3,105,034) (2,668,649)
Net Income/(Loss) Attributable to Common Stock Shareholders $ (6,000,441) $ (3,188,417) $ (8,448,606) $ (2,078,194) $ (10,526,800) $ (13,715,217) $ (19,715,658) $ (11,871,720) $ 23,198,529
Net income/(loss) per share                  
Basic $ (0.05) $ (0.03) $ (0.07) $ (0.02) $ (0.09) $ (0.12) $ (0.17) $ (0.1) $ 0.21
Diluted $ (0.05) $ (0.03) $ (0.07) $ (0.02) $ (0.09) $ (0.12) $ (0.17) $ (0.1) $ 0.2
Ammunition Sales [Member]                  
Net revenues                  
Total revenues $ 22,445,216 $ 17,322,967 $ 15,516,589 $ 14,106,029 $ 29,622,618 $ 46,945,585 $ 69,390,801 [1],[2] $ 114,116,044 [1],[2] $ 161,459,025 [1],[2]
Marketplace Fee Revenue [Member]                  
Net revenues                  
Total revenues 13,570,124 13,985,034 12,474,716 13,912,202 26,386,918 40,371,952 53,942,076 63,149,673 64,608,516
Ammunition Casings Sales [Member]                  
Net revenues                  
Total revenues 4,405,807 4,698,463 6,381,081 6,236,344 12,617,425 17,315,888 21,721,695 14,174,084 14,201,625
As Previously Reported [Member]                  
Net revenues                  
Total revenues 40,421,147 36,006,464 34,372,386 34,254,575 68,626,961 104,633,425 145,054,572 191,439,801 240,269,166
Cost of revenues 31,021,560 25,096,088 26,084,120 20,230,035 46,314,155 71,410,243 102,431,803 136,031,204 151,505,657
Gross Profit 9,399,587 10,910,376 8,288,266 14,024,540 22,312,806 33,223,182 42,622,769 55,408,597 88,763,509
Operating expenses                  
Selling and marketing 547,981 236,565 289,952 295,581 585,533 822,098 1,370,079 4,729,540 7,310,216
Corporate general and administrative 7,976,832 5,803,255 7,855,624 7,947,563 15,803,187 21,606,442 29,583,274 24,980,079 16,986,344
Employee salaries and related expenses 3,607,354 3,390,153 5,590,035 4,116,280 9,706,315 13,096,468 16,703,822 15,679,135 13,615,439
Depreciation and amortization expense 3,425,790 3,401,156 3,371,802 3,344,043 6,715,845 10,117,001 13,542,791 13,278,762 13,702,148
Total operating expenses 15,557,957 12,831,129 17,107,413 15,703,467 32,810,880 45,642,009 61,199,966 58,667,516 51,614,147
Income/(Loss) from Operations (6,158,370) (1,920,753) (8,819,147) (1,678,927) (10,498,074) (12,418,827) (18,577,197) (3,258,919) 37,149,362
Other expenses                  
Other income (708,779) 4,576 (321,341) 692,951 371,610 376,186 (332,593) 25,181 21,840
Interest expense 163,088 (193,046) (212,314) (204,201) (416,515) (609,561) (446,473) (632,062) (637,797)
Total other expense (545,691) (188,470) (533,655) 488,750 (44,905) (233,375) (779,066) (606,881) (615,957)
Income/(Loss) before Income Taxes (6,704,061) (2,109,223) (9,352,802) (1,190,177) (10,542,979) (12,652,202) (19,356,263) (3,865,800) 36,533,405
Provision for income taxes 1,371,180 465,234 1,857,505 97,144 1,954,649 2,419,883 3,791,063 (730,238) (3,285,969)
Net Income/(Loss) (5,332,881) (1,643,989) (7,495,297) (1,093,033) (8,588,330) (10,232,319) (15,565,200) (4,596,038) 33,247,436
Preferred Stock Dividend (782,639) (782,639) (782,639) (774,132) (1,556,771) (2,339,410) (3,122,049) (3,105,034) (2,668,649)
Net Income/(Loss) Attributable to Common Stock Shareholders $ (6,115,520) $ (2,426,628) $ (8,277,936) $ (1,867,165) $ (10,145,101) $ (12,571,729) $ (18,687,249) $ (7,701,072) $ 30,578,787
Net income/(loss) per share                  
Basic $ (0.05) $ (0.02) $ (0.07) $ (0.02) $ (0.09) $ (0.11) $ (0.16) $ (0.07) $ 0.27
Diluted $ (0.05) $ (0.02) $ (0.07) $ (0.02) $ (0.09) $ (0.11) $ (0.16) $ (0.07) $ 0.27
As Previously Reported [Member] | Ammunition Sales [Member]                  
Net revenues                  
Total revenues $ 22,445,216 $ 17,322,967 $ 15,516,589 $ 14,106,029 $ 29,622,618 $ 46,945,585 $ 69,390,801 $ 114,116,044 $ 161,459,025
As Previously Reported [Member] | Marketplace Fee Revenue [Member]                  
Net revenues                  
Total revenues 13,570,124 13,985,034 12,474,716 13,912,202 26,386,918 40,371,952 53,942,076 63,149,673 64,608,516
As Previously Reported [Member] | Ammunition Casings Sales [Member]                  
Net revenues                  
Total revenues 4,405,807 4,698,463 6,381,081 6,236,344 12,617,425 17,315,888 $ 21,721,695 $ 14,174,084 $ 14,201,625
Stock Based Payments Adjustments [Member]                  
Operating expenses                  
Employee salaries and related expenses (136,380) 643,923 180,985 307,652 488,637 1,132,560      
Total operating expenses (136,380) 643,923 180,985 307,652 488,637 1,132,560      
Income/(Loss) from Operations 136,380 (643,923) (180,985) (307,652) (488,637) (1,132,560)      
Other expenses                  
Income/(Loss) before Income Taxes 136,380 (643,923) (180,985) (307,652) (488,637) (1,132,560)      
Net Income/(Loss) 136,380 (643,923) (180,985) (307,652) (488,637) (1,132,560)      
Net Income/(Loss) Attributable to Common Stock Shareholders 136,380 (643,923) (180,985) (307,652) (488,637) (1,132,560)      
Other Adjustments [Member]                  
Net revenues                  
Cost of revenues 11,821 11,821 11,821 11,821 23,642 35,463      
Gross Profit (11,821) (11,821) (11,821) (11,821) (23,642) (35,463)      
Operating expenses                  
Income/(Loss) from Operations (11,821) (11,821) (11,821) (11,821) (23,642) (35,463)      
Other expenses                  
Income/(Loss) before Income Taxes (11,821) (11,821) (11,821) (11,821) (23,642) (35,463)      
Provision for income taxes (9,480) (106,045) 22,136 108,444 130,580 24,535      
Net Income/(Loss) (21,301) (117,866) 10,315 96,623 106,938 (10,928)      
Net Income/(Loss) Attributable to Common Stock Shareholders $ (21,301) $ (117,866) $ 10,315 $ 96,623 $ 106,938 $ (10,928)      
[1]
(1)
Included in revenue for the years ended March 31, 2024, 2023, and 2022 are excise taxes of $6,155,524, $9,789,897, and $14,646,983, respectively.
[2] Included in revenue for the years ended March 31, 2024, 2023, and 2022 are excises taxes of $6,155,524, $9,789,897, and $14,646,983, respectively.
v3.25.1
SCHEDULE OF QUARTERLY BALANCE SHEET INFORMATION (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Mar. 31, 2022
Apr. 30, 2021
Mar. 31, 2021
Current Assets:                
Cash and cash equivalents $ 55,586,441 $ 54,679,868 $ 49,564,868 $ 47,505,047 $ 39,134,027 $ 23,281,475   $ 118,341,471
Accounts receivable, net 28,221,321 21,121,450 23,030,851 21,348,226 29,346,380 43,955,084    
Inventories 45,563,334 49,502,732 53,014,205 55,924,655 54,344,819 59,016,152    
Prepaid expenses 2,154,170 3,708,865 3,920,007 5,294,454 5,126,667 3,423,925    
Current portion of restricted cash       500,000 500,000 0    
Total Current Assets 131,525,266 129,012,915 129,529,931 130,572,382 128,451,893 129,691,636    
Equipment, net 58,082,040 57,278,603 55,821,414 55,923,867 55,963,255 37,637,806    
Other Assets:                
Deposits 349,278 2,265,932 3,189,518 4,064,582 7,028,947 11,360,322    
Intangible assets, net 115,805,073              
Other intangible assets, net   114,296,627 117,440,022 120,583,416        
Goodwill 90,870,094 90,870,094 90,870,094 90,870,094 90,870,094 90,870,094 $ 90,870,094  
Right of use assets - operating leases 2,000,093 2,113,943 1,017,982 1,141,418 1,261,634 2,791,850    
Deferred income tax asset 4,407,491 3,044,238 2,684,640 802,855 595,756 1,350,868    
TOTAL ASSETS 403,039,335 403,773,545 405,579,981 409,120,181 413,195,143 415,840,465    
Current Liabilities:                
Accounts payable 23,156,495 19,146,138 19,598,548 16,356,614 18,079,397 26,817,083    
Accrued liabilities 7,065,444 6,603,892 6,282,980 4,677,757 4,388,132 6,213,592    
Current portion of operating lease liability 479,651 463,059 370,980 421,477 470,734 831,429    
Note payable related party         180,850 684,639    
Current portion of construction note payable 273,459 265,977 265,977 277,216 260,429      
Insurance premium note payable   173,029 1,157,745 2,204,293 2,118,635      
Total Current Liabilities 30,975,049 26,652,095 27,676,230 23,937,357 25,498,177 35,858,089    
Long-term Liabilities:                
Contingent consideration payable 59,838 80,080 99,302 119,354 140,378 204,142    
Income tax payable 1,609,520 1,609,520 1,609,520 1,609,520 1,609,520 1,609,520    
Construction note payable, net of unamortized issuance costs 10,735,241 10,797,696 10,830,663 10,861,510 10,922,443 38,330    
Operating lease liability, net of current portion 1,609,836 1,737,615 744,616 825,043 903,490 2,091,351    
Deferred income tax liability     0 0 0      
Total Liabilities 44,989,484 40,877,006 40,960,331 37,352,784 39,074,008 39,982,564    
Shareholders’ Equity:                
Series A cumulative perpetual preferred Stock 1,400 1,400 1,400 1,400 1,400 1,400    
Common stock 119,181 118,644 118,461 117,946 118,294 116,487    
Additional paid-in capital 430,525,824 429,381,115 427,619,626 425,920,655 424,739,847 414,084,541    
Accumulated deficit (69,923,398) (63,931,464) (60,743,047) (52,294,441) (50,216,248) (38,344,527)   (61,543,056)
Treasury Stock (2,673,156) (2,673,156) (2,376,790) (1,978,163) (522,158)      
Total Shareholders’ Equity 358,049,851 362,896,539 364,619,650 371,767,397 374,121,135 375,857,901   160,729,013
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY 403,039,335 403,773,545 405,579,981 409,120,181 413,195,143 415,840,465    
As Previously Reported [Member]                
Current Assets:                
Cash and cash equivalents 55,586,441 54,679,868 49,564,868 47,505,047 39,134,027 23,281,475   118,341,471
Accounts receivable, net 28,221,321 21,121,450 23,030,851 21,348,226 29,346,380 43,955,084    
Inventories 45,563,334 49,502,732 53,014,205 55,924,655 54,344,819 59,016,152    
Prepaid expenses 2,154,170 3,708,865 3,920,007 5,294,454 5,126,667 3,423,925    
Current portion of restricted cash       500,000 500,000      
Total Current Assets 131,525,266 129,012,915 129,529,931 130,572,382 128,451,893 129,691,636    
Equipment, net 58,082,040 57,278,603 55,821,414 55,923,867 55,963,255 37,637,806    
Other Assets:                
Deposits 349,278 2,265,932 3,189,518 4,064,582 7,028,947 11,360,322    
Other intangible assets, net   114,296,627 117,440,022 120,583,416        
Goodwill 90,870,094 90,870,094 90,870,094 90,870,094 90,870,094 90,870,094    
Right of use assets - operating leases 2,000,093 2,113,943 1,017,982 1,141,418 1,261,634 2,791,850    
Deferred income tax asset 1,487,088 115,908            
TOTAL ASSETS 399,902,216 400,616,678 402,654,983 408,065,147 412,335,387 414,178,313    
Current Liabilities:                
Accounts payable 23,156,495 19,146,138 19,598,548 16,356,614 18,079,397 26,817,083    
Accrued liabilities 7,030,667 6,570,668 6,250,164 4,641,469 4,353,354 6,178,814    
Current portion of operating lease liability 479,651 463,059 370,980 421,477 470,734 831,429    
Note payable related party         180,850 684,639    
Current portion of construction note payable 273,459 265,977 265,977 277,216 260,429      
Insurance premium note payable   173,029 1,157,745 2,204,293 2,118,635      
Total Current Liabilities 30,940,272 26,618,871 27,643,414 23,901,069 25,463,399 35,823,311    
Long-term Liabilities:                
Contingent consideration payable 59,838 80,080 99,302 119,354 140,378 204,142    
Construction note payable, net of unamortized issuance costs 10,735,241 10,797,696 10,830,663 10,861,510 10,922,443 38,330    
Operating lease liability, net of current portion 1,609,836 1,737,615 744,616 825,043 903,490 2,091,351    
Deferred income tax liability     349,327 2,212,448 2,309,592 1,536,481    
Total Liabilities 43,345,187 39,234,262 39,667,322 37,919,424 39,739,302 39,874,747    
Shareholders’ Equity:                
Series A cumulative perpetual preferred Stock 1,400 1,400 1,400 1,400 1,400 1,400    
Common stock 119,181 118,644 118,461 117,946 118,294 116,487    
Additional paid-in capital 396,730,170 395,449,082 394,331,516 392,813,530 391,940,374 385,426,431    
Accumulated deficit (37,620,566) (31,513,554) (29,086,926) (20,808,990) (18,941,825) (11,240,752)   (41,819,539)
Treasury Stock (2,673,156) (2,673,156) (2,376,790) (1,978,163) (522,158)      
Total Shareholders’ Equity 356,557,029 361,382,416 362,987,661 370,145,723 372,596,085 374,303,566   $ 160,347,529
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY 399,902,216 400,616,678 402,654,983 408,065,147 412,335,387 414,178,313    
Restatement Adjustment on Stock-Based Compensation [Member]                
Shareholders’ Equity:                
Additional paid-in capital   13,310,965 12,667,042 12,486,057        
Accumulated deficit   (13,310,965) (12,667,042) (12,486,057)        
Restatement Adjustment on Equity Issuance Costs [Member]                
Shareholders’ Equity:                
Additional paid-in capital   7,420,492 7,420,492 7,420,492        
Accumulated deficit   (7,420,492) (7,420,492) (7,420,492)        
Restatement Adjustment on Convertible Notes [Member]                
Shareholders’ Equity:                
Additional paid-in capital   6,024,240 6,024,240 6,024,240        
Accumulated deficit   (6,024,240) (6,024,240) (6,024,240)        
Restatement Adjustment on Warrants [Member]                
Shareholders’ Equity:                
Additional paid-in capital   1,298,336 1,298,336 1,298,336        
Accumulated deficit   (1,298,336) (1,298,336) (1,298,336)        
Restatement Adjustment on Acquisition [Member]                
Shareholders’ Equity:                
Additional paid-in capital   5,225,000 5,225,000 5,225,000        
Accumulated deficit   (5,225,000) (5,225,000) (5,225,000)        
Restatement Adjustment Other [Member]                
Other Assets:                
Deferred income tax asset   2,928,330 2,684,640 802,855        
TOTAL ASSETS   3,156,867 2,924,998 1,055,034        
Current Liabilities:                
Accrued liabilities   33,224 32,816 36,288        
Total Current Liabilities   33,224 32,816 36,288        
Long-term Liabilities:                
Income tax payable   1,609,520 1,609,520 1,609,520        
Deferred income tax liability   (1,642,744) (349,327) (2,212,448)        
Total Liabilities     1,293,009 (566,640)        
Shareholders’ Equity:                
Additional paid-in capital   653,000 653,000 653,000        
Accumulated deficit   861,123 978,989 968,674        
Total Shareholders’ Equity   1,514,123 1,631,989 1,621,674        
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY   3,156,867 2,924,998 1,055,034        
Patents [Member]                
Other Assets:                
Intangible assets, net 4,756,006 4,891,193 5,026,380 5,161,567 5,296,754 5,837,502    
Patents [Member] | As Previously Reported [Member]                
Other Assets:                
Intangible assets, net $ 4,539,290 4,662,656 4,786,022 4,909,388 $ 5,032,754 $ 5,526,218    
Patents [Member] | Restatement Adjustment Other [Member]                
Other Assets:                
Intangible assets, net   $ 228,537 $ 240,358 $ 252,179        
v3.25.1
SCHEDULE OF QUARTERLY STATEMENTS OF STOCKHOLDERS' EQUITY (Details) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Sep. 30, 2023
Dec. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Balance $ 362,896,539 $ 364,619,650 $ 371,767,397 $ 374,121,135 $ 374,121,135 $ 374,121,135 $ 374,121,135 $ 375,857,901 $ 160,729,013
Employee stock awards (restated)   1,381,772 1,699,684 1,181,199          
Dividends accumulated on preferred stock   (144,618) (136,093) (136,094)     (144,618) (144,618) (144,562)
Common stock purchase options   380,045         430,458    
Preferred stock dividend   (638,021) (646,545) (638,038)     (2,330,852) (2,322,346)  
Preferred stock dividends declared             (638,071) (638,071) (2,524,087)
Net income/(loss) (5,217,802) (2,405,778) (7,665,967) (1,304,062) (8,970,029) (11,375,807) (16,593,609) (8,766,686) 25,867,178
Treasury shares purchased             (2,152,080) (522,426)  
Treasury shares purchased   (296,511) (398,825) (1,456,744)          
Balance 358,049,851 362,896,539 364,619,650 371,767,397 364,619,650 362,896,539 358,049,851 374,121,135 375,857,901
Employee stock awards   1,381,772 1,699,684 1,181,199          
As Previously Reported [Member]                  
Balance 361,382,416 362,987,661 370,145,723 372,596,085 372,596,085 372,596,085 372,596,085 374,303,566 160,347,529
Net income/(loss) (5,332,881) (1,643,989) (7,495,297) (1,093,033) (8,588,330) (10,232,319) (15,565,200) (4,596,038) 33,247,436
Balance 356,557,029 361,382,416 362,987,661 370,145,723 362,987,661 361,382,416 356,557,029 372,596,085 374,303,566
Preferred Stock [Member]                  
Balance $ 1,400 $ 1,400 $ 1,400 $ 1,400 $ 1,400 $ 1,400 $ 1,400 $ 1,400  
Balance, shares 1,400,000 1,400,000 1,400,000 1,400,000 1,400,000 1,400,000 1,400,000 1,400,000  
Dividends accumulated on preferred stock              
Common stock purchase options                
Preferred stock dividend                
Preferred stock dividends declared              
Net income/(loss)              
Treasury shares purchased                
Balance $ 1,400 $ 1,400 $ 1,400 $ 1,400 $ 1,400 $ 1,400 $ 1,400 $ 1,400 $ 1,400
Balance, shares 1,400,000 1,400,000 1,400,000 1,400,000 1,400,000 1,400,000 1,400,000 1,400,000 1,400,000
Preferred Stock [Member] | As Previously Reported [Member]                  
Balance                
Balance, shares                
Common Stock [Member]                  
Balance $ 118,644 $ 118,461 $ 117,946 $ 118,294 $ 118,294 $ 118,294 $ 118,294 $ 116,487 $ 93,100
Balance, shares 118,643,593 118,460,743 117,945,758 118,294,478 118,294,478 118,294,478 118,294,478 116,485,747 93,099,967
Employee stock awards (restated)   $ 328 $ 713 $ 391          
Employee stock awards (restated), shares   328,333 712,783 390,111          
Dividends accumulated on preferred stock            
Preferred stock dividend              
Preferred stock dividends declared            
Net income/(loss)            
Treasury shares purchased   $ (145) $ (198) $ (739)     (1,082) (268)  
Treasury shares purchased, shares   (145,483) (197,798) (738,831)          
Balance $ 119,181 $ 118,644 $ 118,461 $ 117,946 $ 118,461 $ 118,644 $ 119,181 $ 118,294 $ 116,487
Balance, shares 119,181,067 118,643,593 118,460,743 117,945,758 118,460,743 118,643,593 119,181,067 118,294,478 116,485,747
Employee stock awards   $ 328 $ 713 $ 391          
Common Stock [Member] | As Previously Reported [Member]                  
Balance                 $ 93,100
Balance, shares                 93,099,967
Additional Paid-in Capital [Member]                  
Balance $ 429,381,115 427,619,626 425,920,655 424,739,847 $ 424,739,847 $ 424,739,847 $ 424,739,847 $ 414,084,541 $ 222,178,969
Employee stock awards (restated)   1,381,444 1,698,971 1,180,808     5,279,351 10,126,460 7,428,650
Dividends accumulated on preferred stock            
Common stock purchase options   380,045         430,458    
Preferred stock dividend              
Preferred stock dividends declared            
Net income/(loss)            
Treasury shares purchased              
Balance 430,525,824 429,381,115 427,619,626 425,920,655 427,619,626 429,381,115 430,525,824 424,739,847 414,084,541
Employee stock awards   1,381,444 1,698,971 1,180,808     5,279,351 10,126,460 7,428,650
Additional Paid-in Capital [Member] | As Previously Reported [Member]                  
Balance                 202,073,968
Employee stock awards (restated)   686,771 1,467,236 822,406     4,080,170 5,806,003 5,759,000
Employee stock awards   686,771 1,467,236 822,406     4,080,170 5,806,003 5,759,000
Stock grants   50,750 50,750 50,750          
Additional Paid-in Capital [Member] | Reclassification [Member]                  
Employee stock awards (restated)   50,750 50,750 50,750     203,000 179,094 252,488
Employee stock awards   50,750 50,750 50,750     203,000 179,094 252,488
Stock grants   (50,750) (50,750) (50,750)          
Additional Paid-in Capital [Member] | Current Period Adjustment [Member]                  
Employee stock awards (restated)   643,923 180,985 307,652          
Employee stock awards   643,923 180,985 307,652          
Accumulated (Deficit) [Member]                  
Balance (63,931,464) (60,743,047) (52,294,441) (50,216,248) (50,216,248) (50,216,248) (50,216,248) (38,344,527) (61,543,056)
Dividends accumulated on preferred stock   (144,618) (136,093) (136,094)     (144,618) (144,618) (144,562)
Preferred stock dividend   (638,021) (646,545) (638,038)     (2,330,852) (2,322,346)  
Preferred stock dividends declared             (638,071) (638,071) (2,524,087)
Net income/(loss)   (2,405,778) (7,665,967) (1,304,062)     (16,593,609) (8,766,686) 25,867,178
Treasury shares purchased              
Balance (69,923,398) (63,931,464) (60,743,047) (52,294,441) (60,743,047) (63,931,464) (69,923,398) (50,216,248) (38,344,527)
Accumulated (Deficit) [Member] | As Previously Reported [Member]                  
Balance                 (41,819,539)
Treasury Stock, Common [Member]                  
Balance (2,673,156) (2,376,790) (1,978,163) (522,158) (522,158) (522,158) (522,158)
Dividends accumulated on preferred stock            
Preferred stock dividend              
Preferred stock dividends declared            
Net income/(loss)                
Treasury shares purchased             (2,150,998) (522,158)  
Treasury shares purchased   (296,366) (398,627) (1,456,005)          
Balance $ (2,673,156) $ (2,673,156) $ (2,376,790) $ (1,978,163) $ (2,376,790) $ (2,673,156) $ (2,673,156) $ (522,158)
Treasury Stock, Common [Member] | As Previously Reported [Member]                  
Balance                
v3.25.1
SCHEDULE OF QUARTERLY STATEMENTS OF CASH FLOWS (Details) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Sep. 30, 2023
Dec. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:                  
Net Income (Loss) $ (5,217,802) $ (2,405,778) $ (7,665,967) $ (1,304,062) $ (8,970,029) $ (11,375,807) $ (16,593,609) $ (8,766,686) $ 25,867,178
Adjustments to reconcile net loss to cash provided by operations:                  
Depreciation and amortization       4,631,908 9,317,208 14,082,679 18,861,181 17,567,233 17,409,294
Debt discount amortization       20,813 41,626 62,440 83,253 83,253 38,330
Employee stock awards       1,181,199 2,880,883 4,262,655 5,281,288 10,128,236 7,430,457
Common stock purchase options           380,045 430,457
Contingent consideration payable fair value       (21,024) (41,076) (60,298) (80,540) (63,764) (385,750)
Allowance for credit losses       909,717          
Allowance for doubtful accounts         1,047,587 1,117,565 419,527 191,299 2,748,250
(Gain)/loss on disposal of assets             259,540 (12,044)
Reduction in right of use asset       120,216 243,652 362,402 476,252 629,140 720,491
Deferred income taxes       (207,098) (2,088,883) (2,448,481) (3,811,735) 712,239 293,430
Accounts receivable       7,088,437 5,267,942 7,107,365 705,532 14,417,405 (20,707,052)
Inventories       (1,579,836) 1,330,614 4,842,087 8,781,485 4,671,333 (43,149,234)
Prepaid expenses       888,412 2,262,859 2,474,001 4,028,696 2,763,855 1,996,287
Deposits       2,964,365 3,839,429 4,763,015 6,679,669 4,306,375 (8,826,504)
Accounts payable       (1,722,783) 1,519,151 1,066,741 5,077,098 (8,694,813) 9,930,191
Accrued liabilities       153,531 1,758,754 2,071,142 2,532,695 (1,970,078) 2,374,686
Operating lease liability       (127,704) (258,628) (388,261) (499,448) (647,480) (732,468)
Net cash provided by operating activities       12,996,091 18,151,089 28,319,290 32,631,341 35,556,366 1,766,211
Cash flows from investing activities:                  
Purchase of property, plant, and equipment       (1,313,939) (2,618,205) (5,562,283) (8,024,765) (12,541,325) (19,218,982)
Net cash used in investing activities       (1,313,939) (2,618,205) (5,562,283) (8,021,015) (12,541,325) (69,677,022)
Cash flows from financing activities:                  
Payments on inventory facility, net             (825,675) (265,422)
Proceeds from factoring liability       14,610,314 26,047,370 37,252,869 37,252,869 71,348,761 121,488,045
Payments on factoring liability       (14,610,314) (26,047,370) (37,252,869) (37,252,869) (71,834,432) (122,844,562)
Payments on note payable - related party       (180,850) (180,850) (180,850) (180,850) (684,921) (625,147)
Payments on insurance premium note payment       (970,541) (2,017,089) (3,001,805) (3,174,834) (2,134,143) (2,208,369)
Proceeds from construction note payable             1,000,000
Payments on construction note payable       (64,959) (127,858) (181,639) (257,425) (150,743)
Preferred stock dividends paid       (638,038) (1,420,677) (2,194,792) (2,968,923) (2,960,416) (2,524,087)
Common stock repurchase plan       (1,456,744) (1,855,569) (2,152,080) (2,152,080) (522,426)
Net cash used in financing activities       (3,311,132) (5,602,043) (7,711,166) (8,657,912) (6,662,489) (27,149,185)
Net increase/(decrease) in cash       8,371,020 9,930,841 15,045,841 15,952,414 16,352,552 (95,059,996)
Cash, beginning of period 54,679,868 49,564,868 47,505,047 39,134,027 39,134,027 39,134,027 39,134,027 23,281,475 118,341,471
Restricted cash, beginning of period     500,000 500,000 500,000 500,000 500,000  
Cash and restricted cash, end of period 55,586,441 54,679,868 49,564,868 48,005,047 49,564,868 54,679,868 55,586,441 39,634,027 23,281,475
Restricted cash, end of period 0     500,000     0 500,000
Cash, end of period 55,586,441 54,679,868 49,564,868 47,505,047 49,564,868 54,679,868 55,586,441 39,134,027 23,281,475
As Previously Reported [Member]                  
Cash flows from operating activities:                  
Net Income (Loss) (5,332,881) (1,643,989) (7,495,297) (1,093,033) (8,588,330) (10,232,319) (15,565,200) (4,596,038) 33,247,436
Adjustments to reconcile net loss to cash provided by operations:                  
Depreciation and amortization       4,620,087 9,293,566 14,047,216 18,813,897 17,519,949 17,339,093
Debt discount amortization       20,813 41,626 62,440 83,253 83,253 38,330
Employee stock awards       873,547 2,392,246 3,130,095 4,285,108 5,986,873 6,011,488
Common stock purchase options           380,045 430,457    
Contingent consideration payable fair value       (21,024) (41,076) (60,298) (80,540) (63,764) (385,750)
Allowance for credit losses       909,717          
Allowance for doubtful accounts         1,047,587 1,117,565 419,527 191,299 2,748,250
(Gain)/loss on disposal of assets             259,540   (12,044)
Reduction in right of use asset       120,216 243,652 362,402 476,252 629,140 720,491
Deferred income taxes       (97,144) (1,960,265) (2,425,500) (3,796,680) 730,238 1,536,481
Accounts receivable       7,088,437 5,267,942 7,107,365 705,532 14,417,405 (20,707,052)
Inventories       (1,579,836) 1,330,614 4,842,087 8,781,485 4,671,333 (43,149,234)
Prepaid expenses       888,412 2,262,859 2,474,001 4,028,696 2,763,855 1,996,287
Deposits       2,964,365 3,839,429 4,763,015 6,679,669 4,306,375 (8,826,504)
Accounts payable       (1,722,783) 1,519,151 1,066,741 5,077,098 (8,694,813) 9,930,191
Accrued liabilities       152,021 1,760,716 2,072,696 2,532,695 (1,970,078) 2,374,686
Operating lease liability       (127,704) (258,628) (388,261) (499,448) (647,480) (732,468)
Net cash provided by operating activities       12,996,091 18,151,089 28,319,290 32,631,341 35,556,366 2,852,583
Cash flows from investing activities:                  
Purchase of property, plant, and equipment       (1,313,939) (2,618,205) (5,562,283) (8,024,765) (12,541,325) (19,218,982)
Net cash used in investing activities       (1,313,939) (2,618,205) (5,562,283) (8,021,015) (12,541,325) (69,677,022)
Cash flows from financing activities:                  
Payments on inventory facility, net               (825,675) (265,422)
Proceeds from factoring liability       14,610,314 26,047,370 37,252,869 37,252,869 71,348,761 121,488,045
Payments on factoring liability       (14,610,314) (26,047,370) (37,252,869) (37,252,869) (71,834,432) (122,844,562)
Payments on note payable - related party       (180,850) (180,850) (180,850) (180,850) (684,921) (625,147)
Payments on insurance premium note payment       (970,541) (2,017,089) (3,001,805) (3,174,834) (2,134,143) (2,208,369)
Proceeds from construction note payable               1,000,000  
Payments on construction note payable       (64,959) (127,858) (181,639) (257,425) (150,743)  
Preferred stock dividends paid       (638,038) (1,420,677) (2,194,792) (2,968,923) (2,960,416) (2,524,087)
Common stock repurchase plan       (1,456,744) (1,855,569) (2,152,080) (2,152,080) (522,426)  
Net cash used in financing activities       (3,311,132) (5,602,043) (7,711,166) (8,657,912) (6,662,489) (28,235,557)
Net increase/(decrease) in cash       8,371,020 9,930,841 15,045,841 15,952,414 16,352,552 (95,059,996)
Cash, beginning of period 54,679,868 49,564,868 47,505,047 39,134,027 39,134,027 39,134,027 39,134,027 23,281,475 118,341,471
Restricted cash, beginning of period     500,000 500,000 500,000 500,000 500,000    
Cash and restricted cash, end of period 55,586,441 54,679,868 49,564,868 48,005,047 49,564,868 54,679,868 55,586,441 39,634,027 23,281,475
Restricted cash, end of period       500,000       500,000  
Cash, end of period $ 55,586,441 $ 54,679,868 $ 49,564,868 47,505,047 49,564,868 54,679,868 $ 55,586,441 $ 39,134,027 $ 23,281,475
Restatement Adjustment on Stock-Based Compensation [Member]                  
Cash flows from operating activities:                  
Net Income (Loss)       (307,652) (488,637) (1,132,560)      
Adjustments to reconcile net loss to cash provided by operations:                  
Employee stock awards       307,652 488,637 1,132,560      
Restatement Adjustment Other [Member]                  
Cash flows from operating activities:                  
Net Income (Loss)       96,623 106,938 (10,928)      
Adjustments to reconcile net loss to cash provided by operations:                  
Depreciation and amortization       11,821 23,642 35,463      
Deferred income taxes       (109,954) (128,618) (22,981)      
Accrued liabilities       $ 1,510 $ (1,962) $ (1,554)      
v3.25.1
SUBSEQUENT EVENTS (Details Narrative) - USD ($)
Apr. 18, 2025
Apr. 08, 2025
Jan. 20, 2025
Sep. 19, 2024
Jun. 24, 2024
Apr. 30, 2021
Apr. 30, 2021
Aug. 08, 2024
Jul. 26, 2024
Jul. 12, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jul. 26, 2023
Jul. 17, 2023
Jun. 30, 2023
Mar. 31, 2023
Subsequent Event [Line Items]                                    
Letter of credit                             $ 1,600,000      
Certificate of deposit                               $ 1,600,000    
Treasury stock                       $ 2,673,156 $ 2,673,156 $ 2,376,790     $ 1,978,163 $ 522,158
Settlement Agreement [Member]                                    
Subsequent Event [Line Items]                                    
Escrow deposit               $ 8,000,000                    
Settlement amount         $ 8,000,000                          
Treasury stock                     $ 4,800,000              
Pledge and Escrow Agreement [Member]                                    
Subsequent Event [Line Items]                                    
Value of stock issued           $ 2,800,000                        
Number of common stock shares issued           2,857,143 4,000,000                      
Subsequent Event [Member] | Restated Revolving Line Promissory Note [Member] | Sunflower Bank, NA [Member] | Loan Amendment [Member]                                    
Subsequent Event [Line Items]                                    
Line of credit $ 5,000,000                                  
Line of credit available 100.00%                                  
Olin Winchester LLC [Member] | Subsequent Event [Member] | Asset Purchase Agreement [Member]                                    
Subsequent Event [Line Items]                                    
Gross purchase price     $ 75,000,000                              
Rob Wiley [Member] | Subsequent Event [Member] | Settlement Agreement [Member]                                    
Subsequent Event [Line Items]                                    
Shares issued       50,000                            
Rob Wiley [Member] | Subsequent Event [Member] | Separation Agreements [Member]                                    
Subsequent Event [Line Items]                                    
Seperation Compensation amount       $ 406,250                            
Fred W. Wagenhals [Member] | Subsequent Event [Member] | Separation Agreements [Member]                                    
Subsequent Event [Line Items]                                    
Seperation Compensation amount   $ 700,000                                
Lump sum payment amount equal to nine months annual base salary   300,000                                
Lump sum payment amount equal to twelve months annual base salary   $ 400,000                                
Northern Trust [Member] | Subsequent Event [Member]                                    
Subsequent Event [Line Items]                                    
Letter of credit                   $ 1,600,000                
Certificate of deposit                 $ 1,600,000                  
Debt instrument interest rate stated percentage                 5.00%                  
v3.25.1
SUBSEQUENT EVENTS - Schedule of Impairment of Assets (Details) - USD ($)
12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Subsequent Event [Line Items]        
Total Impairment   $ 0 $ 0 $ 0
Forecast [Member]        
Subsequent Event [Line Items]        
Inventory $ 17,129,874      
Property, plant and equipment 25,381,646      
Other assets 530,195      
Intangible assets 2,805,715      
Total Impairment $ 45,847,430